Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23424.Total Lipids in VLDL,AGRP,Agouti-related protein,40058,0.290274680599902,0.00455463027850481,0.281347605254032,0.299201755945771,0
NMR metabolomics,X23424.Total Lipids in VLDL,CCL27,C-C motif chemokine 27,39868,0.267803816737281,0.00556696586202758,0.256892563647707,0.278715069826855,0
NMR metabolomics,X23424.Total Lipids in VLDL,CCN1,CCN family member 1,39758,0.39264009421361,0.00657682242156146,0.37974952226735,0.405530666159871,0
NMR metabolomics,X23424.Total Lipids in VLDL,CES1,Liver carboxylesterase 1,39854,0.287892220333447,0.00724391743321583,0.273694142164344,0.30209029850255,0
NMR metabolomics,X23424.Total Lipids in VLDL,F7,Coagulation factor VII,39899,0.123404476270545,0.00268065527166315,0.118150391938086,0.128658560603005,0
NMR metabolomics,X23424.Total Lipids in VLDL,FURIN,Furin,39913,0.123642366272189,0.0030777178390078,0.117610039307733,0.129674693236644,0
NMR metabolomics,X23424.Total Lipids in VLDL,GCG,Pro-glucagon,39477,0.450641228603501,0.0111278151077528,0.428830710992305,0.472451746214696,0
NMR metabolomics,X23424.Total Lipids in VLDL,GHR,Growth hormone receptor,37124,0.103305101134124,0.00260039006238246,0.0982083366118544,0.108401865656394,0
NMR metabolomics,X23424.Total Lipids in VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,0.293973114962638,0.00687854457343749,0.2804911675987,0.307455062326575,0
NMR metabolomics,X23424.Total Lipids in VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,0.0879225552652863,0.0019472770732589,0.0841058922016989,0.0917392183288738,0
NMR metabolomics,X23424.Total Lipids in VLDL,LDLR,Low-density lipoprotein receptor,39882,0.432881945968995,0.00365912583600434,0.425710059330426,0.440053832607563,0
NMR metabolomics,X23424.Total Lipids in VLDL,LPL,Lipoprotein lipase,39868,-0.170529646770436,0.00429845783002212,-0.178954624117279,-0.162104669423592,0
NMR metabolomics,X23424.Total Lipids in VLDL,MFGE8,Lactadherin,39858,0.236404850677972,0.00373019015079231,0.229093677982419,0.243716023373524,0
NMR metabolomics,X23424.Total Lipids in VLDL,NPY,Pro-neuropeptide Y,40030,0.369433629583286,0.00560661237290437,0.358444669332393,0.380422589834178,0
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.152244400497938,0.00264343689295427,0.147063264187748,0.157425536808128,0
NMR metabolomics,X23424.Total Lipids in VLDL,PROC,Vitamin K-dependent protein C,39908,0.102174194245104,0.00231863839561896,0.097629662989691,0.106718725500517,0
NMR metabolomics,X23424.Total Lipids in VLDL,PTH,Parathyroid hormone,37039,0.297852046391911,0.0071663360405138,0.283806027752504,0.311898065031318,0
NMR metabolomics,X23424.Total Lipids in VLDL,RARRES2,Retinoic acid receptor responder protein 2,39949,0.188287056868619,0.00424507082879167,0.179966718044187,0.19660739569305,0
NMR metabolomics,X23424.Total Lipids in VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,40030,0.132384837021315,0.0029366178036318,0.126629066126197,0.138140607916434,0
NMR metabolomics,X23424.Total Lipids in VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,0.164098576688026,0.00383941837987113,0.156573316663478,0.171623836712573,0
NMR metabolomics,X23424.Total Lipids in VLDL,TFPI,Tissue factor pathway inhibitor,39843,0.117800615067959,0.00284783828146621,0.112218852036286,0.123382378099633,0
NMR metabolomics,X23424.Total Lipids in VLDL,CD4,T-cell surface glycoprotein CD4,39839,0.101978156771756,0.00263009521100213,0.0968231701581918,0.10713314338532,1.11253800615479e-308
NMR metabolomics,X23424.Total Lipids in VLDL,APCS,Serum amyloid P-component,37333,0.121617069717816,0.00315872803337036,0.11542596277241,0.127808176663222,8.88656262921189e-308
NMR metabolomics,X23424.Total Lipids in VLDL,CCL23,C-C motif chemokine 23,39931,0.140113647270264,0.00376236537972309,0.132739411126007,0.147487883414522,3.04469577661516e-291
NMR metabolomics,X23424.Total Lipids in VLDL,PRAP1,Proline-rich acidic protein 1,37437,0.136957614836614,0.00366508130607289,0.129774055476711,0.144141174196516,5.36235124974417e-291
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF9,Protein turtle homolog A,37437,0.275801313436561,0.00750914164500558,0.26108339581235,0.290519231060772,1.20447278453127e-281
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD1,Mothers against decapentaplegic homolog 1,39477,0.27518908184214,0.00756345482980781,0.260364710375717,0.290013453308563,2.72318804395048e-278
NMR metabolomics,X23424.Total Lipids in VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,0.0631820389413442,0.00176946123555641,0.0597138949196536,0.0666501829630347,1.03692239768325e-268
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB1,DnaJ homolog subfamily B member 1,39788,0.281880345512096,0.00796724949080713,0.266264536510114,0.297496154514078,5.13013891758063e-264
NMR metabolomics,X23424.Total Lipids in VLDL,GPR37,Prosaposin receptor GPR37,39585,0.208950819638749,0.00590565384010501,0.197375738112143,0.220525901165354,6.48615282259656e-264
NMR metabolomics,X23424.Total Lipids in VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,0.215737955502107,0.00610430872345582,0.203773510404134,0.227702400600081,1.78315678317814e-263
NMR metabolomics,X23424.Total Lipids in VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,0.273645439502327,0.00776439253270361,0.258427230138228,0.288863648866426,5.91971795309273e-262
NMR metabolomics,X23424.Total Lipids in VLDL,SLC39A5,Zinc transporter ZIP5,39866,0.170918791611434,0.0048517035233341,0.1614094527057,0.180428130517169,6.55345241486729e-262
NMR metabolomics,X23424.Total Lipids in VLDL,TTR,Transthyretin,37309,0.0811679198436828,0.00230239016529505,0.0766552351197045,0.0856806045676611,1.77011115757521e-260
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,39585,0.465359915165507,0.0132943224759948,0.439303043112558,0.491416787218457,1.44141586393753e-258
NMR metabolomics,X23424.Total Lipids in VLDL,INHBC,Inhibin beta C chain,39858,0.132333964641572,0.00381117121824542,0.124864069053811,0.139803860229333,9.25839328873943e-255
NMR metabolomics,X23424.Total Lipids in VLDL,NCS1,Neuronal calcium sensor 1,40030,0.0895661501791405,0.00258562993629402,0.0844983155040042,0.0946339848542768,1.07431614792398e-253
NMR metabolomics,X23424.Total Lipids in VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,0.107808938842138,0.00311709543411143,0.10169943179128,0.113918445892997,6.05747442578935e-253
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS15,Enteropeptidase,39788,0.28308691167482,0.00819006049125584,0.267034393111959,0.299139430237681,1.65129078017151e-252
NMR metabolomics,X23424.Total Lipids in VLDL,CPM,Carboxypeptidase M,39955,0.107063778964053,0.00317388409082454,0.100842966146037,0.113284591782069,4.37135278282759e-241
NMR metabolomics,X23424.Total Lipids in VLDL,BCHE,Cholinesterase,37208,0.0853888455459696,0.00252986582738982,0.0804303085242855,0.0903473825676536,1.01072565682627e-239
NMR metabolomics,X23424.Total Lipids in VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,0.244725331904095,0.0073173658692968,0.230383294800274,0.259067369007917,4.51623182759725e-237
NMR metabolomics,X23424.Total Lipids in VLDL,PAMR1,Inactive serine protease PAMR1,39858,0.0852862689222603,0.00255456206973151,0.0802793272655865,0.0902932105789341,2.6069739368975e-236
NMR metabolomics,X23424.Total Lipids in VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,0.325787138257069,0.00981916627338471,0.306541572361235,0.345032704152903,1.78800549167388e-233
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL6,C-X-C motif chemokine 6,40058,0.234680145921498,0.00707806940058988,0.220807129896342,0.248553161946654,2.71116628174998e-233
NMR metabolomics,X23424.Total Lipids in VLDL,NRP1,Neuropilin-1,39949,-0.0834051511030509,0.0025559831239885,-0.0884148780260683,-0.0783954241800334,3.25178125866592e-226
NMR metabolomics,X23424.Total Lipids in VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,0.0578000577971545,0.00177778993102383,0.0543155895323478,0.0612845260619612,2.21725717961208e-224
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA4,Kallistatin,37241,0.0697210980185417,0.00215309457935514,0.0655010326430056,0.0739411633940778,1.55686493811585e-221
NMR metabolomics,X23424.Total Lipids in VLDL,GSTA1,Glutathione S-transferase A1,39841,0.252951662086442,0.00783960138993488,0.23758604336217,0.268317280810715,2.48876469512116e-221
NMR metabolomics,X23424.Total Lipids in VLDL,CFP,Properdin,37453,0.068670505530812,0.00213142229059844,0.0644929178412391,0.072848093220385,1.58541460922949e-219
NMR metabolomics,X23424.Total Lipids in VLDL,DSG2,Desmoglein-2,39858,-0.0785668400192513,0.00246716542198541,-0.0834024842463427,-0.0737311957921599,7.94386406565023e-216
NMR metabolomics,X23424.Total Lipids in VLDL,CFI,Complement factor I,37453,0.0587149814055568,0.00183953164769974,0.0551094993760653,0.0623204634350483,1.21490201420193e-215
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA5,Plasma serine protease inhibitor,37283,0.0934496958737175,0.00293214895253624,0.0877026839267464,0.0991967078206885,6.23812490663646e-215
NMR metabolomics,X23424.Total Lipids in VLDL,CFH,Complement factor H,36763,0.0690401541835374,0.00216568483233009,0.0647954119121704,0.0732848964549044,9.8192148048003e-215
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF8,Immunoglobulin superfamily member 8,39868,0.0879743849173548,0.0027919584806781,0.0825021462952257,0.0934466235394839,1.72979839954329e-211
NMR metabolomics,X23424.Total Lipids in VLDL,PLAT,Tissue-type plasminogen activator,40002,0.144392057163022,0.00459089150222096,0.135393909818669,0.153390204507375,8.61648423021817e-211
NMR metabolomics,X23424.Total Lipids in VLDL,CRIP2,Cysteine-rich protein 2,39749,0.104049607492544,0.00332187986265306,0.0975387229617436,0.110560492023344,4.94522501704987e-209
NMR metabolomics,X23424.Total Lipids in VLDL,CHMP6,Charged multivesicular body protein 6,37437,0.163788050341604,0.00523100828213753,0.153535274108615,0.174040826574594,7.40629516187771e-208
NMR metabolomics,X23424.Total Lipids in VLDL,SERPIND1,Heparin cofactor 2,37424,0.0810780227371031,0.00259913447217932,0.0759837191716316,0.0861723263025746,2.270054108649e-206
NMR metabolomics,X23424.Total Lipids in VLDL,KYNU,Kynureninase,40058,0.130662331375818,0.00420884728140569,0.122412990704263,0.138911672047373,1.35248578703558e-205
NMR metabolomics,X23424.Total Lipids in VLDL,ACY1,Aminoacylase-1,39868,0.177129646311224,0.00571224432118645,0.165933647441698,0.188325645180749,4.53576382742447e-205
NMR metabolomics,X23424.Total Lipids in VLDL,GSTA3,Glutathione S-transferase A3,39477,0.219171094279333,0.00707503002010872,0.20530403543992,0.233038153118746,1.55278272222777e-204
NMR metabolomics,X23424.Total Lipids in VLDL,SNCA,Alpha-synuclein,37124,0.332305706377338,0.0107091564996628,0.311315759637999,0.353295653116677,3.82079703511358e-204
NMR metabolomics,X23424.Total Lipids in VLDL,ASGR1,Asialoglycoprotein receptor 1,39749,0.083287245218522,0.00269404018555553,0.0780069264548332,0.0885675639822108,7.68820571510974e-204
NMR metabolomics,X23424.Total Lipids in VLDL,ADIPOQ,Adiponectin,37453,-0.188883743841535,0.00610226568347855,-0.200844184581153,-0.176923303101917,2.41761085535391e-203
NMR metabolomics,X23424.Total Lipids in VLDL,PROS1,Vitamin K-dependent protein S,37453,0.0696839837501633,0.00226235170986565,0.0652497743988267,0.0741181931015,1.92123545854007e-201
NMR metabolomics,X23424.Total Lipids in VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,0.322437062027499,0.0105005405255077,0.301856002597504,0.343018121457494,3.08340627070916e-201
NMR metabolomics,X23424.Total Lipids in VLDL,RBP5,Retinol-binding protein 5,39788,0.15913598124824,0.00518272055004082,0.14897784897016,0.16929411352632,3.38588400687637e-201
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN3,Contactin-3,39858,0.0928855964908372,0.00302541212946539,0.086955788717085,0.0988154042645894,3.52159400562275e-201
NMR metabolomics,X23424.Total Lipids in VLDL,F9,Coagulation factor IX,39908,0.0516331892052933,0.00168357542286528,0.0483333813764773,0.0549329970341093,8.82052419380834e-201
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.167104179173275,0.00547041303621257,-0.177826188724252,-0.156382169622298,3.40794911400752e-199
NMR metabolomics,X23424.Total Lipids in VLDL,P4HB,Protein disulfide-isomerase,39776,0.109756329064553,0.00360516028018926,0.102690214915383,0.116822443213724,6.44529319612768e-198
NMR metabolomics,X23424.Total Lipids in VLDL,FLI1,Friend leukemia integration 1 transcription factor,39477,0.308056035732253,0.0102062055321456,0.288051872889248,0.328060198575258,1.45325332262051e-194
NMR metabolomics,X23424.Total Lipids in VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.089213568989368,0.00296442890128611,0.0834032883428473,0.0950238496358888,1.3013213164731e-193
NMR metabolomics,X23424.Total Lipids in VLDL,AFM,Afamin,37453,0.0529090274348037,0.00175495785784327,0.0494693100334309,0.0563487448361765,2.42736843113836e-193
NMR metabolomics,X23424.Total Lipids in VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,0.0697947821893723,0.00232614963084232,0.0652355289129213,0.0743540354658232,1.70166753197513e-192
NMR metabolomics,X23424.Total Lipids in VLDL,F10,Coagulation factor X,37445,0.0736087361874902,0.00245180458316919,0.0688031992044786,0.0784142731705018,8.59954194148755e-192
NMR metabolomics,X23424.Total Lipids in VLDL,GRP,Gastrin-releasing peptide,37043,0.14452871811145,0.00481524648623508,0.135090834998429,0.153966601224471,1.61231065966037e-191
NMR metabolomics,X23424.Total Lipids in VLDL,GUSB,Beta-glucuronidase,39919,0.162174483116817,0.00544616665052297,0.151499996481792,0.172848969751842,1.04668586059247e-189
NMR metabolomics,X23424.Total Lipids in VLDL,SOST,Sclerostin,39846,0.105182580451565,0.00354986163528588,0.0982248516464048,0.112140309256725,7.07869205812322e-188
NMR metabolomics,X23424.Total Lipids in VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,0.162446624763289,0.00549157744688849,0.151683132967388,0.173210116559191,3.65191354546765e-187
NMR metabolomics,X23424.Total Lipids in VLDL,AGR3,Anterior gradient protein 3,39464,0.161624315916845,0.00547228339393028,0.150898640464741,0.172349991368948,1.3370151824385e-186
NMR metabolomics,X23424.Total Lipids in VLDL,UPB1,Beta-ureidopropionase,37437,0.251653158690115,0.00852306110648664,0.234947958921402,0.268358358458829,9.26350973258731e-186
NMR metabolomics,X23424.Total Lipids in VLDL,ELN,Elastin,37437,0.0918174810863759,0.00310977277566269,0.085722326446077,0.0979126357266747,9.44129306194399e-186
NMR metabolomics,X23424.Total Lipids in VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,39948,0.0846803910569793,0.00288314722777059,0.079029422490549,0.0903313596234097,9.40596076523488e-185
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINF1,Pigment epithelium-derived factor,37254,0.069573505441733,0.00236798337664796,0.064932258023503,0.074214752859963,6.16781974730406e-184
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,40012,-0.168727816619616,0.00577104202709406,-0.18003905899272,-0.157416574246511,3.7499824030562e-183
NMR metabolomics,X23424.Total Lipids in VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,0.0574752718845293,0.00196873300460578,0.053616555195502,0.0613339885735566,1.24418944618142e-182
NMR metabolomics,X23424.Total Lipids in VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,0.141801616890409,0.00485951664850523,0.132276964259339,0.15132626952148,1.81919505771781e-182
NMR metabolomics,X23424.Total Lipids in VLDL,CDHR2,Cadherin-related family member 2,39788,0.194840441215488,0.00677881418149569,0.181553965419757,0.20812691701122,3.61784751918468e-177
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,39931,0.0737578356229968,0.00257249280071872,0.0687157497335881,0.0787999215124055,2.29363911893469e-176
NMR metabolomics,X23424.Total Lipids in VLDL,AMBP,Protein AMBP,40003,0.0514844706141667,0.00179671658448327,0.0479629061085795,0.0550060351197539,3.49012675264432e-176
NMR metabolomics,X23424.Total Lipids in VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,0.0801192088962214,0.00279829919651161,0.0746345424710586,0.0856038753213841,7.53203486096979e-176
NMR metabolomics,X23424.Total Lipids in VLDL,ATRN,"Attractin, Isoform 2",37453,0.0432098592423648,0.00151114098142441,0.0402480229187729,0.0461716955659566,1.11426321537021e-174
NMR metabolomics,X23424.Total Lipids in VLDL,SORT1,Sortilin,39846,0.0988057380395566,0.00346712876210083,0.092010165665839,0.105601310413274,2.75049721200333e-174
NMR metabolomics,X23424.Total Lipids in VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,37368,0.223133141820774,0.00783527299960496,0.207776006741548,0.238490276899999,2.73891646539641e-173
NMR metabolomics,X23424.Total Lipids in VLDL,KDR,Vascular endothelial growth factor receptor 2,39913,0.06743260984667,0.00237498829144167,0.0627776327954443,0.0720875868978957,4.55758507268049e-173
NMR metabolomics,X23424.Total Lipids in VLDL,SYAP1,Synapse-associated protein 1,37124,0.151408318381579,0.00533760815229237,0.140946606403086,0.161870030360072,6.74551265671484e-172
NMR metabolomics,X23424.Total Lipids in VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,0.194756996487305,0.00689355392182051,0.181245630800537,0.208268362174074,2.24748382575541e-171
NMR metabolomics,X23424.Total Lipids in VLDL,NOS3,"Nitric oxide synthase, endothelial",39489,0.133982558151994,0.00474768263862352,0.124677100180292,0.143288016123696,6.12005362736421e-171
NMR metabolomics,X23424.Total Lipids in VLDL,C9,Complement component C9,37445,-0.137993150693136,0.00492446085349646,-0.147645093965989,-0.128341207420283,5.02456197642968e-168
NMR metabolomics,X23424.Total Lipids in VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,0.175654093638677,0.00628972393028035,0.163326234735328,0.187981952542027,1.58632626582203e-167
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD2,Mothers against decapentaplegic homolog 2,37368,0.180080901295809,0.00643979877078934,0.167458895705062,0.192702906886556,2.49586824066045e-167
NMR metabolomics,X23424.Total Lipids in VLDL,LATS1,Serine/threonine-protein kinase LATS1,37056,0.223604923635675,0.00799830890897914,0.207928238174076,0.239281609097275,3.87335470673606e-167
NMR metabolomics,X23424.Total Lipids in VLDL,FGFR2,Fibroblast growth factor receptor 2,39913,0.055840406350296,0.00200810922969272,0.0519045122600983,0.0597763004404937,2.99234036647709e-166
NMR metabolomics,X23424.Total Lipids in VLDL,ENO3,Beta-enolase,37043,0.155912775506119,0.00560555180156923,0.144925893975043,0.166899657037195,1.67789280657515e-165
NMR metabolomics,X23424.Total Lipids in VLDL,STAB2,Stabilin-2,37437,0.0722770049146196,0.00260528088639256,0.0671706543772901,0.077383355451949,8.10742339903563e-165
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,40017,-0.315768093400615,0.0114451790972229,-0.338200644431172,-0.293335542370058,9.04504792669614e-164
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINF2,Alpha-2-antiplasmin,37224,0.0346549260938788,0.00125365864404002,0.0321977551515604,0.0371120970361973,1.2941812382655e-163
NMR metabolomics,X23424.Total Lipids in VLDL,HEG1,Protein HEG homolog 1,37124,0.0695367698702637,0.00251861190182675,0.0646002905426832,0.0744732491978441,3.38853539568322e-163
NMR metabolomics,X23424.Total Lipids in VLDL,CCL16,C-C motif chemokine 16,40052,0.133411287453798,0.00485758818470808,0.12389041461177,0.142932160295826,2.39383773706126e-162
NMR metabolomics,X23424.Total Lipids in VLDL,KLKB1,Plasma kallikrein,37187,0.0637606653082839,0.00232364191270207,0.0592063271593879,0.06831500345718,2.66268894536903e-161
NMR metabolomics,X23424.Total Lipids in VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,0.0550509358756025,0.00200936299765858,0.0511125844001917,0.0589892873510133,8.47787746560925e-161
NMR metabolomics,X23424.Total Lipids in VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,0.358273832757566,0.0131067627366457,0.33258457779374,0.383963087721391,3.52631650050924e-160
NMR metabolomics,X23424.Total Lipids in VLDL,GGT1,Glutathione hydrolase 1 proenzyme,39826,0.126282339348454,0.0046327759002767,0.117202098583912,0.135362580112996,5.91514944522321e-160
NMR metabolomics,X23424.Total Lipids in VLDL,CCL22,C-C motif chemokine 22,39686,0.127816660464677,0.00469506967248208,0.118614323906612,0.137018997022742,1.57713443429107e-159
NMR metabolomics,X23424.Total Lipids in VLDL,MME,Neprilysin,39788,0.198759917810444,0.00733089286677856,0.184391367791558,0.21312846782933,2.67818799584881e-158
NMR metabolomics,X23424.Total Lipids in VLDL,SNAPIN,SNARE-associated protein Snapin,37411,0.146444758879079,0.0053918845574819,0.135876665146414,0.157012852611744,3.17877068524461e-158
NMR metabolomics,X23424.Total Lipids in VLDL,LAT2,Linker for activation of T-cells family member 2,39788,0.314305573761032,0.0116008817865849,0.291567845459326,0.337043302062738,4.43011515795831e-158
NMR metabolomics,X23424.Total Lipids in VLDL,ADH1B,All-trans-retinol dehydrogenase,37124,0.191038908946068,0.00704935895467145,0.177222165394912,0.204855652497224,1.82564505001609e-157
NMR metabolomics,X23424.Total Lipids in VLDL,NUMB,Protein numb homolog,37056,0.213153648174836,0.007873627036487,0.197721339183322,0.228585957166351,3.9700455776581e-157
NMR metabolomics,X23424.Total Lipids in VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,0.116504853336716,0.00433458250475704,0.108009071627393,0.12500063504604,1.21485522601683e-155
NMR metabolomics,X23424.Total Lipids in VLDL,NPPC,C-type natriuretic peptide,39866,0.113869486882513,0.00426036076312861,0.10551917978678,0.122219793978245,5.2821698466947e-154
NMR metabolomics,X23424.Total Lipids in VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,40052,-0.084397158930742,0.00316915889232431,-0.0906087103596977,-0.0781856075017864,5.78120896849265e-153
NMR metabolomics,X23424.Total Lipids in VLDL,ERP44,Endoplasmic reticulum resident protein 44,39758,0.0645129904052114,0.00242486112333133,0.059760262603482,0.0692657182069408,1.28444776214303e-152
NMR metabolomics,X23424.Total Lipids in VLDL,FN1,Fibronectin,37453,0.0660431193850298,0.00248028479814532,0.061181761180665,0.0709044775893947,2.56126949905227e-152
NMR metabolomics,X23424.Total Lipids in VLDL,DTYMK,Thymidylate kinase,37437,0.170001219841867,0.0063930803478765,0.157470782360029,0.182531657323705,6.40550684028945e-152
NMR metabolomics,X23424.Total Lipids in VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,0.154383393599193,0.00582217315033418,0.142971934224538,0.165794852973848,1.39170164354784e-151
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL13,C-X-C motif chemokine 13,40009,0.145170252561542,0.00549081237901484,0.134408260298673,0.155932244824411,7.83217965883669e-151
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL17,C-X-C motif chemokine 17,40058,0.105174434091015,0.00400484520030822,0.0973249374984113,0.11302393068362,6.7467419270083e-149
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,0.0717684629892542,0.0027273715430342,0.0664228147649072,0.0771141112136012,6.92368993848329e-149
NMR metabolomics,X23424.Total Lipids in VLDL,EEF1D,Elongation factor 1-delta,37437,0.223711611880165,0.0085024592799222,0.207046791691517,0.240376432068812,7.41774257504297e-149
NMR metabolomics,X23424.Total Lipids in VLDL,NAA80,N-alpha-acetyltransferase 80,37039,0.295833989630584,0.0112487053353493,0.273786527173299,0.317881452087868,1.28657930914156e-148
NMR metabolomics,X23424.Total Lipids in VLDL,SCLY,Selenocysteine lyase,39984,0.120404402244938,0.00459219614356,0.11140369780356,0.129405106686316,2.03030531781692e-148
NMR metabolomics,X23424.Total Lipids in VLDL,YTHDF3,YTH domain-containing family protein 3,39587,0.208402262708431,0.0079585395217782,0.192803525245745,0.224001000171116,5.59699926466285e-148
NMR metabolomics,X23424.Total Lipids in VLDL,IL16,Pro-interleukin-16,40058,0.100593815965181,0.00384335821555016,0.0930608338627025,0.108126798067659,6.24955422525782e-148
NMR metabolomics,X23424.Total Lipids in VLDL,SKAP1,Src kinase-associated phosphoprotein 1,39713,0.175402377356926,0.00672558300718564,0.162220234662842,0.18858452005101,7.58244332676986e-147
NMR metabolomics,X23424.Total Lipids in VLDL,SNAP29,Synaptosomal-associated protein 29,39913,0.22210322894364,0.00852517859739389,0.205393878892748,0.238812578994532,1.37671045272195e-146
NMR metabolomics,X23424.Total Lipids in VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,0.0950372443971021,0.00365371957680165,0.0878759540265708,0.102198534767633,4.10207878276513e-146
NMR metabolomics,X23424.Total Lipids in VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,37437,0.15668361336559,0.00601609113018508,0.144892074750427,0.168475151980753,5.85439678417148e-146
NMR metabolomics,X23424.Total Lipids in VLDL,AP1G2,AP-1 complex subunit gamma-like 2,37368,0.193866994477873,0.0074524459591116,0.179260200398014,0.208473788557732,1.29079948247696e-145
NMR metabolomics,X23424.Total Lipids in VLDL,MLN,Promotilin,39866,0.215801449397959,0.00831408874329716,0.199505835461096,0.232097063334821,1.56585520174281e-145
NMR metabolomics,X23424.Total Lipids in VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,0.132207228582451,0.00509962141069292,0.122211970617493,0.142202486547409,3.84220042018451e-145
NMR metabolomics,X23424.Total Lipids in VLDL,PLTP,Phospholipid transfer protein,39976,-0.0868218401023757,0.0033547930892326,-0.0933972345572716,-0.0802464456474798,9.98069868876931e-145
NMR metabolomics,X23424.Total Lipids in VLDL,GLA,Alpha-galactosidase A,37088,0.0912557231178212,0.00352320597835813,0.0843502394002392,0.0981612068354031,2.47197410324408e-144
NMR metabolomics,X23424.Total Lipids in VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,0.0944856655793618,0.0036631984388821,0.0873057966391529,0.101665534519571,8.34931083278305e-144
NMR metabolomics,X23424.Total Lipids in VLDL,MYH9,Myosin-9,37437,0.267950943353365,0.0103920996617412,0.247582428016352,0.288319458690378,3.62839888022622e-143
NMR metabolomics,X23424.Total Lipids in VLDL,SORD,Sorbitol dehydrogenase,39963,0.164520595204701,0.00639896879627905,0.151978616363994,0.177062574045408,6.71765329540049e-143
NMR metabolomics,X23424.Total Lipids in VLDL,FAM20A,Pseudokinase FAM20A,37437,0.0677396928023911,0.00263417185926936,0.0625767159582231,0.072902669646559,1.94821647562998e-142
NMR metabolomics,X23424.Total Lipids in VLDL,MTSS1,Protein MTSS 1,37382,0.264663503676586,0.0102987822367765,0.244477890492504,0.284849116860667,3.06626244870012e-142
NMR metabolomics,X23424.Total Lipids in VLDL,DPY30,Protein dpy-30 homolog,39979,0.141734985240594,0.00553509881822211,0.130886191556879,0.152583778924309,8.67914890133545e-142
NMR metabolomics,X23424.Total Lipids in VLDL,NOMO1,Nodal modulator 1,39858,0.0567339013286375,0.00221700349152007,0.0523885744852581,0.0610792281720168,1.35812471710967e-141
NMR metabolomics,X23424.Total Lipids in VLDL,YES1,Tyrosine-protein kinase Yes,39788,0.272100140818593,0.0106490273968458,0.251228047120775,0.292972234516411,3.61965662845989e-141
NMR metabolomics,X23424.Total Lipids in VLDL,FCN2,Ficolin-2,39810,0.0962639889347652,0.0037848109653364,0.0888457594427059,0.103682218426825,6.38471867422901e-140
NMR metabolomics,X23424.Total Lipids in VLDL,F11R,Junctional adhesion molecule A,39858,0.134343379617401,0.00528844579665393,0.123978025855959,0.144708733378842,1.34142270641024e-139
NMR metabolomics,X23424.Total Lipids in VLDL,ABL1,Tyrosine-protein kinase ABL1,39788,0.162195671751718,0.00638818460080962,0.149674829934131,0.174716513569305,1.90522912863286e-139
NMR metabolomics,X23424.Total Lipids in VLDL,CCL17,C-C motif chemokine 17,39836,0.213965695344554,0.00843141433853707,0.197440123241021,0.230491267448086,2.55346045405658e-139
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,0.103227044785244,0.00407740745436658,0.0952353261746852,0.111218763395802,1.13492589323348e-138
NMR metabolomics,X23424.Total Lipids in VLDL,MXRA8,Matrix remodeling-associated protein 8,37124,-0.0711420766914944,0.00280731568983408,-0.0766444154435692,-0.0656397379394196,2.12030488317799e-138
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL2,Angiopoietin-related protein 2,39877,0.0930205888032483,0.00368167349446758,0.0858045087540918,0.100236668852405,3.79793830105756e-138
NMR metabolomics,X23424.Total Lipids in VLDL,KHK,Ketohexokinase,37043,0.152412625807978,0.00604098328477469,0.140572298569819,0.164252953046136,3.309486916435e-137
NMR metabolomics,X23424.Total Lipids in VLDL,CDHR5,Cadherin-related family member 5,39868,0.0909772515695876,0.00362585780556077,0.0838705702706885,0.0980839328684867,2.63335551599071e-136
NMR metabolomics,X23424.Total Lipids in VLDL,SHBG,Sex hormone-binding globulin,37445,-0.120817567051516,0.00481312753232021,-0.130251297014864,-0.111383837088169,5.83987361476844e-136
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD5,Mothers against decapentaplegic homolog 5,39788,0.0479503219197727,0.00191699810421623,0.0441930056355089,0.0517076382040365,1.78302519590598e-135
NMR metabolomics,X23424.Total Lipids in VLDL,CPB2,Carboxypeptidase B2,37424,0.0527875304313418,0.00210829522375538,0.0486552717927812,0.0569197890699023,2.71959009124564e-135
NMR metabolomics,X23424.Total Lipids in VLDL,ACE2,Angiotensin-converting enzyme 2,39585,0.11657408849429,0.00466860817620396,0.10742361646893,0.125724560519649,5.47496280409009e-135
NMR metabolomics,X23424.Total Lipids in VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0855878612574821,0.00342282098636408,0.0788791321242085,0.0922965903907557,6.0980279338295e-135
NMR metabolomics,X23424.Total Lipids in VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,0.0691633361491091,0.0027663224551104,0.0637413441370927,0.0745853281611254,6.59683805395329e-135
NMR metabolomics,X23424.Total Lipids in VLDL,DKK1,Dickkopf-related protein 1,40009,0.139298386408694,0.00558620740025338,0.128349419904197,0.15024735291319,1.05401304525131e-134
NMR metabolomics,X23424.Total Lipids in VLDL,IL18R1,Interleukin-18 receptor 1,40058,0.0754184621695564,0.00304399566871243,0.06945223065888,0.0813846936802327,4.8043510245662e-133
NMR metabolomics,X23424.Total Lipids in VLDL,FYB1,FYN-binding protein 1,39836,0.212281701024287,0.00858807119179624,0.195449081488367,0.229114320560208,2.0690941628011e-132
NMR metabolomics,X23424.Total Lipids in VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,0.0599053371554908,0.00242275098805339,0.0551567452189062,0.0646539290920755,4.69140983752645e-132
NMR metabolomics,X23424.Total Lipids in VLDL,NT5E,5'-nucleotidase,39913,0.127627156178256,0.00517459327740998,0.117484953354533,0.13776935900198,7.29608269991188e-132
NMR metabolomics,X23424.Total Lipids in VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,37368,0.120662740996654,0.00489125250947808,0.111075886078077,0.130249595915231,1.82365098161735e-131
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA3F,Semaphorin-3F,39868,0.0587180641038362,0.00238779439688552,0.0540379870859405,0.0633981411217318,4.22767779441637e-131
NMR metabolomics,X23424.Total Lipids in VLDL,CANT1,Soluble calcium-activated nucleotidase 1,39816,0.0456715966799577,0.00186349621761155,0.042019144093439,0.0493240492664763,3.03002105244116e-130
NMR metabolomics,X23424.Total Lipids in VLDL,DCXR,L-xylulose reductase,39913,0.12344053795137,0.00504322213012707,0.113555822576321,0.133325253326419,6.25553011658988e-130
NMR metabolomics,X23424.Total Lipids in VLDL,SARG,Specifically androgen-regulated gene protein,37390,0.250374734532606,0.0102375025163622,0.230309229600536,0.270440239464676,2.68952274491187e-129
NMR metabolomics,X23424.Total Lipids in VLDL,COL18A1,Collagen alpha-1(XVIII) chain,39893,0.0514824237532212,0.00211474273298673,0.0473375279965672,0.0556273195098752,1.41429048812595e-128
NMR metabolomics,X23424.Total Lipids in VLDL,GH1,Somatotropin,39846,-0.410534667711117,0.0168924396271262,-0.443643849380284,-0.37742548604195,3.82296133935453e-128
NMR metabolomics,X23424.Total Lipids in VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,0.0937309252927618,0.00385364759578101,0.0861777760050311,0.101284074580493,6.18939265069216e-128
NMR metabolomics,X23424.Total Lipids in VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,0.203204549163051,0.00838550224000281,0.186768964772646,0.219640133553457,2.05667800259162e-127
NMR metabolomics,X23424.Total Lipids in VLDL,FGF21,Fibroblast growth factor 21,40011,0.270292978008984,0.0111613329030583,0.24841676551899,0.292169190498979,2.71968300991955e-127
NMR metabolomics,X23424.Total Lipids in VLDL,CEP20,Centrosomal protein 20,39477,0.167069143722063,0.00691580194978496,0.153514171900484,0.180624115543641,1.29322712835444e-126
NMR metabolomics,X23424.Total Lipids in VLDL,MVK,Mevalonate kinase,39587,0.178830945363515,0.00740844581240786,0.164310391571195,0.193351499155834,1.93331220319827e-126
NMR metabolomics,X23424.Total Lipids in VLDL,HBEGF,Proheparin-binding EGF-like growth factor,39984,0.163451789905364,0.00678342540213405,0.150156276117181,0.176747303693547,4.64400305465742e-126
NMR metabolomics,X23424.Total Lipids in VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,0.0586069030646315,0.00242939610859791,0.0538452866917796,0.0633685194374834,7.32478954839606e-126
NMR metabolomics,X23424.Total Lipids in VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,0.0651249171598008,0.00271221086743928,0.0598089838596198,0.0704408504599818,3.2106752941823e-125
NMR metabolomics,X23424.Total Lipids in VLDL,AGRN,Agrin,39931,0.0733059875989217,0.00305530860832133,0.0673175827266119,0.0792943924712316,5.14920772958275e-125
NMR metabolomics,X23424.Total Lipids in VLDL,CKB,Creatine kinase B-type,37437,-0.13054523606934,0.00544294143487094,-0.141213401281687,-0.119877070856993,1.55115084190257e-124
NMR metabolomics,X23424.Total Lipids in VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,0.153285657789613,0.00639639682245985,0.140748720017592,0.165822595561635,2.94636850822064e-124
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,0.189908274933223,0.00793848874959369,0.17434883698402,0.205467712882427,7.64340498718282e-124
NMR metabolomics,X23424.Total Lipids in VLDL,FUOM,Fucose mutarotase,37124,0.142101010301473,0.00594105008234791,0.130456552140071,0.153745468462875,8.07765599777175e-124
NMR metabolomics,X23424.Total Lipids in VLDL,BTD,Biotinidase,37453,0.0459198662250808,0.00192099849982074,0.0421547091654321,0.0496850232847294,9.74637859353586e-124
NMR metabolomics,X23424.Total Lipids in VLDL,EHBP1,EH domain-binding protein 1,37437,0.167863419450689,0.00702352822366809,0.154097304132299,0.181629534769078,1.07590584712236e-123
NMR metabolomics,X23424.Total Lipids in VLDL,SELPLG,P-selectin glycoprotein ligand 1,39866,0.0620833992035579,0.00260458074837741,0.0569784209367382,0.0671883774703776,1.97272559227949e-123
NMR metabolomics,X23424.Total Lipids in VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,0.105781649865251,0.00443736416557778,0.0970844161007189,0.114478883629784,5.04131879344775e-123
NMR metabolomics,X23424.Total Lipids in VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,0.109117862858727,0.00458354130360504,0.100134121903661,0.118101603813793,1.05346300192417e-122
NMR metabolomics,X23424.Total Lipids in VLDL,LEP,Leptin,39868,0.150539453401349,0.00634757448711243,0.138098207406608,0.162980699396089,3.12973161833074e-122
NMR metabolomics,X23424.Total Lipids in VLDL,TJAP1,Tight junction-associated protein 1,39913,0.182643753648273,0.00778499683275942,0.167385159856064,0.197902347440481,1.04646109957036e-119
NMR metabolomics,X23424.Total Lipids in VLDL,MAPK9,Mitogen-activated protein kinase 9,39866,0.095410992419063,0.00406962203432874,0.0874345332317787,0.103387451606347,1.5360441651397e-119
NMR metabolomics,X23424.Total Lipids in VLDL,COL4A1,Collagen alpha-1(IV) chain,39868,-0.0857242262888029,0.00366171017341406,-0.0929011782286944,-0.0785472743489113,3.29825366533708e-119
NMR metabolomics,X23424.Total Lipids in VLDL,NPL,N-acetylneuraminate lyase,37437,0.0965490925808852,0.0041193789454447,0.0884751098478136,0.104623075313957,4.02202121574224e-119
NMR metabolomics,X23424.Total Lipids in VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,0.1130003395642,0.00483302109358578,0.103527618220772,0.122473060907628,7.27096404913464e-119
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,-0.0841238345718822,0.00360199616402107,-0.0911837470533635,-0.0770639220904009,1.15757965492703e-118
NMR metabolomics,X23424.Total Lipids in VLDL,F13B,Coagulation factor XIII B chain,37380,0.0556994587398784,0.00238836473608113,0.0510182638571594,0.0603806536225974,5.67800446743047e-118
NMR metabolomics,X23424.Total Lipids in VLDL,APOC1,Apolipoprotein C-I,37424,0.0817422141728077,0.0035070380749836,0.0748684195458399,0.0886160087997756,7.49593773399371e-118
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,0.178931498725817,0.00768115543223678,0.163876434078633,0.193986563373001,1.03028261857479e-117
NMR metabolomics,X23424.Total Lipids in VLDL,CD63,CD63 antigen,39720,0.111975079315917,0.00482758911444454,0.102513004651606,0.121437153980229,4.52438077187619e-117
NMR metabolomics,X23424.Total Lipids in VLDL,EZR,Ezrin,40009,0.0522456095776033,0.00225353075132027,0.0478286893050156,0.056662529850191,5.34890788499888e-117
NMR metabolomics,X23424.Total Lipids in VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,0.212290278319751,0.00915450120616071,0.194347455955676,0.230233100683826,1.06676026186299e-116
NMR metabolomics,X23424.Total Lipids in VLDL,PLIN1,Perilipin-1,39489,0.0749527694438391,0.00324579173102852,0.0685910176510232,0.081314521236655,4.80766106665702e-116
NMR metabolomics,X23424.Total Lipids in VLDL,PPY,Pancreatic prohormone,39826,0.216730487785215,0.00939014510047733,0.19832580338828,0.235135172182151,5.69153102527614e-116
NMR metabolomics,X23424.Total Lipids in VLDL,RTBDN,Retbindin,39788,0.0633493141254617,0.00274871394981618,0.057961834783822,0.0687367934671014,1.22264630400601e-115
NMR metabolomics,X23424.Total Lipids in VLDL,TARBP2,RISC-loading complex subunit TARBP2,39489,0.172009851487507,0.00746503676000285,0.157378379437901,0.186641323537112,1.47727285909441e-115
NMR metabolomics,X23424.Total Lipids in VLDL,CD300LG,CMRF35-like molecule 9,39858,-0.0791393114995201,0.00343640038924046,-0.0858746562624314,-0.0724039667366087,1.76157882177418e-115
NMR metabolomics,X23424.Total Lipids in VLDL,PON3,Serum paraoxonase/lactonase 3,39931,-0.0607259695258183,0.00264088477093901,-0.0659021036768587,-0.0555498353747778,3.7875854486086e-115
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC1B,C-type lectin domain family 1 member B,40009,0.207708195038288,0.00903585012089483,0.189997928801334,0.225418461275242,4.3810969288691e-115
NMR metabolomics,X23424.Total Lipids in VLDL,TXLNA,Alpha-taxilin,39749,0.192361095861968,0.00836734898621834,0.17596109184898,0.208761099874956,4.4481757384318e-115
NMR metabolomics,X23424.Total Lipids in VLDL,APOM,Apolipoprotein M,39908,0.0573416341243581,0.00249620681654721,0.0524490687639256,0.0622341994847907,6.36936762006252e-115
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.0558593840738458,0.002436244369446,0.0510843451097317,0.06063442303796,1.59751532740159e-114
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,0.0748482228477115,0.00326727860296288,0.0684443567859043,0.0812520889095187,2.58918106970104e-114
NMR metabolomics,X23424.Total Lipids in VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,0.123137768353189,0.00537466010874952,0.11260343454004,0.133672102166338,6.00643748216796e-114
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFC,Vascular endothelial growth factor C,39913,0.119211908620661,0.00521353221090831,0.10899338548728,0.129430431754041,6.6632340774328e-114
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL5,C-X-C motif chemokine 5,39805,0.243922255478273,0.010682995454323,0.2229835843878,0.264860926568746,1.42698026110754e-113
NMR metabolomics,X23424.Total Lipids in VLDL,SELP,P-selectin,39931,0.122686780030723,0.00538024658814378,0.112141496717961,0.133232063343485,2.65971418292237e-113
NMR metabolomics,X23424.Total Lipids in VLDL,THOP1,Thimet oligopeptidase,39798,0.0650523459038008,0.00285384004934897,0.0594588194070768,0.0706458724005248,3.32145791571348e-113
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE4,Ribonuclease 4,37051,0.0555735519460675,0.00243430168496704,0.0508023206435321,0.0603447832486029,3.60435666405398e-113
NMR metabolomics,X23424.Total Lipids in VLDL,NUCB2,Nucleobindin-2,39995,0.079957699262901,0.00351740148765454,0.0730635923470981,0.0868518061787039,1.26130158660536e-112
NMR metabolomics,X23424.Total Lipids in VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,0.240701277317284,0.0106151908877124,0.219895503177367,0.2615070514572,1.01690017408386e-111
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJA2,DnaJ homolog subfamily A member 2,40009,0.174609407577919,0.00772638121201989,0.15946570040236,0.189753114753478,2.34325217254142e-111
NMR metabolomics,X23424.Total Lipids in VLDL,DAB2,Disabled homolog 2,40030,0.236000845586712,0.0104683027610313,0.21548297217509,0.256518718998333,7.75077477165292e-111
NMR metabolomics,X23424.Total Lipids in VLDL,CCL5,C-C motif chemokine 5,39931,0.21323033226936,0.00947187347684142,0.194665460254751,0.231795204283969,1.61186234105883e-110
NMR metabolomics,X23424.Total Lipids in VLDL,MTSS2,Protein MTSS 2,37368,0.210386797426379,0.00935166886453288,0.192057526451895,0.228716068400864,4.59195715815022e-110
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA1,Ephrin type-A receptor 1,39904,0.0703750591044842,0.00313378729440432,0.0642328360074517,0.0765172822015167,5.40207058308853e-110
NMR metabolomics,X23424.Total Lipids in VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,0.20532940508736,0.0091616170100666,0.18737263574763,0.223286174427091,1.47928465838307e-109
NMR metabolomics,X23424.Total Lipids in VLDL,ARF6,ADP-ribosylation factor 6,37382,0.223943143147319,0.00997857007063511,0.204385145808874,0.243501140485764,1.50263549553248e-109
NMR metabolomics,X23424.Total Lipids in VLDL,CRHBP,Corticotropin-releasing factor-binding protein,39862,0.0589555754362324,0.00263150566704102,0.053797824328832,0.0641133265436328,1.73651618453104e-109
NMR metabolomics,X23424.Total Lipids in VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,0.206208695517777,0.0092055229919233,0.188165870453607,0.224251520581947,1.86006470818585e-109
NMR metabolomics,X23424.Total Lipids in VLDL,AP3S2,AP-3 complex subunit sigma-2,37388,0.0990494266540989,0.00441566463807513,0.0903947239634716,0.107704129344726,1.90481913040111e-109
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL10,C-X-C motif chemokine 10,39931,0.138551788580595,0.00618686663901654,0.126425529968123,0.150678047193067,2.08911605224257e-109
NMR metabolomics,X23424.Total Lipids in VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,0.228074411443495,0.0101812508774251,0.208119159723741,0.248029663163248,3.64454190628533e-109
NMR metabolomics,X23424.Total Lipids in VLDL,CCN2,CCN family member 2,39880,0.122382618641136,0.00548871066526091,0.111624745737224,0.133140491545047,1.75055893294992e-108
NMR metabolomics,X23424.Total Lipids in VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,39866,0.222349546580389,0.0099762392109229,0.20279611772698,0.241902975433798,2.14548878958526e-108
NMR metabolomics,X23424.Total Lipids in VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,0.114126883110056,0.00512006683458801,0.104091552114263,0.124162214105848,2.27584668204992e-108
NMR metabolomics,X23424.Total Lipids in VLDL,PLXNA4,Plexin-A4,39866,0.169272587954441,0.00762101264354283,0.154335403173097,0.184209772735785,1.12478936293946e-107
NMR metabolomics,X23424.Total Lipids in VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,39919,0.0691464860213382,0.00311471022541965,0.0630416539795157,0.0752513180631608,1.41902582848783e-107
NMR metabolomics,X23424.Total Lipids in VLDL,KRT18,"Keratin, type I cytoskeletal 18",39788,0.169470747633416,0.00763373012818214,0.154508636582179,0.184432858684653,1.45341436901697e-107
NMR metabolomics,X23424.Total Lipids in VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,0.147872375001642,0.00666160944719074,0.134815620485148,0.160929129518136,1.65245226897435e-107
NMR metabolomics,X23424.Total Lipids in VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,0.172253304744361,0.00775612904104428,0.157051291823915,0.187455317664808,2.53106035388165e-107
NMR metabolomics,X23424.Total Lipids in VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,0.139988516936387,0.00631256286373061,0.127615893723475,0.152361140149299,2.62743593093453e-107
NMR metabolomics,X23424.Total Lipids in VLDL,TCTN3,Tectonic-3,37437,0.0614102178526245,0.00276693160833449,0.0559870319002889,0.0668334038049601,3.11156140215562e-107
NMR metabolomics,X23424.Total Lipids in VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,0.111103918872001,0.00501863116637389,0.101267401785909,0.120940435958094,5.57386067705173e-107
NMR metabolomics,X23424.Total Lipids in VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,39866,0.0764054272320224,0.00345245430922012,0.069638616785951,0.0831722376780939,6.38270580681961e-107
NMR metabolomics,X23424.Total Lipids in VLDL,AXIN1,Axin-1,39866,0.197959747607638,0.00895795687965121,0.180402152123521,0.215517343091754,1.26999139309621e-106
NMR metabolomics,X23424.Total Lipids in VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,0.171906170407735,0.00779428296014509,0.156629375805851,0.187182965009619,3.51939126309431e-106
NMR metabolomics,X23424.Total Lipids in VLDL,NHLRC3,NHL repeat-containing protein 3,36838,0.0660667654701645,0.00299246483683727,0.0602015343899635,0.0719319965503655,4.58427232655433e-106
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA5,Integrin alpha-5,39858,0.0513082568177361,0.0023290176912079,0.0467433821429686,0.0558731314925035,5.56338860122146e-106
NMR metabolomics,X23424.Total Lipids in VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,0.0485832907642822,0.00220564520540995,0.0442602261616787,0.0529063553668857,5.95888128029408e-106
NMR metabolomics,X23424.Total Lipids in VLDL,CD6,T-cell differentiation antigen CD6,40040,0.108299922010432,0.0049223797481126,0.0986520577041309,0.117947786316732,9.83427945598821e-106
NMR metabolomics,X23424.Total Lipids in VLDL,MAMDC4,Apical endosomal glycoprotein,37368,0.115128185068257,0.00523177434048799,0.1048739073609,0.125382462775613,1.79711655149915e-105
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,37043,0.149702517562768,0.00682246965099198,0.136330477046823,0.163074558078712,7.59028580852306e-105
NMR metabolomics,X23424.Total Lipids in VLDL,KAZN,Kazrin,37382,0.214395433668887,0.00977923402132835,0.195228134987083,0.23356273235069,1.02284779061107e-104
NMR metabolomics,X23424.Total Lipids in VLDL,HJV,Hemojuvelin,37411,0.0911732032619329,0.004164320863334,0.0830111343697982,0.0993352721540675,1.90105781402154e-104
NMR metabolomics,X23424.Total Lipids in VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,0.0464213141809975,0.00212444415044645,0.0422574036461224,0.0505852247158725,2.68505917302653e-104
NMR metabolomics,X23424.Total Lipids in VLDL,PDLIM7,PDZ and LIM domain protein 7,39931,0.258432440595213,0.0118670597036931,0.235173003575974,0.281691877614452,1.19504751081821e-103
NMR metabolomics,X23424.Total Lipids in VLDL,TGFB1,Transforming growth factor beta-1 proprotein,40040,0.0784686681577742,0.00361507546834613,0.0713831202398158,0.0855542160757326,5.28862252787628e-103
NMR metabolomics,X23424.Total Lipids in VLDL,BECN1,Beclin-1,37043,0.123337754197078,0.00568179899369618,0.112201428169434,0.134474080224723,1.08391703092325e-102
NMR metabolomics,X23424.Total Lipids in VLDL,CTSO,Cathepsin O,40058,0.0608776366960912,0.00281203319303315,0.0553660516377462,0.0663892217544362,1.75453508166416e-102
NMR metabolomics,X23424.Total Lipids in VLDL,CEP85,Centrosomal protein of 85 kDa,39477,0.129943662364488,0.00600099244794329,0.11818171716652,0.141705607562457,1.79431644845232e-102
NMR metabolomics,X23424.Total Lipids in VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,0.185460337482906,0.00856924013253292,0.168664626823141,0.202256048142671,2.21612209626786e-102
NMR metabolomics,X23424.Total Lipids in VLDL,RAB11FIP3,Rab11 family-interacting protein 3,37437,0.219076695556735,0.0101109417020517,0.199259249820714,0.238894141292756,2.24440694768865e-102
NMR metabolomics,X23424.Total Lipids in VLDL,ATG16L1,Autophagy-related protein 16-1,37382,0.174552649062828,0.0080777441185991,0.158720270590374,0.190385027535282,7.72279495840115e-102
NMR metabolomics,X23424.Total Lipids in VLDL,BPIFB1,BPI fold-containing family B member 1,39786,-0.128350866497478,0.00595107864472476,-0.140014980641139,-0.116686752353817,1.02651009755385e-101
NMR metabolomics,X23424.Total Lipids in VLDL,RTN4R,Reticulon-4 receptor,40030,0.0671475306049531,0.00311416070505889,0.0610437756230377,0.0732512855868686,1.10034277809667e-101
NMR metabolomics,X23424.Total Lipids in VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,0.22127541847868,0.010255766572229,0.201174115997112,0.241376720960249,1.56294570104974e-101
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RN,Interleukin-1 receptor antagonist protein,39820,0.108271740634918,0.00503088000604964,0.0984112158230603,0.118132265446775,2.68896753309935e-101
NMR metabolomics,X23424.Total Lipids in VLDL,CD2AP,CD2-associated protein,39868,0.12766980918387,0.00595265571524605,0.116002603981988,0.139337014385752,1.25011513053126e-100
NMR metabolomics,X23424.Total Lipids in VLDL,CREG1,Protein CREG1,39660,0.0755635814096467,0.00353629464945779,0.0686324438967094,0.0824947189225839,6.84422110470498e-100
NMR metabolomics,X23424.Total Lipids in VLDL,ERBIN,Erbin,39788,0.205788056003684,0.00965600962955443,0.186862277129757,0.224713834877611,2.14155395045313e-99
NMR metabolomics,X23424.Total Lipids in VLDL,HGF,Hepatocyte growth factor,40058,0.0679868981737294,0.0031925183682292,0.0617295621720002,0.0742442341754587,2.84670436631127e-99
NMR metabolomics,X23424.Total Lipids in VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,0.208721124350561,0.00981155330259698,0.189490479877471,0.227951768823651,4.82570301293663e-99
NMR metabolomics,X23424.Total Lipids in VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,0.16904709262853,0.00794117333341244,0.153482392895041,0.184611792362018,6.14212981442536e-99
NMR metabolomics,X23424.Total Lipids in VLDL,DCTN1,Dynactin subunit 1,40030,0.129815250143165,0.00611336120133114,0.117833062188556,0.141797438097775,1.01403911428258e-98
NMR metabolomics,X23424.Total Lipids in VLDL,CTBS,Di-N-acetylchitobiase,37296,0.055150639192176,0.00259371220067137,0.0500669632788601,0.0602343151054918,1.04414800008533e-98
NMR metabolomics,X23424.Total Lipids in VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,0.14842486379456,0.00700345289023392,0.134698096129702,0.162151631459419,4.73788782471233e-98
NMR metabolomics,X23424.Total Lipids in VLDL,OTUD7B,OTU domain-containing protein 7B,37411,0.127701189168896,0.00602744187990937,0.115887403084273,0.139514975253518,4.89721081203124e-98
NMR metabolomics,X23424.Total Lipids in VLDL,FETUB,Fetuin-B,39908,0.0669230638636015,0.00316292452271753,0.0607237317990752,0.0731223959281279,4.99856674685512e-98
NMR metabolomics,X23424.Total Lipids in VLDL,MINK1,Misshapen-like kinase 1,37388,0.184864999951771,0.00873473170661379,0.167744925806808,0.201985074096734,7.7853885706038e-98
NMR metabolomics,X23424.Total Lipids in VLDL,CMIP,C-Maf-inducing protein,37368,0.164690039149522,0.00779492963198748,0.149411977070826,0.179968101228217,1.65544303649607e-97
NMR metabolomics,X23424.Total Lipids in VLDL,BCR,Breakpoint cluster region protein,39866,0.18218396076975,0.00864000232466161,0.165249556213413,0.199118365326086,2.24275624359884e-97
NMR metabolomics,X23424.Total Lipids in VLDL,TPD52L2,Tumor protein D54,37124,0.216490690287495,0.0102624717417211,0.196376245673722,0.236605134901268,3.43465283276391e-97
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,0.0530122061627946,0.00251909237860678,0.0480747851007253,0.0579496272248639,5.36799308084447e-97
NMR metabolomics,X23424.Total Lipids in VLDL,STC1,Stanniocalcin-1,40009,0.0829572787676328,0.00394303731249927,0.0752289256351342,0.0906856319001313,5.75692199795094e-97
NMR metabolomics,X23424.Total Lipids in VLDL,CTSD,Cathepsin D,38721,0.0776262316043372,0.00369163394158752,0.0703906290788257,0.0848618341298488,9.36015158560387e-97
NMR metabolomics,X23424.Total Lipids in VLDL,CES3,Carboxylesterase 3,39788,0.135954194150205,0.00647172505407919,0.12326961304421,0.148638775256201,1.14421540230767e-96
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS8,Prostasin,39805,0.0792381941877012,0.00377242941852071,0.0718442325274006,0.0866321558480018,1.20940559899203e-96
NMR metabolomics,X23424.Total Lipids in VLDL,PAK4,Serine/threonine-protein kinase PAK 4,39489,0.121475370946188,0.00578624148468519,0.110134337636205,0.132816404256171,1.59898131367231e-96
NMR metabolomics,X23424.Total Lipids in VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,0.140278811926609,0.00667952581123006,0.127186941336598,0.15337068251662,2.16013223336528e-96
NMR metabolomics,X23424.Total Lipids in VLDL,CCL13,C-C motif chemokine 13,40024,0.135552637736251,0.0064679451762134,0.122875465190873,0.14822981028163,3.03785411490843e-96
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFB,Platelet-derived growth factor subunit B,39931,0.168528301107491,0.00805869232947509,0.15273326414172,0.184323338073263,7.74385562121498e-96
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINH1,Serpin H1,37169,0.252299932510576,0.0120659938010251,0.228650584660566,0.275949280360585,1.48228255022542e-95
NMR metabolomics,X23424.Total Lipids in VLDL,FABP4,"Fatty acid-binding protein, adipocyte",40052,0.0952705971306305,0.00456571861771133,0.0863217886399163,0.104219405621345,1.9400964837116e-95
NMR metabolomics,X23424.Total Lipids in VLDL,TNIP1,TNFAIP3-interacting protein 1,37388,0.173177385956284,0.0082945014053049,0.156920163201886,0.189434608710681,2.65148306881301e-95
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFC,Platelet-derived growth factor C,39477,0.0571892908311051,0.00274287405414708,0.0518132576849768,0.0625653239772333,3.00472599770056e-95
NMR metabolomics,X23424.Total Lipids in VLDL,SNAP23,Synaptosomal-associated protein 23,39868,0.170470097483312,0.0081800738848087,0.154437152669087,0.186503042297537,3.46005370208572e-95
NMR metabolomics,X23424.Total Lipids in VLDL,SUGP1,SURP and G-patch domain-containing protein 1,37382,0.0787132453137725,0.00377542722195085,0.0713134079587488,0.0861130826687962,4.85128451556642e-95
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP4,Metalloproteinase inhibitor 4,39858,-0.0767369520665138,0.00369107930534984,-0.0839714675049994,-0.0695024366280281,9.53872894548079e-95
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,0.184762064788532,0.00890556412834784,0.16730715909697,0.202216970480094,2.25995270520771e-94
NMR metabolomics,X23424.Total Lipids in VLDL,PLSCR3,Phospholipid scramblase 3,37373,0.116161673448649,0.00559883900117167,0.105187949006352,0.127135397890945,3.768178600847e-94
NMR metabolomics,X23424.Total Lipids in VLDL,CST3,Cystatin-C,39897,0.0516978006947045,0.00249816732177286,0.0468013927440297,0.0565942086453793,6.5567049848925e-94
NMR metabolomics,X23424.Total Lipids in VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,39817,0.0633812125366135,0.00306331695373463,0.0573771113072937,0.0693853137659334,7.19397069830208e-94
NMR metabolomics,X23424.Total Lipids in VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,37043,0.20071778166906,0.00968752271846879,0.181730237140861,0.219705326197259,7.22671075846439e-94
NMR metabolomics,X23424.Total Lipids in VLDL,SLA2,Src-like-adapter 2,37411,0.20451975161901,0.0099101593104932,0.185095839370443,0.223943663867577,3.41377522267488e-93
NMR metabolomics,X23424.Total Lipids in VLDL,YOD1,Ubiquitin thioesterase OTU1,37021,0.118789411295342,0.0057726087518478,0.107475098141721,0.130103724448964,1.22965500314822e-92
NMR metabolomics,X23424.Total Lipids in VLDL,NCK2,Cytoplasmic protein NCK2,39931,0.205341871118368,0.00999546720415937,0.185750755398216,0.224932986838521,1.35739532130823e-92
NMR metabolomics,X23424.Total Lipids in VLDL,PAXX,Protein PAXX,37124,0.0889354204216739,0.00432386341391554,0.0804606481303994,0.0974101927129483,1.4524464884762e-92
NMR metabolomics,X23424.Total Lipids in VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,40003,0.115764037952062,0.0056445219721932,0.104700774886564,0.126827301017561,2.67358713872968e-92
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,0.200266554110062,0.00977280619028994,0.181111853977094,0.21942125424303,3.83420542832177e-92
NMR metabolomics,X23424.Total Lipids in VLDL,AAMDC,Mth938 domain-containing protein,37043,0.103146040913513,0.00502818243577952,0.0932908033393855,0.113001278487641,4.4327351561129e-92
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R9B,Neurabin-2,40058,0.18238618873532,0.00890959837822245,0.164923375914004,0.199849001556636,5.7086326343424e-92
NMR metabolomics,X23424.Total Lipids in VLDL,HMOX2,Heme oxygenase 2,39489,0.0910572229855201,0.00444868735700854,0.0823377957657834,0.0997766502052569,6.59337173342344e-92
NMR metabolomics,X23424.Total Lipids in VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,39477,0.0949720828132109,0.00464008688172126,0.0858775125250372,0.104066653101385,6.68645742201434e-92
NMR metabolomics,X23424.Total Lipids in VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,0.144138787694005,0.00704536636708037,0.130329869614527,0.157947705773482,1.32940948799854e-91
NMR metabolomics,X23424.Total Lipids in VLDL,CDH2,Cadherin-2,39868,0.0674530572514473,0.0033017351376528,0.0609816563816478,0.0739244581212468,1.34067052137052e-91
NMR metabolomics,X23424.Total Lipids in VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,0.135365139611628,0.0066257129985689,0.122378742134433,0.148351537088823,1.3860401825944e-91
NMR metabolomics,X23424.Total Lipids in VLDL,FABP5,Fatty acid-binding protein 5,39972,0.130894896813416,0.00641986364856711,0.118311964062224,0.143477829564607,2.95776561263786e-91
NMR metabolomics,X23424.Total Lipids in VLDL,STAT5B,Signal transducer and activator of transcription 5B,39788,0.263946189249841,0.0129509877345526,0.238562253290118,0.289330125209565,3.62147801931288e-91
NMR metabolomics,X23424.Total Lipids in VLDL,NFX1,Transcriptional repressor NF-X1,37021,0.129282254937251,0.0063373240369481,0.116861099824832,0.141703410049669,4.24823829744622e-91
NMR metabolomics,X23424.Total Lipids in VLDL,PHACTR2,Phosphatase and actin regulator 2,37411,0.219802795127619,0.0107786922285483,0.198676558359665,0.240929031895574,4.52536335625151e-91
NMR metabolomics,X23424.Total Lipids in VLDL,DOK2,Docking protein 2,39868,0.23512122905088,0.0115450484554253,0.212492934078246,0.257749524023514,4.80286004717088e-91
NMR metabolomics,X23424.Total Lipids in VLDL,S100A4,Protein S100-A4,39913,0.108779257951769,0.00535164617619893,0.0982900314464195,0.119268484457119,1.04006995345701e-90
NMR metabolomics,X23424.Total Lipids in VLDL,SRPK2,SRSF protein kinase 2,39866,0.160771713434402,0.00791161396098949,0.145264950070863,0.176278476797941,1.16527579732726e-90
NMR metabolomics,X23424.Total Lipids in VLDL,HAO1,Hydroxyacid oxidase 1,40030,0.245611267116884,0.0121381486209557,0.221820495819811,0.269402038413957,6.28271545794307e-90
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4B,Eukaryotic translation initiation factor 4B,39749,0.110344889620121,0.00546511613320625,0.099633261999037,0.121056517241205,1.5632018829863e-89
NMR metabolomics,X23424.Total Lipids in VLDL,USO1,General vesicular transport factor p115,39788,0.170475627695689,0.00844583439764732,0.153921792276301,0.187029463115078,1.75521538931345e-89
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD5,Programmed cell death protein 5,40009,0.110174626837931,0.00545939197815932,0.0994742185607389,0.120875035115123,1.82856845637371e-89
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,0.189079257325084,0.00937543753276728,0.17070339976086,0.207455114889308,2.35638532305868e-89
NMR metabolomics,X23424.Total Lipids in VLDL,PLXNB3,Plexin-B3,39812,0.0901751679791647,0.00448510282324407,0.0813843664456063,0.098965969512723,8.30161238860896e-89
NMR metabolomics,X23424.Total Lipids in VLDL,GFRA1,GDNF family receptor alpha-1,40011,0.0508692157680019,0.00253216936764396,0.0459061638074197,0.055832267728584,1.10915413712615e-88
NMR metabolomics,X23424.Total Lipids in VLDL,GOLM2,Protein GOLM2,40009,0.0418641282362142,0.00208476676753768,0.0377779853718403,0.045950271100588,1.30389042821295e-88
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINE1,Plasminogen activator inhibitor 1,40052,0.127922107256594,0.00637166035953152,0.115433652951912,0.140410561561276,1.40777985578202e-88
NMR metabolomics,X23424.Total Lipids in VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,0.120653667867876,0.00602223739368943,0.108850082576244,0.132457253159507,5.11063831289605e-88
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL3,Angiopoietin-related protein 3,39892,0.0663248304545266,0.00331628653161635,0.0598249088525585,0.0728247520564946,6.52321507783664e-88
NMR metabolomics,X23424.Total Lipids in VLDL,LAT,Linker for activation of T-cells family member 1,40058,0.142761084882526,0.0071408528739192,0.128765013249645,0.156757156515408,7.3781891146391e-88
NMR metabolomics,X23424.Total Lipids in VLDL,PYY,Peptide YY,37021,0.174131987313173,0.00869933731501384,0.157081286175746,0.1911826884506,7.94471104943914e-88
NMR metabolomics,X23424.Total Lipids in VLDL,BACH1,Transcription regulator protein BACH1,39866,0.139359368677442,0.00697802639889296,0.125682436935612,0.153036300419272,1.14444749210463e-87
NMR metabolomics,X23424.Total Lipids in VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,0.0827485793640799,0.00414612154018294,0.0746221811453214,0.0908749775828385,1.49572783454871e-87
NMR metabolomics,X23424.Total Lipids in VLDL,FOXO1,Forkhead box protein O1,39866,0.161391343360239,0.00809319432787343,0.145528682477607,0.177254004242871,2.03796725144246e-87
NMR metabolomics,X23424.Total Lipids in VLDL,MMP10,Stromelysin-2,39857,-0.110168670228236,0.00552679495830797,-0.12100118834652,-0.0993361521099523,2.38798078391011e-87
NMR metabolomics,X23424.Total Lipids in VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,39788,0.158609116641787,0.00795745626637531,0.143012502359691,0.174205730923882,2.48051575203337e-87
NMR metabolomics,X23424.Total Lipids in VLDL,LSP1,Lymphocyte-specific protein 1,39866,0.0758017657782849,0.00380547455892372,0.0683430356427944,0.0832604959137754,3.15869176549771e-87
NMR metabolomics,X23424.Total Lipids in VLDL,SEC31A,Protein transport protein Sec31A,37043,0.144506991307737,0.00725208243863072,0.130292909728021,0.158721072887453,4.58218207465752e-87
NMR metabolomics,X23424.Total Lipids in VLDL,CD99L2,CD99 antigen-like protein 2,39858,0.0450969403121447,0.00226927977322377,0.0406491519566261,0.0495447286676633,7.79342535027603e-87
NMR metabolomics,X23424.Total Lipids in VLDL,PCBP2,Poly(rC)-binding protein 2,37411,0.135707071273527,0.00682782778273622,0.122324528819364,0.14908961372769,1.1316943882471e-86
NMR metabolomics,X23424.Total Lipids in VLDL,IKBKG,NF-kappa-B essential modulator,39866,0.171994487564191,0.00867406187799283,0.154993326283325,0.188995648845057,1.83675978086707e-86
NMR metabolomics,X23424.Total Lipids in VLDL,CLUL1,Clusterin-like protein 1,39840,-0.0843357325077103,0.00425618487005683,-0.0926778548530216,-0.0759936101623989,2.40647662842044e-86
NMR metabolomics,X23424.Total Lipids in VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,0.100084523752669,0.00504655286722999,0.0901932801328986,0.10997576737244,2.75100615060545e-86
NMR metabolomics,X23424.Total Lipids in VLDL,SDC4,Syndecan-4,39868,0.0845117210960494,0.00427245323286176,0.0761377127596403,0.0928857294324584,4.65417965495885e-86
NMR metabolomics,X23424.Total Lipids in VLDL,IL1R2,Interleukin-1 receptor type 2,39830,0.0365024322351797,0.00184684305245265,0.0328826198523725,0.0401222446179869,6.35795865834916e-86
NMR metabolomics,X23424.Total Lipids in VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,39477,0.120657113239512,0.00610561653717777,0.108690104826643,0.13262412165238,7.11650638320559e-86
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,0.201655360489397,0.0101972157478229,0.181668817623664,0.22164190335513,7.86288570957562e-86
NMR metabolomics,X23424.Total Lipids in VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,0.142103156058617,0.007188025748934,0.128014625590707,0.156191686526528,8.74667739372812e-86
NMR metabolomics,X23424.Total Lipids in VLDL,THPO,Thrombopoietin,39585,0.0709248858752985,0.00359315916591226,0.0638822939101104,0.0779674778404865,1.08754798858509e-85
NMR metabolomics,X23424.Total Lipids in VLDL,ISM1,Isthmin-1,39866,0.073999106737907,0.00375395514081362,0.0666413546619123,0.0813568588139017,1.74281318155338e-85
NMR metabolomics,X23424.Total Lipids in VLDL,CSNK2A1,Casein kinase II subunit alpha,37411,-0.0834747743754287,0.00423063700782966,-0.0917668229107748,-0.0751827258400826,1.84148232318925e-85
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,0.051928669635683,0.00263783178904832,0.0467585193291483,0.0570988199422177,2.9200614985081e-85
NMR metabolomics,X23424.Total Lipids in VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,39866,0.209674466806472,0.0106610851648566,0.188778739883353,0.230570193729591,4.15131036272668e-85
NMR metabolomics,X23424.Total Lipids in VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,0.143540332924707,0.00729508451506162,0.129241967275186,0.157838698574228,5.26567084801315e-85
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,0.168088923017233,0.00854646381652907,0.151337853936836,0.18483999209763,6.24407913054764e-85
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFA,Vascular endothelial growth factor A,39993,0.105448179676455,0.00536781979001888,0.0949272528880177,0.115969106464892,6.31939255204611e-85
NMR metabolomics,X23424.Total Lipids in VLDL,TANK,TRAF family member-associated NF-kappa-B activator,39587,0.13099677065769,0.00667273520213947,0.117918209661496,0.144075331653883,8.5747197946849e-85
NMR metabolomics,X23424.Total Lipids in VLDL,CES2,Cocaine esterase,39788,0.0999164245811294,0.00509846451849467,0.0899234341248799,0.109909415037379,1.60902766247868e-84
NMR metabolomics,X23424.Total Lipids in VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,0.179204853193795,0.00914420957117069,0.1612822024343,0.197127503953289,1.64779261360025e-84
NMR metabolomics,X23424.Total Lipids in VLDL,CIRBP,Cold-inducible RNA-binding protein,37382,0.17810042227819,0.00908350187466508,0.160296758603846,0.195904085952533,1.99555834538904e-84
NMR metabolomics,X23424.Total Lipids in VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,0.17454182166751,0.00891395081876385,0.157070478062733,0.192013165272287,2.22477937769876e-84
NMR metabolomics,X23424.Total Lipids in VLDL,CMC1,COX assembly mitochondrial protein homolog,37437,0.166611132131076,0.00853629659656625,0.149879990801806,0.183342273460346,1.07945535430844e-83
NMR metabolomics,X23424.Total Lipids in VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,0.167002168175665,0.00856686192487394,0.150211118802912,0.183793217548418,1.72177765322732e-83
NMR metabolomics,X23424.Total Lipids in VLDL,DAG1,Dystroglycan,39931,0.0890161862221794,0.00457347739750538,0.0800521705230689,0.09798020192129,2.03808389745404e-83
NMR metabolomics,X23424.Total Lipids in VLDL,STK11,Serine/threonine-protein kinase STK11,39585,0.134303189836768,0.00691169748880287,0.120756262758715,0.147850116914822,3.95299101446687e-83
NMR metabolomics,X23424.Total Lipids in VLDL,PENK,Proenkephalin-A,37124,0.0533808459311397,0.00274501126736067,0.0480006238471128,0.0587610680151666,4.45813325830733e-83
NMR metabolomics,X23424.Total Lipids in VLDL,ANG,Angiogenin,39843,0.0617108784246795,0.00318224721311894,0.0554736738869664,0.0679480829623926,8.01623500154613e-83
NMR metabolomics,X23424.Total Lipids in VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,37368,0.2089834296469,0.0107856646665401,0.187843526900482,0.230123332393319,1.61455604538929e-82
NMR metabolomics,X23424.Total Lipids in VLDL,FKBPL,FK506-binding protein-like,37382,0.108630156090436,0.00561226825320277,0.0976301103141582,0.119630201866713,2.35855774968657e-82
NMR metabolomics,X23424.Total Lipids in VLDL,CRELD1,Protein disulfide isomerase CRELD1,37124,0.0678585957899716,0.00350717183169407,0.0609845389998512,0.074732652580092,2.84340261915809e-82
NMR metabolomics,X23424.Total Lipids in VLDL,F2,Prothrombin,37453,0.0267668163084896,0.00138383241644117,0.0240545047722649,0.0294791278447143,2.99285011037831e-82
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINC1,Antithrombin-III,37424,0.0265342066017967,0.00137189643655977,0.0238452895861396,0.0292231236174539,3.0816576203505e-82
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL3,C-X-C motif chemokine 3,39859,0.172394129353862,0.00892967464217883,0.154891967055192,0.189896291652533,4.12072274166754e-82
NMR metabolomics,X23424.Total Lipids in VLDL,PSIP1,PC4 and SFRS1-interacting protein,39866,0.114798220095978,0.00595415604779701,0.103128074242296,0.126468365949661,6.65520256768134e-82
NMR metabolomics,X23424.Total Lipids in VLDL,CDC27,Cell division cycle protein 27 homolog,39477,0.111329819116167,0.00577960370051635,0.100001795863155,0.122657842369179,9.81651660803159e-82
NMR metabolomics,X23424.Total Lipids in VLDL,HCLS1,Hematopoietic lineage cell-specific protein,40058,0.101492964424021,0.00527919030303443,0.0911457514300732,0.111840177417968,1.84150553599903e-81
NMR metabolomics,X23424.Total Lipids in VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,0.0921886873594307,0.00479265477245044,0.0827950840054279,0.101582290713434,2.44790287188834e-81
NMR metabolomics,X23424.Total Lipids in VLDL,CRELD2,Protein disulfide isomerase CRELD2,39908,0.0939604094651243,0.00490509259258528,0.0843464279836571,0.103574390946591,6.92784549144185e-81
NMR metabolomics,X23424.Total Lipids in VLDL,BID,BH3-interacting domain death agonist,39866,0.11934933893378,0.00623099073887281,0.107136597085589,0.13156208078197,7.16867135434453e-81
NMR metabolomics,X23424.Total Lipids in VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,0.202235214933563,0.0105599202629487,0.181537771218183,0.222932658648942,7.72747595817296e-81
NMR metabolomics,X23424.Total Lipids in VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,0.125428242696784,0.00654300731991865,0.112603948349743,0.138252537043824,7.77844872700745e-81
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.0519923476941516,0.00271790920337959,0.0466652456555276,0.0573194497327756,1.11047723832677e-80
NMR metabolomics,X23424.Total Lipids in VLDL,CEP43,Centrosomal protein 43,39476,0.126216358488885,0.00659734427427201,0.113285563711312,0.139147153266458,1.1563137221595e-80
NMR metabolomics,X23424.Total Lipids in VLDL,MUC13,Mucin-13,39489,0.0913187538467217,0.00477346077833563,0.0819627707211838,0.10067473697226,1.17340867419283e-80
NMR metabolomics,X23424.Total Lipids in VLDL,ASAH2,Neutral ceramidase,39749,0.0943519526115179,0.00493839027340799,0.0846727076756382,0.104031197547398,1.80149193847398e-80
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB6,DnaJ homolog subfamily B member 6,37013,0.154271329802204,0.00806595188738982,0.13846206410292,0.170080595501488,1.88085428072359e-80
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS1,Galectin-1,39868,0.0603164438327224,0.00315950262536897,0.0541238186869992,0.0665090689784456,2.36395445982776e-80
NMR metabolomics,X23424.Total Lipids in VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,0.0480020927143862,0.00251504232773495,0.0430726097520257,0.0529315756767467,2.56562110852259e-80
NMR metabolomics,X23424.Total Lipids in VLDL,HEXIM1,Protein HEXIM1,39866,0.146702826980404,0.007692078618047,0.131626352889032,0.161779301071776,3.34560313510754e-80
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,0.0751011667907742,0.00394338220591479,0.0673721376671812,0.0828301959143672,5.74963420341888e-80
NMR metabolomics,X23424.Total Lipids in VLDL,LBR,Delta(14)-sterol reductase LBR,40009,0.119718353809514,0.00629703203352648,0.107376171023802,0.132060536595226,1.00895624911855e-79
NMR metabolomics,X23424.Total Lipids in VLDL,LEFTY2,Left-right determination factor 2,40011,0.0955885448373873,0.00502980630167586,0.0857301244861026,0.105446965188672,1.15903525381667e-79
NMR metabolomics,X23424.Total Lipids in VLDL,NIT2,Omega-amidase NIT2,37377,0.134860613484037,0.00710737741770556,0.120930153745334,0.14879107322274,2.94809534795315e-79
NMR metabolomics,X23424.Total Lipids in VLDL,AKT1S1,Proline-rich AKT1 substrate 1,39489,0.120276111357189,0.00634633213412882,0.107837300374297,0.132714922340081,3.27802530412546e-79
NMR metabolomics,X23424.Total Lipids in VLDL,VNN1,Pantetheinase,37445,0.129406552393258,0.00683029622566182,0.11601917179096,0.142793932995555,4.96509361323932e-79
NMR metabolomics,X23424.Total Lipids in VLDL,AP3B1,AP-3 complex subunit beta-1,37382,0.137099154217042,0.00723702728008484,0.122914580748076,0.151283727686009,5.19240717565284e-79
NMR metabolomics,X23424.Total Lipids in VLDL,PGF,Placenta growth factor,40058,0.0458646368701892,0.0024243279326616,0.0411129541221725,0.050616319618206,5.69807548180856e-79
NMR metabolomics,X23424.Total Lipids in VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,0.18285599025813,0.00965818250938289,0.163925952539739,0.20178602797652,6.40822360559045e-79
NMR metabolomics,X23424.Total Lipids in VLDL,GPC5,Glypican-5,39749,0.0996975757707245,0.00527302527378518,0.0893624462341056,0.110032705307343,7.30949279061638e-79
NMR metabolomics,X23424.Total Lipids in VLDL,MASP1,Mannan-binding lectin serine protease 1,39713,0.0419313833698407,0.00222077930107349,0.0375786559397366,0.0462841107999447,1.18227379674892e-78
NMR metabolomics,X23424.Total Lipids in VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,0.0545511367190983,0.00288939549947831,0.0488879215401208,0.0602143518980758,1.70324239760889e-78
NMR metabolomics,X23424.Total Lipids in VLDL,HYOU1,Hypoxia up-regulated protein 1,40052,0.0381780680259197,0.00202550001979873,0.0342080879871142,0.0421480480647252,2.07758798390458e-78
NMR metabolomics,X23424.Total Lipids in VLDL,KRT5,"Keratin, type II cytoskeletal 5",39489,0.0897203848325425,0.00476177800419433,0.0803872999443216,0.0990534697207634,2.52897864488703e-78
NMR metabolomics,X23424.Total Lipids in VLDL,CD36,Platelet glycoprotein 4,37056,0.0813022173200003,0.00431324791691982,0.0728482514028375,0.0897561832371632,3.15522939971905e-78
NMR metabolomics,X23424.Total Lipids in VLDL,TOP2B,DNA topoisomerase 2-beta,37056,0.141461419063582,0.00750723370616205,0.126747240999504,0.156175597127659,3.52819515546908e-78
NMR metabolomics,X23424.Total Lipids in VLDL,SIAE,Sialate O-acetylesterase,39875,0.0835965825891935,0.0044508944353581,0.0748728294958916,0.0923203356824954,7.27362923348657e-78
NMR metabolomics,X23424.Total Lipids in VLDL,AHSG,Alpha-2-HS-glycoprotein,37445,0.0471999094561345,0.0025134580302379,0.0422735317168682,0.0521262871954008,1.0802156663258e-77
NMR metabolomics,X23424.Total Lipids in VLDL,DNMBP,Dynamin-binding protein,39749,0.109737424390138,0.00584942981381665,0.0982725419550572,0.121202306825219,1.09933215952342e-77
NMR metabolomics,X23424.Total Lipids in VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,0.135435984743749,0.00723640069007116,0.121252639391209,0.149619330096288,2.47671952505255e-77
NMR metabolomics,X23424.Total Lipids in VLDL,MPHOSPH8,M-phase phosphoprotein 8,39585,0.133954515710609,0.00716431484568534,0.119912458613065,0.147996572808152,3.56137288711978e-77
NMR metabolomics,X23424.Total Lipids in VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,0.123414489438236,0.00660006340574592,0.110478365162974,0.136350613713498,4.98906571615931e-77
NMR metabolomics,X23424.Total Lipids in VLDL,SYTL4,Synaptotagmin-like protein 4,37437,0.127164055870204,0.00681507696229101,0.113806505024114,0.140521606716295,9.66017655021455e-77
NMR metabolomics,X23424.Total Lipids in VLDL,OGFR,Opioid growth factor receptor,39788,0.0574449559439987,0.00308192131513462,0.0514043901663349,0.0634855217216626,1.00841373669554e-76
NMR metabolomics,X23424.Total Lipids in VLDL,EGLN1,Egl nine homolog 1,39866,0.0937176728579475,0.00502921319121077,0.0838604150031744,0.103574930712721,1.0885522756681e-76
NMR metabolomics,X23424.Total Lipids in VLDL,COCH,Cochlin,37437,0.0803796110795426,0.00431214398862415,0.0719278088618392,0.0888314132972459,1.36443688061396e-76
NMR metabolomics,X23424.Total Lipids in VLDL,SKAP2,Src kinase-associated phosphoprotein 2,39931,0.182594282366969,0.00981717491521558,0.163352619533146,0.201835945200791,2.05539568665959e-76
NMR metabolomics,X23424.Total Lipids in VLDL,VAMP8,Vesicle-associated membrane protein 8,37056,0.155381983578622,0.00834997720852587,0.139016028249911,0.171747938907333,2.58196630067281e-76
NMR metabolomics,X23424.Total Lipids in VLDL,DLK1,Protein delta homolog 1,40052,0.0977098332299834,0.00525959641794208,0.087401024250817,0.10801864220915,3.03144624508217e-76
NMR metabolomics,X23424.Total Lipids in VLDL,EREG,Proepiregulin,39713,0.139794066539005,0.007532208269214,0.125030938331345,0.154557194746664,4.3680903122431e-76
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP3,Metalloproteinase inhibitor 3,39931,0.226776662294458,0.0122233423702757,0.202818911248717,0.250734413340198,4.81886453609137e-76
NMR metabolomics,X23424.Total Lipids in VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,0.109693096347828,0.00591093694781882,0.0981076599301027,0.121278532765552,6.18154649329569e-76
NMR metabolomics,X23424.Total Lipids in VLDL,SH2B3,SH2B adapter protein 3,39477,0.172173134545769,0.00929504095625894,0.153954854271502,0.190391414820037,8.70615994021763e-76
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,0.114888535133261,0.0062026364322463,0.102731367726058,0.127045702540463,1.16435489966522e-75
NMR metabolomics,X23424.Total Lipids in VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,0.111313917985032,0.0060147334659268,0.0995250403918153,0.123102795578248,1.16949769715264e-75
NMR metabolomics,X23424.Total Lipids in VLDL,LYN,Tyrosine-protein kinase Lyn,39788,0.14764812909416,0.00798330409671845,0.132000853064591,0.163295405123728,1.40978153213709e-75
NMR metabolomics,X23424.Total Lipids in VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,39489,0.0474235484912967,0.00256663284039167,0.042392948124129,0.0524541488584643,2.01021519447983e-75
NMR metabolomics,X23424.Total Lipids in VLDL,QDPR,Dihydropteridine reductase,39790,0.0757454644067514,0.00410117769461202,0.0677071561253119,0.083783772688191,2.2353979400752e-75
NMR metabolomics,X23424.Total Lipids in VLDL,GIGYF2,GRB10-interacting GYF protein 2,37411,0.133572349853239,0.00722698752542102,0.119407454303414,0.147737245403065,2.40568507740743e-75
NMR metabolomics,X23424.Total Lipids in VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,0.185186451357029,0.0100187790450594,0.165549644428713,0.204823258285346,2.43239414863999e-75
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF3,Immunoglobulin superfamily member 3,39788,0.0616824807506225,0.00334117577483514,0.0551337762319456,0.0682311852692993,2.57969892303863e-75
NMR metabolomics,X23424.Total Lipids in VLDL,KLK10,Kallikrein-10,39856,0.0685842067387289,0.00371622158530826,0.0613004124315247,0.0758680010459331,2.85177172615067e-75
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS9,Galectin-9,39859,0.0548296931718904,0.00297118782828345,0.0490061650284548,0.0606532213153259,2.93279237185774e-75
NMR metabolomics,X23424.Total Lipids in VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,0.176537084768395,0.00956798708905445,0.157783830073848,0.195290339462942,3.09359611434342e-75
NMR metabolomics,X23424.Total Lipids in VLDL,RABEP1,Rab GTPase-binding effector protein 1,37124,0.135746825309677,0.0073537935171483,0.121333390016066,0.150160260603287,3.81409314863438e-75
NMR metabolomics,X23424.Total Lipids in VLDL,PXN,Paxillin,39489,0.0897164190964365,0.00487650895704916,0.0801584615406201,0.0992743766522529,8.43990430898876e-75
NMR metabolomics,X23424.Total Lipids in VLDL,C1S,Complement C1s subcomponent,37453,0.0363662725682199,0.00197531685909433,0.032494651524395,0.0402378936120448,8.77988312837494e-75
NMR metabolomics,X23424.Total Lipids in VLDL,METAP2,Methionine aminopeptidase 2,40011,0.100132148210349,0.00544770943849445,0.0894546377109,0.110809658709798,1.08432146406427e-74
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD1,Sushi domain-containing protein 1,39585,0.0843795663593785,0.00459086991633463,0.0753814613233627,0.0933776713953944,1.15140470738904e-74
NMR metabolomics,X23424.Total Lipids in VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,0.106359246042958,0.00579096578044579,0.0950089531132842,0.117709538972632,1.42671272682632e-74
NMR metabolomics,X23424.Total Lipids in VLDL,VSNL1,Visinin-like protein 1,37388,0.0653346526239944,0.0035648360985545,0.0583475738708276,0.0723217313771613,3.92884420526185e-74
NMR metabolomics,X23424.Total Lipids in VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,0.0540796283523765,0.00295112872976104,0.0482954160420449,0.0598638406627082,4.33047111552391e-74
NMR metabolomics,X23424.Total Lipids in VLDL,ESM1,Endothelial cell-specific molecule 1,39862,-0.0587714321398408,0.00321448936937628,-0.0650718313038183,-0.0524710329758633,6.35595446119659e-74
NMR metabolomics,X23424.Total Lipids in VLDL,MYDGF,Myeloid-derived growth factor,37437,0.174874508180949,0.00955757867711651,0.156141653973801,0.193607362388098,6.74801021983519e-74
NMR metabolomics,X23424.Total Lipids in VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,39931,0.0654493660161845,0.00358126688813788,0.0584300829154342,0.0724686491169347,7.25943688193519e-74
NMR metabolomics,X23424.Total Lipids in VLDL,TIA1,Nucleolysin TIA-1 isoform p40,39374,0.211954560776909,0.0116023341237078,0.189213985894442,0.234695135659376,8.78102125831665e-74
NMR metabolomics,X23424.Total Lipids in VLDL,SNCG,Gamma-synuclein,39749,0.111920515583371,0.00613132897382195,0.0999031107946798,0.123937920372062,1.09065565976103e-73
NMR metabolomics,X23424.Total Lipids in VLDL,TBC1D23,TBC1 domain family member 23,39788,0.154986281312889,0.00849347363296675,0.138339072992274,0.171633489633503,1.21347113230784e-73
NMR metabolomics,X23424.Total Lipids in VLDL,CNST,Consortin,39868,0.185944570760637,0.0101905075319681,0.16597117599798,0.205917965523295,1.22165965503685e-73
NMR metabolomics,X23424.Total Lipids in VLDL,AMN,Protein amnionless,39587,0.0819350425588479,0.00449749390062462,0.0731199545136237,0.0907501306040722,2.11313882827784e-73
NMR metabolomics,X23424.Total Lipids in VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,0.200872922039164,0.0110365573972331,0.179241269540588,0.222504574537741,2.8154289982759e-73
NMR metabolomics,X23424.Total Lipids in VLDL,SELE,E-selectin,40052,0.0854737620442568,0.00469841104941614,0.0762648763874011,0.0946826477011124,3.19619756957336e-73
NMR metabolomics,X23424.Total Lipids in VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,0.176736091377754,0.00973062403044375,0.157664068278084,0.195808114477423,5.42523658526072e-73
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,0.048082882760929,0.00264906423729648,0.0428907168558279,0.05327504866603,6.79431407490296e-73
NMR metabolomics,X23424.Total Lipids in VLDL,ARSB,Arylsulfatase B,39788,0.0946288792533781,0.00521364775326959,0.0844101296569697,0.104847628849787,6.93337341952513e-73
NMR metabolomics,X23424.Total Lipids in VLDL,MITD1,MIT domain-containing protein 1,39749,0.166138032785729,0.00917305163994172,0.148158851571443,0.184117214000015,1.38710740021381e-72
NMR metabolomics,X23424.Total Lipids in VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,0.148544627756511,0.00820242938761651,0.132467866156783,0.16462138935624,1.40644562480665e-72
NMR metabolomics,X23424.Total Lipids in VLDL,GIT1,ARF GTPase-activating protein GIT1,37056,0.167123398056463,0.00922294205401039,0.149046431630603,0.185200364482324,1.66091469210986e-72
NMR metabolomics,X23424.Total Lipids in VLDL,AZI2,5-azacytidine-induced protein 2,37411,0.0946954656752892,0.00523230039734777,0.0844401568964876,0.104950774454091,2.33526562691137e-72
NMR metabolomics,X23424.Total Lipids in VLDL,RGCC,Regulator of cell cycle RGCC,37411,0.129334802639331,0.00714874068402198,0.115323270898648,0.143346334380014,2.61004194258233e-72
NMR metabolomics,X23424.Total Lipids in VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,0.0764605786578747,0.00423922774325012,0.0681516922811045,0.0847694650346449,5.2444181029273e-72
NMR metabolomics,X23424.Total Lipids in VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,0.136809972978254,0.00758434825213168,0.121944650404076,0.151675295552433,6.72717112447858e-72
NMR metabolomics,X23424.Total Lipids in VLDL,ORM1,Alpha-1-acid glycoprotein 1,37389,0.0338278093184603,0.00187557092787447,0.0301516902998263,0.0375039283370942,7.04715193938458e-72
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,0.127570667669839,0.00708881676532249,0.113676586809807,0.141464748529871,1.06410936678381e-71
NMR metabolomics,X23424.Total Lipids in VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,0.186943536644195,0.0103898250092923,0.166579479625982,0.207307593662408,1.11686301806145e-71
NMR metabolomics,X23424.Total Lipids in VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,0.123576231111762,0.00686904568526536,0.110112901568642,0.137039560654882,1.58307533056629e-71
NMR metabolomics,X23424.Total Lipids in VLDL,PDLIM5,PDZ and LIM domain protein 5,37411,0.203183192602167,0.0113011345363016,0.181032968911016,0.225333416293318,1.92018470879785e-71
NMR metabolomics,X23424.Total Lipids in VLDL,TBCC,Tubulin-specific chaperone C,39749,0.137849952824027,0.00767525093483272,0.122806460991755,0.1528934446563,2.02462514711172e-71
NMR metabolomics,X23424.Total Lipids in VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,0.15968409744633,0.00889315209163335,0.142253519346728,0.177114675545931,2.2277729248544e-71
NMR metabolomics,X23424.Total Lipids in VLDL,TAX1BP1,Tax1-binding protein 1,37388,0.106998745612216,0.00595816409757156,0.0953207439809758,0.118676747243456,2.77162323371457e-71
NMR metabolomics,X23424.Total Lipids in VLDL,VWA1,von Willebrand factor A domain-containing protein 1,40011,0.0722739238313896,0.00402964605168381,0.0643758175700893,0.0801720300926898,3.05425669710895e-71
NMR metabolomics,X23424.Total Lipids in VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,0.122124389363801,0.00681352880828173,0.108769872899569,0.135478905828033,5.27755498001239e-71
NMR metabolomics,X23424.Total Lipids in VLDL,COMMD1,COMM domain-containing protein 1,37043,0.104884289315241,0.00585219132930022,0.0934139943098123,0.116354584320669,5.48992064948347e-71
NMR metabolomics,X23424.Total Lipids in VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,39859,0.085129063186534,0.00475682709498457,0.0758056820803642,0.0944524442927037,6.20267988624695e-71
NMR metabolomics,X23424.Total Lipids in VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,0.0924278229394764,0.00516653267558132,0.082301418895337,0.102554226983616,7.14122652301501e-71
NMR metabolomics,X23424.Total Lipids in VLDL,PLG,Plasminogen,37162,0.0381997865090057,0.00213675028408961,0.03401175595219,0.0423878170658213,1.18194551951837e-70
NMR metabolomics,X23424.Total Lipids in VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,0.150342648146755,0.00841650404853926,0.133846300211618,0.166838996081892,1.48251599873642e-70
NMR metabolomics,X23424.Total Lipids in VLDL,STAMBP,STAM-binding protein,39713,0.108450961112679,0.00608072863595633,0.0965327329862042,0.120369189239153,1.83746482927101e-70
NMR metabolomics,X23424.Total Lipids in VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,0.0897531916214662,0.00502928194556307,0.0798957990081626,0.0996105842347698,1.98612847612321e-70
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM5,Tripartite motif-containing protein 5,39866,0.145211883883404,0.00814444071071614,0.1292487800904,0.161174987676407,1.99775310046278e-70
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP45,Rho GTPase-activating protein 45,37124,0.139460204521019,0.00781848978162512,0.124135964549034,0.154784444493004,2.40418049750827e-70
NMR metabolomics,X23424.Total Lipids in VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,0.179590892999952,0.0100705486089917,0.159852617726328,0.199329168273576,2.47660697178853e-70
NMR metabolomics,X23424.Total Lipids in VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,0.122206209210257,0.00686226131912386,0.108756177024775,0.13565624139574,2.87995853835602e-70
NMR metabolomics,X23424.Total Lipids in VLDL,SNX15,Sorting nexin-15,37124,0.0906205918492537,0.00508946974850077,0.0806452311421921,0.100595952556315,4.1831449523939e-70
NMR metabolomics,X23424.Total Lipids in VLDL,NAGK,N-acetyl-D-glucosamine kinase,37026,0.0966698682776424,0.00543262238768772,0.0860219283977745,0.10731780815751,5.15376786955544e-70
NMR metabolomics,X23424.Total Lipids in VLDL,NPDC1,Neural proliferation differentiation and control protein 1,39868,0.0494784036473496,0.00278427482615342,0.0440212249880889,0.0549355823066103,5.60304285597646e-70
NMR metabolomics,X23424.Total Lipids in VLDL,TXNDC5,Thioredoxin domain-containing protein 5,40009,0.114889048604853,0.00647132719573103,0.10220524730122,0.127572849908485,7.45561536753417e-70
NMR metabolomics,X23424.Total Lipids in VLDL,CCL11,Eotaxin,40058,0.0639448019339714,0.00360225779388268,0.0568843766579614,0.0710052272099815,7.71793744112845e-70
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4G,C-type lectin domain family 4 member G,39866,0.0555297860258914,0.00313216350922503,0.0493907455478103,0.0616688265039724,1.16218183713355e-69
NMR metabolomics,X23424.Total Lipids in VLDL,A1BG,Alpha-1B-glycoprotein,37453,0.0285828565755982,0.00161337273210564,0.0254206460206712,0.0317450671305253,1.89381259766223e-69
NMR metabolomics,X23424.Total Lipids in VLDL,BRAP,BRCA1-associated protein,37249,0.184348093914106,0.0104088808369391,0.163946687473705,0.204749500354506,2.14268362167586e-69
NMR metabolomics,X23424.Total Lipids in VLDL,PALM2,Paralemmin-2,37388,0.0632900035932294,0.00357403287083773,0.0562848991663875,0.0702951080200714,2.19181210793178e-69
NMR metabolomics,X23424.Total Lipids in VLDL,GHRL,Appetite-regulating hormone,39868,0.127982811038174,0.00724272900033911,0.11378706219751,0.142178559878839,3.21102310411047e-69
NMR metabolomics,X23424.Total Lipids in VLDL,IDUA,Alpha-L-iduronidase,40030,0.0765340986376133,0.00433213874998208,0.0680431066876485,0.0850250905875782,3.38753620017734e-69
NMR metabolomics,X23424.Total Lipids in VLDL,GORASP2,Golgi reassembly-stacking protein 2,37382,0.0791997467267576,0.00447937869225921,0.0704201644899296,0.0879793289635857,3.52369747072261e-69
NMR metabolomics,X23424.Total Lipids in VLDL,TDRKH,Tudor and KH domain-containing protein,39489,0.142248579813989,0.00805197364419608,0.126466711471365,0.158030448156614,3.58295686382306e-69
NMR metabolomics,X23424.Total Lipids in VLDL,PON2,Serum paraoxonase/arylesterase 2,39585,0.0573986779049405,0.00325102060077793,0.0510266775274157,0.0637706782824652,4.2757829674313e-69
NMR metabolomics,X23424.Total Lipids in VLDL,GMPR,GMP reductase 1,40058,0.0826515781212609,0.00468386867880135,0.0734711955108102,0.0918319607317115,4.83154005512698e-69
NMR metabolomics,X23424.Total Lipids in VLDL,C3,Complement C3,36816,0.0769176756038395,0.00435467013771991,0.0683825221339085,0.0854528290737705,5.1707815886177e-69
NMR metabolomics,X23424.Total Lipids in VLDL,MTDH,Protein LYRIC,37056,0.154344262913037,0.00874645657374925,0.137201208028489,0.171487317797586,6.68509706814814e-69
NMR metabolomics,X23424.Total Lipids in VLDL,FAM13A,Protein FAM13A,37382,0.112791515815827,0.00640210506791617,0.100243389882711,0.125339641748942,1.04999075917164e-68
NMR metabolomics,X23424.Total Lipids in VLDL,CRKL,Crk-like protein,39881,0.177840106464133,0.0101073283025713,0.158029742991093,0.197650469937173,1.18583355116589e-68
NMR metabolomics,X23424.Total Lipids in VLDL,RILPL2,RILP-like protein 2,37437,0.164159998925408,0.00932542873896549,0.145882158597036,0.182437839253781,1.33702973458426e-68
NMR metabolomics,X23424.Total Lipids in VLDL,IST1,IST1 homolog,37287,0.166002213437923,0.00943272705115746,0.147514068417654,0.184490358458192,1.4844151474908e-68
NMR metabolomics,X23424.Total Lipids in VLDL,DDHD2,Phospholipase DDHD2,37411,0.110673673834152,0.00630193650990678,0.0983218782747342,0.123025469393569,2.75020880974109e-68
NMR metabolomics,X23424.Total Lipids in VLDL,DBNL,Drebrin-like protein,39931,0.154102307405007,0.00878761175527823,0.136878588364662,0.171326026445352,3.26562767479927e-68
NMR metabolomics,X23424.Total Lipids in VLDL,C19orf12,Protein C19orf12,39489,0.107459450708564,0.00613064548483905,0.0954433855582795,0.119475515858849,3.90965081751089e-68
NMR metabolomics,X23424.Total Lipids in VLDL,HS1BP3,HCLS1-binding protein 3,37043,0.151665368575395,0.00865107933037293,0.134709253087864,0.168621484062926,4.87267773275321e-68
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,0.138714159476527,0.00791547871693022,0.123199821191344,0.154228497761711,5.26602501491954e-68
NMR metabolomics,X23424.Total Lipids in VLDL,SULT2A1,Bile salt sulfotransferase,39866,0.0921570938258933,0.00527190478851461,0.0818241604404047,0.102490027211382,8.55187398415674e-68
NMR metabolomics,X23424.Total Lipids in VLDL,PARP1,Poly [ADP-ribose] polymerase 1,39866,0.0903133551730035,0.00516758194605692,0.0801848945587319,0.100441815787275,9.14360446446874e-68
NMR metabolomics,X23424.Total Lipids in VLDL,SH2D1A,SH2 domain-containing protein 1A,39866,0.0933171266080478,0.00533984181241451,0.0828510366557153,0.10378321656038,9.34609890625047e-68
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA11,Annexin A11,39829,0.110158987276022,0.00630976996125994,0.0977918381519528,0.122526136400092,1.25946749286736e-67
NMR metabolomics,X23424.Total Lipids in VLDL,SH3GLB2,Endophilin-B2,37388,0.109253675528143,0.0062529059932723,0.0969979797813289,0.121509371274956,1.28152216175158e-67
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL16,C-X-C motif chemokine 16,40034,0.0382893138992211,0.0021947071085957,0.0339876879663735,0.0425909398320687,1.5273009668272e-67
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS8,Galectin-8,40009,0.100746990013635,0.00577776259982164,0.0894225753179844,0.112071404709285,1.79208108839697e-67
NMR metabolomics,X23424.Total Lipids in VLDL,CNPY4,Protein canopy homolog 4,39788,0.124557804696411,0.00714304064379945,0.110557445034564,0.138558164358258,1.80801704774265e-67
NMR metabolomics,X23424.Total Lipids in VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,0.0921619679359517,0.00528611281158519,0.0818011868252448,0.102522749046659,1.86399073745594e-67
NMR metabolomics,X23424.Total Lipids in VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,0.243215314243751,0.0139387101481395,0.215895442353398,0.270535186134105,1.91993148105514e-67
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL7,Angiopoietin-related protein 7,40030,0.0613333844201732,0.00351835205542368,0.0544374143915428,0.0682293544488036,1.93603843390348e-67
NMR metabolomics,X23424.Total Lipids in VLDL,FGF19,Fibroblast growth factor 19,39931,0.125938141885614,0.00722687431797649,0.11177346822238,0.140102815548848,2.16665153101983e-67
NMR metabolomics,X23424.Total Lipids in VLDL,GTPBP2,GTP-binding protein 2,37039,0.133215536314578,0.00764068387001739,0.118239795929344,0.148191276699812,2.54293235126236e-67
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT5,ADP-sugar pyrophosphatase,39858,0.0848556531289329,0.00487450662801987,0.075301620138014,0.0944096861198518,2.98524794604659e-67
NMR metabolomics,X23424.Total Lipids in VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,0.13985337617412,0.00803699607396732,0.124100863869144,0.155605888479096,3.47423178041049e-67
NMR metabolomics,X23424.Total Lipids in VLDL,OPHN1,Oligophrenin-1,37388,0.176950497438276,0.0102049072001078,0.156948879326064,0.196952115550487,1.23661146300279e-66
NMR metabolomics,X23424.Total Lipids in VLDL,MAX,Protein max,39489,0.172372339715266,0.00995855826628306,0.152853565513351,0.191891113917181,1.677553459375e-66
NMR metabolomics,X23424.Total Lipids in VLDL,WASHC3,WASH complex subunit 3,37388,0.124025511495266,0.00716428429691526,0.109983514273312,0.13806750871722,1.99437775677613e-66
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,0.1362602215678,0.00788042988624359,0.120814578990763,0.151705864144837,2.20493866542727e-66
NMR metabolomics,X23424.Total Lipids in VLDL,RAB27B,Ras-related protein Rab-27B,37437,0.133490778514155,0.00774954375550905,0.118301672753357,0.148679884274953,8.52207964974834e-66
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,0.126949021782625,0.00737513410583121,0.112493758935196,0.141404284630054,1.05626990711147e-65
NMR metabolomics,X23424.Total Lipids in VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,0.0969990161185564,0.00563939250827861,0.0859458068023303,0.108052225434782,1.31692762674832e-65
NMR metabolomics,X23424.Total Lipids in VLDL,SCARA5,Scavenger receptor class A member 5,40009,0.0473440277894452,0.00275771368431509,0.0419389089681876,0.0527491466107028,1.76104589072611e-65
NMR metabolomics,X23424.Total Lipids in VLDL,BAG4,BAG family molecular chaperone regulator 4,37056,0.0809972503013481,0.00472046908753216,0.071745130889785,0.0902493697129111,2.75827973418674e-65
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,37124,0.0630644005913922,0.00367603869947845,0.0558593647404144,0.0702694364423699,2.88698938248078e-65
NMR metabolomics,X23424.Total Lipids in VLDL,STAT2,Signal transducer and activator of transcription 2,37056,0.127671284579253,0.00744956155946033,0.113070143922711,0.142272425235795,3.90370274814579e-65
NMR metabolomics,X23424.Total Lipids in VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.14989444584688,0.00875660278516734,-0.167057387305808,-0.132731504387952,4.14421754198722e-65
NMR metabolomics,X23424.Total Lipids in VLDL,OGA,Protein O-GlcNAcase,37382,0.115268589353346,0.00672968649940308,0.102078403814516,0.128458774892176,4.42348215752495e-65
NMR metabolomics,X23424.Total Lipids in VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,37056,0.147568725361689,0.00861667330540872,0.130680045683088,0.16445740504029,4.78802008635324e-65
NMR metabolomics,X23424.Total Lipids in VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,0.0447831181989497,0.00262144895274553,0.0396450782515685,0.049921158146331,9.7122996785992e-65
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R2,Protein phosphatase inhibitor 2,39868,0.129693254799844,0.00762798927926026,0.114742395812494,0.144644113787194,2.89362578031736e-64
NMR metabolomics,X23424.Total Lipids in VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,0.0816010489474769,0.00480249387712162,0.0721881609483186,0.0910139369466353,3.58613536657965e-64
NMR metabolomics,X23424.Total Lipids in VLDL,NSFL1C,NSFL1 cofactor p47,40009,0.104227257501181,0.00614110934263771,0.0921906831896114,0.116263831812751,4.74709250932027e-64
NMR metabolomics,X23424.Total Lipids in VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,0.100406979572578,0.00591057407126704,0.0888222543928942,0.111991704752261,4.86950233331259e-64
NMR metabolomics,X23424.Total Lipids in VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,0.0920986388836691,0.00543577455216913,0.0814445207614176,0.102752757005921,7.72682871188337e-64
NMR metabolomics,X23424.Total Lipids in VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,37338,0.0719150304463945,0.00424206746065748,0.0636005782235059,0.0802294826692832,8.39637280025172e-64
NMR metabolomics,X23424.Total Lipids in VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,0.0913776080026524,0.00539210387105765,0.0808090844153795,0.101946131589925,9.28899348562319e-64
NMR metabolomics,X23424.Total Lipids in VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,0.0475938279635672,0.00281312150664174,0.0420801098105494,0.053107546116585,1.18998287655001e-63
NMR metabolomics,X23424.Total Lipids in VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,0.0808656979198554,0.00477682755612226,0.0715031159098558,0.090228279929855,1.24754318992638e-63
NMR metabolomics,X23424.Total Lipids in VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,0.138292561805297,0.00816841784779509,0.122282462823619,0.154302660786976,1.25962423796576e-63
NMR metabolomics,X23424.Total Lipids in VLDL,GYS1,"Glycogen [starch] synthase, muscle",39585,0.149174521192655,0.00882384948585526,0.131879776200379,0.166469266184932,1.48361685520745e-63
NMR metabolomics,X23424.Total Lipids in VLDL,DGKA,Diacylglycerol kinase alpha,37056,0.0874216444344132,0.00518255290126655,0.0772638407479307,0.0975794481208956,3.52069867488831e-63
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFA,Platelet-derived growth factor subunit A,40052,0.114378941346427,0.00678798883815853,0.101074483223636,0.127683399469218,3.60984578483346e-63
NMR metabolomics,X23424.Total Lipids in VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,0.124610930814633,0.00739404411581729,0.110118604347631,0.139103257281635,3.61169363555594e-63
NMR metabolomics,X23424.Total Lipids in VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,0.0740857571854236,0.00440047593644325,0.0654608243499949,0.0827106900208524,4.64943995741603e-63
NMR metabolomics,X23424.Total Lipids in VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,0.0900535428287651,0.00535328867693505,0.0795610970219724,0.100545988635558,5.84504884466089e-63
NMR metabolomics,X23424.Total Lipids in VLDL,CCL7,C-C motif chemokine 7,39866,0.0925752196565987,0.00550550607585422,0.0817844277479244,0.103366011565273,6.56440418085174e-63
NMR metabolomics,X23424.Total Lipids in VLDL,TALDO1,Transaldolase,37415,0.0711486484036543,0.00422953516762275,0.0628587594751137,0.0794385373321949,7.31792026165543e-63
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,0.0976272185741647,0.00581461332471322,0.0862305764577268,0.109023860690603,9.94130060303709e-63
NMR metabolomics,X23424.Total Lipids in VLDL,MAVS,Mitochondrial antiviral-signaling protein,39477,0.146870083023005,0.00874911389360868,0.129721819791532,0.164018346254478,1.07919933671134e-62
NMR metabolomics,X23424.Total Lipids in VLDL,TWF2,Twinfilin-2,37437,0.134300088738295,0.00799600531111768,0.118627918328504,0.149972259148085,1.12119637090602e-62
NMR metabolomics,X23424.Total Lipids in VLDL,SPART,Spartin,37124,0.123857654556189,0.00738126181471286,0.109390381399351,0.138324927713026,1.50734175397617e-62
NMR metabolomics,X23424.Total Lipids in VLDL,MOCS2,Molybdopterin synthase catalytic subunit,37124,0.107844095128209,0.00643647514528325,0.0952286038434541,0.120459586412964,2.27055628950188e-62
NMR metabolomics,X23424.Total Lipids in VLDL,CCL4,C-C motif chemokine 4,39882,0.0985075443895718,0.00589313548213443,0.0869569988445883,0.110058089934555,3.39086414898204e-62
NMR metabolomics,X23424.Total Lipids in VLDL,YJU2,Splicing factor YJU2,37368,0.0513676522026239,0.00307089702034061,0.0453486940427563,0.0573866103624915,3.50072250069226e-62
NMR metabolomics,X23424.Total Lipids in VLDL,PSME1,Proteasome activator complex subunit 1,39738,0.0583154118059954,0.00349331179632783,0.0514685206851928,0.0651623029267979,4.94129954470829e-62
NMR metabolomics,X23424.Total Lipids in VLDL,CHMP1A,Charged multivesicular body protein 1a,39749,0.125675622761567,0.00752947443613966,0.110917852866734,0.140433392656401,5.12697976958898e-62
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP5,Microfibrillar-associated protein 5,40052,0.0633662052163463,0.00380247885528303,0.0559133466599916,0.070819063772701,7.77954931409803e-62
NMR metabolomics,X23424.Total Lipids in VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,0.0518952330933134,0.00311126083402659,0.0457971618586213,0.0579933043280055,8.07284308925766e-62
NMR metabolomics,X23424.Total Lipids in VLDL,CASC3,Protein CASC3,37039,0.0660673643986383,0.00396458482388407,0.0582967781438255,0.073837950653451,1.01743437785353e-61
NMR metabolomics,X23424.Total Lipids in VLDL,DOK1,Docking protein 1,37388,0.216098549130479,0.0129812596957805,0.190655280126749,0.241541818134208,1.30427723156648e-61
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC80,Coiled-coil domain-containing protein 80,39868,0.0513321966909335,0.00308632938846771,0.0452829910895368,0.0573814022923302,1.34087733667555e-61
NMR metabolomics,X23424.Total Lipids in VLDL,DPP4,Dipeptidyl peptidase 4,39575,0.0470862393332912,0.00283300838354281,0.0415335429015473,0.0526389357650351,1.65612533346661e-61
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,0.0460067352460655,0.00277206172179304,0.0405734942713511,0.0514399762207798,2.39808297568206e-61
NMR metabolomics,X23424.Total Lipids in VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,0.0916386094684236,0.00551811940082075,0.080823095442815,0.102454123494032,2.58295377842018e-61
NMR metabolomics,X23424.Total Lipids in VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,0.114770241156404,0.00691912611554777,0.10120875396993,0.128331728342877,2.79113535502892e-61
NMR metabolomics,X23424.Total Lipids in VLDL,CD22,B-cell receptor CD22,40058,0.0627760943959029,0.0037902987628369,0.0553471088207426,0.0702050799710633,4.14921894918655e-61
NMR metabolomics,X23424.Total Lipids in VLDL,CD69,Early activation antigen CD69,39785,0.137529150034327,0.00830698113717398,0.121247467005466,0.153810833063188,4.70204952637781e-61
NMR metabolomics,X23424.Total Lipids in VLDL,IFNLR1,Interferon lambda receptor 1,39866,0.0585028571059234,0.00353407992487662,0.0515760604531652,0.0654296537586816,4.82479965716189e-61
NMR metabolomics,X23424.Total Lipids in VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,37411,0.105902053721065,0.00640990643163208,0.0933386371150661,0.118465470327064,1.00540317387806e-60
NMR metabolomics,X23424.Total Lipids in VLDL,ICA1,Islet cell autoantigen 1,39587,0.125189016977056,0.00758395377102688,0.110324467585843,0.140053566368269,1.05678167396493e-60
NMR metabolomics,X23424.Total Lipids in VLDL,CD5,T-cell surface glycoprotein CD5,40003,0.0512487570213021,0.0031072798501202,0.0451584885150666,0.0573390255275377,1.28751366314871e-60
NMR metabolomics,X23424.Total Lipids in VLDL,GOLGA3,Golgin subfamily A member 3,37411,0.121220664906728,0.0073448731088229,0.106824713613435,0.135616616200021,1.33607887945602e-60
NMR metabolomics,X23424.Total Lipids in VLDL,SRP14,Signal recognition particle 14 kDa protein,39788,0.0928867247379154,0.00563835004671056,0.0818355586463627,0.103937890829468,1.78154134478962e-60
NMR metabolomics,X23424.Total Lipids in VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,0.0705761629403225,0.00428444580383495,0.0621786491648059,0.078973676715839,1.86584256743396e-60
NMR metabolomics,X23424.Total Lipids in VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,0.116441292906673,0.00707207671487687,0.102580022545514,0.130302563267831,2.07198829084157e-60
NMR metabolomics,X23424.Total Lipids in VLDL,MAP2,Microtubule-associated protein 2,37388,0.0717484960009782,0.00435595447898505,0.0632108252221675,0.0802861667797889,2.27832928875251e-60
NMR metabolomics,X23424.Total Lipids in VLDL,PPBP,Platelet basic protein,37371,0.132397102192204,0.00804176576227551,0.116635241298144,0.148158963086264,2.584351961058e-60
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA4D,Semaphorin-4D,40009,0.0465649268592039,0.00283142007891864,0.0410153435045234,0.0521145102138844,2.77843958833525e-60
NMR metabolomics,X23424.Total Lipids in VLDL,GASK1A,Golgi-associated kinase 1A,37021,0.0665821590483673,0.00405003851365136,0.0586440835616106,0.074520234535124,3.93551140903177e-60
NMR metabolomics,X23424.Total Lipids in VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,0.122541074444362,0.00746462867934241,0.107910402232851,0.137171746655874,4.64997960553417e-60
NMR metabolomics,X23424.Total Lipids in VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,0.0592543305228822,0.0036102276843087,0.0521782842616371,0.0663303767841272,4.80902379401029e-60
NMR metabolomics,X23424.Total Lipids in VLDL,EGF,Pro-epidermal growth factor,39808,0.160857548872401,0.00980107813504548,0.141647435727712,0.18006766201709,4.85519997198242e-60
NMR metabolomics,X23424.Total Lipids in VLDL,GDF2,Growth/differentiation factor 2,39868,0.0547111070081804,0.00333554370817035,0.0481734413401665,0.0612487726761943,5.66413720617996e-60
NMR metabolomics,X23424.Total Lipids in VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,0.0772787238528464,0.00470792021549258,0.0680512002304809,0.0865062474752118,5.83077915301627e-60
NMR metabolomics,X23424.Total Lipids in VLDL,GP1BB,Platelet glycoprotein Ib beta chain,37021,0.105157781968938,0.00641075548135064,0.0925927012254912,0.117722862712386,7.10145730674026e-60
NMR metabolomics,X23424.Total Lipids in VLDL,CD207,C-type lectin domain family 4 member K,39496,0.0582992221274194,0.00355708192738677,0.0513273415497413,0.0652711027050975,7.15848763425861e-60
NMR metabolomics,X23424.Total Lipids in VLDL,OXT,Oxytocin-neurophysin 1,40009,0.214609993407522,0.0131055689871995,0.188923078192611,0.240296908622433,8.67885219476182e-60
NMR metabolomics,X23424.Total Lipids in VLDL,PKD2,Polycystin-2,37021,0.0924399996258151,0.0056400182146776,0.081385563925047,0.103494435326583,8.80311185427666e-60
NMR metabolomics,X23424.Total Lipids in VLDL,RWDD1,RWD domain-containing protein 1,40009,0.0986461934712602,0.00603657516951688,0.0868145061390072,0.110477880803513,1.50453144097679e-59
NMR metabolomics,X23424.Total Lipids in VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,0.121482438816324,0.00743655311016574,0.106906794720399,0.136058082912249,1.67535682570036e-59
NMR metabolomics,X23424.Total Lipids in VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,0.118594381510163,0.00726970185915737,0.104345765866215,0.132842997154112,2.44770509017695e-59
NMR metabolomics,X23424.Total Lipids in VLDL,SCRG1,Scrapie-responsive protein 1,37437,0.0408215913913502,0.00250117317497394,0.0359192919684012,0.0457238908142991,2.56714178734679e-59
NMR metabolomics,X23424.Total Lipids in VLDL,ELOA,Elongin-A,39788,0.0786132092656132,0.00483085246759139,0.0691447384291341,0.0880816801020924,4.58395205534572e-59
NMR metabolomics,X23424.Total Lipids in VLDL,SPARC,SPARC,39913,0.108450252854313,0.00666897414733477,0.0953790635255371,0.121521442183089,5.4453106754919e-59
NMR metabolomics,X23424.Total Lipids in VLDL,RBM17,Splicing factor 45,37411,0.117835752046485,0.00724558746489497,0.10363440061529,0.132037103477679,6.51075935964927e-59
NMR metabolomics,X23424.Total Lipids in VLDL,CDNF,Cerebral dopamine neurotrophic factor,39788,0.0484831781887417,0.00298373267644956,0.0426350621429006,0.0543312942345828,6.73728872383302e-59
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RL2,Interleukin-1 receptor-like 2,39587,0.0610373159485793,0.00375725267509225,0.0536731007053984,0.0684015311917601,7.28000273292662e-59
NMR metabolomics,X23424.Total Lipids in VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,0.160769987612703,0.0099055084274576,0.141355191094886,0.18018478413052,9.06128655860294e-59
NMR metabolomics,X23424.Total Lipids in VLDL,SPRY2,Protein sprouty homolog 2,39587,0.142134229658646,0.00876053390449853,0.124963583205829,0.159304876111463,1.0163474363439e-58
NMR metabolomics,X23424.Total Lipids in VLDL,PRKG1,cGMP-dependent protein kinase 1,37124,0.194398243573079,0.0119776787699184,0.170921993184039,0.217874493962119,1.13533763100942e-58
NMR metabolomics,X23424.Total Lipids in VLDL,FUS,RNA-binding protein FUS,39455,0.0601516866302054,0.0037121503011105,0.0528758720400288,0.067427501220382,1.42131169474577e-58
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,0.132973818511596,0.00820618312236251,0.116889699591766,0.149057937431427,1.42162439603071e-58
NMR metabolomics,X23424.Total Lipids in VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",39913,0.0940971936497883,0.00581664068021318,0.0826965779165705,0.105497809383006,2.11365922050831e-58
NMR metabolomics,X23424.Total Lipids in VLDL,OCLN,Occludin,37411,0.0656517668373168,0.00406014758679589,0.0576938775671969,0.0736096561074368,2.8886204732566e-58
NMR metabolomics,X23424.Total Lipids in VLDL,GIP,Gastric inhibitory polypeptide,37043,0.0666930033315066,0.00412464352519597,0.0586087020221225,0.0747773046408907,3.0093267292023e-58
NMR metabolomics,X23424.Total Lipids in VLDL,FLT4,Vascular endothelial growth factor receptor 3,39913,0.051923444814055,0.00321638674321554,0.0456193267973526,0.0582275628307575,3.62714583148812e-58
NMR metabolomics,X23424.Total Lipids in VLDL,CETN3,Centrin-3,37382,0.120751601120899,0.00747581427724837,0.106099005137492,0.135404197104306,3.82633107826236e-58
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPT1,Angiopoietin-1,39794,0.128726385333101,0.00797656159712655,0.113092324602733,0.144360446063469,3.9796240490219e-58
NMR metabolomics,X23424.Total Lipids in VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,0.0738640611841946,0.00457783863502094,0.0648914974595536,0.0828366249088356,5.03311588530775e-58
NMR metabolomics,X23424.Total Lipids in VLDL,FNDC1,Fibronectin type III domain-containing protein 1,37388,0.0702658913138191,0.00435721762545657,0.0617257447679242,0.078806037859714,5.77938005416327e-58
NMR metabolomics,X23424.Total Lipids in VLDL,CCL18,C-C motif chemokine 18,39715,0.107586948376933,0.00667820239398773,0.094497671684717,0.120676225069149,6.23967342210211e-58
NMR metabolomics,X23424.Total Lipids in VLDL,STK24,Serine/threonine-protein kinase 24,39489,0.094803208272679,0.00588477568691415,0.0832690479263273,0.106337368619031,6.36069304354643e-58
NMR metabolomics,X23424.Total Lipids in VLDL,PF4,Platelet factor 4,37385,0.147328371776698,0.00913946335865208,0.12941502359374,0.165241719959656,6.38889359337715e-58
NMR metabolomics,X23424.Total Lipids in VLDL,LPP,Lipoma-preferred partner,37021,0.102472815592816,0.00635647331715664,0.0900141278911887,0.114931503294443,6.50589855654843e-58
NMR metabolomics,X23424.Total Lipids in VLDL,FIS1,Mitochondrial fission 1 protein,39855,0.119170198787127,0.00740196685090306,0.104662343759357,0.133678053814897,7.29098555693546e-58
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH1A1,Retinal dehydrogenase 1,39858,0.0800293911192015,0.00497134078189699,0.0702855631866834,0.0897732190517196,7.48354975473139e-58
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,0.0822795024274546,0.00511160768319992,0.0722607513683828,0.0922982534865264,7.72501061454981e-58
NMR metabolomics,X23424.Total Lipids in VLDL,F11,Coagulation factor XI,37249,0.047672021034471,0.002959419564417,0.0418715586882137,0.0534724833807283,7.75822606018506e-58
NMR metabolomics,X23424.Total Lipids in VLDL,GRAP2,GRB2-related adapter protein 2,39868,0.195494056430373,0.0121458117662919,0.171688265368441,0.219299847492305,7.78895600127535e-58
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM40,E3 ubiquitin ligase TRIM40,37039,0.110733679623002,0.0068750523389127,0.0972585770387329,0.124208782207271,8.16433358321608e-58
NMR metabolomics,X23424.Total Lipids in VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,0.104458601850282,0.00648730919045564,0.091743475836989,0.117173727863575,8.782302602943e-58
NMR metabolomics,X23424.Total Lipids in VLDL,MGLL,Monoglyceride lipase,39908,0.132734599924126,0.00826020979069279,0.116544588734368,0.148924611113884,1.18245569589127e-57
NMR metabolomics,X23424.Total Lipids in VLDL,CD226,CD226 antigen,37056,0.063809132746818,0.00396944885268112,0.056029012995563,0.071589252498073,1.34328205235996e-57
NMR metabolomics,X23424.Total Lipids in VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,0.134665996223329,0.00838940995710876,0.118222752707396,0.151109239739263,1.56680138197442e-57
NMR metabolomics,X23424.Total Lipids in VLDL,NUDC,Nuclear migration protein nudC,40058,0.0976130632538131,0.00608557856632284,0.0856853292638203,0.109540797243806,1.85825000602841e-57
NMR metabolomics,X23424.Total Lipids in VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,0.146192557616979,0.00911700713345681,0.128323223635404,0.164061891598554,2.0331900252968e-57
NMR metabolomics,X23424.Total Lipids in VLDL,APPL2,DCC-interacting protein 13-beta,37124,0.171706523025195,0.0107002733747641,0.150733987210657,0.192679058839732,2.0827041637292e-57
NMR metabolomics,X23424.Total Lipids in VLDL,C4BPB,C4b-binding protein beta chain,39913,0.0601248569195269,0.00375089753070943,0.0527730977593364,0.0674766160797174,2.21830511484211e-57
NMR metabolomics,X23424.Total Lipids in VLDL,DIABLO,"Diablo homolog, mitochondrial",39818,0.16648654681714,0.0103941119180346,0.146114087457792,0.186859006176488,2.70157035283695e-57
NMR metabolomics,X23424.Total Lipids in VLDL,MSTN,Growth/differentiation factor 8,39585,0.0785584883659262,0.0049074014518754,0.0689399815202504,0.088176995211602,3.17348866126547e-57
NMR metabolomics,X23424.Total Lipids in VLDL,SCG2,Secretogranin-2,39949,0.0469716841275473,0.00294281631765701,0.0412037641449396,0.0527396041101551,6.48219588499649e-57
NMR metabolomics,X23424.Total Lipids in VLDL,ST13,Hsc70-interacting protein,37124,0.0835415772561188,0.00523274655936889,0.0732853939997558,0.0937977605124818,7.55952421278157e-57
NMR metabolomics,X23424.Total Lipids in VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,0.0634700954345452,0.00397755237337219,0.0556740927827357,0.0712660980863547,8.39861736888488e-57
NMR metabolomics,X23424.Total Lipids in VLDL,MEP1A,Meprin A subunit alpha,37382,0.108068726234606,0.00677557449908199,0.0947886002164057,0.121348852252807,9.41169121774715e-57
NMR metabolomics,X23424.Total Lipids in VLDL,MMP7,Matrilysin,39563,0.0745022083737783,0.00467962009122053,0.0653301529949861,0.0836742637525706,1.26508002599872e-56
NMR metabolomics,X23424.Total Lipids in VLDL,C2,Complement C2,39908,0.0355643881178281,0.00223454562575994,0.0311846786913386,0.0399440975443176,1.33616279955707e-56
NMR metabolomics,X23424.Total Lipids in VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,0.0867005156922082,0.00546168766314155,0.0759956078724507,0.0974054235119656,2.6306255412883e-56
NMR metabolomics,X23424.Total Lipids in VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,37056,0.0880356004235228,0.00554875908676579,0.0771600326134619,0.0989111682335838,3.60969926008075e-56
NMR metabolomics,X23424.Total Lipids in VLDL,BGLAP,Osteocalcin,37437,0.129826717785959,0.00818502578104505,0.11378406725511,0.145869368316807,3.73649170901009e-56
NMR metabolomics,X23424.Total Lipids in VLDL,IGBP1,Immunoglobulin-binding protein 1,37411,0.0905430291204657,0.00571204401924813,0.0793474228427394,0.101738635398192,4.39486128207415e-56
NMR metabolomics,X23424.Total Lipids in VLDL,CRADD,Death domain-containing protein CRADD,39713,0.114327347462245,0.00722455565588746,0.100167218376705,0.128487476547784,5.62576711159857e-56
NMR metabolomics,X23424.Total Lipids in VLDL,F12,Coagulation factor XII,37453,0.0621039522093697,0.00392449432666708,0.0544119433291022,0.0697959610896372,6.62835897875482e-56
NMR metabolomics,X23424.Total Lipids in VLDL,TRAF2,TNF receptor-associated factor 2,39866,0.106161028251901,0.00671785974575099,0.0929940231502294,0.119328033353573,7.86392840687197e-56
NMR metabolomics,X23424.Total Lipids in VLDL,HNMT,Histamine N-methyltransferase,39669,0.0691192383296231,0.00437485990523024,0.0605445129153719,0.0776939637438744,8.42113047989842e-56
NMR metabolomics,X23424.Total Lipids in VLDL,KLK13,Kallikrein-13,39490,0.0630672310026303,0.00399279066332915,0.0552413613025051,0.0708931007027554,9.05181176315131e-56
NMR metabolomics,X23424.Total Lipids in VLDL,RRAS,Ras-related protein R-Ras,37039,0.197012510286179,0.0124641070333349,0.172582860500843,0.221442160071515,9.13728236904483e-56
NMR metabolomics,X23424.Total Lipids in VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,0.0685146999643285,0.00434073312744708,0.0600068630345322,0.0770225368941248,1.29152193000374e-55
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,0.0833270267219464,0.00528542005335629,0.072967603417368,0.0936864500265247,1.43260115595385e-55
NMR metabolomics,X23424.Total Lipids in VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,0.128571470556357,0.00815066771123884,0.112596161842329,0.144546779270386,1.49313312217131e-55
NMR metabolomics,X23424.Total Lipids in VLDL,GAS6,Growth arrest-specific protein 6,39947,-0.0380388170109411,0.00241642465683929,-0.0427750093383461,-0.0333026246835361,2.02696527055421e-55
NMR metabolomics,X23424.Total Lipids in VLDL,ATOX1,Copper transport protein ATOX1,39913,0.108414909303188,0.00688802259061035,0.0949143850255914,0.121915433580784,2.10009802448035e-55
NMR metabolomics,X23424.Total Lipids in VLDL,DTNB,Dystrobrevin beta,37348,0.065534625982507,0.00416194799135101,0.057377207919459,0.073692044045555,2.27061024078736e-55
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,0.127189959120685,0.00808748888485833,0.111338480906363,0.143041437335007,3.06234417814418e-55
NMR metabolomics,X23424.Total Lipids in VLDL,IL17RB,Interleukin-17 receptor B,39644,-0.0800648825689999,0.00509589131982544,-0.0900528295558577,-0.070076935582142,3.29668580958571e-55
NMR metabolomics,X23424.Total Lipids in VLDL,NIT1,Deaminated glutathione amidase,37043,0.0701243771589216,0.00446096413667054,0.0613808874510473,0.0788678668667958,3.5190471653726e-55
NMR metabolomics,X23424.Total Lipids in VLDL,KIFBP,KIF-binding protein,39788,0.123333100149934,0.00785235903797969,0.107942476435494,0.138723723864374,3.54064461272379e-55
NMR metabolomics,X23424.Total Lipids in VLDL,CETN2,Centrin-2,39489,0.100653862398273,0.0064083847913085,0.0880934282073088,0.113214296589238,3.60033408115097e-55
NMR metabolomics,X23424.Total Lipids in VLDL,VASP,Vasodilator-stimulated phosphoprotein,37445,0.108513585318003,0.00690775891224104,0.0949743778500109,0.122052792785996,4.01065276200316e-55
NMR metabolomics,X23424.Total Lipids in VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,39868,0.0516656209576087,0.00329270749642545,0.0452119142646148,0.0581193276506026,4.48812062908257e-55
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,0.0350128784860489,0.00223617847884682,0.0306299686675091,0.0393957883045886,7.53063719951617e-55
NMR metabolomics,X23424.Total Lipids in VLDL,HPSE,Heparanase,37306,0.13952820493132,0.00891024612252282,0.122064122531175,0.156992287331464,8.74134639225816e-55
NMR metabolomics,X23424.Total Lipids in VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,0.0648476808051762,0.00414275313769098,0.0567278846553018,0.0729674769550505,9.70460069236442e-55
NMR metabolomics,X23424.Total Lipids in VLDL,STIP1,Stress-induced-phosphoprotein 1,39826,0.0958276565336078,0.00612891189343743,0.0838149892224705,0.107840323844745,1.06409065437584e-54
NMR metabolomics,X23424.Total Lipids in VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,0.0808865627664377,0.00517506160824979,0.0707434420142681,0.0910296835186073,1.15710477329266e-54
NMR metabolomics,X23424.Total Lipids in VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,0.145117165332153,0.00928144097293171,0.126925541025207,0.163308789639099,1.25950396734111e-54
NMR metabolomics,X23424.Total Lipids in VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,0.0870749511007904,0.00557598146040555,0.0761460274383955,0.0980038747631853,1.46364371812788e-54
NMR metabolomics,X23424.Total Lipids in VLDL,UBXN1,UBX domain-containing protein 1,37124,0.102659488463633,0.00657350561806696,0.0897754174522216,0.115543559475044,1.6993456856039e-54
NMR metabolomics,X23424.Total Lipids in VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,39862,0.0761928096449237,0.00488520878495709,0.0666178004264078,0.0857678188634396,1.93077702504075e-54
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS2,Trypsin-2,39931,0.0755683453136288,0.00485577481180449,0.066051026682492,0.0850856639447656,3.25079840902699e-54
NMR metabolomics,X23424.Total Lipids in VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,0.125584233018288,0.00807190932164066,0.109763290747872,0.141405175288704,3.57032505424028e-54
NMR metabolomics,X23424.Total Lipids in VLDL,NUB1,NEDD8 ultimate buster 1,39866,0.123861520758309,0.00796975057552132,0.108240809630287,0.139482231886331,4.51502925354084e-54
NMR metabolomics,X23424.Total Lipids in VLDL,CASP7,Caspase-7,37388,0.124167712974108,0.00799015644449138,0.108507006342905,0.139828419605312,5.43621411948614e-54
NMR metabolomics,X23424.Total Lipids in VLDL,AGXT,Serine--pyruvate aminotransferase,39868,0.114388799131758,0.00736739539326214,0.0999487041609642,0.128828894102552,5.69348932282095e-54
NMR metabolomics,X23424.Total Lipids in VLDL,DLG4,Disks large homolog 4,37388,0.105407334863087,0.0067902027780376,0.0920985374181333,0.118716132308041,7.01508338111199e-54
NMR metabolomics,X23424.Total Lipids in VLDL,PMVK,Phosphomevalonate kinase,39480,0.162815273922654,0.010508584840279,0.142218447635707,0.183412100209601,9.6289566219446e-54
NMR metabolomics,X23424.Total Lipids in VLDL,STX8,Syntaxin-8,39866,0.0714706493993668,0.00461387796411819,0.0624274485896952,0.0805138502090385,9.89081263481092e-54
NMR metabolomics,X23424.Total Lipids in VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,0.0699754386616676,0.00451615342978799,0.0611237779392831,0.078827099384052,1.09079950258882e-53
NMR metabolomics,X23424.Total Lipids in VLDL,GLB1,Beta-galactosidase,39749,0.0617690647110095,0.00399039623126818,0.0539478880977239,0.0695902413242952,1.17707321989836e-53
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINE2,Glia-derived nexin,37437,0.0945762062903882,0.00611384540383143,0.0825930692988786,0.106559343281898,1.60204340501556e-53
NMR metabolomics,X23424.Total Lipids in VLDL,TMED8,Protein TMED8,37382,0.151597416089062,0.00980500391699513,0.132379608411751,0.170815223766372,1.81648335348234e-53
NMR metabolomics,X23424.Total Lipids in VLDL,IL7,Interleukin-7,39866,0.0952680350574764,0.00616871663963116,0.0831773504437993,0.107358719671153,2.01886488064686e-53
NMR metabolomics,X23424.Total Lipids in VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,0.140636159905624,0.00911154044731827,0.12277754062888,0.158494779182368,2.31259513655085e-53
NMR metabolomics,X23424.Total Lipids in VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,39788,0.0825693226698516,0.00535294241912588,0.0720775555283649,0.0930610898113383,2.69775482107056e-53
NMR metabolomics,X23424.Total Lipids in VLDL,MPI,Mannose-6-phosphate isomerase,39788,0.125777118184456,0.00816872543993816,0.109766416322177,0.141787820046735,4.11166156854111e-53
NMR metabolomics,X23424.Total Lipids in VLDL,SUOX,"Sulfite oxidase, mitochondrial",37411,0.0915002178853923,0.0059404734852032,0.079856889854394,0.103143545916391,4.40935286383335e-53
NMR metabolomics,X23424.Total Lipids in VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,0.0936305430880103,0.0060858041889524,0.0817023668776636,0.105558719298357,5.90517298008802e-53
NMR metabolomics,X23424.Total Lipids in VLDL,IL18,Interleukin-18,39795,0.0662041761751729,0.00431027628640128,0.0577560346538264,0.0746523176965194,7.30401798053268e-53
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6AP2,Renin receptor,39477,0.0592262241114352,0.00385570653935187,0.0516690392943056,0.0667834089285649,7.31546660629295e-53
NMR metabolomics,X23424.Total Lipids in VLDL,SPON2,Spondin-2,39775,-0.0487254703575392,0.00317283934547684,-0.0549442354746738,-0.0425067052404046,7.60174168334603e-53
NMR metabolomics,X23424.Total Lipids in VLDL,GMPR2,GMP reductase 2,37124,0.0975758047659561,0.00634961709077191,0.0851305552680431,0.110021054263869,7.74496948468893e-53
NMR metabolomics,X23424.Total Lipids in VLDL,RFC4,Replication factor C subunit 4,37368,0.0310971825122838,0.00202396625310277,0.0271302086562024,0.0350641563683652,7.92135033383225e-53
NMR metabolomics,X23424.Total Lipids in VLDL,NEXN,Nexilin,37445,0.100109307330515,0.0065170332661807,0.0873359221288009,0.112882692532229,8.27984798159754e-53
NMR metabolomics,X23424.Total Lipids in VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,0.106687989940769,0.00695005310687747,0.0930658858512889,0.120310094030249,9.91391268252369e-53
NMR metabolomics,X23424.Total Lipids in VLDL,TP53,Cellular tumor antigen p53,39477,0.064014725714232,0.00417993472694817,0.0558220536494136,0.0722073977790504,1.46797678403288e-52
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB3A2,Secretoglobin family 3A member 2,39908,-0.111777941230315,0.00730094400313165,-0.126087791476453,-0.0974680909841772,1.53991398574888e-52
NMR metabolomics,X23424.Total Lipids in VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,0.123976951087255,0.00809460633912295,0.108111522662574,0.139842379511936,1.64519192170103e-52
NMR metabolomics,X23424.Total Lipids in VLDL,ESYT2,Extended synaptotagmin-2,37388,0.119455509987364,0.0078017559702358,0.104164068285701,0.134746951689026,1.76754933001725e-52
NMR metabolomics,X23424.Total Lipids in VLDL,FOXJ3,Forkhead box protein J3,37056,0.0650650483844952,0.00425236655675374,0.0567304099332579,0.0733996868357326,2.12279783682265e-52
NMR metabolomics,X23424.Total Lipids in VLDL,APP,Amyloid-beta precursor protein,39829,0.0962295582500387,0.00630161146270685,0.0838783997831333,0.108580716716944,2.80887413955426e-52
NMR metabolomics,X23424.Total Lipids in VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,0.126997729157639,0.00832011052364235,0.1106903125313,0.143305145783978,3.60238384304785e-52
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD3,Mothers against decapentaplegic homolog 3,37368,0.0737300505558754,0.00483303097738677,0.0642573098401973,0.0832027912715535,4.11516662914181e-52
NMR metabolomics,X23424.Total Lipids in VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,0.11113477641439,0.00728515903405957,0.0968558647076333,0.125413688121147,4.24798589716938e-52
NMR metabolomics,X23424.Total Lipids in VLDL,KITLG,Kit ligand,39868,-0.0534390137387691,0.00350690755559226,-0.0603125525477299,-0.0465654749298083,4.57286665324567e-52
NMR metabolomics,X23424.Total Lipids in VLDL,FAM172A,Cotranscriptional regulator FAM172A,37043,0.0893235759847404,0.00585782578362489,0.0778422374488356,0.100804914520645,4.67520088839835e-52
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,0.0664130532629454,0.00435633274481943,0.0578746410830994,0.0749514654427915,4.9216441242407e-52
NMR metabolomics,X23424.Total Lipids in VLDL,EHD3,EH domain-containing protein 3,37043,0.169707640304846,0.0111339177838802,0.147885161448441,0.191530119161251,5.1313386091764e-52
NMR metabolomics,X23424.Total Lipids in VLDL,HSPA1A,Heat shock 70 kDa protein 1A,39904,0.102960971483825,0.00676215092199714,0.0897071556767106,0.116214787290939,5.48185730647647e-52
NMR metabolomics,X23424.Total Lipids in VLDL,FAP,Prolyl endopeptidase FAP,40052,0.0393137324728065,0.00258245813629534,0.0342521145256676,0.0443753504199454,5.66577903725727e-52
NMR metabolomics,X23424.Total Lipids in VLDL,COMT,Catechol O-methyltransferase,39403,0.122613378951033,0.00805522611023469,0.106825135774973,0.138401622127093,6.02281193235173e-52
NMR metabolomics,X23424.Total Lipids in VLDL,CCL8,C-C motif chemokine 8,40003,0.0868285824794329,0.00571207731670855,0.0756329109386841,0.0980242540201816,7.97104059405458e-52
NMR metabolomics,X23424.Total Lipids in VLDL,TMEM106A,Transmembrane protein 106A,37368,0.102489576684808,0.00674835386096608,0.0892628031173145,0.115716350252302,1.14521687486699e-51
NMR metabolomics,X23424.Total Lipids in VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,0.0514931059002213,0.00339456030502642,0.0448397677023695,0.0581464440980731,1.50086140054493e-51
NMR metabolomics,X23424.Total Lipids in VLDL,CTF1,Cardiotrophin-1,39585,0.121660473767566,0.00803668759551297,0.10590856608036,0.137412381454771,2.08971865540154e-51
NMR metabolomics,X23424.Total Lipids in VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,37043,0.10551102026912,0.00696513181428035,0.0918593619131306,0.11916267862511,2.09951953055127e-51
NMR metabolomics,X23424.Total Lipids in VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,39587,0.0851613560683761,0.00563965236517459,0.0741076374326339,0.0962150747041183,3.67227285366393e-51
NMR metabolomics,X23424.Total Lipids in VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,0.0909570359633121,0.00602531771780509,0.0791474132364141,0.10276665869021,3.84970248221519e-51
NMR metabolomics,X23424.Total Lipids in VLDL,TBCB,Tubulin-folding cofactor B,39749,0.144814239374334,0.00959572173864361,0.126006624766592,0.163621853982075,4.16117377191349e-51
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB6,Serpin B6,39970,0.0858953140904251,0.0056996524338096,0.0747239953201582,0.0970666328606919,5.65418437640646e-51
NMR metabolomics,X23424.Total Lipids in VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,0.132079928250294,0.00876417460860926,0.11490214601742,0.149257710483168,5.66954692446449e-51
NMR metabolomics,X23424.Total Lipids in VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,0.110790385636656,0.00735306942767935,0.0963783695584042,0.125202401714907,5.94974675710522e-51
NMR metabolomics,X23424.Total Lipids in VLDL,AP2B1,AP-2 complex subunit beta,37039,0.0700502567766141,0.00464697800537405,0.0609421798860809,0.0791583336671472,6.34297739110451e-51
NMR metabolomics,X23424.Total Lipids in VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,0.109404200678282,0.00726548525558901,0.0951638495773274,0.123644551779236,6.80374154430273e-51
NMR metabolomics,X23424.Total Lipids in VLDL,BAG6,Large proline-rich protein BAG6,39585,0.0526734049340304,0.00350141344845245,0.0458106345750636,0.0595361752929972,8.59664744645584e-51
NMR metabolomics,X23424.Total Lipids in VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,0.138634718096233,0.00921046904698185,0.120582198764148,0.156687237428317,8.86199285897785e-51
NMR metabolomics,X23424.Total Lipids in VLDL,VAV3,Guanine nucleotide exchange factor VAV3,36991,0.141719506569573,0.00942181501474328,0.123252749140676,0.16018626399847,1.03555044615763e-50
NMR metabolomics,X23424.Total Lipids in VLDL,JAM3,Junctional adhesion molecule C,37124,0.072082521057407,0.00479505514106181,0.0626842129809258,0.0814808291338881,1.17152795479186e-50
NMR metabolomics,X23424.Total Lipids in VLDL,ERP29,Endoplasmic reticulum resident protein 29,37124,0.169825224340622,0.0113184505239757,0.14764106131363,0.192009387367614,1.78512399267211e-50
NMR metabolomics,X23424.Total Lipids in VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,0.139589087127632,0.00931298721872518,0.121335632178931,0.157842542076333,1.95308020257361e-50
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN2L,Ataxin-2-like protein,37411,0.0681906710273799,0.00455083194713935,0.0592710404109868,0.0771103016437731,2.35542745087291e-50
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC59,Leucine-rich repeat-containing protein 59,37437,0.0662622004722321,0.00442422732604042,0.0575907149131929,0.0749336860312713,2.61173781594666e-50
NMR metabolomics,X23424.Total Lipids in VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,0.0882328959803777,0.0059040497191572,0.0766609585308296,0.0998048334299259,4.23228864135494e-50
NMR metabolomics,X23424.Total Lipids in VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,0.0375319393777216,0.00251833065690291,0.0325960112901919,0.0424678674652513,6.76009210165173e-50
NMR metabolomics,X23424.Total Lipids in VLDL,CTSL,Cathepsin L1,39868,0.0336651100800979,0.00226111202070535,0.0292333305195154,0.0380968896406804,8.40118191640844e-50
NMR metabolomics,X23424.Total Lipids in VLDL,RBKS,Ribokinase,39504,0.0697262057514437,0.00469024865577584,0.0605333183861231,0.0789190931167644,1.19186967651296e-49
NMR metabolomics,X23424.Total Lipids in VLDL,OTUD6B,Deubiquitinase OTUD6B,37382,0.0821616807977783,0.0055287339466352,0.0713253622623733,0.0929979993331833,1.45551410533478e-49
NMR metabolomics,X23424.Total Lipids in VLDL,CTSZ,Cathepsin Z,39865,0.0435614531440778,0.00293533960006408,0.0378081875279522,0.0493147187602034,1.71375896394794e-49
NMR metabolomics,X23424.Total Lipids in VLDL,CACYBP,Calcyclin-binding protein,37088,0.146064360630056,0.00983618945873625,0.126785429290933,0.165343291969179,1.74880741619588e-49
NMR metabolomics,X23424.Total Lipids in VLDL,DFFA,DNA fragmentation factor subunit alpha,40058,0.0951184569739777,0.00641620780854052,0.0825426896692383,0.107694224278717,2.13719104624148e-49
NMR metabolomics,X23424.Total Lipids in VLDL,HSPB1,Heat shock protein beta-1,39617,0.0977580778570047,0.00659565714689125,0.0848305898490979,0.110685565864912,2.28456482676544e-49
NMR metabolomics,X23424.Total Lipids in VLDL,NACC1,Nucleus accumbens-associated protein 1,37368,0.0772411488163579,0.00521376055325008,0.0670221781319877,0.0874601195007281,2.8596370658452e-49
NMR metabolomics,X23424.Total Lipids in VLDL,IMPACT,Protein IMPACT,37388,0.0776871606092798,0.00524883981005271,0.0673994345815765,0.0879748866369831,3.5073911244967e-49
NMR metabolomics,X23424.Total Lipids in VLDL,CD164,Sialomucin core protein 24,39858,0.0367092067545002,0.00248227521403432,0.0318439473349929,0.0415744661740074,3.66794536638348e-49
NMR metabolomics,X23424.Total Lipids in VLDL,NID1,Nidogen-1,39892,0.0525756277253636,0.00355605171717165,0.0456057663597072,0.0595454890910201,3.86622942555388e-49
NMR metabolomics,X23424.Total Lipids in VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,0.15768941551351,0.0106752627037085,0.136765900614242,0.178612930412779,4.79138795899737e-49
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS3,Galectin-3,39901,0.041268230314966,0.00279496385486545,0.0357901011594297,0.0467463594705023,5.15093378803216e-49
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,0.131064446139365,0.00887483302226793,0.11366977341572,0.14845911886301,5.6499582414373e-49
NMR metabolomics,X23424.Total Lipids in VLDL,F2R,Proteinase-activated receptor 1,39908,0.0816111848338549,0.0055311393941362,0.070770151621348,0.0924522180463619,5.99113638684746e-49
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,0.156826675859462,0.0106304669241891,0.135990960688051,0.177662391030872,6.18861389000385e-49
NMR metabolomics,X23424.Total Lipids in VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,0.140624787960206,0.00953411906241974,0.121937914597864,0.159311661322549,6.47902130945209e-49
NMR metabolomics,X23424.Total Lipids in VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,0.124417357838333,0.00844263172352742,0.10786979966022,0.140964916016447,8.90483304230609e-49
NMR metabolomics,X23424.Total Lipids in VLDL,BLMH,Bleomycin hydrolase,40052,0.0446088567032903,0.00302990262502537,0.0386702475582406,0.05054746584834,9.49883709694972e-49
NMR metabolomics,X23424.Total Lipids in VLDL,LACTB2,Endoribonuclease LACTB2,39868,0.0928126132754916,0.00630727911487825,0.0804503462103302,0.105174880340653,1.07178166263095e-48
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA4,Protein disulfide-isomerase A4,37437,0.085693272215151,0.00582725925970395,0.0742718440661313,0.0971147003641708,1.4025752283636e-48
NMR metabolomics,X23424.Total Lipids in VLDL,BMPER,BMP-binding endothelial regulator protein,37124,0.0313255617271095,0.00213005391445252,0.0271506560547825,0.0355004673994364,1.41290061198722e-48
NMR metabolomics,X23424.Total Lipids in VLDL,BIN2,Bridging integrator 2,39858,0.124632267334692,0.00849622717980225,0.10797966206228,0.141284872607105,2.09611464663038e-48
NMR metabolomics,X23424.Total Lipids in VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,0.131660943807797,0.00897497558543333,0.114069991660347,0.149251895955246,2.36944689119333e-48
NMR metabolomics,X23424.Total Lipids in VLDL,CFB,Complement factor B,37220,0.0458767707455443,0.00312763092622843,0.0397466141301366,0.052006927360952,2.44670549554256e-48
NMR metabolomics,X23424.Total Lipids in VLDL,STX4,Syntaxin-4,39788,0.0822304158179381,0.00561152670116788,0.071231823483649,0.0932290081522271,2.62597963246497e-48
NMR metabolomics,X23424.Total Lipids in VLDL,TBC1D5,TBC1 domain family member 5,39866,0.107888348454355,0.00737689388739936,0.0934296364350525,0.122347060473658,3.96696964595252e-48
NMR metabolomics,X23424.Total Lipids in VLDL,CTSS,Cathepsin S,36543,0.0338517493515045,0.00231326442020612,0.0293177510879005,0.0383857476151085,4.21720492936247e-48
NMR metabolomics,X23424.Total Lipids in VLDL,CASP10,Caspase-10,39489,0.0987033065655145,0.00676743172994795,0.0854391403748165,0.111967472756213,7.21337361247987e-48
NMR metabolomics,X23424.Total Lipids in VLDL,MESD,LRP chaperone MESD,39858,0.168672796899358,0.0115663726614799,0.146002706482857,0.191342887315859,7.3045190415463e-48
NMR metabolomics,X23424.Total Lipids in VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,0.0582675258026025,0.00399615406263443,0.050435063839839,0.066099987765366,8.70121614758853e-48
NMR metabolomics,X23424.Total Lipids in VLDL,DNM3,Dynamin-3,37411,0.0757395126456446,0.00520185673812158,0.0655438734389263,0.0859351518523629,1.1536754173628e-47
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN3,Ataxin-3,37388,0.0845857627933173,0.0058128143519999,0.0731926466633975,0.0959788789232371,1.30549782228269e-47
NMR metabolomics,X23424.Total Lipids in VLDL,CEMIP2,Cell surface hyaluronidase,37056,0.0441746379624167,0.00303635945431539,0.0382233734319586,0.0501259024928749,1.39243843884455e-47
NMR metabolomics,X23424.Total Lipids in VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,0.0777514641893279,0.00535051629740288,0.0672644522464183,0.0882384761322376,1.5611605067832e-47
NMR metabolomics,X23424.Total Lipids in VLDL,TADA3,Transcriptional adapter 3,37368,0.0545848633419283,0.00375549407947063,0.0472240949461658,0.0619456317376907,1.66762479916614e-47
NMR metabolomics,X23424.Total Lipids in VLDL,PPP3R1,Calcineurin subunit B type 1,39749,0.0571241242591885,0.00393391059027941,0.0494136595022408,0.0648345890161361,1.79754243411382e-47
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM24,Transcription intermediary factor 1-alpha,37135,0.0896851068222773,0.00617434963718984,0.0775833815333852,0.101786832111169,1.93177644722646e-47
NMR metabolomics,X23424.Total Lipids in VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,0.0647743839204982,0.00446069442185723,0.0560314228536581,0.0735173449873384,2.02020672479333e-47
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,0.0789964977748146,0.00544471550819474,0.0683248553787529,0.0896681401708763,2.13988626454526e-47
NMR metabolomics,X23424.Total Lipids in VLDL,SCARF1,Scavenger receptor class F member 1,40052,0.0587807569721489,0.00405175739234564,0.0508393124831514,0.0667222014611463,2.1543106363377e-47
NMR metabolomics,X23424.Total Lipids in VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,0.0414333330711515,0.00285749616731079,0.0358326405832224,0.0470340255590807,2.40859007715444e-47
NMR metabolomics,X23424.Total Lipids in VLDL,MYO9B,Unconventional myosin-IXb,39587,0.0907380516604965,0.00626094286865534,0.078466603637932,0.103009499683061,2.71747092010572e-47
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,37437,0.039227609509978,0.00270623391484047,0.0339233910368906,0.0445318279830653,2.92395456201869e-47
NMR metabolomics,X23424.Total Lipids in VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,0.0840919313290796,0.00580804379476102,0.0727081654913481,0.0954756971668112,3.30249829231848e-47
NMR metabolomics,X23424.Total Lipids in VLDL,YWHAQ,14-3-3 protein theta,37124,0.101960128838541,0.00704044331497414,0.0881608599411916,0.11575939773589,3.60128865978985e-47
NMR metabolomics,X23424.Total Lipids in VLDL,TP53I3,Quinone oxidoreductase PIG3,36874,0.073461136517449,0.00507218507226856,0.0635196537758027,0.0834026192590954,3.60263652318241e-47
NMR metabolomics,X23424.Total Lipids in VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,0.0920365354962583,0.006361231836038,0.0795685210976238,0.104504549894893,4.37025082007432e-47
NMR metabolomics,X23424.Total Lipids in VLDL,GLOD4,Glyoxalase domain-containing protein 4,39832,0.0490324521033388,0.00339180716939069,0.0423845100513331,0.0556803941553446,4.54475808564215e-47
NMR metabolomics,X23424.Total Lipids in VLDL,FST,Follistatin,39908,0.070356459545,0.00487121498835081,0.0608088781678324,0.0799040409221676,5.4451144974783e-47
NMR metabolomics,X23424.Total Lipids in VLDL,CERT,Ceramide transfer protein,39489,0.0841322518549673,0.00583664721888434,0.072692423305954,0.0955720804039806,8.3741755879146e-47
NMR metabolomics,X23424.Total Lipids in VLDL,SNAP25,Synaptosomal-associated protein 25,36991,0.0645763677308155,0.00447815486356815,0.055799184198222,0.0733535512634091,8.77762546614264e-47
NMR metabolomics,X23424.Total Lipids in VLDL,CDCP1,CUB domain-containing protein 1,39749,0.0680888332557557,0.00472643851760946,0.0588250137612412,0.0773526527502703,9.3549612669446e-47
NMR metabolomics,X23424.Total Lipids in VLDL,GP5,Platelet glycoprotein V,37124,0.0493727769709765,0.00343079254691809,0.0426484235790171,0.056097130362936,1.3206480005165e-46
NMR metabolomics,X23424.Total Lipids in VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,0.0643072648481731,0.00447277495423889,0.0555406259378648,0.0730739037584813,1.61013818660565e-46
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB14,DnaJ homolog subfamily B member 14,37382,0.0885574155610829,0.00616070657878201,0.0764824306666701,0.100632400455496,1.64533252555166e-46
NMR metabolomics,X23424.Total Lipids in VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,40002,0.0434274347469248,0.0030234806571394,0.0375014126589315,0.049353456834918,1.6991228073808e-46
NMR metabolomics,X23424.Total Lipids in VLDL,BPIFB2,BPI fold-containing family B member 2,37405,0.0837042339775825,0.00582424399142144,0.0722887157543965,0.0951197522007686,1.71148122429429e-46
NMR metabolomics,X23424.Total Lipids in VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,0.129083249878171,0.00899040833141051,0.111462049548607,0.146704450207736,1.8539811169202e-46
NMR metabolomics,X23424.Total Lipids in VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,39868,0.0925521655967798,0.00644863981724146,0.0799128315549865,0.105191499638573,2.00369442713975e-46
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2L1,Bcl-2-like protein 1,37388,0.135941708857042,0.00949204583216277,0.117337299026002,0.154546118688081,3.48676561476757e-46
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT16,U8 snoRNA-decapping enzyme,37366,0.119908927596164,0.00837298413037036,0.103497878700638,0.13631997649169,3.52664450265644e-46
NMR metabolomics,X23424.Total Lipids in VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,0.139023482722408,0.00970768273893724,0.119996424554091,0.158050540890725,3.59159293372314e-46
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH9,Protocadherin-9,37382,0.0451099762005976,0.00315246532499461,0.0389311441636082,0.051288808237587,4.1471644402048e-46
NMR metabolomics,X23424.Total Lipids in VLDL,GPI,Glucose-6-phosphate isomerase,37445,0.0643866440715249,0.00450056181164331,0.055565542920704,0.0732077452223458,4.31615886182649e-46
NMR metabolomics,X23424.Total Lipids in VLDL,RAB33A,Ras-related protein Rab-33A,37021,0.0911630533746917,0.00637237881567968,0.0786731908959596,0.103652915853424,4.44791288219097e-46
NMR metabolomics,X23424.Total Lipids in VLDL,APOA2,Apolipoprotein A-II,37445,-0.0645603348493005,0.00451397709787543,-0.0734077299611364,-0.0557129397374647,4.57022689355418e-46
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL1,Growth-regulated alpha protein,39839,0.128529731221568,0.00899317760082954,0.110903103123942,0.146156359319194,4.72447359347765e-46
NMR metabolomics,X23424.Total Lipids in VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,0.10254494418643,0.0071737557635068,0.0884843828899569,0.116605505482904,5.1103888638797e-46
NMR metabolomics,X23424.Total Lipids in VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,0.100628995315429,0.00704970904695445,0.0868115655833985,0.11444642504746,6.16056441655868e-46
NMR metabolomics,X23424.Total Lipids in VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,0.141693864753397,0.00992396655854733,0.122242890298645,0.16114483920815,6.57092538298835e-46
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,0.134676834236757,0.00943722616352357,0.116179870956251,0.153173797517263,7.15009758696445e-46
NMR metabolomics,X23424.Total Lipids in VLDL,UROD,Uroporphyrinogen decarboxylase,37124,0.093894549688544,0.00658036204698761,0.0809970400764483,0.10679205930064,7.46629703713865e-46
NMR metabolomics,X23424.Total Lipids in VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,0.110658356587782,0.00776370379604653,0.0954414971475307,0.125875216028033,8.15473786670053e-46
NMR metabolomics,X23424.Total Lipids in VLDL,STXBP1,Syntaxin-binding protein 1,37411,0.105475135784355,0.00741298674956638,0.0909456817552053,0.120004589813505,1.30009458966909e-45
NMR metabolomics,X23424.Total Lipids in VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,0.145648620626204,0.0102428022332888,0.125572728248957,0.16572451300345,1.47553755372786e-45
NMR metabolomics,X23424.Total Lipids in VLDL,SUGT1,Protein SGT1 homolog,39477,0.10895845624485,0.007681124063287,0.0939034530808079,0.124013459408893,2.16450836162875e-45
NMR metabolomics,X23424.Total Lipids in VLDL,THTPA,Thiamine-triphosphatase,37345,0.118813634199227,0.0083751488683339,0.102398342417292,0.135228925981161,2.35504115924199e-45
NMR metabolomics,X23424.Total Lipids in VLDL,SLMAP,Sarcolemmal membrane-associated protein,37382,0.112666631759718,0.00794441270827641,0.0970955828514963,0.12823768066794,2.50640491626369e-45
NMR metabolomics,X23424.Total Lipids in VLDL,TSC22D1,TSC22 domain family protein 1,37411,0.0910852934586608,0.00642601386692322,0.0784903062794913,0.10368028063783,2.77671351667786e-45
NMR metabolomics,X23424.Total Lipids in VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,0.0915532848932622,0.00646488437056217,0.0788821115269604,0.104224458259564,3.01620221813226e-45
NMR metabolomics,X23424.Total Lipids in VLDL,CPA1,Carboxypeptidase A1,40052,0.07914205998782,0.00560337846994278,0.0681594381867321,0.0901246817889078,5.00131588392306e-45
NMR metabolomics,X23424.Total Lipids in VLDL,CD244,Natural killer cell receptor 2B4,40058,0.0357233589182743,0.0025295773189057,0.0307653873732191,0.0406813304633294,5.12263791547114e-45
NMR metabolomics,X23424.Total Lipids in VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,0.106911575372573,0.00756933453338753,0.0920756796871335,0.121747471058013,5.72808726764575e-45
NMR metabolomics,X23424.Total Lipids in VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,0.0819882366046147,0.00580722488376762,0.0706060758324302,0.0933703973767992,6.22355633949135e-45
NMR metabolomics,X23424.Total Lipids in VLDL,REEP4,Receptor expression-enhancing protein 4,37411,0.0834643132565722,0.00591308894594724,0.0718746589225156,0.0950539675906288,6.37065705966256e-45
NMR metabolomics,X23424.Total Lipids in VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,0.0503989547667254,0.00357368500974489,0.0433945321476254,0.0574033773858254,7.59155692829046e-45
NMR metabolomics,X23424.Total Lipids in VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,0.160963892925231,0.011431662395244,0.138557834630552,0.183369951219909,9.23191605559356e-45
NMR metabolomics,X23424.Total Lipids in VLDL,MSR1,Macrophage scavenger receptor types I and II,40009,0.060918738457854,0.00432883986987063,0.0524342123129076,0.0694032646028005,1.02605883996641e-44
NMR metabolomics,X23424.Total Lipids in VLDL,RP2,Protein XRP2,39788,0.0556547910882078,0.00395585680405462,0.0479013117522607,0.0634082704241548,1.09113505697218e-44
NMR metabolomics,X23424.Total Lipids in VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,0.0629506824436428,0.0044746387872506,0.0541803904206316,0.071720974466654,1.09165503647571e-44
NMR metabolomics,X23424.Total Lipids in VLDL,PTGDS,Prostaglandin-H2 D-isomerase,39762,0.0377638275898965,0.00268676732896361,0.0324977636251278,0.0430298915546651,1.31819711842973e-44
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB1,Leukocyte elastase inhibitor,39811,0.119261623822605,0.00848561998510078,0.102629808651808,0.135893438993403,1.33295764637905e-44
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,0.126216372730861,0.00899518368930257,0.108585812699828,0.143846932761894,1.84132718630568e-44
NMR metabolomics,X23424.Total Lipids in VLDL,CD72,B-cell differentiation antigen CD72,37124,0.0552402721803733,0.00393812870922137,0.0475215399102994,0.0629590044504472,2.20993478891461e-44
NMR metabolomics,X23424.Total Lipids in VLDL,DPT,Dermatopontin,40052,0.0355860459417334,0.0025395187714823,0.0306085891496281,0.0405635027338387,2.36008587950107e-44
NMR metabolomics,X23424.Total Lipids in VLDL,CCL3,C-C motif chemokine 3,39866,0.0833271686563458,0.00594641632569668,0.0716721926579803,0.0949821446547113,2.37316686792341e-44
NMR metabolomics,X23424.Total Lipids in VLDL,CIAPIN1,Anamorsin,39913,0.0838239142351565,0.00598382278992076,0.0720956215669118,0.0955522069034012,2.52501152783414e-44
NMR metabolomics,X23424.Total Lipids in VLDL,AIF1,Allograft inflammatory factor 1,39477,0.0700078514324292,0.00499911504189358,0.0602095859503178,0.0798061169145406,2.72829979443695e-44
NMR metabolomics,X23424.Total Lipids in VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,0.0658491155743014,0.00470234147755128,0.0566325262783009,0.0750657048703019,3.12688236562638e-44
NMR metabolomics,X23424.Total Lipids in VLDL,LAP3,Cytosol aminopeptidase,39587,0.0644231630170711,0.00460964516561882,0.0553882584924582,0.073458067541684,4.02557219655248e-44
NMR metabolomics,X23424.Total Lipids in VLDL,MIA,Melanoma-derived growth regulatory protein,39913,0.0478682415704426,0.00342624836318448,0.041152794778601,0.0545836883622842,4.24426511378967e-44
NMR metabolomics,X23424.Total Lipids in VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,0.0860663695225425,0.00616277302529823,0.073987334392958,0.098145404652127,5.21313333134187e-44
NMR metabolomics,X23424.Total Lipids in VLDL,PNMA1,Paraneoplastic antigen Ma1,37043,0.0754936621325519,0.00540736167424673,0.0648952332510283,0.0860920910140755,5.52225198662469e-44
NMR metabolomics,X23424.Total Lipids in VLDL,SERPING1,Plasma protease C1 inhibitor,37424,0.0248776007753894,0.00178402461262315,0.021380912534648,0.0283742890161308,6.81114908029897e-44
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4E,Eukaryotic translation initiation factor 4E,37056,0.120636687022193,0.00865236786830564,0.103678046000313,0.137595328044072,7.14103829717121e-44
NMR metabolomics,X23424.Total Lipids in VLDL,GZMA,Granzyme A,40058,0.0446043912523466,0.00320260872678158,0.0383272781478547,0.0508815043568385,7.71514802622625e-44
NMR metabolomics,X23424.Total Lipids in VLDL,SDHB,Succinate dehydrogenase,37382,0.0927627456440821,0.00665657258671489,0.0797158633741209,0.105809627914043,7.74420135305127e-44
NMR metabolomics,X23424.Total Lipids in VLDL,DYNLT1,Dynein light chain Tctex-type 1,37039,0.105515686726714,0.00757119630888989,0.0906761419612899,0.120355231492138,7.78203156484991e-44
NMR metabolomics,X23424.Total Lipids in VLDL,DDT,D-dopachrome decarboxylase,37437,0.0530575438047434,0.00380871472528987,0.0455924629431753,0.0605226246663116,8.26854136145199e-44
NMR metabolomics,X23424.Total Lipids in VLDL,AMOT,Angiomotin,37124,0.0545551124842349,0.00391994705551316,0.0468720162554291,0.0622382087130407,1.00896893840799e-43
NMR metabolomics,X23424.Total Lipids in VLDL,GMFG,Glia maturation factor gamma,37437,0.0950575202232594,0.00683219660171186,0.0816664148839042,0.108448625562615,1.05108651075621e-43
NMR metabolomics,X23424.Total Lipids in VLDL,SCARB2,Lysosome membrane protein 2,39486,0.0378993620654935,0.00272656165336589,0.0325553012248964,0.0432434229060907,1.15151447910845e-43
NMR metabolomics,X23424.Total Lipids in VLDL,CPB1,Carboxypeptidase B,40052,0.07559746951899,0.00544230791877534,0.0649305459981903,0.0862643930397897,1.28332947975945e-43
NMR metabolomics,X23424.Total Lipids in VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,0.130119787215424,0.00936525929573119,0.111763878995791,0.148475695435057,1.3711224583251e-43
NMR metabolomics,X23424.Total Lipids in VLDL,CASP2,Caspase-2,39866,0.0897744553586251,0.00647356855026373,0.0770862610001082,0.102462649717142,1.77027595909113e-43
NMR metabolomics,X23424.Total Lipids in VLDL,CRYBB1,Beta-crystallin B1,37437,0.0874501571485835,0.00631347668840705,0.0750757428393057,0.0998245714578613,2.46062363826915e-43
NMR metabolomics,X23424.Total Lipids in VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.0319711928457659,0.0023100146975995,0.0274435640384709,0.036498821653061,2.58853325095945e-43
NMR metabolomics,X23424.Total Lipids in VLDL,SFRP1,Secreted frizzled-related protein 1,39689,0.0557360912771325,0.00402870040574657,0.0478398384818692,0.0636323440723958,2.80874833086398e-43
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,39585,0.147359193337153,0.0106562007900769,0.126473039788602,0.168245346885704,3.07281205703989e-43
NMR metabolomics,X23424.Total Lipids in VLDL,TST,Thiosulfate sulfurtransferase,39455,0.100200748980377,0.00724616461710473,0.0859982663308513,0.114403231629902,3.10398927788012e-43
NMR metabolomics,X23424.Total Lipids in VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,0.052408217442618,0.00378965227288389,0.0449804989877656,0.0598359358974705,3.32988729801882e-43
NMR metabolomics,X23424.Total Lipids in VLDL,LARP1,La-related protein 1,37368,0.0839738787744979,0.00608123820308286,0.0720546518964555,0.0958931056525403,4.43129740720369e-43
NMR metabolomics,X23424.Total Lipids in VLDL,BST2,Bone marrow stromal antigen 2,40009,0.0695773830326719,0.00504524333472054,0.0596887060966197,0.0794660599687242,5.08373138611446e-43
NMR metabolomics,X23424.Total Lipids in VLDL,FMNL1,Formin-like protein 1,39489,0.0796287825259137,0.00577526299610134,0.0683092670535551,0.0909482979982723,5.3800199056068e-43
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB9,Serpin B9,39749,0.0436631961078417,0.00316950068860839,0.0374509747581693,0.0498754174575142,6.26895257435738e-43
NMR metabolomics,X23424.Total Lipids in VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,37043,0.120942686867289,0.0087738602207077,0.103745920834702,0.138139452899876,6.27539664095487e-43
NMR metabolomics,X23424.Total Lipids in VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,0.0425216499836121,0.00308757762002448,0.0364699978483641,0.0485733021188601,6.63067284031834e-43
NMR metabolomics,X23424.Total Lipids in VLDL,PTX3,Pentraxin-related protein PTX3,39866,-0.0647785731364024,0.00470894398653292,-0.0740081033500069,-0.0555490429227978,8.15707393620725e-43
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4A,C-type lectin domain family 4 member A,39866,-0.0451956492180159,0.00329215247498751,-0.0516482680689914,-0.0387430303670404,1.19878958406245e-42
NMR metabolomics,X23424.Total Lipids in VLDL,AKT2,RAC-beta serine/threonine-protein kinase,37411,0.165571145010109,0.0120570989609693,0.141939231046609,0.189203058973609,1.25522973176274e-42
NMR metabolomics,X23424.Total Lipids in VLDL,CASP3,Caspase-3,40052,0.115720719720111,0.00843207556660463,0.0991938516095658,0.132247587830656,1.2653450447382e-42
NMR metabolomics,X23424.Total Lipids in VLDL,ASS1,Argininosuccinate synthase,37021,0.104116925135454,0.00758867804304369,0.0892431161710881,0.118990734099819,1.51108527968637e-42
NMR metabolomics,X23424.Total Lipids in VLDL,CCL24,C-C motif chemokine 24,39908,0.106929479188217,0.00781254752344544,0.0916168860422635,0.12224207233417,2.10402478114936e-42
NMR metabolomics,X23424.Total Lipids in VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,37437,0.0311563247945825,0.00227602884665834,0.0266953082551321,0.0356173413340328,2.26027678856432e-42
NMR metabolomics,X23424.Total Lipids in VLDL,JPT2,Jupiter microtubule associated homolog 2,37382,0.114577627804622,0.00837916125344871,0.0981544717478629,0.131000783861382,2.76934477789078e-42
NMR metabolomics,X23424.Total Lipids in VLDL,ADD1,Alpha-adducin,37124,0.0894963434727477,0.00654650532391367,0.076665193037877,0.102327493907619,2.9307383288944e-42
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP25,Rho GTPase-activating protein 25,39477,0.0781372746403118,0.00572270155108573,0.0669207796001837,0.0893537696804398,3.34239642635011e-42
NMR metabolomics,X23424.Total Lipids in VLDL,MIF,Macrophage migration inhibitory factor,39826,0.088280614270468,0.00646662850805606,0.0756060223946781,0.100955206146258,3.40187090416653e-42
NMR metabolomics,X23424.Total Lipids in VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,0.0865044742433512,0.00633445321489077,0.0740889459421653,0.0989200025445371,3.59330094322273e-42
NMR metabolomics,X23424.Total Lipids in VLDL,SPINT2,Kunitz-type protease inhibitor 2,39931,0.0531361833897118,0.00389475788176198,0.0455024579414583,0.0607699088379653,3.81551726655942e-42
NMR metabolomics,X23424.Total Lipids in VLDL,FAM3C,Protein FAM3C,39846,0.0373884808132346,0.00274319443088356,0.0320118197287028,0.0427651418977663,4.59202164825185e-42
NMR metabolomics,X23424.Total Lipids in VLDL,CCL26,C-C motif chemokine 26,39866,0.110456593477149,0.00810714546147877,0.0945665883726504,0.126346598581647,4.90667528988903e-42
NMR metabolomics,X23424.Total Lipids in VLDL,AFP,Alpha-fetoprotein,39699,0.0872574086712635,0.00640691665003947,0.0746998520371861,0.0998149653053408,5.30478051844092e-42
NMR metabolomics,X23424.Total Lipids in VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,0.0668806934267873,0.00490831310202923,0.05726039974681,0.0765009871067646,5.39509408243757e-42
NMR metabolomics,X23424.Total Lipids in VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,37124,0.114032860643469,0.00837274774488249,0.0976222750634992,0.130443446223439,5.86881688046631e-42
NMR metabolomics,X23424.Total Lipids in VLDL,CEBPB,CCAAT/enhancer-binding protein beta,39585,0.0481774381652856,0.00354310471885318,0.0412329529163334,0.0551219234142378,7.14470560919396e-42
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC3B,Tetranectin,37138,0.0273052961019391,0.00200869575672252,0.0233682524187629,0.0312423397851152,8.32694221132556e-42
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,0.057203309632029,0.00421237729486649,0.0489470501340907,0.0654595691299673,9.02386534874827e-42
NMR metabolomics,X23424.Total Lipids in VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,0.0495190159128121,0.00364651351182969,0.0423718494296259,0.0566661823959983,9.90051809943256e-42
NMR metabolomics,X23424.Total Lipids in VLDL,MICALL2,MICAL-like protein 2,37039,0.0876014686849163,0.0064529445490457,0.0749536973687868,0.100249240001046,1.06795754328715e-41
NMR metabolomics,X23424.Total Lipids in VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,0.140725346873049,0.0103736379838941,0.120393016424617,0.161057677321482,1.23786338446943e-41
NMR metabolomics,X23424.Total Lipids in VLDL,TXNDC9,Thioredoxin domain-containing protein 9,37388,0.0691813129193017,0.00510149125927835,0.0591823900511161,0.0791802357874872,1.27559990912573e-41
NMR metabolomics,X23424.Total Lipids in VLDL,BDNF,Brain-derived neurotrophic factor,37437,0.106150082497002,0.00783154313728869,0.0908002579479162,0.121499907046088,1.39511542069216e-41
NMR metabolomics,X23424.Total Lipids in VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,0.0740380402208932,0.00546521085295379,0.0633262269491037,0.0847498534926826,1.39657499270121e-41
NMR metabolomics,X23424.Total Lipids in VLDL,DCTD,Deoxycytidylate deaminase,37124,0.12313297655,0.00908837512820772,0.105319761298713,0.140946191801287,1.52966624765042e-41
NMR metabolomics,X23424.Total Lipids in VLDL,DBI,Acyl-CoA-binding protein,39793,0.102657398868473,0.00758182141266381,0.0877970288996515,0.117517768837294,1.54227027318282e-41
NMR metabolomics,X23424.Total Lipids in VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,0.157072805567264,0.0116130252354289,0.134311276105823,0.179834335028705,1.86661718197873e-41
NMR metabolomics,X23424.Total Lipids in VLDL,C1R,Complement C1r subcomponent,37453,0.0248167854958067,0.00183498698951518,0.021220210996357,0.0284133599952565,2.08425174840873e-41
NMR metabolomics,X23424.Total Lipids in VLDL,TMSB10,Thymosin beta-10,39858,0.0989816592277417,0.00732596026355854,0.084622777111167,0.113340541344316,2.26842009931113e-41
NMR metabolomics,X23424.Total Lipids in VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,0.103062213080911,0.00762762806166717,0.0881120620800434,0.118012364081779,2.51122380146976e-41
NMR metabolomics,X23424.Total Lipids in VLDL,GP6,Platelet glycoprotein VI,39836,0.113473746928546,0.00841164706290362,0.0969869186852545,0.129960575171837,3.0094242203791e-41
NMR metabolomics,X23424.Total Lipids in VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,39391,0.0743836507726294,0.005530941890324,0.0635430046675944,0.0852242968776644,5.31846001580755e-41
NMR metabolomics,X23424.Total Lipids in VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,0.0472475671640812,0.00351154259232658,0.0403649436831211,0.0541301906450413,5.3479825690656e-41
NMR metabolomics,X23424.Total Lipids in VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,0.0773315176208411,0.00575829399843305,0.0660452613839123,0.0886177738577699,7.49816785058406e-41
NMR metabolomics,X23424.Total Lipids in VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,37220,0.0710480149214623,0.00529259104965673,0.0606745364641352,0.0814214933787895,8.03685176865375e-41
NMR metabolomics,X23424.Total Lipids in VLDL,IL10RB,Interleukin-10 receptor subunit beta,39931,0.0356390329009017,0.00265716848715258,0.0304309826660827,0.0408470831357208,8.4773865757072e-41
NMR metabolomics,X23424.Total Lipids in VLDL,NRGN,Neurogranin,37445,0.116716880455539,0.00870147176486523,0.0996619957964028,0.133771765114675,9.1615885551013e-41
NMR metabolomics,X23424.Total Lipids in VLDL,RILP,Rab-interacting lysosomal protein,39984,0.0754208025421385,0.00562665787476182,0.0643925531076054,0.0864490519766717,9.44349307997339e-41
NMR metabolomics,X23424.Total Lipids in VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,0.0942762515179767,0.0070307296194661,0.0804960214638231,0.10805648157213,9.70376666139657e-41
NMR metabolomics,X23424.Total Lipids in VLDL,SMTN,Smoothelin,37342,0.12258850013188,0.00914670993997099,0.104660948649537,0.140516051614223,1.06527719077435e-40
NMR metabolomics,X23424.Total Lipids in VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,0.0295769838171796,0.00221067519875619,0.0252440604276174,0.0339099072067417,1.32598197385581e-40
NMR metabolomics,X23424.Total Lipids in VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,37411,0.0489611416621362,0.00365830619786624,0.0417908615143184,0.056131421809954,1.36560872822548e-40
NMR metabolomics,X23424.Total Lipids in VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,0.0463058025423558,0.00346009658967993,0.0395240132265831,0.0530875918581285,1.4031026000881e-40
NMR metabolomics,X23424.Total Lipids in VLDL,CNDP1,Beta-Ala-His dipeptidase,39931,0.0576977092952022,0.00431631326077916,0.049237735304075,0.0661576832863293,1.5444651807366e-40
NMR metabolomics,X23424.Total Lipids in VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,0.0731420699367058,0.00547287960056699,0.0624152259195945,0.0838689139538171,1.6143007375255e-40
NMR metabolomics,X23424.Total Lipids in VLDL,FOXO3,Forkhead box protein O3,39477,0.123648355061839,0.00925891735317525,0.105500877049616,0.141795833074063,1.8583052777746e-40
NMR metabolomics,X23424.Total Lipids in VLDL,GBP1,Guanylate-binding protein 1,37376,0.0806017310903258,0.00603394728860231,0.0687751944046652,0.0924282677759863,1.91868128065196e-40
NMR metabolomics,X23424.Total Lipids in VLDL,EGFL7,Epidermal growth factor-like protein 7,39477,0.049877841780578,0.00373756153682498,0.042552221168401,0.057203462392755,2.10783847639086e-40
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA3,Annexin A3,39985,0.0882269420090817,0.00661982249191989,0.0752520899249187,0.101201794093245,2.61071859985756e-40
NMR metabolomics,X23424.Total Lipids in VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,0.0549270449859565,0.00412258317019987,0.0468467819723648,0.0630073079995483,2.80557976797608e-40
NMR metabolomics,X23424.Total Lipids in VLDL,GGCT,Gamma-glutamylcyclotransferase,37430,0.0608625959400194,0.00457163393795557,0.0519021934216265,0.0698229984584123,3.47037898088788e-40
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP1,Metalloproteinase inhibitor 1,39698,0.0348236307626639,0.00261707669219023,0.029694160445971,0.0399531010793568,3.49596110559598e-40
NMR metabolomics,X23424.Total Lipids in VLDL,IMMT,MICOS complex subunit MIC60,37368,0.055405336876453,0.00416465795959461,0.0472426072756475,0.0635680664772584,3.93959521529043e-40
NMR metabolomics,X23424.Total Lipids in VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,0.0826075278544554,0.00621869520788479,0.0704188852470012,0.0947961704619095,4.66730461000774e-40
NMR metabolomics,X23424.Total Lipids in VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,0.0486596124270132,0.00366132063033775,0.0414834239915512,0.0558358008624752,4.76701117799178e-40
NMR metabolomics,X23424.Total Lipids in VLDL,WDR46,WD repeat-containing protein 46,37368,0.0454580450491918,0.00342365980822703,0.0387476718250668,0.0521684182733168,5.55723208950221e-40
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX6,Peroxiredoxin-6,40030,-0.0742529519209564,0.00560514328944727,-0.0852390327682731,-0.0632668710736398,7.54570635707916e-40
NMR metabolomics,X23424.Total Lipids in VLDL,NPC2,NPC intracellular cholesterol transporter 2,37268,0.037431122433683,0.00282415953939011,0.0318957697364783,0.0429664751308876,7.62695776119068e-40
NMR metabolomics,X23424.Total Lipids in VLDL,CEP170,Centrosomal protein of 170 kDa,37043,0.0968837457669334,0.00732308401838995,0.0825305010908891,0.111236990442978,1.05559278063491e-39
NMR metabolomics,X23424.Total Lipids in VLDL,INPP1,Inositol polyphosphate 1-phosphatase,39788,0.0675081010794786,0.00511598087218078,0.0574807785700043,0.077535423588953,1.50121195469523e-39
NMR metabolomics,X23424.Total Lipids in VLDL,CALB2,Calretinin,39489,0.0364808117246431,0.00276587842642528,0.0310596900088495,0.0419019334404366,1.63771316558827e-39
NMR metabolomics,X23424.Total Lipids in VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.0503543645475713,0.00381961299059068,0.0428679230860135,0.057840806009129,1.77179723480224e-39
NMR metabolomics,X23424.Total Lipids in VLDL,CBLN4,Cerebellin-4,40030,0.0387515298784937,0.00293981658936139,0.0329894893633454,0.0445135703936421,1.78930805104211e-39
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB2,DnaJ homolog subfamily B member 2,37124,0.066716959679001,0.00506024511193879,0.056798879259601,0.076635040098401,1.90690889744828e-39
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF6,SLAM family member 6,39477,0.0471411964330623,0.003579265338939,0.0401258363687418,0.0541565564973827,2.10056399135126e-39
NMR metabolomics,X23424.Total Lipids in VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,0.0380114511301055,0.0028868549821452,0.0323532153651009,0.0436696868951101,2.37764861684299e-39
NMR metabolomics,X23424.Total Lipids in VLDL,CDC37,Hsp90 co-chaperone Cdc37,39913,0.104374362730851,0.0079396016153702,0.0888127435647258,0.119935981896977,2.86077993268127e-39
NMR metabolomics,X23424.Total Lipids in VLDL,DXO,Decapping and exoribonuclease protein,37388,0.0567780987288846,0.00431788402183634,0.0483150460460854,0.0652411514116838,2.98082297216791e-39
NMR metabolomics,X23424.Total Lipids in VLDL,CD83,CD83 antigen,39866,0.0408525200688432,0.00310990308701922,0.0347571100182855,0.0469479301194009,3.25534855365734e-39
NMR metabolomics,X23424.Total Lipids in VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,37437,0.0619298138837777,0.00471342282817162,0.0526915051405613,0.0711681226269941,3.41134862267627e-39
NMR metabolomics,X23424.Total Lipids in VLDL,PARK7,Parkinson disease protein 7,39858,0.0652669506039529,0.00497595512853631,0.0555140785520217,0.075019822655884,4.21712081069448e-39
NMR metabolomics,X23424.Total Lipids in VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,0.0810805814462733,0.00618071134721939,0.0689663872057232,0.0931947756868233,4.47855343883707e-39
NMR metabolomics,X23424.Total Lipids in VLDL,CCT5,T-complex protein 1 subunit epsilon,39477,0.0556816892646783,0.00424669329647599,0.0473581704035854,0.0640052081257712,4.53401037177533e-39
NMR metabolomics,X23424.Total Lipids in VLDL,GIPC3,PDZ domain-containing protein GIPC3,37382,0.123256722438302,0.00940194649264074,0.104828907312726,0.141684537563878,5.01081563319595e-39
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAL,Integrin alpha-L,37056,0.0532044309643203,0.00406050825656468,0.0452458347814535,0.0611630271471871,5.54858290052255e-39
NMR metabolomics,X23424.Total Lipids in VLDL,ROBO2,Roundabout homolog 2,40009,0.0281556679861244,0.00215630771177957,0.0239293048710365,0.0323820311012124,9.06821016781618e-39
NMR metabolomics,X23424.Total Lipids in VLDL,SPOCK1,Testican-1,39749,0.031386510846325,0.00240755729827617,0.0266676985417037,0.0361053231509463,1.19501888836846e-38
NMR metabolomics,X23424.Total Lipids in VLDL,TPK1,Thiamin pyrophosphokinase 1,37437,0.0341352604489992,0.00261829125852161,0.0290034095822968,0.0392671113157015,1.28138015739996e-38
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM1,Intercellular adhesion molecule 1,39822,0.0351240909727377,0.0026955883820813,0.0298407377438584,0.0404074442016171,1.29659256459205e-38
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G4A,Cytosolic phospholipase A2,39931,0.108953864421925,0.00836595944927136,0.0925565839013533,0.125351144942497,1.41064654412702e-38
NMR metabolomics,X23424.Total Lipids in VLDL,MARCO,Macrophage receptor MARCO,39868,0.0323766500770218,0.00248609845185681,0.0275038971113824,0.0372494030426611,1.42044888278017e-38
NMR metabolomics,X23424.Total Lipids in VLDL,ESAM,Endothelial cell-selective adhesion molecule,40052,0.0386047895602138,0.00296451457025786,0.0327943410025084,0.0444152381179193,1.42758081040316e-38
NMR metabolomics,X23424.Total Lipids in VLDL,CTRB1,Chymotrypsinogen B,39858,0.0659681247131032,0.00506890594336634,0.0560330690641052,0.0759031803621012,1.59253051144416e-38
NMR metabolomics,X23424.Total Lipids in VLDL,FRMD4B,FERM domain-containing protein 4B,37021,0.0869413714609298,0.00668258352614177,0.0738435077496919,0.100039235172168,1.8495588032422e-38
NMR metabolomics,X23424.Total Lipids in VLDL,DBN1,Drebrin,37056,0.0647646166351542,0.00497905655894476,0.0550056657796225,0.0745235674906859,1.91336222469342e-38
NMR metabolomics,X23424.Total Lipids in VLDL,RASSF2,Ras association domain-containing protein 2,39477,0.0678305448172892,0.00522457422613064,0.0575903793340732,0.0780707103005052,2.4132927003156e-38
NMR metabolomics,X23424.Total Lipids in VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,37021,0.0856777118610217,0.00659682483996254,0.0727479351746951,0.0986074885473483,2.47050544293374e-38
NMR metabolomics,X23424.Total Lipids in VLDL,ZNRD2,Protein ZNRD2,37382,0.083520658795569,0.00644987054375892,0.0708789125298015,0.0961624050613365,4.00033521454242e-38
NMR metabolomics,X23424.Total Lipids in VLDL,BAG3,BAG family molecular chaperone regulator 3,39720,0.048545238665657,0.00375104910448789,0.0411931824208607,0.0558972949104532,4.07818569132122e-38
NMR metabolomics,X23424.Total Lipids in VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,0.0705037131844527,0.00545336959890723,0.0598151087705945,0.0811923175983109,5.28886419939994e-38
NMR metabolomics,X23424.Total Lipids in VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,39587,0.0800626703842413,0.0062047713688146,0.0679013185013647,0.0922240222671179,6.70564956309663e-38
NMR metabolomics,X23424.Total Lipids in VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,0.0802717521187764,0.00622513146395715,0.0680704944494204,0.0924730097881324,7.51320149688428e-38
NMR metabolomics,X23424.Total Lipids in VLDL,CCL2,C-C motif chemokine 2,39720,0.0631468132561965,0.0049018246776369,0.0535392368880282,0.0727543896243648,8.758562793828e-38
NMR metabolomics,X23424.Total Lipids in VLDL,CFHR5,Complement factor H-related protein 5,37267,0.0505367666941446,0.00392183501709782,0.0428499700606328,0.0582235633276563,9.04250681775379e-38
NMR metabolomics,X23424.Total Lipids in VLDL,GGACT,Gamma-glutamylaminecyclotransferase,37437,0.0873333135885097,0.00677791927272614,0.0740485918139664,0.100618035363053,9.10357640398491e-38
NMR metabolomics,X23424.Total Lipids in VLDL,CPXM1,Probable carboxypeptidase X1,39913,0.082927591797042,0.00644019127405385,0.0703048168998965,0.0955503666941876,9.37796656044592e-38
NMR metabolomics,X23424.Total Lipids in VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,0.147519671891148,0.01145654698807,0.12506483979453,0.169974503987765,9.40435462374203e-38
NMR metabolomics,X23424.Total Lipids in VLDL,TTF2,Transcription termination factor 2,37039,0.060165296888576,0.00467006654035411,0.051011966469482,0.0693186273076701,9.45854833501497e-38
NMR metabolomics,X23424.Total Lipids in VLDL,IGF1R,Insulin-like growth factor 1 receptor,39788,0.0264628912651783,0.0020584673185109,0.0224282953208969,0.0304974872094596,1.23050271117677e-37
NMR metabolomics,X23424.Total Lipids in VLDL,CCL25,C-C motif chemokine 25,40058,0.0607270510090787,0.00472585175893997,0.0514643815615563,0.069989720456601,1.31353190790295e-37
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,39585,0.048211961485351,0.00375712890809452,0.0408479888254857,0.0555759341452163,1.67101748076159e-37
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH7,Protocadherin-7,37382,0.0409280864958333,0.00318997702599963,0.034675731524874,0.0471804414667926,1.83653151794425e-37
NMR metabolomics,X23424.Total Lipids in VLDL,CA13,Carbonic anhydrase 13,39657,0.128328437620989,0.0100082707531784,0.108712226944759,0.147944648297218,1.89226882569016e-37
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,0.0840808577995715,0.006561772900528,0.0712197829145366,0.0969419326846064,2.08690777675042e-37
NMR metabolomics,X23424.Total Lipids in VLDL,EGFR,Epidermal growth factor receptor,40052,0.0194379239400977,0.00152101169298972,0.0164567410218378,0.0224191068583575,3.22501749018589e-37
NMR metabolomics,X23424.Total Lipids in VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,0.0737807408056678,0.00577323304046077,0.0624652040463647,0.0850962775649709,3.23247153267891e-37
NMR metabolomics,X23424.Total Lipids in VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,0.0939410419027338,0.00734775073060738,0.0795394504707434,0.108342633334724,3.26467138750218e-37
NMR metabolomics,X23424.Total Lipids in VLDL,FADD,FAS-associated death domain protein,39868,0.0931544488919781,0.00729220404856965,0.0788617289567815,0.107447168827175,3.45650246742469e-37
NMR metabolomics,X23424.Total Lipids in VLDL,IFT20,Intraflagellar transport protein 20 homolog,37039,0.0528120382364097,0.00413445024204885,0.044708515761994,0.0609155607108255,3.8203713705001e-37
NMR metabolomics,X23424.Total Lipids in VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",37397,0.0487430818886886,0.00382149604308892,0.0412529496442343,0.0562332141331429,4.77828674989834e-37
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN9,Septin-9,39788,0.0341573327384392,0.00268620285497925,0.0288923751426798,0.0394222903341985,7.29525121420526e-37
NMR metabolomics,X23424.Total Lipids in VLDL,GET3,ATPase GET3,37437,0.0675243359695566,0.00531715139597394,0.0571027192334476,0.0779459527056655,9.64628750839986e-37
NMR metabolomics,X23424.Total Lipids in VLDL,FAM3B,Protein FAM3B,39788,0.0431736791750878,0.00340468697442596,0.0365004927052129,0.0498468656449627,1.13840000086904e-36
NMR metabolomics,X23424.Total Lipids in VLDL,GGH,Gamma-glutamyl hydrolase,39573,0.0408180335387358,0.00322066311200913,0.0345055338391979,0.0471305332382737,1.24834099830386e-36
NMR metabolomics,X23424.Total Lipids in VLDL,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.0381672917744821,0.00301509569130131,0.0322577042195315,0.0440768793294326,1.49231551528433e-36
NMR metabolomics,X23424.Total Lipids in VLDL,RAB2B,Ras-related protein Rab-2B,37368,0.0753592915927327,0.00595674692491858,0.0636840676198923,0.0870345155655731,1.77658214103641e-36
NMR metabolomics,X23424.Total Lipids in VLDL,GRK5,G protein-coupled receptor kinase 5,39585,0.0635990623729865,0.00502952647270471,0.0537411904864852,0.0734569342594877,1.79115451428849e-36
NMR metabolomics,X23424.Total Lipids in VLDL,APOL1,Apolipoprotein L1,37445,0.0737066217825706,0.00582656157501906,0.0622865610955333,0.085126682469608,1.79371030239901e-36
NMR metabolomics,X23424.Total Lipids in VLDL,MATN2,Matrilin-2,39885,0.0356799446682488,0.00282203150477025,0.0301487629188991,0.0412111264175985,1.81800440753246e-36
NMR metabolomics,X23424.Total Lipids in VLDL,CD40LG,CD40 ligand,40058,0.0931847929606016,0.00737735447106188,0.0787251781973203,0.107644407723883,2.10982579588539e-36
NMR metabolomics,X23424.Total Lipids in VLDL,PTGR1,Prostaglandin reductase 1,37437,0.095518843884467,0.00756127840754872,0.0806987382056715,0.110338949563263,2.23500772259518e-36
NMR metabolomics,X23424.Total Lipids in VLDL,CD274,Programmed cell death 1 ligand 1,39749,0.0401729041104299,0.0031835959181802,0.0339330561107967,0.0464127521100631,2.4871240244566e-36
NMR metabolomics,X23424.Total Lipids in VLDL,BLNK,B-cell linker protein,37056,0.0469259895212545,0.00371719453092795,0.0396402882406357,0.0542116908018733,2.52358625678037e-36
NMR metabolomics,X23424.Total Lipids in VLDL,RNASEH2A,Ribonuclease H2 subunit A,37411,0.0590733453398098,0.00468211497233277,0.0498963999940376,0.0682502906855821,2.7286611270152e-36
NMR metabolomics,X23424.Total Lipids in VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,0.0919705036209743,0.00729139343039838,0.0776793724973935,0.106261634744555,2.84461964073824e-36
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA2,Integrin alpha-2,37124,0.0402588787859057,0.00319477819850922,0.0339971135168276,0.0465206440549838,3.34102487591146e-36
NMR metabolomics,X23424.Total Lipids in VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.118134411169491,0.00939078772724491,0.0997284672240905,0.136540355114891,4.03655624696852e-36
NMR metabolomics,X23424.Total Lipids in VLDL,MZT1,Mitotic-spindle organizing protein 1,39477,0.0636724422882631,0.00506312744753301,0.0537487124910984,0.0735961720854278,4.29610437259844e-36
NMR metabolomics,X23424.Total Lipids in VLDL,TBCA,Tubulin-specific chaperone A,37124,0.103095681173412,0.00821334620187982,0.086997522617727,0.119193839729096,6.18539999762962e-36
NMR metabolomics,X23424.Total Lipids in VLDL,MDK,Midkine,39843,0.0601597673549699,0.0047995935451995,0.0507525640063789,0.0695669707035609,7.1425442116444e-36
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA6,Integrin alpha-6,39866,0.0630343769134776,0.00503147420614642,0.0531726874694306,0.0728960663575246,7.72602257410193e-36
NMR metabolomics,X23424.Total Lipids in VLDL,EPPK1,Epiplakin,37043,0.088749817678797,0.00708445502986518,0.0748642858202613,0.102635349537333,8.45247114130758e-36
NMR metabolomics,X23424.Total Lipids in VLDL,TREH,Trehalase,37437,0.0895595654164459,0.0071585643003983,0.0755287793876652,0.103590351445227,1.02508985221882e-35
NMR metabolomics,X23424.Total Lipids in VLDL,CDC26,Anaphase-promoting complex subunit CDC26,37362,0.084491998462938,0.00675513603254195,0.0712519318391557,0.0977320650867202,1.06690173449616e-35
NMR metabolomics,X23424.Total Lipids in VLDL,HSPB6,Heat shock protein beta-6,40030,0.0444168035569853,0.0035558093330068,0.037447417264292,0.0513861898496787,1.21582269191545e-35
NMR metabolomics,X23424.Total Lipids in VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,0.0531805277739091,0.00425761729165818,0.0448355978822591,0.0615254576655592,1.33412820581199e-35
NMR metabolomics,X23424.Total Lipids in VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,-0.02343111324891,0.00187788719548897,-0.0271117721520684,-0.0197504543457516,1.45462563070778e-35
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS3BP,Galectin-3-binding protein,37453,0.035685521807817,0.00286203531471317,0.0300759325909792,0.0412951110246548,1.73187553692796e-35
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJC9,DnaJ homolog subfamily C member 9,37382,0.0898805899522572,0.00720999520135832,0.0757489993575949,0.10401218054692,1.78997348330808e-35
NMR metabolomics,X23424.Total Lipids in VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,39788,0.0529535801884273,0.00425212528004,0.044619414639549,0.0612877457373057,1.95852715095396e-35
NMR metabolomics,X23424.Total Lipids in VLDL,IL12A_IL12B,Interleukin-12,39788,0.0869234690360095,0.00698612391478573,0.0732306661630295,0.10061627190899,2.24868720467841e-35
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL11,C-X-C motif chemokine 11,40009,0.091692263412788,0.00738507215254869,0.0772175219937926,0.106167004831783,3.10315658596054e-35
NMR metabolomics,X23424.Total Lipids in VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,39477,0.0402774985817639,0.00324436934948555,0.0339185346567722,0.0466364625067556,3.19355082952579e-35
NMR metabolomics,X23424.Total Lipids in VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,0.0326523271012559,0.00263743602188251,0.0274829524983662,0.0378217017041456,4.82196575251309e-35
NMR metabolomics,X23424.Total Lipids in VLDL,APOE,Apolipoprotein E,37453,0.0851729805160129,0.00688721739838704,0.0716740344151743,0.0986719266168515,6.09016495572335e-35
NMR metabolomics,X23424.Total Lipids in VLDL,CALCA,Calcitonin,39713,0.0715013767901959,0.00578496162401894,0.0601628520071188,0.082839901573273,6.24045739500795e-35
NMR metabolomics,X23424.Total Lipids in VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,39477,0.0577897151974806,0.00467599689154002,0.0486247612900621,0.066954669104899,6.35848925177464e-35
NMR metabolomics,X23424.Total Lipids in VLDL,CD46,Membrane cofactor protein,39777,0.0332422606388616,0.00269000636308872,0.0279698481672077,0.0385146731105155,6.40101997877568e-35
NMR metabolomics,X23424.Total Lipids in VLDL,NFAT5,Nuclear factor of activated T-cells 5,37056,0.101440384999428,0.00820981045774376,0.08534915650225,0.117531613496605,7.04781249220589e-35
NMR metabolomics,X23424.Total Lipids in VLDL,FGF2,Fibroblast growth factor 2,39866,0.078064595236093,0.00632258897937423,0.0656723208365195,0.0904568696356664,7.29250541736278e-35
NMR metabolomics,X23424.Total Lipids in VLDL,MCAM,Cell surface glycoprotein MUC18,39931,-0.0382671579846688,0.00310023752357733,-0.0443436235308804,-0.0321906924384573,7.61511212472623e-35
NMR metabolomics,X23424.Total Lipids in VLDL,NBN,Nibrin,39587,0.0602832065224478,0.00488880979391912,0.0507011393263663,0.0698652737185293,8.9447362557264e-35
NMR metabolomics,X23424.Total Lipids in VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.103380000392674,0.00838705146019675,0.0869413795306888,0.11981862125466,9.42541347338634e-35
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.0418091416486604,0.00339077084058817,0.0351632308011076,0.0484550524962132,9.56262439747385e-35
NMR metabolomics,X23424.Total Lipids in VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,0.0751972674926178,0.00611038265441406,0.0632209174899662,0.0871736174952693,1.20945915463083e-34
NMR metabolomics,X23424.Total Lipids in VLDL,BMP6,Bone morphogenetic protein 6,39568,0.048831735822658,0.00396923978617024,0.0410520258417643,0.0566114458035517,1.26690159581894e-34
NMR metabolomics,X23424.Total Lipids in VLDL,BTC,Probetacellulin,39477,0.0862913354587527,0.00702434261983869,0.0725236239238688,0.100059046993637,1.58154986408603e-34
NMR metabolomics,X23424.Total Lipids in VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,0.0620204380135727,0.00504724486583415,0.0521278380765378,0.0719130379506076,1.62339088927809e-34
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC134,Coiled-coil domain-containing protein 134,37368,0.0567319162922621,0.00462268418830172,0.0476714552831908,0.0657923773013335,1.94115670713989e-34
NMR metabolomics,X23424.Total Lipids in VLDL,ADM,Pro-adrenomedullin,40030,0.0306015389186813,0.00249747919264591,0.0257064797010953,0.0354965981362673,2.30042798701945e-34
NMR metabolomics,X23424.Total Lipids in VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,0.0329406313374364,0.00269025895151951,0.0276677237924582,0.0382135388824147,2.75839975868822e-34
NMR metabolomics,X23424.Total Lipids in VLDL,LGMN,Legumain,39931,0.0416660603261377,0.0034077948175525,0.0349867824837348,0.0483453381685406,3.17722301129652e-34
NMR metabolomics,X23424.Total Lipids in VLDL,PARD3,Partitioning defective 3 homolog,37169,0.085896274861228,0.00702392911599,0.0721293737938876,0.0996631759285684,3.31655780360673e-34
NMR metabolomics,X23424.Total Lipids in VLDL,ERMAP,Erythroid membrane-associated protein,37056,0.0517921409324498,0.00423575471990147,0.0434900616814429,0.0600942201834567,3.39897687118424e-34
NMR metabolomics,X23424.Total Lipids in VLDL,PECAM1,Platelet endothelial cell adhesion molecule,39858,0.0348035914596229,0.00284937520598764,0.0292188160558871,0.0403883668633587,3.69371228656008e-34
NMR metabolomics,X23424.Total Lipids in VLDL,PDZD2,PDZ domain-containing protein 2,37021,0.0696622326811069,0.00570219489950556,0.058485930678076,0.0808385346841378,3.87254359872907e-34
NMR metabolomics,X23424.Total Lipids in VLDL,BAP18,Chromatin complexes subunit BAP18,37388,0.0754746569457892,0.00618619114993616,0.0633497222919143,0.0875995915996641,4.66362746894945e-34
NMR metabolomics,X23424.Total Lipids in VLDL,ATG4A,Cysteine protease ATG4A,39477,0.0680947816918287,0.00558609014398196,0.057146045009624,0.0790435183740333,5.01301299158788e-34
NMR metabolomics,X23424.Total Lipids in VLDL,RAB10,Ras-related protein Rab-10,37437,0.0618833027805826,0.00508582821588789,0.0519150794774424,0.0718515260837229,6.92544489788096e-34
NMR metabolomics,X23424.Total Lipids in VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,0.0957435900123932,0.00788885023741357,0.0802814435470626,0.111205736477724,9.51054992723513e-34
NMR metabolomics,X23424.Total Lipids in VLDL,STXBP3,Syntaxin-binding protein 3,39477,0.0508845170051034,0.00419414408864853,0.0426639945913523,0.0591050394188545,1.01028491520582e-33
NMR metabolomics,X23424.Total Lipids in VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,0.0522501610070721,0.00430500590471252,0.0438123494338355,0.0606879725803086,1.01606446691431e-33
NMR metabolomics,X23424.Total Lipids in VLDL,ENAH,Protein enabled homolog,39587,0.0552391353199105,0.00455412762393644,0.046313045176995,0.0641652254628259,1.04270069439931e-33
NMR metabolomics,X23424.Total Lipids in VLDL,RGS10,Regulator of G-protein signaling 10,37411,0.0690494427168197,0.00569192569997933,0.0578932683448602,0.0802056170887792,1.08011635872695e-33
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS27,Serine protease 27,39818,0.0462253402922572,0.00381242130421932,0.0387529945359873,0.053697686048527,1.09603740276123e-33
NMR metabolomics,X23424.Total Lipids in VLDL,MENT,Protein MENT,37124,-0.0255911497002627,0.00211202605726527,-0.0297307207725026,-0.0214515786280228,1.29397452076233e-33
NMR metabolomics,X23424.Total Lipids in VLDL,ABHD14B,Protein ABHD14B,39687,0.0660758457269263,0.00545852380798466,0.0553771390632763,0.0767745523905762,1.39713895029254e-33
NMR metabolomics,X23424.Total Lipids in VLDL,CD74,HLA class II histocompatibility antigen gamma chain,40009,0.0388963042077436,0.00321375816266678,0.0325973382089167,0.0451952702065705,1.42192826449908e-33
NMR metabolomics,X23424.Total Lipids in VLDL,FGF23,Fibroblast growth factor 23,40008,0.0669248841851774,0.00554149733782654,0.0560635494030374,0.0777862189673174,1.9462179909291e-33
NMR metabolomics,X23424.Total Lipids in VLDL,ACRBP,Acrosin-binding protein,37368,0.0440388710211086,0.00364809417041475,0.0368886064470956,0.0511891355951215,2.21208624799116e-33
NMR metabolomics,X23424.Total Lipids in VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,0.0549745211151047,0.00455970442086484,0.0460375004502096,0.0639115417799998,2.6784062886305e-33
NMR metabolomics,X23424.Total Lipids in VLDL,ASGR2,Asialoglycoprotein receptor 2,37445,0.0289910233944131,0.002406448820753,0.0242743837057373,0.033707663083089,2.96336014824415e-33
NMR metabolomics,X23424.Total Lipids in VLDL,MRI1,Methylthioribose-1-phosphate isomerase,37039,0.0770725937694373,0.00640227664850137,0.0645241315383746,0.0896210560004999,3.3372002726611e-33
NMR metabolomics,X23424.Total Lipids in VLDL,ITPA,Inosine triphosphate pyrophosphatase,37021,0.0775059778586673,0.00644542983860619,0.0648729353749991,0.0901390203423354,3.91865045056795e-33
NMR metabolomics,X23424.Total Lipids in VLDL,NGRN,Neugrin,37388,0.02436867357054,0.00202691436523883,0.0203959214146719,0.0283414257264081,3.98992136966988e-33
NMR metabolomics,X23424.Total Lipids in VLDL,ARFIP1,Arfaptin-1,37411,0.0790734888046445,0.00658066463495296,0.0661753861201367,0.0919715914891523,4.31072253348388e-33
NMR metabolomics,X23424.Total Lipids in VLDL,ARSA,Arylsulfatase A,39858,0.0512502754659853,0.00426901516397107,0.042883005744602,0.0596175451873686,4.62914681453096e-33
NMR metabolomics,X23424.Total Lipids in VLDL,DMD,Dystrophin,37043,0.0590931599921574,0.0049216429795488,0.0494467397522417,0.068739580232073,4.86638769054803e-33
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.0297622983452625,0.002481340152613,0.024898871646141,0.0346257250443839,5.57410000612107e-33
NMR metabolomics,X23424.Total Lipids in VLDL,VGF,Neurosecretory protein VGF,37411,0.0333000186586827,0.00277776344519918,0.0278556023060923,0.0387444350112731,6.02242331486764e-33
NMR metabolomics,X23424.Total Lipids in VLDL,OPLAH,5-oxoprolinase,37043,0.0788876234045441,0.00659083388101313,0.0659695889977583,0.0918056578113298,7.61509961698438e-33
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,0.0820228607131793,0.00686662276518435,0.068564280093418,0.0954814413329406,9.53677144935576e-33
NMR metabolomics,X23424.Total Lipids in VLDL,FGL1,Fibrinogen-like protein 1,37445,-0.0703112772992399,0.00588462420771982,-0.0818451407463708,-0.0587774138521091,9.66708610727106e-33
NMR metabolomics,X23424.Total Lipids in VLDL,ING1,Inhibitor of growth protein 1,39453,0.0510223175307575,0.00427254216193249,0.0426481348933698,0.0593965001681452,9.94013452521886e-33
NMR metabolomics,X23424.Total Lipids in VLDL,CXADR,Coxsackievirus and adenovirus receptor,39866,0.0574035396760487,0.00480808070377641,0.0479797014966469,0.0668273778554505,1.02080398543044e-32
NMR metabolomics,X23424.Total Lipids in VLDL,GSR,"Glutathione reductase, mitochondrial",37403,0.0255426433736503,0.00214055794899398,0.0213471497936221,0.0297381369536785,1.16522444575369e-32
NMR metabolomics,X23424.Total Lipids in VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,0.045867577735982,0.00384709354046355,0.0383272743966734,0.0534078810752906,1.32729568583995e-32
NMR metabolomics,X23424.Total Lipids in VLDL,LAMA4,Laminin subunit alpha-4,39931,0.0379798237713747,0.00319191079457556,0.0317236786140066,0.0442359689287428,1.64463835849065e-32
NMR metabolomics,X23424.Total Lipids in VLDL,RAD23B,UV excision repair protein RAD23 homolog B,39477,0.053239928991881,0.00447571395596024,0.044467529638199,0.0620123283455631,1.7296638367273e-32
NMR metabolomics,X23424.Total Lipids in VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,0.135488702014929,0.0113951026506596,0.113154300819636,0.157823103210221,1.82498627422576e-32
NMR metabolomics,X23424.Total Lipids in VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,0.099005220049261,0.00832489628058029,0.0826884233393236,0.115322016759198,1.87528939614564e-32
NMR metabolomics,X23424.Total Lipids in VLDL,PIGR,Polymeric immunoglobulin receptor,39677,0.041011997762362,0.00345243885412797,0.0342452176082711,0.0477787779164528,2.08659073688619e-32
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,0.0273103363322081,0.00230323754690109,0.022795990740282,0.0318246819241343,2.69155457682029e-32
NMR metabolomics,X23424.Total Lipids in VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,0.0539520817633041,0.00455189714062281,0.0450303633676834,0.0628738001589248,3.01066566939217e-32
NMR metabolomics,X23424.Total Lipids in VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,0.0997378407020946,0.00842153736198391,0.0832316274726061,0.116244053931583,3.19945667365221e-32
NMR metabolomics,X23424.Total Lipids in VLDL,DYNLT3,Dynein light chain Tctex-type 3,37368,0.0492538744708359,0.00415738507059932,0.0411053997324613,0.0574023492092106,3.20777961338437e-32
NMR metabolomics,X23424.Total Lipids in VLDL,PALM,Paralemmin-1,37299,0.0320169627627227,0.00270361030387416,0.0267178865671294,0.0373160389583161,3.41005208038346e-32
NMR metabolomics,X23424.Total Lipids in VLDL,SLC27A4,Long-chain fatty acid transport protein 4,39489,0.0759379901219757,0.00642273372428705,0.0633494320223731,0.0885265482215783,4.05371597199815e-32
NMR metabolomics,X23424.Total Lipids in VLDL,LONP1,"Lon protease homolog, mitochondrial",37043,0.0979612141436661,0.00830295921250634,0.0816874140871537,0.114235014200179,5.763334642912e-32
NMR metabolomics,X23424.Total Lipids in VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,0.0614573372786648,0.00522051157494483,0.051225134591773,0.0716895399655567,7.39518153056908e-32
NMR metabolomics,X23424.Total Lipids in VLDL,PVR,Poliovirus receptor,40009,0.0415523470381625,0.00353181897459908,0.0346299818479483,0.0484747122283767,7.96137339212444e-32
NMR metabolomics,X23424.Total Lipids in VLDL,EFNA4,Ephrin-A4,39720,0.0308872605476758,0.0026281736434675,0.0257360402064795,0.0360384808888721,9.29977864930945e-32
NMR metabolomics,X23424.Total Lipids in VLDL,TSNAX,Translin-associated protein X,37021,0.0438208257852446,0.00373035376325296,0.0365093324092688,0.0511323191612204,1.05220840332471e-31
NMR metabolomics,X23424.Total Lipids in VLDL,CCL19,C-C motif chemokine 19,40009,0.128882490309345,0.0109813599800902,0.107359024748368,0.150405955870322,1.11444258945468e-31
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,0.0707295617526561,0.00603155308740788,0.0589077177013367,0.0825514058039755,1.25453346940943e-31
NMR metabolomics,X23424.Total Lipids in VLDL,SCRN1,Secernin-1,39866,0.0625882534703969,0.00533801477228092,0.0521257445167263,0.0730507624240675,1.27810018116031e-31
NMR metabolomics,X23424.Total Lipids in VLDL,CCN4,CCN family member 4,40030,0.044557848265087,0.00380258498229286,0.037104781699793,0.052010914830381,1.38676532332673e-31
NMR metabolomics,X23424.Total Lipids in VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,0.0557458066530233,0.00476126826787656,0.0464137208479852,0.0650778924580614,1.55119281016611e-31
NMR metabolomics,X23424.Total Lipids in VLDL,NID2,Nidogen-2,39858,0.0807633026510653,0.00689960786222711,0.0672400712411002,0.0942865340610304,1.60611333534184e-31
NMR metabolomics,X23424.Total Lipids in VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,0.0306672140845693,0.00262833908904937,0.0255156694700326,0.0358187586991061,2.65131202888445e-31
NMR metabolomics,X23424.Total Lipids in VLDL,MCEMP1,Mast cell-expressed membrane protein 1,37056,0.0999456259639112,0.00857659127629164,0.0831355070623795,0.116755744865443,3.13890976853217e-31
NMR metabolomics,X23424.Total Lipids in VLDL,UNC79,Protein unc-79 homolog,36962,0.0625949678185827,0.00537597302656997,0.0520580606865056,0.0731318749506599,3.52758164617682e-31
NMR metabolomics,X23424.Total Lipids in VLDL,MEP1B,Meprin A subunit beta,39868,0.127225843923273,0.0109336048477337,0.105795978421714,0.148655709424831,3.60045573793979e-31
NMR metabolomics,X23424.Total Lipids in VLDL,KLF4,Krueppel-like factor 4,36991,0.043565121784818,0.00374723657823307,0.0362205380914812,0.0509097054781548,4.31991028233483e-31
NMR metabolomics,X23424.Total Lipids in VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,0.0255898805598118,0.0022045896761439,0.0212688847945698,0.0299108763250539,5.03580800434907e-31
NMR metabolomics,X23424.Total Lipids in VLDL,PPL,Periplakin,37056,0.0354193296639575,0.00305255401938889,0.0294363237859553,0.0414023355419597,5.61274129578012e-31
NMR metabolomics,X23424.Total Lipids in VLDL,TNF,Tumor necrosis factor,39555,0.041858391494321,0.00361008593570687,0.0347826230603356,0.0489341599283065,5.85189179951152e-31
NMR metabolomics,X23424.Total Lipids in VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,39931,-0.0221359155815631,0.00191318853496558,-0.0258857651100957,-0.0183860660530306,7.73334140041461e-31
NMR metabolomics,X23424.Total Lipids in VLDL,COL15A1,Collagen alpha-1(XV) chain,37437,0.0274761565579569,0.00237746851643013,0.0228163182657538,0.0321359948501599,9.48775206394284e-31
NMR metabolomics,X23424.Total Lipids in VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,0.0766609979416816,0.00663994053877891,0.0636467144856749,0.0896752813976882,1.03155236391264e-30
NMR metabolomics,X23424.Total Lipids in VLDL,PSAP,Prosaposin,37347,0.0306840988674386,0.00265957662620391,0.0254713286800789,0.0358968690547982,1.19285058593137e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CORO1A,Coronin-1A,39520,0.0979309657771512,0.00849520598205009,0.081280362052333,0.114581569501969,1.27019449224143e-30
NMR metabolomics,X23424.Total Lipids in VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,0.0476639174098442,0.00413552692789455,0.0395582846311709,0.0557695501885175,1.37561373758811e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CD84,SLAM family member 5,39866,0.0340534860481006,0.00295641927638203,0.0282589042663918,0.0398480678298093,1.40515100869606e-30
NMR metabolomics,X23424.Total Lipids in VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,0.0442693286573794,0.0038465664474363,0.0367300584204042,0.0518085988943545,1.65213305851125e-30
NMR metabolomics,X23424.Total Lipids in VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,0.112049730717188,0.0097420157521247,0.0929553798430239,0.131144081591353,1.79251120477173e-30
NMR metabolomics,X23424.Total Lipids in VLDL,ACYP1,Acylphosphatase-1,37073,0.0717928701982758,0.00624458196224246,0.0595534895522805,0.084032250844271,1.90998171076768e-30
NMR metabolomics,X23424.Total Lipids in VLDL,ASAH1,Acid ceramidase,37340,0.0516547136959928,0.00449487759563997,0.0428447536085385,0.0604646737834471,2.00760777615795e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CPA2,Carboxypeptidase A2,39933,0.0702200861357657,0.00611999120671702,0.0582249033706003,0.082215268900931,2.342858198994e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,0.0644183349580575,0.00562646153735187,0.0533904703448479,0.0754461995712672,3.1338716926328e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CLTA,Clathrin light chain A,39585,0.0505505308323519,0.00442218937738365,0.04188303965268,0.0592180220120239,3.84535452521855e-30
NMR metabolomics,X23424.Total Lipids in VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,0.072657323721798,0.00635716143785217,0.0601972873036078,0.0851173601399883,4.13326610010919e-30
NMR metabolomics,X23424.Total Lipids in VLDL,WAS,Wiskott-Aldrich syndrome protein,39587,0.0731311037081876,0.00640198954373226,0.0605832042024723,0.0856790032139028,4.20944099259126e-30
NMR metabolomics,X23424.Total Lipids in VLDL,FSHB,Follitropin subunit beta,37043,0.0710353780192653,0.00621970773574325,0.0588447508572086,0.0832260051813221,4.54685996743423e-30
NMR metabolomics,X23424.Total Lipids in VLDL,SNX9,Sorting nexin-9,39868,0.0748898381547659,0.00658307650729566,0.0619870082004664,0.0877926681090654,7.16233354947062e-30
NMR metabolomics,X23424.Total Lipids in VLDL,AK2,"Adenylate kinase 2, mitochondrial",37388,0.115319345753595,0.0101414532812549,0.0954420973223357,0.135196594184855,7.95692666465883e-30
NMR metabolomics,X23424.Total Lipids in VLDL,ENO2,Gamma-enolase,40009,0.071362698691443,0.00628567295937042,0.059042779691077,0.083682617691809,9.26752788222316e-30
NMR metabolomics,X23424.Total Lipids in VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,0.102155062319282,0.00901335716141458,0.0844888822829092,0.119821242355654,1.16119999434996e-29
NMR metabolomics,X23424.Total Lipids in VLDL,SH3BP1,SH3 domain-binding protein 1,37382,0.0516526370985336,0.0045609773071597,0.0427131215765006,0.0605921526205666,1.3427057557782e-29
NMR metabolomics,X23424.Total Lipids in VLDL,TGFA,Protransforming growth factor alpha,39866,0.0492649231728413,0.00435540436613511,0.0407283306152165,0.0578015157304661,1.49509537802948e-29
NMR metabolomics,X23424.Total Lipids in VLDL,TREML2,Trem-like transcript 2 protein,39858,0.0355071170014338,0.00314700012361368,0.029338996759151,0.0416752372437166,2.06007906421101e-29
NMR metabolomics,X23424.Total Lipids in VLDL,CCL14,C-C motif chemokine 14,39843,0.0415201429581993,0.00369285633959804,0.0342821445325871,0.0487581413838114,3.21410156362839e-29
NMR metabolomics,X23424.Total Lipids in VLDL,VCAM1,Vascular cell adhesion protein 1,39908,-0.0284614346802415,0.00253143028696766,-0.0334230380426981,-0.0234998313177849,3.21607999268071e-29
NMR metabolomics,X23424.Total Lipids in VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,0.0975421747457187,0.00867594049476713,0.0805373313759752,0.114547018115462,3.38235719072368e-29
NMR metabolomics,X23424.Total Lipids in VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,37388,0.0332575870329337,0.00296214169827117,0.0274517893043222,0.0390633847615452,4.01718342148282e-29
NMR metabolomics,X23424.Total Lipids in VLDL,SOD1,Superoxide dismutase [Cu-Zn],39487,0.0515617033052362,0.00459838339157715,0.042548871857745,0.0605745347527274,4.54527345775169e-29
NMR metabolomics,X23424.Total Lipids in VLDL,DNM1,Dynamin-1,37382,0.122239071661777,0.0109026930832642,0.100869793218579,0.143608350104975,4.79162884723769e-29
NMR metabolomics,X23424.Total Lipids in VLDL,KIF22,Kinesin-like protein KIF22,37021,0.129281032758178,0.011537847252488,0.106666852143302,0.151895213373055,5.2163164864289e-29
NMR metabolomics,X23424.Total Lipids in VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,0.0953808433583359,0.00851837903040122,0.0786848204587495,0.112076866257922,5.68407575588091e-29
NMR metabolomics,X23424.Total Lipids in VLDL,COLEC12,Collectin-12,39862,0.0263725464676148,0.00235808902498519,0.0217506919786439,0.0309944009565858,6.26193140576009e-29
NMR metabolomics,X23424.Total Lipids in VLDL,GDNF,Glial cell line-derived neurotrophic factor,39489,0.0406718426968862,0.00363947934499933,0.0335384631806875,0.0478052222130849,6.94071025207636e-29
NMR metabolomics,X23424.Total Lipids in VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,-0.0318348363526084,0.00285379290564792,-0.0374282704476783,-0.0262414022575385,8.6114051876141e-29
NMR metabolomics,X23424.Total Lipids in VLDL,XCL1,Lymphotactin,40030,0.0580317945629671,0.00520775156767957,0.0478246014903151,0.0682389876356191,9.81890585788442e-29
NMR metabolomics,X23424.Total Lipids in VLDL,CD1C,T-cell surface glycoprotein CD1c,39913,0.024777224127827,0.0022279376432217,0.0204104663471124,0.0291439819085415,1.25945286770771e-28
NMR metabolomics,X23424.Total Lipids in VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.0423166970171421,0.00380846784128985,0.034852100048214,0.0497812939860702,1.40762990006082e-28
NMR metabolomics,X23424.Total Lipids in VLDL,HEPH,Hephaestin,37437,0.0278081852326453,0.00250313626282849,0.0229020381575015,0.0327143323077891,1.49999658222127e-28
NMR metabolomics,X23424.Total Lipids in VLDL,PQBP1,Polyglutamine-binding protein 1,39477,0.0576384415603307,0.00519541644719671,0.0474554253238252,0.0678214577968363,1.71238492240604e-28
NMR metabolomics,X23424.Total Lipids in VLDL,NFASC,Neurofascin,40058,0.0291302451868683,0.00262925544947422,0.0239769045058988,0.0342835858678377,2.00071092747255e-28
NMR metabolomics,X23424.Total Lipids in VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",39868,0.0764149447665807,0.00690506257092341,0.0628810221275708,0.0899488674055906,2.31099818842814e-28
NMR metabolomics,X23424.Total Lipids in VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,0.0743074371291972,0.00671673528784919,0.0611426359650128,0.0874722382933816,2.52517629251125e-28
NMR metabolomics,X23424.Total Lipids in VLDL,PKN3,Serine/threonine-protein kinase N3,37169,0.079899605704481,0.00722673218600174,0.0657352106199176,0.0940640007890444,2.71892009839086e-28
NMR metabolomics,X23424.Total Lipids in VLDL,TPP1,Tripeptidyl-peptidase 1,39767,0.0487690303411228,0.00441813332062799,0.040109489032692,0.0574285716495537,3.15885266821518e-28
NMR metabolomics,X23424.Total Lipids in VLDL,PER3,Period circadian protein homolog 3,37056,0.123425891726631,0.011180617522637,0.101511881382262,0.145339902070999,3.28224584209462e-28
NMR metabolomics,X23424.Total Lipids in VLDL,IMPA1,Inositol monophosphatase 1,39749,0.0642757498899562,0.00582656248930234,0.0528556874109236,0.0756958123689888,3.40882442062637e-28
NMR metabolomics,X23424.Total Lipids in VLDL,FCN1,Ficolin-1,37430,0.0588702454125469,0.00534966415349109,0.0483849036717043,0.0693555871533894,4.77769846139217e-28
NMR metabolomics,X23424.Total Lipids in VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,39477,0.0803462418210138,0.00730351515091144,0.0660313521252274,0.0946611315168002,4.78840845303107e-28
NMR metabolomics,X23424.Total Lipids in VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,0.0292428101318914,0.00266324655840701,0.0240228468774136,0.0344627733863691,6.29304112054317e-28
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA4,Annexin A4,39783,0.0755275374687221,0.00688301248171464,0.0620368330045614,0.0890182419328828,6.48504375004178e-28
NMR metabolomics,X23424.Total Lipids in VLDL,PPM1F,Protein phosphatase 1F,37437,0.0555737600816499,0.00506452745690526,0.0456472862661156,0.0655002338971842,6.73904126779913e-28
NMR metabolomics,X23424.Total Lipids in VLDL,VWC2,Brorin,39684,0.0400846261592337,0.00365962481777511,0.0329117615163945,0.047257490802073,8.07233640248309e-28
NMR metabolomics,X23424.Total Lipids in VLDL,RGMB,RGM domain family member B,40009,0.0264699899475015,0.00242101273763459,0.0217248049817377,0.0312151749132653,9.9777042726281e-28
NMR metabolomics,X23424.Total Lipids in VLDL,DKK4,Dickkopf-related protein 4,39718,0.047068873662613,0.00430650721249636,0.0386281195261201,0.0555096277991058,1.04354807052567e-27
NMR metabolomics,X23424.Total Lipids in VLDL,ARAF,Serine/threonine-protein kinase A-Raf,37169,0.0695399169229821,0.0063625424391258,0.0570693337422956,0.0820105001036687,1.09130336556916e-27
NMR metabolomics,X23424.Total Lipids in VLDL,NADK,NAD kinase,39868,0.0553259091011909,0.00506966832738296,0.0453893591795203,0.0652624590228615,1.24833244372491e-27
NMR metabolomics,X23424.Total Lipids in VLDL,UMOD,Uromodulin,40012,-0.0546296522053012,0.00500631116650535,-0.0644420220916517,-0.0448172823189507,1.25905734061443e-27
NMR metabolomics,X23424.Total Lipids in VLDL,ENTR1,Endosome-associated-trafficking regulator 1,37043,0.0620564002693701,0.00569519599416016,0.0508938161208162,0.073218984417924,1.57328298968708e-27
NMR metabolomics,X23424.Total Lipids in VLDL,PTN,Pleiotrophin,39585,0.0521008404513184,0.0047872314021071,0.0427178669031885,0.0614838139994483,1.73523626722437e-27
NMR metabolomics,X23424.Total Lipids in VLDL,BOLA2_BOLA2B,BolA-like protein 2,37043,0.0568208859107929,0.00522005979531233,0.0465895687119808,0.0670522031096051,1.77662393743252e-27
NMR metabolomics,X23424.Total Lipids in VLDL,C1RL,Complement C1r subcomponent-like protein,37432,0.0199180710492032,0.00183018279341637,0.0163309127741071,0.0235052293242993,1.80179044829374e-27
NMR metabolomics,X23424.Total Lipids in VLDL,FXN,"Frataxin, mitochondrial",40030,0.0758265516165862,0.00697211239537662,0.062161211321648,0.0894918919115244,1.87335099646635e-27
NMR metabolomics,X23424.Total Lipids in VLDL,ADA,Adenosine deaminase,40058,0.0358679563767339,0.00330113835075121,0.0293977252092616,0.0423381875442063,2.09618419209977e-27
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA9,Serpin A9,39715,0.0749786547309215,0.0069021265489805,0.0614504866949197,0.0885068227669232,2.15715747858503e-27
NMR metabolomics,X23424.Total Lipids in VLDL,PAEP,Glycodelin,39749,-0.149297989628575,0.0137577315405878,-0.176263143448127,-0.122332835809023,2.43495081505603e-27
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJC21,DnaJ homolog subfamily C member 21,37388,0.0396274059413593,0.00365809026135581,0.0324575490291019,0.0467972628536166,3.11271469882593e-27
NMR metabolomics,X23424.Total Lipids in VLDL,ABCA2,ATP-binding cassette sub-family A member 2,37021,0.0377946863012645,0.00349779563109426,0.0309390068643198,0.0446503657382093,4.2218839864646e-27
NMR metabolomics,X23424.Total Lipids in VLDL,CCL15,C-C motif chemokine 15,40052,0.0444636300470514,0.00411772356151302,0.0363928918664859,0.052534368227617,4.34545319839426e-27
NMR metabolomics,X23424.Total Lipids in VLDL,XRCC4,DNA repair protein XRCC4,39489,0.0380640193357339,0.0035300564150257,0.0311451087622835,0.0449829299091843,5.16403502101195e-27
NMR metabolomics,X23424.Total Lipids in VLDL,DSCAM,Down syndrome cell adhesion molecule,37411,0.0361376954547487,0.00335345531781076,0.0295649230318396,0.0427104678776578,5.7316549562311e-27
NMR metabolomics,X23424.Total Lipids in VLDL,CTSE,Cathepsin E,37124,0.0541136052997438,0.00502547711891283,0.0442636701466746,0.0639635404528129,6.3085426993962e-27
NMR metabolomics,X23424.Total Lipids in VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,0.034013514966766,0.00316315556614549,0.0278137300571208,0.0402132998764112,7.06680535147546e-27
NMR metabolomics,X23424.Total Lipids in VLDL,RAB6A,Ras-related protein Rab-6A,39866,0.0471818050590841,0.00439352813658469,0.0385704899113782,0.0557931202067901,8.24502962758766e-27
NMR metabolomics,X23424.Total Lipids in VLDL,POMC,Pro-opiomelanocortin,37043,0.0722397753816976,0.00675143072070879,0.0590069711691084,0.0854725795942868,1.30986490288605e-26
NMR metabolomics,X23424.Total Lipids in VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,-0.04527609897407,0.00423508512301425,-0.0535768658151779,-0.0369753321329621,1.38062964019434e-26
NMR metabolomics,X23424.Total Lipids in VLDL,SLIT2,Slit homolog 2 protein,39489,0.0523225036959241,0.00490171961507732,0.0427151332503726,0.0619298741414756,1.65658727749545e-26
NMR metabolomics,X23424.Total Lipids in VLDL,SWAP70,Switch-associated protein 70,37382,0.0364371216530363,0.00341547412104829,0.0297427923757816,0.0431314509302909,1.82598562117488e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CCS,Copper chaperone for superoxide dismutase,39749,0.0478108353510911,0.00448661015968053,0.0390170794381172,0.0566045912640649,2.00041615413589e-26
NMR metabolomics,X23424.Total Lipids in VLDL,KLRD1,Natural killer cells antigen CD94,40058,0.0461620397468526,0.00433812616352087,0.0376593124663517,0.0546647670273536,2.34658099357202e-26
NMR metabolomics,X23424.Total Lipids in VLDL,IL12B,Interleukin-12 subunit beta,40058,0.0528710078580604,0.00496988202094837,0.0431300390970016,0.0626119766191192,2.41577456434981e-26
NMR metabolomics,X23424.Total Lipids in VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,37437,0.0323087777637574,0.00304401139601861,0.026342515427561,0.0382750400999539,3.25385658318248e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CD302,CD302 antigen,39788,0.0292551738076425,0.00275892969739234,0.0238476716007535,0.0346626760145315,3.49765933707508e-26
NMR metabolomics,X23424.Total Lipids in VLDL,KLB,Beta-klotho,39489,-0.0741433550847543,0.00699385964325483,-0.0878513199855337,-0.0604353901839748,3.60957139355556e-26
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA2,Annexin A2,36879,0.0700613668614793,0.00662928506288793,0.0570679681382189,0.0830547655847396,5.31753209985352e-26
NMR metabolomics,X23424.Total Lipids in VLDL,TAFA5,Chemokine-like protein TAFA-5,39788,0.0341417855965703,0.00323283129218439,0.0278054362638889,0.0404781349292518,5.50918840861479e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CHRDL1,Chordin-like protein 1,39908,0.0306654326391203,0.00291174835043224,0.0249584058722731,0.0363724594059675,7.4998633683436e-26
NMR metabolomics,X23424.Total Lipids in VLDL,IFNAR1,Interferon alpha/beta receptor 1,37382,0.025528146741349,0.002426631849946,0.0207719483154548,0.0302843451672431,8.78869017482731e-26
NMR metabolomics,X23424.Total Lipids in VLDL,POSTN,Periostin,37437,-0.037176748233267,0.00353651067643162,-0.044108309159073,-0.030245187307461,9.52408133696555e-26
NMR metabolomics,X23424.Total Lipids in VLDL,STX16,Syntaxin-16,39477,0.0581833619390137,0.00553672208108182,0.0473313866600933,0.069035337217934,9.60736868539685e-26
NMR metabolomics,X23424.Total Lipids in VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,0.0836593858308425,0.007970529064448,0.0680371488645244,0.0992816227971606,1.13410632082794e-25
NMR metabolomics,X23424.Total Lipids in VLDL,HRG,Histidine-rich glycoprotein,37380,0.0315868563595578,0.00301075900752617,0.0256857687048065,0.0374879440143091,1.188009156484e-25
NMR metabolomics,X23424.Total Lipids in VLDL,THBD,Thrombomodulin,39868,0.0270781155715673,0.00258312971958848,0.0220151813211739,0.0321410498219608,1.2561766250897e-25
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS7_LGALS7B,Galectin-7,39822,0.0405020752557773,0.00386371639779561,0.0329291911160979,0.0480749593954567,1.25692490427699e-25
NMR metabolomics,X23424.Total Lipids in VLDL,DCTN6,Dynactin subunit 6,39489,0.0707248750854793,0.00674693406343732,0.0575008843211422,0.0839488658498165,1.26406564673725e-25
NMR metabolomics,X23424.Total Lipids in VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,0.0730179877598595,0.00697467678312088,0.0593476212649426,0.0866883542547765,1.4526055339554e-25
NMR metabolomics,X23424.Total Lipids in VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0388839069689547,0.00371416570941442,0.0316041421785024,0.0461636717594069,1.4537849573654e-25
NMR metabolomics,X23424.Total Lipids in VLDL,NECTIN2,Nectin-2,39846,0.0279839455985303,0.00267901663866231,0.0227330729867522,0.0332348182103085,1.85354270143438e-25
NMR metabolomics,X23424.Total Lipids in VLDL,GNAS,Neuroendocrine secretory protein 55,37411,0.0898139156707949,0.00859866471126183,0.0729605328367217,0.106667298504868,1.92724524963699e-25
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,37124,0.0362351362367476,0.00346996254547646,0.0294340096476137,0.0430362628258814,1.98953082073514e-25
NMR metabolomics,X23424.Total Lipids in VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,39489,0.0501422071902894,0.00480444354004396,0.0407254978518032,0.0595589165287755,2.0447101870328e-25
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,0.0412410743794629,0.00395726971524658,0.0334848257375796,0.0489973230213462,2.3897257333555e-25
NMR metabolomics,X23424.Total Lipids in VLDL,FGA,Fibrinogen alpha chain,37149,0.0304964551957964,0.00293236247117619,0.0247490247522911,0.0362438856393018,3.09975942676459e-25
NMR metabolomics,X23424.Total Lipids in VLDL,CSTB,Cystatin-B,39619,0.041920384576033,0.00403303976199454,0.0340156266425237,0.0498251425095423,3.17768083379745e-25
NMR metabolomics,X23424.Total Lipids in VLDL,TCOF1,Treacle protein,37437,0.0301191757578047,0.00289707680307893,0.02444090522377,0.0357974462918394,3.20164854139718e-25
NMR metabolomics,X23424.Total Lipids in VLDL,KLK6,Kallikrein-6,39889,0.0292060277142017,0.00281072502389808,0.0236970066673615,0.0347150487610419,3.27906471244941e-25
NMR metabolomics,X23424.Total Lipids in VLDL,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.0366390041626039,0.00353095667165817,0.0297183290861539,0.0435596792390539,3.82821372310153e-25
NMR metabolomics,X23424.Total Lipids in VLDL,MTUS1,Microtubule-associated tumor suppressor 1,37169,0.0551020830195545,0.0053121793510896,0.0446902114914189,0.0655139545476901,4.11053211562666e-25
NMR metabolomics,X23424.Total Lipids in VLDL,GLRX,Glutaredoxin-1,39771,0.0551324328367041,0.00532761474119636,0.0446903079439593,0.065574557729449,5.10708574339799e-25
NMR metabolomics,X23424.Total Lipids in VLDL,MMP1,Interstitial collagenase,39314,0.0901208453789208,0.00871304364643455,0.0730432798319091,0.107198410925933,5.42000890265495e-25
NMR metabolomics,X23424.Total Lipids in VLDL,SPAG1,Sperm-associated antigen 1,37411,0.0573808113720544,0.00554798210719128,0.0465067664419595,0.0682548563021493,5.59670327403802e-25
NMR metabolomics,X23424.Total Lipids in VLDL,DCTN2,Dynactin subunit 2,39788,0.0926871430842583,0.00900950379750329,0.0750285156411519,0.110345770527365,9.56891954978996e-25
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL1,Angiopoietin-related protein 1,39617,0.0285808860077979,0.00277937986738185,0.0231333014677295,0.0340284705478663,1.00447821668474e-24
NMR metabolomics,X23424.Total Lipids in VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,37043,-0.0592276154644372,0.00575889896119268,-0.0705150574283749,-0.0479401735004996,1.02584628672521e-24
NMR metabolomics,X23424.Total Lipids in VLDL,EFCAB2,Dynein regulatory complex protein 8,37169,0.0342479767919408,0.00333159064292984,0.0277180591317983,0.0407778944520833,1.07531230597662e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,0.0579504714895694,0.00564304136038936,0.0468901104232063,0.0690108325559325,1.19224424265906e-24
NMR metabolomics,X23424.Total Lipids in VLDL,PRG2,Bone marrow proteoglycan,37437,-0.0495395234788697,0.00482469957098654,-0.0589959346380033,-0.0400831123197361,1.20993185853636e-24
NMR metabolomics,X23424.Total Lipids in VLDL,BGN,Biglycan,39448,-0.11632990661914,0.0113355521414495,-0.138547588816381,-0.0941122244218989,1.24677167609097e-24
NMR metabolomics,X23424.Total Lipids in VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,0.0366744055982221,0.00357410654303467,0.0296691567738742,0.0436796544225701,1.25717390942275e-24
NMR metabolomics,X23424.Total Lipids in VLDL,PSMG3,Proteasome assembly chaperone 3,39866,0.0483538804015558,0.00472010598920562,0.0391024726627128,0.0576052881403988,1.49564888824287e-24
NMR metabolomics,X23424.Total Lipids in VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,0.0471263756974347,0.00460223704003605,0.038105991098964,0.0561467602959054,1.61446869977735e-24
NMR metabolomics,X23424.Total Lipids in VLDL,STK4,Serine/threonine-protein kinase 4,39868,0.0848451206980006,0.00828840897276689,0.0685998391113775,0.101090402284624,1.61763027713823e-24
NMR metabolomics,X23424.Total Lipids in VLDL,AMOTL2,Angiomotin-like protein 2,37333,0.0470753923723617,0.00460787689080058,0.0380439536663925,0.0561068310783308,2.05769854556909e-24
NMR metabolomics,X23424.Total Lipids in VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,0.029068648577494,0.00284786897401281,0.0234868253884289,0.0346504717665591,2.25558286281052e-24
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,0.0454786580793329,0.0044747971334634,0.0367080556977447,0.0542492604609212,3.53038784864918e-24
NMR metabolomics,X23424.Total Lipids in VLDL,LEPR,Leptin receptor,39868,-0.0297190527486073,0.00293631958646622,-0.0354742391380811,-0.0239638663591335,5.25503739778764e-24
NMR metabolomics,X23424.Total Lipids in VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,0.0838637876363533,0.00828492637587847,0.0676253319396315,0.100102243333075,5.34801911479959e-24
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB6,Integrin beta-6,39587,0.0285172494639019,0.00281884529212468,0.0229923126913375,0.0340421862364663,5.51968144127134e-24
NMR metabolomics,X23424.Total Lipids in VLDL,TREML1,Trem-like transcript 1 protein,37445,0.050943137631958,0.00504486506279158,0.0410552021088865,0.0608310731550295,6.84466894367269e-24
NMR metabolomics,X23424.Total Lipids in VLDL,SV2A,Synaptic vesicle glycoprotein 2A,37039,0.0589688895278262,0.00584083429428541,0.0475208543110268,0.0704169247446256,7.02962215711974e-24
NMR metabolomics,X23424.Total Lipids in VLDL,VIT,Vitrin,37437,0.0353137076762282,0.00349944525752743,0.0284547949714744,0.042172620380982,7.33199301195239e-24
NMR metabolomics,X23424.Total Lipids in VLDL,TLR3,Toll-like receptor 3,40058,0.058351845801603,0.00578910393685023,0.0470052020853766,0.0696984895178295,7.99431638771513e-24
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP1,Rho GTPase-activating protein 1,39477,0.0449293981205746,0.00445879671330365,0.0361901565624995,0.0536686396786498,8.29204859435023e-24
NMR metabolomics,X23424.Total Lipids in VLDL,IL6R,Interleukin-6 receptor subunit alpha,39805,0.0322210730494226,0.00319915166775146,0.0259507357806297,0.0384914103182154,8.67612122309526e-24
NMR metabolomics,X23424.Total Lipids in VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,0.059143288929918,0.00587520189073898,0.0476278932240696,0.0706586846357664,9.40330121072364e-24
NMR metabolomics,X23424.Total Lipids in VLDL,ELOB,Elongin-B,37021,0.0375824280825294,0.00373925597690999,0.0302534863677858,0.044911369797273,1.10954838334714e-23
NMR metabolomics,X23424.Total Lipids in VLDL,COL6A3,Collagen alpha-3(VI) chain,40052,0.0305465293617283,0.00304206727098988,0.0245840775105882,0.0365089812128685,1.17597958575722e-23
NMR metabolomics,X23424.Total Lipids in VLDL,SPRR3,Small proline-rich protein 3,37388,0.0625756906582633,0.00623539069724471,0.0503543248916637,0.074797056424863,1.28624837987499e-23
NMR metabolomics,X23424.Total Lipids in VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,-0.0369379694676894,0.00368724679981321,-0.0441649731953233,-0.0297109657400555,1.49412013701762e-23
NMR metabolomics,X23424.Total Lipids in VLDL,C5,Complement C5,37453,0.0145049876344732,0.00144804357870396,0.0116668222202134,0.017343153048733,1.54942592934087e-23
NMR metabolomics,X23424.Total Lipids in VLDL,CCL20,C-C motif chemokine 20,40058,0.0800107141930712,0.00800226090734778,0.0643262828146696,0.0956951455714729,1.80942109461843e-23
NMR metabolomics,X23424.Total Lipids in VLDL,PTGES2,Prostaglandin E synthase 2,36961,0.0529218924759129,0.00529370482842776,0.0425462310121945,0.0632975539396313,1.90341723979253e-23
NMR metabolomics,X23424.Total Lipids in VLDL,TF,Serotransferrin,37453,0.0207631308365513,0.0020781338504377,0.0166899884896934,0.0248362731834092,2.00527186524333e-23
NMR metabolomics,X23424.Total Lipids in VLDL,ECI2,Enoyl-CoA delta isomerase 2,37021,0.0588429101157403,0.00589452161801503,0.0472896477444309,0.0703961724870498,2.19873199953985e-23
NMR metabolomics,X23424.Total Lipids in VLDL,ERI1,3'-5' exoribonuclease 1,37169,0.0317595388584979,0.00318508000342444,0.025516782051786,0.0380022956652098,2.45649084368045e-23
NMR metabolomics,X23424.Total Lipids in VLDL,DENR,Density-regulated protein,37056,0.0548975974814658,0.00550665051833783,0.0441045624655237,0.0656906324974079,2.51062933079019e-23
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,0.0392462316768121,0.00393998599516573,0.0315238591262873,0.046968604227337,2.63766793033851e-23
NMR metabolomics,X23424.Total Lipids in VLDL,SCRIB,Protein scribble homolog,37043,0.0855258264306589,0.00858900500918419,0.0686913766126579,0.10236027624866,2.82324692988473e-23
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,0.0327365260026432,0.00329305451716318,0.0262821391490034,0.0391909128562831,3.22416464474904e-23
NMR metabolomics,X23424.Total Lipids in VLDL,SLITRK2,SLIT and NTRK-like protein 2,40030,0.036440744021363,0.00366820582006573,0.0292510606140342,0.0436304274286918,3.44346907311807e-23
NMR metabolomics,X23424.Total Lipids in VLDL,LAMB1,Laminin subunit beta-1,37043,0.0287082371939611,0.00289396849099402,0.0230360589516128,0.0343804154363093,4.10494189022014e-23
NMR metabolomics,X23424.Total Lipids in VLDL,FRZB,Secreted frizzled-related protein 3,39695,0.0248200549888732,0.00250614575926078,0.0199080093007221,0.0297321006770244,4.68209824578816e-23
NMR metabolomics,X23424.Total Lipids in VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,0.0908810240034598,0.00918261776740173,0.0728830931793524,0.108878954827567,4.99883696937238e-23
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G15,Phospholipase A2 group XV,39913,0.0248769075669309,0.00251464186301175,0.0199482095154279,0.029805605618434,5.20435750161571e-23
NMR metabolomics,X23424.Total Lipids in VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,0.0339188325344918,0.00342943204656645,0.0271971457232216,0.0406405193457621,5.31809815534353e-23
NMR metabolomics,X23424.Total Lipids in VLDL,IL32,Interleukin-32,39866,-0.0402194235034274,0.00406794459077446,-0.0481925949013454,-0.0322462521055095,5.52120561395247e-23
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,0.0398397143675344,0.0040289606675456,0.031942951459145,0.0477364772759237,5.59707816571546e-23
NMR metabolomics,X23424.Total Lipids in VLDL,PMM2,Phosphomannomutase 2,37021,0.0566558940860356,0.00573203261327705,0.0454211101640126,0.0678906780080586,5.86662293622995e-23
NMR metabolomics,X23424.Total Lipids in VLDL,IFNGR2,Interferon gamma receptor 2,39749,0.0488609817867673,0.00494916026508739,0.039160627667196,0.0585613359063386,6.37181405951924e-23
NMR metabolomics,X23424.Total Lipids in VLDL,GLO1,Lactoylglutathione lyase,39585,0.0542875231987919,0.00550325736657494,0.0435011387603051,0.0650739076372788,6.90575947939827e-23
NMR metabolomics,X23424.Total Lipids in VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,0.049272093336935,0.00500716547538785,0.0394580490051748,0.0590861376686952,9.04156576743388e-23
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,0.0277852689613053,0.00282617143525747,0.0222459729482007,0.03332456497441,9.54912667160113e-23
NMR metabolomics,X23424.Total Lipids in VLDL,CBS,Cystathionine beta-synthase,37043,0.0477145572460464,0.00485283276568509,0.0382030050253036,0.0572261094667891,9.78400403084296e-23
NMR metabolomics,X23424.Total Lipids in VLDL,CTSF,Cathepsin F,39913,0.0377313664494725,0.00384404712609967,0.0301970340823171,0.0452656988166278,1.11808690773389e-22
NMR metabolomics,X23424.Total Lipids in VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,-0.103114168381923,0.0105068780789571,-0.123707649416679,-0.0825206873471673,1.13716357274461e-22
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL8,Interleukin-8,39750,0.0612041917520153,0.0062812653964526,0.0488929115749682,0.0735154719290624,2.26219890182673e-22
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,40030,0.0499988234946295,0.005137658046699,0.0399290137230995,0.0600686332661595,2.53997866517076e-22
NMR metabolomics,X23424.Total Lipids in VLDL,HLA_E,,39866,0.0253115741526848,0.00260165200874942,0.020212336215536,0.0304108120898337,2.61401704728001e-22
NMR metabolomics,X23424.Total Lipids in VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,-0.0284986792185793,0.00293007874366118,-0.0342416335561553,-0.0227557248810034,2.68185823467065e-22
NMR metabolomics,X23424.Total Lipids in VLDL,CGA,Glycoprotein hormones alpha chain,39858,0.0817650395903793,0.00840929566094878,0.0652828200949196,0.0982472590858389,2.76837908813446e-22
NMR metabolomics,X23424.Total Lipids in VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,0.0611574714482238,0.00630061324350857,0.048808269490947,0.0735066734055006,3.33824343346665e-22
NMR metabolomics,X23424.Total Lipids in VLDL,MMP12,Macrophage metalloelastase,39900,0.0462543011560936,0.00477527852986532,0.0368947552375576,0.0556138470746296,3.96825360664272e-22
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL1,Fc receptor-like protein 1,39868,0.0403060746358769,0.00417201160321109,0.0321289318935832,0.0484832173781707,5.06759338449186e-22
NMR metabolomics,X23424.Total Lipids in VLDL,BRDT,Bromodomain testis-specific protein,37021,0.0336077376811551,0.00348339956191667,0.0267802745397985,0.0404352008225118,5.92697601107596e-22
NMR metabolomics,X23424.Total Lipids in VLDL,APOD,Apolipoprotein D,36780,-0.039914844479395,0.00413863308951169,-0.0480265653348379,-0.0318031236239521,6.15143462087342e-22
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,39825,0.0252244085043183,0.00262393986282886,0.0200814863731738,0.0303673306354629,8.05965261443755e-22
NMR metabolomics,X23424.Total Lipids in VLDL,XG,Glycoprotein Xg,39985,0.0274544293880152,0.00285835697132402,0.0218520497242202,0.0330568090518103,8.71302475567593e-22
NMR metabolomics,X23424.Total Lipids in VLDL,BPIFA2,BPI fold-containing family A member 2,36593,-0.0995136557052631,0.0103635458986832,-0.119826205666682,-0.079201105743844,9.2659252393763e-22
NMR metabolomics,X23424.Total Lipids in VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,37365,0.0382716284922266,0.00398993162717646,0.0304513625029608,0.0460918944814925,1.01270740066648e-21
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1F,V-type proton ATPase subunit F,39453,0.060310996139753,0.00629175272217147,0.0479791608042969,0.0726428314752091,1.05373398158391e-21
NMR metabolomics,X23424.Total Lipids in VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,0.054433360345882,0.00568078244919463,0.0432990267454605,0.0655676939463034,1.09072655776471e-21
NMR metabolomics,X23424.Total Lipids in VLDL,HPCAL1,Hippocalcin-like protein 1,40058,0.0674715108793004,0.00704846919603326,0.0536565112550752,0.0812865105035255,1.19059256146516e-21
NMR metabolomics,X23424.Total Lipids in VLDL,RARRES1,Retinoic acid receptor responder protein 1,39477,0.0307878462565123,0.00322043659423844,0.024475790531805,0.0370999019812197,1.34734752522248e-21
NMR metabolomics,X23424.Total Lipids in VLDL,BOLA1,BolA-like protein 1,36991,0.049952938636751,0.00522831991497651,0.039705431603397,0.060200445670105,1.46209633747084e-21
NMR metabolomics,X23424.Total Lipids in VLDL,MAGED1,Melanoma-associated antigen D1,39477,0.043876888535069,0.0046031571890893,0.0348547004444539,0.052899076625684,1.76647127282449e-21
NMR metabolomics,X23424.Total Lipids in VLDL,EDF1,Endothelial differentiation-related factor 1,37411,0.0624227509883275,0.00655609740870972,0.0495728000672564,0.0752727019093986,1.99500165700488e-21
NMR metabolomics,X23424.Total Lipids in VLDL,ALCAM,CD166 antigen,40052,0.0175184192715531,0.00184487995080413,0.013902454567977,0.0211343839751291,2.48572604945889e-21
NMR metabolomics,X23424.Total Lipids in VLDL,TPMT,Thiopurine S-methyltransferase,39477,0.0654692780719565,0.00691860543887451,0.0519088114117624,0.0790297447321505,3.41718121585801e-21
NMR metabolomics,X23424.Total Lipids in VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,0.0452933156612513,0.0047860266322957,0.0359127034619518,0.0546739278605509,3.47139463943418e-21
NMR metabolomics,X23424.Total Lipids in VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,0.0603849856781366,0.00640295422922892,0.0478351953888479,0.0729347759674253,4.72148814524815e-21
NMR metabolomics,X23424.Total Lipids in VLDL,C7orf50,Uncharacterized protein C7orf50,37388,0.019614066521502,0.00208724665031296,0.0155230630868886,0.0237050699561154,6.49507000746388e-21
NMR metabolomics,X23424.Total Lipids in VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,0.0364046000116707,0.00387466282215012,0.0288102608802564,0.0439989391430849,6.61488441440708e-21
NMR metabolomics,X23424.Total Lipids in VLDL,WFDC1,WAP four-disulfide core domain protein 1,37123,0.046948319430693,0.00500447423799934,0.0371395499242143,0.0567570889371717,7.56296533226741e-21
NMR metabolomics,X23424.Total Lipids in VLDL,FGR,Tyrosine-protein kinase Fgr,39489,0.0501720062606591,0.00536182672996457,0.0396628258699285,0.0606811866513896,9.27227998085894e-21
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX1,Peroxiredoxin-1,39434,-0.0807651915917224,0.00863266757766405,-0.097685220043944,-0.0638451631395009,9.40792496455952e-21
NMR metabolomics,X23424.Total Lipids in VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,0.0815768435965471,0.00871856361193759,0.0644884589171494,0.0986652282759448,9.54031172575753e-21
NMR metabolomics,X23424.Total Lipids in VLDL,STX7,Syntaxin-7,37056,0.0439761235963603,0.00470431121516634,0.0347556736146342,0.0531965735780863,1.03451652236558e-20
NMR metabolomics,X23424.Total Lipids in VLDL,BSG,Basigin,40040,0.017261213295741,0.00184817125835685,0.0136387976293616,0.0208836289621205,1.08989328525099e-20
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,0.032453445671613,0.00347612924999852,0.0256402323416159,0.0392666590016101,1.15740011886575e-20
NMR metabolomics,X23424.Total Lipids in VLDL,KLK7,Kallikrein-7,36818,0.0347002989652373,0.00371868571138924,0.0274116749709144,0.0419889229595602,1.21339012931231e-20
NMR metabolomics,X23424.Total Lipids in VLDL,S100P,Protein S100-P,39585,0.0467223041773456,0.00501120397740978,0.0369003443816225,0.0565442639730688,1.27143629225146e-20
NMR metabolomics,X23424.Total Lipids in VLDL,REG4,Regenerating islet-derived protein 4,39885,0.0415700642015518,0.00446662358869538,0.0328154819677089,0.0503246464353947,1.48406306625543e-20
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,0.0420417104878898,0.00451962914536285,0.0331832373629786,0.050900183612801,1.55727374482287e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CD101,Immunoglobulin superfamily member 2,37382,0.0373331940746086,0.00401260033384446,0.0294684974202734,0.0451978907289437,1.55774626988569e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CFHR4,Complement factor H-related protein 4,37409,0.0636615627276596,0.00685205702355686,0.0502315309614882,0.0770915944938311,1.76042145039301e-20
NMR metabolomics,X23424.Total Lipids in VLDL,C1QA,Complement C1q subcomponent subunit A,39971,-0.0202637910495889,0.00218177806433261,-0.0245400760556809,-0.015987506043497,1.77283563045823e-20
NMR metabolomics,X23424.Total Lipids in VLDL,JAM2,Junctional adhesion molecule B,40009,0.0220894119050273,0.00238420827752,0.017416363681088,0.0267624601289665,2.19376004504365e-20
NMR metabolomics,X23424.Total Lipids in VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,37437,0.05188841204768,0.00560929051721316,0.0408942026339422,0.0628826214614177,2.56494153887458e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CASP8,Caspase-8,39984,0.0541284192847506,0.00586318495624326,0.0426365767705138,0.0656202617989874,2.98192756086214e-20
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,0.0317695698858027,0.00344885323984402,0.0250098175357084,0.038529322235897,3.59749248741431e-20
NMR metabolomics,X23424.Total Lipids in VLDL,ROBO1,Roundabout homolog 1,39885,0.0206162198097026,0.00224368776548388,0.0162185917893542,0.025013847830051,4.46030271457212e-20
NMR metabolomics,X23424.Total Lipids in VLDL,ANPEP,Aminopeptidase N,39891,0.0243763845399239,0.00265448621958032,0.0191735915495465,0.0295791775303014,4.69067791292092e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CAPG,Macrophage-capping protein,39739,0.0506489218833968,0.00552165412679595,0.0398264797948767,0.0614713639719169,5.16478462161176e-20
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,0.0338104423383212,0.00369051209245245,0.0265770386371144,0.041043846039528,5.73343870350775e-20
NMR metabolomics,X23424.Total Lipids in VLDL,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.0222485301988818,0.00242878659617479,0.0174881084703792,0.0270089519273843,5.78714558862452e-20
NMR metabolomics,X23424.Total Lipids in VLDL,FEN1,Flap endonuclease 1,39477,0.0543275956484234,0.0059312270224064,0.0427023906845069,0.06595280061234,5.84415682451995e-20
NMR metabolomics,X23424.Total Lipids in VLDL,BRK1,Protein BRICK1,39489,0.0386914485737909,0.00423259494032549,0.030395562490753,0.0469873346568289,6.91495627778795e-20
NMR metabolomics,X23424.Total Lipids in VLDL,STX6,Syntaxin-6,39477,0.0592847294879472,0.00648571759985113,0.046572722992239,0.0719967359836554,6.94706116586085e-20
NMR metabolomics,X23424.Total Lipids in VLDL,GRN,Progranulin,39787,0.0214587602870374,0.00234892752558696,0.0168548623368869,0.0260626582371878,7.2750226304749e-20
NMR metabolomics,X23424.Total Lipids in VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,0.0424031405124897,0.00464342960868649,0.0333020184794642,0.0515042625455152,7.52238491212039e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CRYM,Ketimine reductase mu-crystallin,36991,0.0666808309615999,0.00730006522089094,0.0523727031286536,0.0809889587945461,7.53707626174783e-20
NMR metabolomics,X23424.Total Lipids in VLDL,TEK,Angiopoietin-1 receptor,39913,0.0187540995964285,0.00205985939211251,0.0147167751878879,0.022791424004969,9.66173536501027e-20
NMR metabolomics,X23424.Total Lipids in VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,37265,0.0479052442850175,0.00526077399756021,0.0375941272497995,0.0582163613202355,9.73087164854466e-20
NMR metabolomics,X23424.Total Lipids in VLDL,AMIGO2,Amphoterin-induced protein 2,39788,0.0194360694060394,0.00213600744970173,0.015249494804624,0.0236226440074548,1.01512656794051e-19
NMR metabolomics,X23424.Total Lipids in VLDL,C7,Complement component C7,37149,-0.027794592814888,0.00305433597272044,-0.03378109132142,-0.0218080943083559,1.02991507239636e-19
NMR metabolomics,X23424.Total Lipids in VLDL,AGT,Angiotensinogen,37445,0.0193805668224081,0.00213498374059554,0.0151959986908409,0.0235651349539754,1.26063403632314e-19
NMR metabolomics,X23424.Total Lipids in VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,0.0548074473596837,0.00604776412689395,0.0429538296709716,0.0666610650483959,1.45353713648266e-19
NMR metabolomics,X23424.Total Lipids in VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,0.0349323258541444,0.00385847888511681,0.0273697072393155,0.0424949444689734,1.54557364980515e-19
NMR metabolomics,X23424.Total Lipids in VLDL,COL2A1,Collagen alpha-1(II) chain,37043,0.0693700573911868,0.0076621518531123,0.0543522397590867,0.0843878750232869,1.57530228013578e-19
NMR metabolomics,X23424.Total Lipids in VLDL,NAA10,N-alpha-acetyltransferase 10,37021,0.0436160284231418,0.00481932308808715,0.034170155170491,0.0530619016757926,1.62458677886865e-19
NMR metabolomics,X23424.Total Lipids in VLDL,NPHS1,Nephrin,37056,0.0295261029388732,0.00326415228631809,0.0231283644576898,0.0359238414200567,1.69459243694983e-19
NMR metabolomics,X23424.Total Lipids in VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,37382,0.0982975546195862,0.0108793078198215,0.076974111292736,0.119620997946436,1.8550229638781e-19
NMR metabolomics,X23424.Total Lipids in VLDL,NEK7,Serine/threonine-protein kinase Nek7,37169,0.0636312218972445,0.00704753275537291,0.0498180576967136,0.0774443860977754,1.97022260851949e-19
NMR metabolomics,X23424.Total Lipids in VLDL,APLP1,Amyloid-like protein 1,39868,-0.0439323499821678,0.00486821943547538,-0.0534740600756996,-0.0343906398886361,2.0099102869748e-19
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,0.0404009781829628,0.00447934543909277,0.031621461122341,0.0491804952435847,2.10736731972563e-19
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,0.0191542657313727,0.00212337308906836,0.0149924544767988,0.0233160769859467,2.11692594585161e-19
NMR metabolomics,X23424.Total Lipids in VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,37411,0.0449984283125366,0.00498956641863953,0.0352188781320031,0.0547779784930701,2.15960491461237e-19
NMR metabolomics,X23424.Total Lipids in VLDL,CLU,Clusterin,37453,0.0273089342716406,0.00303365479834765,0.0213629708668792,0.033254897676402,2.50735260053956e-19
NMR metabolomics,X23424.Total Lipids in VLDL,SFRP4,Secreted frizzled-related protein 4,37124,0.0355070049464075,0.00395422122665882,0.0277567313421562,0.0432572785506588,3.08181045535241e-19
NMR metabolomics,X23424.Total Lipids in VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,37453,-0.0216804844222729,0.00242044822816911,-0.0264245629494843,-0.0169364058950614,3.7574341613726e-19
NMR metabolomics,X23424.Total Lipids in VLDL,VAMP5,Vesicle-associated membrane protein 5,39585,0.0450125525216183,0.0050266129615972,0.0351603911168878,0.0548647139263488,3.77648346524256e-19
NMR metabolomics,X23424.Total Lipids in VLDL,MANSC1,MANSC domain-containing protein 1,39913,-0.0230018613124825,0.00256932754504595,-0.0280377433007725,-0.0179659793241924,3.84967492571156e-19
NMR metabolomics,X23424.Total Lipids in VLDL,SF3B4,Splicing factor 3B subunit 4,39788,0.0620333732124687,0.00693542249115602,0.0484399451298029,0.0756268012951345,4.14291740906515e-19
NMR metabolomics,X23424.Total Lipids in VLDL,S100A13,Protein S100-A13,37056,0.0295981229921621,0.00331267866191439,0.0231052728148099,0.0360909731695143,4.61418311944215e-19
NMR metabolomics,X23424.Total Lipids in VLDL,C2orf69,UPF0565 protein C2orf69,37039,0.049716302423971,0.0055644151979094,0.0388100486360686,0.0606225562118734,4.61966783232115e-19
NMR metabolomics,X23424.Total Lipids in VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,0.0430873002588395,0.00482751166731654,0.033625377390899,0.0525492231267799,4.91456999976294e-19
NMR metabolomics,X23424.Total Lipids in VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,40011,0.0554270396734125,0.00621193781678142,0.0432516415525209,0.0676024377943041,5.03192200612134e-19
NMR metabolomics,X23424.Total Lipids in VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,0.100754030425543,0.0112961702616905,0.07861353671263,0.122894524138457,5.28749462520567e-19
NMR metabolomics,X23424.Total Lipids in VLDL,HDGF,Hepatoma-derived growth factor,40014,0.079461680369207,0.00892680159069077,0.0619651492514531,0.0969582114869609,6.08627435685914e-19
NMR metabolomics,X23424.Total Lipids in VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,39489,0.054601527794062,0.00615232117559685,0.0425429782898922,0.0666600772982319,7.74333989266471e-19
NMR metabolomics,X23424.Total Lipids in VLDL,TPR,Nucleoprotein TPR,37021,0.0398118812909919,0.00448654901171243,0.0310182452280355,0.0486055173539482,7.98630997511988e-19
NMR metabolomics,X23424.Total Lipids in VLDL,CSNK1D,Casein kinase I isoform delta,37056,0.0546517397771376,0.00616298993747259,0.0425722794996913,0.0667312000545839,8.41387147521388e-19
NMR metabolomics,X23424.Total Lipids in VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,0.0549859032013364,0.00625248545347717,0.0427310317125211,0.0672407746901516,1.61736805649023e-18
NMR metabolomics,X23424.Total Lipids in VLDL,PLXNB2,Plexin-B2,39984,0.019703244864575,0.00224624067666819,0.0153006131383053,0.0241058765908446,1.93387927907478e-18
NMR metabolomics,X23424.Total Lipids in VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,0.0588129325705274,0.00671482791093135,0.045651869865102,0.0719739952759529,2.17198787766912e-18
NMR metabolomics,X23424.Total Lipids in VLDL,AGER,Advanced glycosylation end product-specific receptor,39817,0.0329055835641595,0.0037648258146057,0.0255265249675323,0.0402846421607867,2.55356329269182e-18
NMR metabolomics,X23424.Total Lipids in VLDL,NPPB,Natriuretic peptides B,39585,-0.105108435337198,0.0120483207176875,-0.128723143943865,-0.0814937267305304,2.95307884188506e-18
NMR metabolomics,X23424.Total Lipids in VLDL,GAST,Gastrin,37388,0.09617747820124,0.0110637068738398,0.074492612728514,0.117862343673966,3.93004934187036e-18
NMR metabolomics,X23424.Total Lipids in VLDL,PNLIP,Pancreatic triacylglycerol lipase,37445,0.0505743819593383,0.00583321964430056,0.0391412714565092,0.0620074924621674,4.80340766079998e-18
NMR metabolomics,X23424.Total Lipids in VLDL,IL6ST,Interleukin-6 receptor subunit beta,39868,0.0144762668125008,0.00167148645952489,0.011200153351832,0.0177523802731696,5.12923824205885e-18
NMR metabolomics,X23424.Total Lipids in VLDL,TFPI2,Tissue factor pathway inhibitor 2,39864,0.0329675163519946,0.00381463789428128,0.0254908260792033,0.0404442066247859,6.01944757290032e-18
NMR metabolomics,X23424.Total Lipids in VLDL,IL17D,Interleukin-17D,39587,0.0278281480036136,0.00322193327422576,0.0215131587861311,0.0341431372210961,6.31237091175675e-18
NMR metabolomics,X23424.Total Lipids in VLDL,DDX58,Antiviral innate immune response receptor RIG-I,39477,0.046924734921385,0.00543370912199672,0.0362746650422714,0.0575748048004986,6.38491847436905e-18
NMR metabolomics,X23424.Total Lipids in VLDL,RPL14,60S ribosomal protein L14,37043,0.033206598072124,0.00385427579107383,0.0256522175216193,0.0407609786226287,7.74775436803329e-18
NMR metabolomics,X23424.Total Lipids in VLDL,PKD1,Polycystin-1,37437,0.0214484298930803,0.00249533812180829,0.0165575671743361,0.0263392926118246,9.19626036543652e-18
NMR metabolomics,X23424.Total Lipids in VLDL,PVALB,Parvalbumin alpha,39971,0.0931991611516827,0.010857045875727,0.0719193512352578,0.114478971068108,9.97037773165052e-18
NMR metabolomics,X23424.Total Lipids in VLDL,CHCHD6,MICOS complex subunit MIC25,37368,0.0237650750812405,0.00276792386064902,0.0183399443143684,0.0291902058481126,9.99109709782995e-18
NMR metabolomics,X23424.Total Lipids in VLDL,CD59,CD59 glycoprotein,39173,0.017257464630382,0.00201051888522102,0.0133168476153488,0.0211980816454152,1.0069271222612e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CILP,Cartilage intermediate layer protein 1,37437,0.043826914157219,0.00512194575825116,0.0337879004710467,0.0538659278433913,1.28499885612286e-17
NMR metabolomics,X23424.Total Lipids in VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.0127227599049693,0.00149024689297347,0.00980187599474134,0.0156436438151973,1.49370388955299e-17
NMR metabolomics,X23424.Total Lipids in VLDL,ACAN,Aggrecan core protein,39730,0.0228727727402109,0.00267922622023136,0.0176214893485575,0.0281240561318644,1.49971255878536e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,40034,0.0451818815466754,0.00530072906640456,0.0347924525765224,0.0555713105168283,1.6799005153832e-17
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,0.0257386771620111,0.00302353991837286,0.0198125389220003,0.0316648154020219,1.84706070413762e-17
NMR metabolomics,X23424.Total Lipids in VLDL,DAPK2,Death-associated protein kinase 2,37056,0.0432169838803904,0.00507647922887729,0.0332670845917909,0.0531668831689899,1.8737379532289e-17
NMR metabolomics,X23424.Total Lipids in VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,0.0298986786873819,0.00351419825601542,0.0230108501055916,0.0367865072691721,1.92490901080546e-17
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0262313933556022,0.00308568001336645,0.0201834605294039,0.0322793261818004,2.07397775030317e-17
NMR metabolomics,X23424.Total Lipids in VLDL,FOLR2,Folate receptor beta,40009,-0.0233018876163689,0.00274178092068181,-0.0286757782209052,-0.0179279970118325,2.08059096067559e-17
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB8,Serpin B8,40058,0.0444340446710175,0.00523543224702699,0.0341725974668446,0.0546954918751904,2.29819304937206e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CASP9,Caspase-9,37056,0.0511731784904855,0.00603815828076736,0.0393383882601815,0.0630079687207896,2.59902224756184e-17
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS22,Brain-specific serine protease 4,37056,0.0271719554280797,0.00320696602209208,0.0208863020247792,0.0334576088313802,2.64771541014137e-17
NMR metabolomics,X23424.Total Lipids in VLDL,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.0437085191411532,0.0051601783955512,-0.0538224687964336,-0.0335945694858729,2.65665200692179e-17
NMR metabolomics,X23424.Total Lipids in VLDL,SFTPD,Pulmonary surfactant-associated protein D,39868,0.0529334559675995,0.00626793541052071,0.0406483025629789,0.0652186093722201,3.29499773590699e-17
NMR metabolomics,X23424.Total Lipids in VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,37043,0.0235245268107638,0.00280609169377801,0.0180245870909589,0.0290244665305687,5.66109912404122e-17
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA3,Protein disulfide-isomerase A3,37124,0.020222233945846,0.00241442202269454,0.0154899667813647,0.0249545011103273,6.04215282112712e-17
NMR metabolomics,X23424.Total Lipids in VLDL,DHPS,Deoxyhypusine synthase,37368,0.0326818146192167,0.00390371222509362,0.0250305386580332,0.0403330905804002,6.21892646217166e-17
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB3A1,Secretoglobin family 3A member 1,37124,-0.0195154464980939,0.00233253037576858,-0.0240872060346003,-0.0149436869615875,6.5168692713706e-17
NMR metabolomics,X23424.Total Lipids in VLDL,SCT,Secretin,37039,0.0351476627808462,0.00420605465765697,0.0269037956518385,0.0433915299098539,7.10641894237712e-17
NMR metabolomics,X23424.Total Lipids in VLDL,ECE1,Endothelin-converting enzyme 1,39489,0.0277820922161309,0.00332614186979225,0.0212628541513381,0.0343013302809237,7.22971496859365e-17
NMR metabolomics,X23424.Total Lipids in VLDL,YAP1,Transcriptional coactivator YAP1,37388,0.0202953203491223,0.00243021021579496,0.0155321083261642,0.0250585323720805,7.40563172983757e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,0.0274521526066521,0.00329120400392367,0.0210013927589617,0.0339029124543425,7.95811598297954e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CBLIF,Cobalamin binding intrinsic factor,39846,0.0543692785438688,0.0065241252908659,0.0415819929737716,0.067156564113966,8.47470796600186e-17
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTSL2,ADAMTS-like protein 2,37437,0.0251378903711985,0.0030268570310015,0.0192052505904356,0.0310705301519615,1.09247737331645e-16
NMR metabolomics,X23424.Total Lipids in VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,37362,0.0321244111155549,0.00386933955262826,0.0245405055924036,0.0397083166387063,1.11755675489749e-16
NMR metabolomics,X23424.Total Lipids in VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,0.033662403203806,0.0040638970079425,0.0256971650682386,0.0416276413393733,1.31314118034789e-16
NMR metabolomics,X23424.Total Lipids in VLDL,TXN,Thioredoxin,37289,0.0339380186666588,0.00411243759086652,0.0258776409885604,0.0419983963447572,1.6943596923556e-16
NMR metabolomics,X23424.Total Lipids in VLDL,SMS,Spermine synthase,36991,0.0503603013757402,0.00610870297452521,0.0383872435456708,0.0623333592058096,1.82230465254601e-16
NMR metabolomics,X23424.Total Lipids in VLDL,LACRT,Extracellular glycoprotein lacritin,37339,0.0378672152801013,0.00459647115093832,0.0288581318242622,0.0468762987359405,1.90637844071551e-16
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBR2,TGF-beta receptor type-2,39913,0.023342844059269,0.0028345437892422,0.0177871382323543,0.0288985498861837,1.93041740157898e-16
NMR metabolomics,X23424.Total Lipids in VLDL,LTA,Lymphotoxin-alpha,39866,0.0309126309885679,0.0037547524996606,0.0235533160892331,0.0382719458879027,1.96645821234292e-16
NMR metabolomics,X23424.Total Lipids in VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,0.0291632893944339,0.00354487300193799,0.0222153383106355,0.0361112404782324,2.10041052188858e-16
NMR metabolomics,X23424.Total Lipids in VLDL,AK1,Adenylate kinase isoenzyme 1,39868,0.0489849727852628,0.00595724809291763,0.0373087665231443,0.0606611790473814,2.14009594836162e-16
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,0.024894288078074,0.00303445415850324,0.0189467579274076,0.0308418182287403,2.5050360679316e-16
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINI2,Serpin I2,37382,0.0447223528248134,0.00545618670471971,0.0340282268835628,0.0554164787660641,2.693207881602e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CLSTN3,Calsyntenin-3,37388,0.0235846409874808,0.00288199704421029,0.0179359267808286,0.029233355194133,3.00352305098562e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CD28,T-cell-specific surface glycoprotein CD28,39477,0.0273848285760328,0.00335024062357632,0.0208183569538232,0.0339513001982424,3.21074784347222e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CDA,Cytidine deaminase,37422,0.0360692679450126,0.00442041437852446,0.0274052557631047,0.0447332801269206,3.65237106828143e-16
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,0.0245712279167301,0.00301653955005259,0.018658810398627,0.0304836454348331,4.05562981996238e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CFHR2,Complement factor H-related protein 2,37364,0.0437054946809271,0.00536992714163974,0.0331804374833132,0.054230551878541,4.33449736060409e-16
NMR metabolomics,X23424.Total Lipids in VLDL,RANBP1,Ran-specific GTPase-activating protein,37043,0.040531057092211,0.00498479478531068,0.0307608593130021,0.0503012548714199,4.63817519149543e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CD300LF,CMRF35-like molecule 1,40030,0.046077022310533,0.00567931055832791,0.0349455736162103,0.0572084710048557,5.28440963637111e-16
NMR metabolomics,X23424.Total Lipids in VLDL,LY75,Lymphocyte antigen 75,39866,0.0297376981218639,0.00367533565827844,0.0225340402316382,0.0369413560120897,6.33118421902889e-16
NMR metabolomics,X23424.Total Lipids in VLDL,ULBP2,UL16-binding protein 2,39749,0.0280601913047958,0.00347498536346547,0.0212492199924035,0.0348711626171882,7.23323802453982e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CA9,Carbonic anhydrase 9,40030,-0.0332280301384293,0.00411714931527247,-0.0412976427963633,-0.0251584174804952,7.48074620800541e-16
NMR metabolomics,X23424.Total Lipids in VLDL,GIMAP8,GTPase IMAP family member 8,36962,0.0381689105801152,0.00472847034257394,0.0289011087086703,0.0474367124515601,7.50656725199536e-16
NMR metabolomics,X23424.Total Lipids in VLDL,RPE,Ribulose-phosphate 3-epimerase,37169,0.0546906374821864,0.00677891116198842,0.0414039716046891,0.0679773033596837,7.76975126188907e-16
NMR metabolomics,X23424.Total Lipids in VLDL,FABP6,Gastrotropin,39564,0.0415083659029731,0.00514682260119536,0.0314205936046301,0.051596138201316,7.85790399484809e-16
NMR metabolomics,X23424.Total Lipids in VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,-0.0268892104226484,0.00333685816385591,-0.0334294524238059,-0.0203489684214908,8.40255871378964e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CIT,Citron Rho-interacting kinase,37039,0.0347184844042573,0.00431574434864429,0.0262596254809145,0.0431773433276001,9.38777851564194e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CCN3,CCN family member 3,40042,0.0247548598452175,0.00307942192182639,0.0187191928784378,0.0307905268119973,9.69429288610728e-16
NMR metabolomics,X23424.Total Lipids in VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.0193958454484334,0.00241347500893988,0.0146654344309112,0.0241262564659555,9.88784403582278e-16
NMR metabolomics,X23424.Total Lipids in VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.0253084074339757,0.00314946020830733,-0.0314813494422581,-0.0191354654256933,1.0064085795756e-15
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB103A_DEFB103B,Beta-defensin 103,37000,0.0307700905418525,0.00383139864669995,0.0232605491943206,0.0382796318893844,1.04843391278042e-15
NMR metabolomics,X23424.Total Lipids in VLDL,COL24A1,Collagen alpha-1(XXIV) chain,37382,0.0423256728057135,0.00527874517897838,0.0319793322549159,0.0526720133565111,1.16137336954079e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CD300E,CMRF35-like molecule 2,39991,0.029315412457225,0.00365895509220328,0.0221438604765066,0.0364869644379434,1.20553641494221e-15
NMR metabolomics,X23424.Total Lipids in VLDL,RNASET2,Ribonuclease T2,39974,0.019371263207792,0.00242309895855536,0.0146219892490235,0.0241205371665605,1.38955282031627e-15
NMR metabolomics,X23424.Total Lipids in VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,39453,0.0317748148921248,0.00398090152092626,0.0239722479111094,0.0395773818731403,1.54178832411124e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CTSC,Dipeptidyl peptidase 1,39856,0.0324640022745955,0.00406906093562893,0.0244886428407628,0.0404393617084282,1.58405273345823e-15
NMR metabolomics,X23424.Total Lipids in VLDL,THBS4,Thrombospondin-4,39892,0.0338892207827396,0.00425107190722601,0.0255571198445766,0.0422213217209026,1.66678185000373e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CD80,T-lymphocyte activation antigen CD80,37437,0.0254702949160262,0.00319673857302845,0.0192046873128904,0.031735902519162,1.74628957569899e-15
NMR metabolomics,X23424.Total Lipids in VLDL,S100A12,Protein S100-A12,39615,0.0566153083653817,0.0071079878503556,0.0426836521786847,0.0705469645520787,1.76404661499746e-15
NMR metabolomics,X23424.Total Lipids in VLDL,PZP,Pregnancy zone protein,37453,0.0417231030637222,0.00524460693499506,0.0314436734711319,0.0520025326563125,1.92557329637665e-15
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,0.02487934900565,0.0031279218672595,0.0187486221458213,0.0310100758654786,1.92647909375139e-15
NMR metabolomics,X23424.Total Lipids in VLDL,SMARCA2,Probable global transcription activator SNF2L2,39489,0.0557590875227884,0.00701336358408672,0.0420128948979784,0.0695052801475983,1.98533486289894e-15
NMR metabolomics,X23424.Total Lipids in VLDL,INSR,Insulin receptor,37056,0.0126169468095714,0.00158686192547774,0.00950669743563499,0.0157271961835077,2.00184953798296e-15
NMR metabolomics,X23424.Total Lipids in VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,0.042748485852645,0.00539531458668095,0.0321736692627504,0.0533233024425397,2.46767873696575e-15
NMR metabolomics,X23424.Total Lipids in VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,0.0456676986459697,0.00576409279671402,0.0343700767644103,0.0569653205275292,2.5076940453283e-15
NMR metabolomics,X23424.Total Lipids in VLDL,GC,Vitamin D-binding protein,37453,0.0195079096887908,0.00246373284454921,0.0146789933134744,0.0243368260641073,2.5993002063054e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,0.0354564650206882,0.00448248751975606,0.0266707894819663,0.0442421405594101,2.73958265768406e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CD14,Monocyte differentiation antigen CD14,39564,0.0307211447854974,0.00390405542337799,0.0230691961556765,0.0383730934153183,3.80566756755987e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CCN5,CCN family member 5,39858,0.0287655958829559,0.00366168110912236,0.0215887009090761,0.0359424908568358,4.22181868126323e-15
NMR metabolomics,X23424.Total Lipids in VLDL,APRT,Adenine phosphoribosyltransferase,39738,0.0359225196353804,0.00457913993570701,0.0269474053613947,0.0448976339093662,4.61036991670589e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,0.0312290072376948,0.00398246442964126,0.0234233769555979,0.0390346375197917,4.72620655138087e-15
NMR metabolomics,X23424.Total Lipids in VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,0.0350264999016639,0.00446912121495336,0.0262670223203553,0.0437859774829725,4.89349675593479e-15
NMR metabolomics,X23424.Total Lipids in VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,0.0603295650857401,0.00770131012304534,0.0452349972445713,0.075424132926909,5.04153523219661e-15
NMR metabolomics,X23424.Total Lipids in VLDL,STAM,Signal transducing adapter molecule 1,37368,0.0271828513476807,0.00346982419353497,0.0203819959283522,0.0339837067670092,5.07453892438607e-15
NMR metabolomics,X23424.Total Lipids in VLDL,EPCAM,Epithelial cell adhesion molecule,39867,-0.0707408890043761,0.00904529991344275,-0.0884696768347239,-0.0530121011740283,5.57730398590843e-15
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,0.0268183280471894,0.00343576853585884,0.0200842217169061,0.0335524343774727,6.28518164537175e-15
NMR metabolomics,X23424.Total Lipids in VLDL,SLITRK6,SLIT and NTRK-like protein 6,39585,-0.024668399393292,0.00316313974620574,-0.0308681532958553,-0.0184686454907288,6.64504425768423e-15
NMR metabolomics,X23424.Total Lipids in VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,0.0216139507645156,0.00277642454598388,0.0161721586543872,0.027055742874644,7.40978034279896e-15
NMR metabolomics,X23424.Total Lipids in VLDL,SNX5,Sorting nexin-5,37043,0.0225909840795795,0.00290318276983232,0.0169007458507081,0.0282812223084508,7.70165364161812e-15
NMR metabolomics,X23424.Total Lipids in VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,0.0577046577424128,0.00741700442914241,0.0431673290612937,0.072241986423532,7.78729746803725e-15
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS11D,Transmembrane protease serine 11D,37357,0.0267735751780982,0.00344866125260546,0.0200141991229915,0.0335329512332049,8.85669255017694e-15
NMR metabolomics,X23424.Total Lipids in VLDL,IGHMBP2,DNA-binding protein SMUBP-2,37021,0.0416721034832084,0.0053746221516385,0.0311378440659969,0.0522063629004198,9.59471915163739e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CR1,Complement receptor type 1,37420,0.0262816545544636,0.00339649194111717,0.019624530349874,0.0329387787590533,1.08208908511105e-14
NMR metabolomics,X23424.Total Lipids in VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,0.0376315110802615,0.00487572300255318,0.0280750939952573,0.0471879281652657,1.25157547347212e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CTSB,Cathepsin B,39847,-0.0376758819521484,0.00488566470565156,-0.0472517847752254,-0.0280999791290713,1.31625459866997e-14
NMR metabolomics,X23424.Total Lipids in VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,0.0278118920835732,0.00360956384602884,0.0207371469453566,0.0348866372217897,1.39849193836451e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CYTL1,Cytokine-like protein 1,37437,0.0167691089962583,0.00218100715728105,0.0124943349679875,0.0210438830245292,1.58829787396361e-14
NMR metabolomics,X23424.Total Lipids in VLDL,PEPD,Xaa-Pro dipeptidase,37445,0.0188207863279924,0.00244859593025832,0.0140215383046861,0.0236200343512988,1.61742744341842e-14
NMR metabolomics,X23424.Total Lipids in VLDL,INSL5,Insulin-like peptide INSL5,37382,0.0709274392161256,0.00923687540189806,0.0528231634284054,0.0890317150038458,1.71683412137812e-14
NMR metabolomics,X23424.Total Lipids in VLDL,MNDA,Myeloid cell nuclear differentiation antigen,39841,0.0709783532595814,0.00926862320406397,0.0528118517796161,0.0891448547395468,1.99753630809704e-14
NMR metabolomics,X23424.Total Lipids in VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.0236886144158994,0.00309348978494736,0.0176253744374025,0.0297518543943962,2.02658312372755e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,0.0613785672733392,0.00801615872342865,0.045666896175419,0.0770902383712593,2.03441760629414e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CD300A,CMRF35-like molecule 8,37124,0.0210798904225963,0.00275735098820005,0.0156754824857242,0.0264842983594685,2.23321391935639e-14
NMR metabolomics,X23424.Total Lipids in VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,0.0306963529411001,0.00401749660456302,0.0228220595961565,0.0385706462860436,2.30545043650022e-14
NMR metabolomics,X23424.Total Lipids in VLDL,GRSF1,G-rich sequence factor 1,36874,0.0589472975384805,0.00771482536781342,0.0438262398175661,0.0740683552593948,2.30983840797648e-14
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,0.0319250314285961,0.00418348797011575,0.0237253950071693,0.040124667850023,2.45642053605462e-14
NMR metabolomics,X23424.Total Lipids in VLDL,DGCR6,Protein DGCR6,36991,0.0314902987306718,0.00412799446353538,0.0233994295821425,0.0395811678792011,2.53877507515769e-14
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2,Apoptosis regulator Bcl-2,37382,0.0367400539296761,0.00482208833114523,0.0272887608006315,0.0461913470587208,2.72367216496817e-14
NMR metabolomics,X23424.Total Lipids in VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,0.0174410135119899,0.00229042229758838,0.0129517858087167,0.0219302412152632,2.78998580366181e-14
NMR metabolomics,X23424.Total Lipids in VLDL,SPTLC1,Serine palmitoyltransferase 1,37388,0.0259067485515666,0.00340776407054363,0.0192275309733011,0.0325859661298321,3.10105196256479e-14
NMR metabolomics,X23424.Total Lipids in VLDL,GPNMB,Transmembrane glycoprotein NMB,39444,0.0203859111362144,0.00268852849939306,0.015116395277404,0.0256554269950248,3.57878790754132e-14
NMR metabolomics,X23424.Total Lipids in VLDL,DGKZ,Diacylglycerol kinase zeta,39587,0.0258642044224476,0.00342486921406945,0.0191514607628714,0.0325769480820237,4.5253722403624e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CRYGD,Gamma-crystallin D,37388,0.0690811115710984,0.00918229394116045,0.0510838154464239,0.0870784076957729,5.67782604722763e-14
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTSL4,ADAMTS-like protein 4,37043,0.0173439869120923,0.00230691640668774,0.0128224307549844,0.0218655430692003,5.90944694296419e-14
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD1,Programmed cell death protein 1,39998,0.0292731331338571,0.00389461969267112,0.0216396785362218,0.0369065877314925,5.92997771628706e-14
NMR metabolomics,X23424.Total Lipids in VLDL,COPB2,Coatomer subunit beta',37021,0.0306321655772197,0.00407816688112739,0.0226389584902101,0.0386253726642294,6.23332131685431e-14
NMR metabolomics,X23424.Total Lipids in VLDL,SNX2,Sorting nexin-2,37368,0.0576815066051758,0.00768382972626039,0.0426212003417054,0.0727418128686461,6.43462714583136e-14
NMR metabolomics,X23424.Total Lipids in VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,0.0739441742078308,0.00985282913355846,0.0546326291060562,0.0932557193096053,6.53292260038056e-14
NMR metabolomics,X23424.Total Lipids in VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,0.0442644353085907,0.00589995692853356,0.0327005197286649,0.0558283508885165,6.65128247519133e-14
NMR metabolomics,X23424.Total Lipids in VLDL,IL1B,Interleukin-1 beta,39478,0.0397796542333024,0.00530749059060429,0.029376972675718,0.0501823357908869,6.98479547671195e-14
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB8,DnaJ homolog subfamily B member 8,39585,0.0405577783690762,0.00542432030052584,0.0299261105800455,0.0511894461581068,8.00283778727508e-14
NMR metabolomics,X23424.Total Lipids in VLDL,SCN4B,Sodium channel subunit beta-4,37043,0.0295079915855733,0.00395023100881146,0.0217655388083028,0.0372504443628437,8.52753094709062e-14
NMR metabolomics,X23424.Total Lipids in VLDL,ASPN,Asporin,37437,0.0191933004597302,0.00257096473974744,0.0141542095698252,0.0242323913496351,8.80950343650391e-14
NMR metabolomics,X23424.Total Lipids in VLDL,LMNB2,Lamin-B2,37388,0.0194558841254234,0.00260736236476697,0.0143454538904802,0.0245663143603667,9.04806862640344e-14
NMR metabolomics,X23424.Total Lipids in VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,0.0383614889276654,0.00514779014972021,0.0282718202342138,0.048451157621117,9.74670603032315e-14
NMR metabolomics,X23424.Total Lipids in VLDL,KIF1C,Kinesin-like protein KIF1C,37021,0.0260051688179452,0.00348986750697222,0.0191650285042797,0.0328453091316108,9.79499959355724e-14
NMR metabolomics,X23424.Total Lipids in VLDL,MMP3,Stromelysin-1,39858,-0.0337811525418314,0.00453706684448444,-0.0426738035570209,-0.0248885015266419,1.01420730324543e-13
NMR metabolomics,X23424.Total Lipids in VLDL,GPR15L,Protein GPR15L,37382,0.0435162850427496,0.00585236363478462,0.0320456523185717,0.0549869177669274,1.10288986823193e-13
NMR metabolomics,X23424.Total Lipids in VLDL,MCTS1,Malignant T-cell-amplified sequence 1,37382,0.0176777897832586,0.00237803542962031,0.0130168403412028,0.0223387392253144,1.11877313023669e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CFC1,Cryptic protein,39477,0.0329760238551826,0.00444271228334881,0.0242683077798189,0.0416837399305462,1.20851106094615e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CST5,Cystatin-D,39559,0.0382223827962054,0.00516510507368937,0.0280987768517742,0.0483459887406366,1.42950717677538e-13
NMR metabolomics,X23424.Total Lipids in VLDL,PPM1A,Protein phosphatase 1A,39477,0.0214923946914191,0.00290630833683439,0.0157960303512237,0.0271887590316145,1.48489776578077e-13
NMR metabolomics,X23424.Total Lipids in VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,0.0383227604009933,0.00519344795391057,0.0281436024113286,0.048501918390658,1.67270654809842e-13
NMR metabolomics,X23424.Total Lipids in VLDL,RBP2,Retinol-binding protein 2,39788,-0.0535759273691805,0.00727080647545984,-0.0678267080610818,-0.0393251466772793,1.80832541927409e-13
NMR metabolomics,X23424.Total Lipids in VLDL,NPTX1,Neuronal pentraxin-1,39858,0.0286060470120731,0.00388788142257696,0.0209857994238223,0.0362262946003239,1.96113963134003e-13
NMR metabolomics,X23424.Total Lipids in VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,39931,0.0174648860125604,0.00237627276783283,0.0128073913876081,0.0221223806375128,2.08206141713362e-13
NMR metabolomics,X23424.Total Lipids in VLDL,NFIC,Nuclear factor 1 C-type,37411,0.0293237429555104,0.00399777122207214,0.021488111360249,0.0371593745507718,2.34271417788703e-13
NMR metabolomics,X23424.Total Lipids in VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,0.0228637260252295,0.00312164010289296,0.0167453114235593,0.0289821406268997,2.54140883900123e-13
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINI1,Neuroserpin,37088,0.0214306217710671,0.00293731216322357,0.0156734899311489,0.0271877536109853,3.13342234018241e-13
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL2,Fc receptor-like protein 2,39990,0.0320738838456455,0.00440254182439559,0.0234449018698301,0.0407028658214609,3.35767668823128e-13
NMR metabolomics,X23424.Total Lipids in VLDL,SYT1,Synaptotagmin-1,37388,0.0256889611001436,0.00353011972205257,0.0187699264449205,0.0326079957553666,3.5991770462422e-13
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC25,Leucine-rich repeat-containing protein 25,39788,0.0268655413011741,0.0036928183495587,0.019627617336039,0.0341034652663091,3.62342911823677e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CSDE1,Cold shock domain-containing protein E1,37021,0.0829292684555344,0.0114298845186612,0.0605266947989585,0.10533184211211,4.22657858343812e-13
NMR metabolomics,X23424.Total Lipids in VLDL,FES,Tyrosine-protein kinase Fes/Fps,39477,0.0326570872329584,0.00450764757268999,0.0238220979904861,0.0414920764754308,4.53252600352818e-13
NMR metabolomics,X23424.Total Lipids in VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,0.0305629034703694,0.00421807542067245,0.0222954756458514,0.0388303312948874,4.54173159627009e-13
NMR metabolomics,X23424.Total Lipids in VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,0.0579060299661138,0.00800351381919856,0.0422191428804847,0.073592917051743,4.86874678444864e-13
NMR metabolomics,X23424.Total Lipids in VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,40009,0.0160267047974528,0.0022169160133504,0.0116815494112861,0.0203718601836196,5.07302083987626e-13
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE6,Ribonuclease K6,37386,0.018988429334128,0.00263333029741452,0.0138271019511956,0.0241497567170605,5.85762626698101e-13
NMR metabolomics,X23424.Total Lipids in VLDL,AFAP1,Actin filament-associated protein 1,37124,0.0582434314668583,0.00809093997452513,0.0423851891167891,0.0741016738169276,6.41080575948038e-13
NMR metabolomics,X23424.Total Lipids in VLDL,HGFAC,Hepatocyte growth factor activator,37318,0.0193736864548034,0.00269830531586341,0.0140850080357111,0.0246623648738956,7.33980086649374e-13
NMR metabolomics,X23424.Total Lipids in VLDL,INSL3,Insulin-like 3,37388,0.0494056525249004,0.00691119334033484,0.0358597135778442,0.0629515914719567,9.21343318569777e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,37324,0.0417014895524818,0.00583891968122561,0.0302572069772796,0.053145772127684,9.67138064502679e-13
NMR metabolomics,X23424.Total Lipids in VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,0.025880000133669,0.00362380412448147,0.0187773440496853,0.0329826562176527,9.69953648452768e-13
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS53,Serine protease 53,37388,0.0253713823877478,0.00355603918033378,0.0184015455942936,0.032341219181202,1.0191103648926e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.0163130203094147,0.00228766621837121,0.0118291945214071,0.0207968460974223,1.03989965647354e-12
NMR metabolomics,X23424.Total Lipids in VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,0.024876882584299,0.00348836331802312,0.0180396904809736,0.0317140746876243,1.04413336923622e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CHAD,Chondroadherin,37124,0.0342397381624447,0.00480679868052738,0.024818412748611,0.0436610635762784,1.10897165961305e-12
NMR metabolomics,X23424.Total Lipids in VLDL,SEL1L,Protein sel-1 homolog 1,37043,0.0212662799037671,0.00298610983726861,0.0154135046227206,0.0271190551848136,1.12104932235494e-12
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH1,Protocadherin-1,40018,0.0140795122086949,0.00197872771019981,0.0102012058967033,0.0179578185206865,1.16242801410754e-12
NMR metabolomics,X23424.Total Lipids in VLDL,NRCAM,Neuronal cell adhesion molecule,39868,0.0187363802548741,0.00263440386369421,0.0135729486820335,0.0238998118277148,1.19048499128033e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,0.0362605612865043,0.00509939624879069,0.0262657446388746,0.0462553779341341,1.21211262354403e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CPQ,Carboxypeptidase Q,37430,0.0255611933426243,0.00359992478951478,0.0185053407551753,0.0326170459300733,1.30509521104191e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CTSH,Pro-cathepsin H,39546,0.0488539305484806,0.00688597542324725,0.035357418718916,0.0623504423780452,1.35176805590802e-12
NMR metabolomics,X23424.Total Lipids in VLDL,RABEPK,Rab9 effector protein with kelch motifs,39477,0.0403957549367566,0.00572150422048753,0.0291816066646011,0.0516099032089122,1.73096669517211e-12
NMR metabolomics,X23424.Total Lipids in VLDL,AHCY,Adenosylhomocysteinase,39868,0.0454646685368348,0.00645019049098715,0.0328222951745,0.0581070418991697,1.88133601362275e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CDH5,Cadherin-5,40052,-0.0204511413955271,0.00290210088118573,-0.0261392591226512,-0.0147630236684031,1.90168120217967e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,0.0285000596101854,0.00404452419922708,0.0205727921797003,0.0364273270406705,1.90816042353625e-12
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.0385331051931269,0.00547986968410116,0.0277925606122886,0.0492736497739652,2.12238052942936e-12
NMR metabolomics,X23424.Total Lipids in VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,0.0319525018593081,0.00454788467026904,0.0230386479055808,0.0408663558130355,2.21433454012641e-12
NMR metabolomics,X23424.Total Lipids in VLDL,BAX,Apoptosis regulator BAX,39456,0.0609567259205619,0.00871384199049424,0.0438775956191932,0.0780358562219306,2.75277867520401e-12
NMR metabolomics,X23424.Total Lipids in VLDL,RSPO3,R-spondin-3,40030,0.0179351260227904,0.00256464885032705,0.0129084142761494,0.0229618377694314,2.7918576589489e-12
NMR metabolomics,X23424.Total Lipids in VLDL,LAG3,Lymphocyte activation gene 3 protein,39788,-0.0269903783789565,0.0038664071552701,-0.0345685364032859,-0.0194122203546271,3.05221242086733e-12
NMR metabolomics,X23424.Total Lipids in VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,0.0302645017154881,0.00434877513403577,0.0217409024527779,0.0387881009781982,3.5807637498244e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CA2,Carbonic anhydrase 2,39821,0.0449525240185147,0.00646452974024178,0.0322820457276409,0.0576230023093886,3.69577099782556e-12
NMR metabolomics,X23424.Total Lipids in VLDL,HSPA2,Heat shock-related 70 kDa protein 2,37368,0.0223758684504889,0.00322432746252857,0.0160561866239329,0.0286955502770449,4.10846796678622e-12
NMR metabolomics,X23424.Total Lipids in VLDL,LIPF,Gastric triacylglycerol lipase,37043,0.0395749272982511,0.0057085598488034,0.0283861499945965,0.0507637046019058,4.32534607865455e-12
NMR metabolomics,X23424.Total Lipids in VLDL,C8B,Complement component C8 beta chain,37453,0.0200216402121732,0.00289082471227871,0.0143556237761069,0.0256876566482394,4.52598105181713e-12
NMR metabolomics,X23424.Total Lipids in VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,0.0462559119288261,0.00669204121614428,0.0331395111451833,0.0593723127124689,4.99575463102188e-12
NMR metabolomics,X23424.Total Lipids in VLDL,FABP2,"Fatty acid-binding protein, intestinal",39868,-0.0511232011465561,0.00740740750898195,-0.0656417198641607,-0.0366046824289515,5.33374002024167e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,39477,0.026654238730064,0.00386346555504064,0.0190818462421844,0.0342266312179437,5.43631145847957e-12
NMR metabolomics,X23424.Total Lipids in VLDL,NXPH1,Neurexophilin-1,39489,0.0246404934814257,0.00357377522840886,0.0176358940337444,0.0316450929291071,5.60032524686017e-12
NMR metabolomics,X23424.Total Lipids in VLDL,TSHB,Thyrotropin subunit beta,39868,0.0490818334844558,0.00712660812180867,0.0351136815657108,0.0630499854032008,5.90499513141204e-12
NMR metabolomics,X23424.Total Lipids in VLDL,SAA4,Serum amyloid A-4 protein,37453,0.0216439122410454,0.00314640926358593,0.0154769500844169,0.0278108743976738,6.29437097226691e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,0.041265464680927,0.00602559153203339,0.0294553052781415,0.0530756240837124,7.74195491628642e-12
NMR metabolomics,X23424.Total Lipids in VLDL,NCF2,Neutrophil cytosol factor 2,39843,0.0540872278147108,0.0079000076088593,0.0386032129013465,0.069571242728075,7.84453110752261e-12
NMR metabolomics,X23424.Total Lipids in VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.0222164146115983,0.0032496920138736,0.0158470182644061,0.0285858109587906,8.46371714615492e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,37021,0.0641960814944816,0.00940948432388863,0.0457534922196599,0.0826386707693034,9.33913894009752e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ENSA,Alpha-endosulfine,37368,0.0341680841528579,0.00500976232938611,0.0243489499872611,0.0439872183184546,9.4714871068002e-12
NMR metabolomics,X23424.Total Lipids in VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,0.018160851245611,0.00266820012298434,0.0129311790045617,0.0233905234866603,1.04395749865846e-11
NMR metabolomics,X23424.Total Lipids in VLDL,GM2A,Ganglioside GM2 activator,37178,0.0234592606955154,0.00344707571917542,0.0167029922859315,0.0302155291050992,1.04967657655374e-11
NMR metabolomics,X23424.Total Lipids in VLDL,MDM1,Nuclear protein MDM1,37039,0.0202670878073386,0.00298177418453869,0.0144228104056428,0.0261113652090344,1.11424353789472e-11
NMR metabolomics,X23424.Total Lipids in VLDL,APOB,Apolipoprotein B-100,37445,0.014675527822464,0.00216015489674736,0.0104416242248392,0.0189094314200888,1.13813772357261e-11
NMR metabolomics,X23424.Total Lipids in VLDL,RCOR1,REST corepressor 1,39585,0.0290320390059968,0.00428116480737221,0.0206409559835472,0.0374231220284463,1.23306707688568e-11
NMR metabolomics,X23424.Total Lipids in VLDL,MYOM3,Myomesin-3,37124,-0.060525075451293,0.00893249680516562,-0.0780327691894176,-0.0430173817131684,1.28916455185288e-11
NMR metabolomics,X23424.Total Lipids in VLDL,LBP,Lipopolysaccharide-binding protein,39931,-0.0372113107413833,0.00551175156896611,-0.0480143438165568,-0.0264082776662097,1.51575868767243e-11
NMR metabolomics,X23424.Total Lipids in VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,0.017164984658818,0.00255832043007491,0.0121506766158712,0.0221792927017648,2.01850412077776e-11
NMR metabolomics,X23424.Total Lipids in VLDL,LXN,Latexin,39682,-0.042681086076921,0.00636449779793434,-0.0551555017608723,-0.0302066703929697,2.06635451235558e-11
NMR metabolomics,X23424.Total Lipids in VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,0.0245735352629172,0.00366444328104545,0.0173912264320681,0.0317558440937662,2.08262642456684e-11
NMR metabolomics,X23424.Total Lipids in VLDL,NAGA,Alpha-N-acetylgalactosaminidase,37037,0.0385586485690656,0.00575618594634328,0.0272765241142327,0.0498407730238984,2.18901058334794e-11
NMR metabolomics,X23424.Total Lipids in VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,0.0193167233037069,0.00288410396718692,0.0136638795280205,0.0249695670793932,2.19021088671653e-11
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE3,Eosinophil cationic protein,39791,0.0682940074320801,0.0102367436592546,0.0482299898599411,0.0883580250042191,2.61617437506215e-11
NMR metabolomics,X23424.Total Lipids in VLDL,LCP1,Plastin-2,37437,0.0298268754632376,0.00447588490553643,0.0210541410483862,0.038599609878089,2.76930375610117e-11
NMR metabolomics,X23424.Total Lipids in VLDL,ZBP1,Z-DNA-binding protein 1,37056,0.0262099676475791,0.00393318267687263,0.0185009296009087,0.0339190056942494,2.77419695452519e-11
NMR metabolomics,X23424.Total Lipids in VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,0.0233339126241158,0.00351066441691279,0.0164530103669667,0.0302148148812649,3.098454227941e-11
NMR metabolomics,X23424.Total Lipids in VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,38022,-0.0194102175974521,0.00292247173267657,-0.0251382621934981,-0.013682173001406,3.21366411064776e-11
NMR metabolomics,X23424.Total Lipids in VLDL,EFHD1,EF-hand domain-containing protein D1,37411,0.0218502343175061,0.00329002935927637,0.0154017767733244,0.0282986918616878,3.22676803763833e-11
NMR metabolomics,X23424.Total Lipids in VLDL,GAS2,Growth arrest-specific protein 2,37169,0.0334996054883016,0.00504912272375306,0.0236033249497456,0.0433958860268576,3.37655074359191e-11
NMR metabolomics,X23424.Total Lipids in VLDL,DSG4,Desmoglein-4,39725,0.030986446131842,0.00467254748204988,0.0218282530670243,0.0401446391966598,3.42803815299099e-11
NMR metabolomics,X23424.Total Lipids in VLDL,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.0252404071675158,0.00381173184980284,0.0177694127419022,0.0327114015931293,3.68711161596692e-11
NMR metabolomics,X23424.Total Lipids in VLDL,PRTG,Protogenin,40030,0.0156587360141335,0.00236972867642274,0.011014067808345,0.0203034042199221,4.02208274638038e-11
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,0.0165235425314681,0.00250201050003829,0.011619601951393,0.0214274831115431,4.12465249058978e-11
NMR metabolomics,X23424.Total Lipids in VLDL,IDS,Iduronate 2-sulfatase,40058,0.00565372396420795,0.000856979182176186,0.00397404476714263,0.00733340316127328,4.31770553549647e-11
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA12,Serpin A12,39405,0.0741517593061693,0.0112416329031153,0.0521181588160634,0.0961853597962752,4.35525763967002e-11
NMR metabolomics,X23424.Total Lipids in VLDL,EFNA1,Ephrin-A1,39826,0.0165195720672684,0.00250908957171402,0.0116017565067089,0.0214373876278279,4.72586604980875e-11
NMR metabolomics,X23424.Total Lipids in VLDL,MPO,Myeloperoxidase,39858,0.0283409814344545,0.00431514988809575,0.0198832876537869,0.0367986752151222,5.26429528143707e-11
NMR metabolomics,X23424.Total Lipids in VLDL,COMP,Cartilage oligomeric matrix protein,39729,0.0208838734929921,0.00318787836542513,0.0146356318967589,0.0271321150892254,5.89011260538502e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,37056,0.0195174023293189,0.00298890396922912,0.0136591505496298,0.025375654109008,6.81998375435674e-11
NMR metabolomics,X23424.Total Lipids in VLDL,GSTT2B,Glutathione S-transferase theta-2B,37388,0.148713479745689,0.0227977915459027,0.10402980831572,0.193397151175658,7.12929657573681e-11
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,39868,-0.0174134672360645,0.00267098161690881,-0.0226485912052057,-0.0121783432669232,7.26519605615012e-11
NMR metabolomics,X23424.Total Lipids in VLDL,FABP9,Fatty acid-binding protein 9,39866,0.034264274315334,0.00526449924286685,0.023945855799315,0.044582692831353,7.81330684626472e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,0.0336794315076929,0.00518397603345079,0.0235188384821294,0.0438400245332565,8.49757905054896e-11
NMR metabolomics,X23424.Total Lipids in VLDL,S100A11,Protein S100-A11,39703,0.0280183641531771,0.0043251465076995,0.0195410769980861,0.0364956513082681,9.56764379169171e-11
NMR metabolomics,X23424.Total Lipids in VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,37043,0.0311375798628549,0.00481333752248634,0.0217034383187817,0.0405717214069281,1.02123974735281e-10
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,0.0139676231021339,0.00216019295390664,0.0097336449124769,0.0182016012917909,1.03569560762881e-10
NMR metabolomics,X23424.Total Lipids in VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,37411,0.0228070749510863,0.00352794332794192,0.0158923060283202,0.0297218438738525,1.04980774898876e-10
NMR metabolomics,X23424.Total Lipids in VLDL,LUZP2,Leucine zipper protein 2,37368,0.0268547808550114,0.00416806240442246,0.0186853785423434,0.0350241831676795,1.21115275608419e-10
NMR metabolomics,X23424.Total Lipids in VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.0219249592805629,0.00341246992641235,0.0152365182247947,0.0286134003363311,1.35701691294989e-10
NMR metabolomics,X23424.Total Lipids in VLDL,DKK3,Dickkopf-related protein 3,40052,-0.0175663442879587,0.00273462652114826,-0.0229262122694093,-0.0122064763065081,1.36735042145654e-10
NMR metabolomics,X23424.Total Lipids in VLDL,APOF,Apolipoprotein F,37445,-0.0158540864801784,0.00246865772588865,-0.0206926556229202,-0.0110155173374367,1.38836318725697e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CD300C,CMRF35-like molecule 6,40009,0.020228068815796,0.00316666909892723,0.0140213973818987,0.0264347402496934,1.72884480407732e-10
NMR metabolomics,X23424.Total Lipids in VLDL,FABP1,"Fatty acid-binding protein, liver",39862,0.0568518320630299,0.0089135327698145,0.0393813078341935,0.0743223562918663,1.84160076733917e-10
NMR metabolomics,X23424.Total Lipids in VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,0.0418883049863132,0.0065875087137743,0.0289767879073156,0.0547998220653108,2.09951642039005e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PRELP,Prolargin,39862,0.013404132525772,0.00211119346412678,0.00926619333608347,0.0175420717154604,2.22445540672631e-10
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,0.0169496956575197,0.00267036614954465,0.0117157780044122,0.0221836133106272,2.24935067785037e-10
NMR metabolomics,X23424.Total Lipids in VLDL,IL34,Interleukin-34,39456,0.0216029538648913,0.00340575919944603,0.0149276658339771,0.0282782418958055,2.3144332922955e-10
NMR metabolomics,X23424.Total Lipids in VLDL,NFYA,Nuclear transcription factor Y subunit alpha,37021,0.0228914951965821,0.00361225947975517,0.0158114666162619,0.0299715237769022,2.41656399114926e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SLC16A1,Monocarboxylate transporter 1,39489,0.0349801359839443,0.00552274340741978,0.0241555589054016,0.0458047130624871,2.45681015764388e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA7,Thyroxine-binding globulin,37453,0.0111961583792406,0.00176892596832461,0.00772906348132439,0.0146632532771569,2.53919676623421e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CX3CL1,Fractalkine,39749,-0.0199895494278548,0.00315941596196817,-0.0261820047133124,-0.0137970941423972,2.56704294844924e-10
NMR metabolomics,X23424.Total Lipids in VLDL,AGR2,Anterior gradient protein 2 homolog,39364,0.0601116879267781,0.00954353325852344,0.0414063627400721,0.078817013113484,3.08278268067292e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,0.022306428066945,0.00355303388129816,0.0153424816596006,0.0292703744742894,3.51491476789834e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CDH1,Cadherin-1,39315,0.0240923701340608,0.00384060689937859,0.0165647806112787,0.0316199596568428,3.63434105324766e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,-0.0182396458062321,0.00290848480076278,-0.0239402760157271,-0.012539015596737,3.69568871689902e-10
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL3,Fc receptor-like protein 3,39587,0.0310844211345279,0.00496407286502543,0.021354838319078,0.0408140039499777,3.9024285745896e-10
NMR metabolomics,X23424.Total Lipids in VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,0.0218486402629999,0.00348944812423753,0.0150093219394944,0.0286879585865055,3.91577228557084e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL9,C-X-C motif chemokine 9,39931,0.0387573958283793,0.00620511038642319,0.0265953794709899,0.0509194121857688,4.31564206355989e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CA7,Carbonic anhydrase 7,37169,-0.0199579098618586,0.0032107912728881,-0.0262510607567193,-0.013664758966998,5.25599881359942e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN8,Septin-8,37357,0.0188483954204099,0.00304086870588269,0.0128882927568798,0.02480849808394,5.87158432000938e-10
NMR metabolomics,X23424.Total Lipids in VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,0.0250227859980298,0.00405157196060552,0.017081704955243,0.0329638670408166,6.76470496019966e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PRKD2,Serine/threonine-protein kinase D2,37021,0.0269410304551656,0.00436404598791599,0.0183875003188503,0.0354945605914809,6.87983104992131e-10
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB1,Integrin beta-1,39862,0.0127609483823693,0.00206835888852312,0.00870696496086396,0.0168149318038746,7.0109874389264e-10
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.0179750193212433,0.00291553408880041,-0.0236894661352921,-0.0122605725071945,7.20867998180918e-10
NMR metabolomics,X23424.Total Lipids in VLDL,GLYR1,Putative oxidoreductase GLYR1,37368,0.0350964570451454,0.00569327680096151,0.0239376345152609,0.04625527957503,7.26984326449413e-10
NMR metabolomics,X23424.Total Lipids in VLDL,APOA1,Apolipoprotein A-I,37453,-0.0160464763026893,0.00260530952591358,-0.02115288297348,-0.0109400696318987,7.52007531765919e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PPME1,Protein phosphatase methylesterase 1,39788,0.0351017864771679,0.00570231547062165,0.0239252481547495,0.0462783247995863,7.65337769711528e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,0.0206014055860362,0.00334970866486787,0.0140359766028952,0.0271668345691772,7.96219858313803e-10
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,0.0200967477722137,0.00326829641689356,0.0136908867951024,0.0265026087493251,7.98028333229686e-10
NMR metabolomics,X23424.Total Lipids in VLDL,EDN1,Endothelin-1,37043,0.0164232078988488,0.00267878338249565,0.0111727924691573,0.0216736233285403,8.99086626602266e-10
NMR metabolomics,X23424.Total Lipids in VLDL,GFAP,Glial fibrillary acidic protein,39453,0.0254813280575738,0.00416187232246807,0.0173240583055364,0.0336385978096113,9.42881868625198e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CLC,Galectin-10,39841,-0.0387015351486388,0.00634033765573964,-0.0511285969538885,-0.0262744733433891,1.05823714017747e-09
NMR metabolomics,X23424.Total Lipids in VLDL,LYZL2,Lysozyme-like protein 2,36962,0.0210102864363748,0.00344303847511756,0.0142619310251444,0.0277586418476052,1.07534188052177e-09
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,0.0208326994247616,0.0034215833130506,0.0141263961311824,0.0275390027183408,1.16464694447206e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM4,Intercellular adhesion molecule 4,39866,-0.0303558119866383,0.00499048286134869,-0.0401371583948817,-0.0205744655783948,1.20832842712816e-09
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN8,Tetraspanin-8,37382,0.0568373608494899,0.0093473142622736,0.0385166248954336,0.0751580968035462,1.22952004195953e-09
NMR metabolomics,X23424.Total Lipids in VLDL,FABP3,"Fatty acid-binding protein, heart",37437,0.0284415429883526,0.00467833339686173,0.0192720095305036,0.0376110764462016,1.23852866206159e-09
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,0.0153356320594765,0.00252986842227097,0.0103770899518254,0.0202941741671276,1.37569758670482e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CD93,Complement component C1q receptor,39238,-0.0177646103714382,0.00293050616419015,-0.0235084024532508,-0.0120208182896255,1.3761509574424e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CA4,Carbonic anhydrase 4,40052,-0.013502740219126,0.00222991367483617,-0.0178733710218049,-0.00913210941644715,1.43273915054004e-09
NMR metabolomics,X23424.Total Lipids in VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,0.0332112929187419,0.00548730315534148,0.0224561787342726,0.0439664071032112,1.45895584852711e-09
NMR metabolomics,X23424.Total Lipids in VLDL,EBI3_IL27,Interleukin-27,40011,-0.0176909507489714,0.00293106301211303,-0.0234358342527129,-0.0119460672452299,1.61757699912269e-09
NMR metabolomics,X23424.Total Lipids in VLDL,NXPH3,Neurexophilin-3,37056,0.0171112646884284,0.00283614262237103,0.0115524251485812,0.0226701042282756,1.64957717980674e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PODXL,Podocalyxin,39788,0.00862884320530256,0.00143165485818869,0.00582279968325272,0.0114348867273524,1.70522343127565e-09
NMR metabolomics,X23424.Total Lipids in VLDL,MST1,Hepatocyte growth factor-like protein,37271,0.0362492359260443,0.00601962042752781,0.0244507798880898,0.0480476919639988,1.76944839984347e-09
NMR metabolomics,X23424.Total Lipids in VLDL,HMOX1,Heme oxygenase 1,39691,-0.0272991516793146,0.00453692257123502,-0.0361915199189352,-0.0184067834396939,1.81474000828479e-09
NMR metabolomics,X23424.Total Lipids in VLDL,NCAM2,Neural cell adhesion molecule 2,39858,-0.0153107826597251,0.00254456881294745,-0.0202981375331021,-0.0103234277863481,1.81503912357979e-09
NMR metabolomics,X23424.Total Lipids in VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,0.0245939165202777,0.00410118768121142,0.0165555886651033,0.032632244375452,2.05675598916274e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,0.0320704003512643,0.0053593127086752,0.0215661474422609,0.0425746532602677,2.23311680719569e-09
NMR metabolomics,X23424.Total Lipids in VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,39836,0.0485439778859324,0.00812547360071978,0.0326180496285217,0.0644699061433432,2.35993189134902e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ITM2A,Integral membrane protein 2A,39866,-0.0335707801102409,0.00562691461711919,-0.0445995327597945,-0.0225420274606873,2.48100723583154e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,0.0305686132891403,0.00512408642368658,0.0205254038987146,0.040611822679566,2.48789683908838e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,37437,-0.0186988123837881,0.00313423359391758,-0.0248419102278666,-0.0125557145397096,2.49203216121268e-09
NMR metabolomics,X23424.Total Lipids in VLDL,DSC2,Desmocollin-2,39673,-0.0188885638700214,0.00317155583522066,-0.0251048133070539,-0.0126723144329889,2.64586424705831e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,39489,0.0229974796464417,0.00386298218464631,0.0154260345645349,0.0305689247283484,2.68419876261448e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CD276,CD276 antigen,39862,-0.0199331224376713,0.00334994371716595,-0.0264990121233166,-0.013367232752026,2.73259176902734e-09
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.0142172687977332,0.00239917422952739,0.0095148873078595,0.0189196502876069,3.16898994278823e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CST1,Cystatin-SN,35640,0.0568736109751411,0.00961842267390043,0.0380215025342963,0.075725719415986,3.45275624849358e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CRISP3,Cysteine-rich secretory protein 3,37325,-0.0151510321285302,0.00256286056256639,-0.0201742388311603,-0.0101278254259,3.46652432597763e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,0.0176749321060455,0.00299035162241541,0.0118138429261113,0.0235360212859797,3.49165939295566e-09
NMR metabolomics,X23424.Total Lipids in VLDL,RAB37,Ras-related protein Rab-37,39587,0.0468904705275318,0.00793638496434118,0.0313351559974231,0.0624457850576405,3.52812813889077e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SDC1,Syndecan-1,39868,0.0223477269070768,0.00378254086767752,0.0149339468064289,0.0297615070077247,3.53039306963709e-09
NMR metabolomics,X23424.Total Lipids in VLDL,LTB,Lymphotoxin-beta,37368,0.019238936000137,0.00325883518659412,0.0128516190344126,0.0256262529658615,3.64137548614759e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,0.0343470527119451,0.00581905607076402,0.0229417028132476,0.0457524026106425,3.66805963273011e-09
NMR metabolomics,X23424.Total Lipids in VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.0150487915740423,0.00254989919024735,0.0100509891611575,0.0200465939869271,3.68325698346019e-09
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,39788,0.0116228371394213,0.00197171362712415,0.00775827843025799,0.0154873958485847,3.82738095285591e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,0.0270721965169751,0.00459582159370514,0.018064386193313,0.0360800068406372,3.92623354037901e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,0.0403192748641438,0.00684403483458339,0.0269049665883604,0.0537335831399273,3.92769560323578e-09
NMR metabolomics,X23424.Total Lipids in VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,-0.0145976973327778,0.00247934753190216,-0.019457218495306,-0.00973817617024958,4.01095964763645e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CABP2,Calcium-binding protein 2,37039,0.0369307191724369,0.00627273088239645,0.0246361666429399,0.0492252717019339,4.01618813086024e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA6,Corticosteroid-binding globulin,37453,0.0098718314469545,0.00167896781014439,0.0065810545390715,0.0131626083548375,4.20650473466837e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAM,Integrin alpha-M,39858,-0.0176001352891138,0.00300343392276582,-0.0234868657777348,-0.0117134048004928,4.71951232921402e-09
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF21,Immunoglobulin superfamily member 21,37043,0.022102620171252,0.00377463809020445,0.0147043295144513,0.0295009108280527,4.86728585662536e-09
NMR metabolomics,X23424.Total Lipids in VLDL,RHOC,Rho-related GTP-binding protein RhoC,39672,0.0656203413449361,0.0112332689149666,0.0436031342716015,0.0876375484182706,5.271507810843e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CKAP4,Cytoskeleton-associated protein 4,39991,0.0141095257604795,0.00241933948687682,0.00936762036620091,0.018851431154758,5.58228962044185e-09
NMR metabolomics,X23424.Total Lipids in VLDL,QPCT,Glutaminyl-peptide cyclotransferase,39862,0.0146862792050713,0.00251930622867719,0.009748438996864,0.0196241194132786,5.66659631851776e-09
NMR metabolomics,X23424.Total Lipids in VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,37039,0.0430737467474007,0.00739513974020866,0.0285792728565917,0.0575682206382097,5.85846781974671e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CRH,Corticoliberin,39455,0.0481706400835132,0.00828202325076737,0.0319378745120092,0.0644034056550172,6.13464783594742e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CA12,Carbonic anhydrase 12,39788,-0.0176214688562419,0.00303343965803717,-0.0235670105859948,-0.0116759271264891,6.40183215892716e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL4,Angiopoietin-related protein 4,39908,-0.0249028394691982,0.00430522033900831,-0.0333410713336545,-0.0164646076047419,7.41546363843756e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ICOSLG,ICOS ligand,39788,0.0103764409509731,0.00179514254703073,0.00685796155879288,0.0138949203431533,7.59677440437286e-09
NMR metabolomics,X23424.Total Lipids in VLDL,EPHB4,Ephrin type-B receptor 4,40052,-0.0129248365020992,0.00223695830554507,-0.0173092747809676,-0.00854039822323088,7.7045407078427e-09
NMR metabolomics,X23424.Total Lipids in VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,0.020177256356452,0.0034930634756117,0.0133308519442531,0.027023660768651,7.77256030372749e-09
NMR metabolomics,X23424.Total Lipids in VLDL,MRC1,Macrophage mannose receptor 1,37445,0.015116016409417,0.00262653148636672,0.00996801469613822,0.0202640181226958,8.84468702633839e-09
NMR metabolomics,X23424.Total Lipids in VLDL,IL18BP,Interleukin-18-binding protein,39931,0.0161665135179421,0.00281219101244532,0.0106546191335493,0.0216784079023349,9.15502404649933e-09
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,0.0150210233199124,0.0026157670329549,0.00989411993532078,0.020147926704504,9.49860900171012e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,0.0165097645535865,0.0028817062350454,0.0108616203328975,0.0221579087742755,1.02726180255169e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,0.0211130042885912,0.00368841016417451,0.0138837203668091,0.0283422882103732,1.06161773080777e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,0.0195233304090338,0.003416662160519,0.0128266725744166,0.0262199882436511,1.12641283597783e-08
NMR metabolomics,X23424.Total Lipids in VLDL,NELL2,Protein kinase C-binding protein NELL2,39931,0.0153126383613441,0.00268159555188572,0.0100567110796481,0.0205685656430401,1.14789554653506e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CLMP,CXADR-like membrane protein,40030,0.0111062157793459,0.00195005208871983,0.00728411368545498,0.0149283178732367,1.25264473258914e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF7,SLAM family member 7,39866,-0.0312600958052464,0.00549347497209919,-0.0420273067505608,-0.020492884859932,1.28957089486654e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CHI3L1,Chitinase-3-like protein 1,39545,0.0407266483922393,0.00716403954231832,0.0266851308892954,0.0547681658951832,1.33240447205018e-08
NMR metabolomics,X23424.Total Lipids in VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,0.0258295021706804,0.00455098882976434,0.0169095640643423,0.0347494402770185,1.41136454199143e-08
NMR metabolomics,X23424.Total Lipids in VLDL,WFDC2,WAP four-disulfide core domain protein 2,39017,0.019323258242332,0.00341550707162701,0.0126288643819431,0.026017652102721,1.56363131908845e-08
NMR metabolomics,X23424.Total Lipids in VLDL,DSG3,Desmoglein-3,39964,0.0179583440021196,0.00317486252931579,0.0117356134446607,0.0241810745595785,1.57192972506598e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,0.0239424755965725,0.00423296097683076,0.0156458720819842,0.0322390791111608,1.57899940203331e-08
NMR metabolomics,X23424.Total Lipids in VLDL,GBP4,Guanylate-binding protein 4,39489,0.026277016774125,0.00465516286068683,0.0171528975671788,0.0354011359810712,1.68340109993366e-08
NMR metabolomics,X23424.Total Lipids in VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,0.0184087328966154,0.00327523482613917,0.0119892726373827,0.0248281931558482,1.93502621595225e-08
NMR metabolomics,X23424.Total Lipids in VLDL,IL7R,Interleukin-7 receptor subunit alpha,39858,-0.0278480389194622,0.00495843885491555,-0.0375665790750967,-0.0181294987638277,1.98345039531467e-08
NMR metabolomics,X23424.Total Lipids in VLDL,TPM3,Tropomyosin alpha-3 chain,37021,-0.0236805039909125,0.00423645696154923,-0.031983959635549,-0.015377048346276,2.31990401134378e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ODAM,Odontogenic ameloblast-associated protein,39456,0.0272251896572333,0.00487580796448659,0.0176686060468395,0.036781773267627,2.39343489534166e-08
NMR metabolomics,X23424.Total Lipids in VLDL,MUC16,Mucin-16,39788,0.098915396748453,0.0177157017966675,0.0641926212269847,0.133638172269921,2.39593066336221e-08
NMR metabolomics,X23424.Total Lipids in VLDL,LEO1,RNA polymerase-associated protein LEO1,37411,0.0148947718417598,0.00266819842640481,0.00966510292600638,0.0201244407575132,2.41870986031034e-08
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,0.0142000995485029,0.00255171078617633,0.00919874640759726,0.0192014526894085,2.67218711836586e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.0183999692068028,0.00332033979197628,0.0118921032145293,0.0249078351990763,3.04408790321695e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PFDN2,Prefoldin subunit 2,39489,0.0294188394034072,0.00531561717118614,0.0190002297478824,0.0398374490589321,3.17287919642231e-08
NMR metabolomics,X23424.Total Lipids in VLDL,FCRLB,Fc receptor-like B,39477,0.0304519103105274,0.00551212866907156,0.0196481381191472,0.0412556825019077,3.35652194739617e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CD248,Endosialin,37437,-0.020904678972105,0.00378445425655287,-0.0283222093149487,-0.0134871486292614,3.37790587460511e-08
NMR metabolomics,X23424.Total Lipids in VLDL,MILR1,Allergin-1,39587,-0.0260260858531937,0.00471428312146745,-0.0352660807712699,-0.0167860909351175,3.43019268673055e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CD86,T-lymphocyte activation antigen CD86,37382,0.0153786161885799,0.00279676005260366,0.00989696648547671,0.0208602658916831,3.8948596503319e-08
NMR metabolomics,X23424.Total Lipids in VLDL,MUC2,Mucin-2,37437,0.0471627471064794,0.00860628249599496,0.0302944334143292,0.0640310607986295,4.32818297024239e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CA6,Carbonic anhydrase 6,39817,-0.0331711428084368,0.00605532848772018,-0.0450395866443684,-0.0213026989725053,4.36647238187546e-08
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,0.0278767299765226,0.00509098426917101,0.0178984008089474,0.0378550591440978,4.43557473462472e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SBSN,Suprabasin,37420,-0.0177396264589708,0.00324062804813479,-0.024091257433315,-0.0113879954846266,4.47476299520858e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CAT,Catalase,37252,0.0275457011724853,0.00503898088545856,0.0176692986369865,0.0374221037079841,4.67167653813573e-08
NMR metabolomics,X23424.Total Lipids in VLDL,NPTXR,Neuronal pentraxin receptor,39868,0.0176864338087156,0.00323788322837663,0.0113401826810974,0.0240326849363338,4.7689532062156e-08
NMR metabolomics,X23424.Total Lipids in VLDL,FGFR4,Fibroblast growth factor receptor 4,37124,0.0272664696160603,0.00503504230709579,0.0173977866941526,0.0371351525379681,6.22380418392529e-08
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC38,Leucine-rich repeat-containing protein 38,37039,0.0248356186399282,0.00460457925727713,0.0158106432956651,0.0338605939841914,7.02216758264004e-08
NMR metabolomics,X23424.Total Lipids in VLDL,TGFB2,Transforming growth factor beta-2 proprotein,37368,0.0270560716474435,0.00501875217923414,0.0172193173761446,0.0368928259187424,7.12461714978423e-08
NMR metabolomics,X23424.Total Lipids in VLDL,RALY,RNA-binding protein Raly,37368,0.0249995315726564,0.00464446587741218,0.0158963784529286,0.0341026846923843,7.46237628316702e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CENPF,Centromere protein F,37169,0.0276946664872677,0.00514702066704641,0.0176065059798568,0.0377828269946787,7.54458512198292e-08
NMR metabolomics,X23424.Total Lipids in VLDL,KLK4,Kallikrein-4,40030,-0.0308077408516718,0.00572985622271514,-0.0420382590481935,-0.0195772226551501,7.691485645979e-08
NMR metabolomics,X23424.Total Lipids in VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.0176321506027257,0.00328063393573967,0.011202108088676,0.0240621931167755,7.78253036998807e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM5,Intercellular adhesion molecule 5,39868,0.0225146085321243,0.00420177873620025,0.0142791222091718,0.0307500948550768,8.51467560583356e-08
NMR metabolomics,X23424.Total Lipids in VLDL,BRD1,Bromodomain-containing protein 1,37169,-0.0156889078360683,0.00293520365762732,-0.0214419070050179,-0.00993590866711878,9.18669685518712e-08
NMR metabolomics,X23424.Total Lipids in VLDL,MERTK,Tyrosine-protein kinase Mer,40058,0.0128354845464214,0.00241357177634402,0.00810488386478715,0.0175660852280557,1.062805544284e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC5A,C-type lectin domain family 5 member A,39818,-0.0143597280636236,0.00270243464069932,-0.0196564999593942,-0.00906295616785289,1.08908660574288e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PRUNE2,Protein prune homolog 2,37169,0.0143803544003024,0.00271873153589717,0.00905164058994395,0.0197090682106609,1.24688482546987e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CA14,Carbonic anhydrase 14,40030,-0.0176261206054458,0.0033433051304931,-0.0241789986612123,-0.0110732425496793,1.36632247004072e-07
NMR metabolomics,X23424.Total Lipids in VLDL,C1QL2,Complement C1q-like protein 2,37056,0.0211024170745256,0.00400698786130652,0.0132487208663648,0.0289561132826864,1.41307523362542e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SPON1,Spondin-1,39885,0.0159505975592955,0.00303299425241491,0.0100059288245623,0.0218952662940287,1.46681094423846e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4D,C-type lectin domain family 4 member D,39866,0.0302393945162516,0.00576861360031562,0.018932911859633,0.0415458771728702,1.60815026200919e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CALB1,Calbindin,39788,0.0208342989603933,0.00399104588639141,0.0130118490230661,0.0286567488977204,1.80916439009914e-07
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA11,Integrin alpha-11,39866,-0.0168968893785026,0.00323775123102793,-0.0232428817913174,-0.0105508969656879,1.82422134948881e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,0.0110346468231388,0.0021183413442625,0.00688269778838428,0.0151865958578933,1.92117265455389e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PREB,Prolactin regulatory element-binding protein,39587,0.0141823822327241,0.00272549644481121,0.00884040920089414,0.0195243552645541,1.9792536782536e-07
NMR metabolomics,X23424.Total Lipids in VLDL,GPC1,Glypican-1,40030,0.0143425011532665,0.00276137477468329,0.00893020659488729,0.0197547957116458,2.08352821159378e-07
NMR metabolomics,X23424.Total Lipids in VLDL,OMD,Osteomodulin,39931,-0.0215084047644363,0.00414192039211795,-0.0296265687329875,-0.0133902407958851,2.09616350113216e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,0.0146581055233016,0.00282594473862159,0.00911925383560333,0.0201969572109999,2.16344256011161e-07
NMR metabolomics,X23424.Total Lipids in VLDL,DCTPP1,dCTP pyrophosphatase 1,39868,0.0156242479816867,0.00301896342877295,0.00970707966129168,0.0215414163020816,2.3021119581291e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.0441232393795893,0.00853797918210732,0.027388800182659,0.0608576785765197,2.39604877138881e-07
NMR metabolomics,X23424.Total Lipids in VLDL,MEPE,Matrix extracellular phosphoglycoprotein,39862,0.0121322473517316,0.00234971009707645,0.00752681556146177,0.0167376791420015,2.45547337651655e-07
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,0.0155131941063642,0.00301000925935079,0.00961357595803669,0.0214128122546918,2.58205020963774e-07
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,0.0133674435211116,0.00259660410134725,0.00827809948247099,0.0184567875597522,2.66403460854386e-07
NMR metabolomics,X23424.Total Lipids in VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,0.0125021775541542,0.00243156358380933,0.00773631292988789,0.0172680421784205,2.75579436701625e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CPA4,Carboxypeptidase A4,36868,0.0213383558583314,0.00416124068510136,0.0131823241155327,0.0294943876011301,2.97228365903301e-07
NMR metabolomics,X23424.Total Lipids in VLDL,NCAN,Neurocan core protein,40009,0.0179238125661233,0.00349686861913437,0.0110699500726199,0.0247776750596266,2.99895031490665e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,0.0188190772926334,0.00367151089696488,0.0116229159345823,0.0260152386506846,2.99905769518794e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,0.0238025343676642,0.00465576832122664,0.01467722845806,0.0329278402772684,3.2229502775207e-07
NMR metabolomics,X23424.Total Lipids in VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,0.0331320051076386,0.00648522994308263,0.0204209544191967,0.0458430557960806,3.28699225175288e-07
NMR metabolomics,X23424.Total Lipids in VLDL,S100A14,Protein S100-A14,37411,0.0248329353056245,0.00487333142645391,0.0152812057097748,0.0343846649014741,3.52168254974656e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PGA4,Pepsin A-4,37445,0.0302210043944019,0.00593440285404094,0.0185895748004817,0.0418524339883222,3.58085769395935e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CNPY2,Protein canopy homolog 2,39585,0.0292429906867931,0.00574362870497124,0.0179854784250495,0.0405005029485367,3.59573904172118e-07
NMR metabolomics,X23424.Total Lipids in VLDL,EGFLAM,Pikachurin,37382,0.014852392870305,0.00292469973617915,0.00911998138739386,0.0205848043532161,3.85970805902835e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,0.0187693550557982,0.00370254734400615,0.0115123622615461,0.0260263478500502,4.03825386092777e-07
NMR metabolomics,X23424.Total Lipids in VLDL,B2M,Beta-2-microglobulin,37453,0.014811978182862,0.00293805378400928,0.00905339276620386,0.0205705635995202,4.68023640339698e-07
NMR metabolomics,X23424.Total Lipids in VLDL,OSM,Oncostatin-M,39785,0.0342673745641881,0.00680664140348463,0.0209263574133583,0.047608391715018,4.84573374338874e-07
NMR metabolomics,X23424.Total Lipids in VLDL,NTF4,Neurotrophin-4,39477,0.0190637540754049,0.00378809851247928,0.0116390809909455,0.0264884271598643,4.89406363754219e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,0.0158247681432809,0.00315085863703387,0.00964908521469456,0.0220004510718673,5.1582165321069e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CA1,Carbonic anhydrase 1,39531,0.0283758492905755,0.0056509770420674,0.0172999342881234,0.0394517642930276,5.18580241241601e-07
NMR metabolomics,X23424.Total Lipids in VLDL,REG3G,Regenerating islet-derived protein 3-gamma,37368,0.0187211786762243,0.00373304874517523,0.0114044031356808,0.0260379542167677,5.37108965418806e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CLGN,Calmegin,37039,0.020879121758712,0.00416352637179954,0.0127186100699849,0.0290396334474391,5.37877834386522e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SRPX,Sushi repeat-containing protein SRPX,37437,-0.0162789974166264,0.0032559982945476,-0.0226607540739397,-0.00989724075931309,5.81374635768885e-07
NMR metabolomics,X23424.Total Lipids in VLDL,EPHB6,Ephrin type-B receptor 6,39713,0.0143883596431883,0.00288105098524298,0.00874149971211202,0.0200352195742645,5.9728057040055e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CCL21,C-C motif chemokine 21,39931,0.0186108807536482,0.00372815497180565,0.0113036970089091,0.0259180644983873,6.03885511960053e-07
NMR metabolomics,X23424.Total Lipids in VLDL,EPHX2,Bifunctional epoxide hydrolase 2,39585,0.0292023005171859,0.0058499051576688,0.0177364864081551,0.0406681146262168,6.04193530186013e-07
NMR metabolomics,X23424.Total Lipids in VLDL,ECM1,Extracellular matrix protein 1,37106,0.0172461955912492,0.00345588167695618,0.010472667504415,0.0240197236780833,6.10226862366443e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,-0.0203621307078936,0.00409964354878235,-0.028397432063507,-0.0123268293522802,6.87635808765651e-07
NMR metabolomics,X23424.Total Lipids in VLDL,HYAL1,Hyaluronidase-1,39747,0.0107708386938657,0.00217166655911638,0.0065143722379976,0.0150273051497338,7.13271522273155e-07
NMR metabolomics,X23424.Total Lipids in VLDL,NEFL,Neurofilament light polypeptide,39438,0.0205252094697689,0.00413984601141731,0.0124111112873909,0.0286393076521468,7.19848494849477e-07
NMR metabolomics,X23424.Total Lipids in VLDL,NEO1,Neogenin,37411,0.0102081678750098,0.00206104757576107,0.00616851462651807,0.0142478211235015,7.39957062869754e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CDH15,Cadherin-15,39973,0.0252377065188165,0.00510774655138251,0.0152265232781068,0.0352488897595262,7.84767056103168e-07
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL5,Fc receptor-like protein 5,39858,-0.026174408505412,0.00532278838530791,-0.0366070737406155,-0.0157417432702085,8.85603308284206e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TDO2,"Tryptophan 2,3-dioxygenase",37039,0.0183657953604562,0.00373531929119218,0.0110445695497195,0.0256870211711929,8.90328526687181e-07
NMR metabolomics,X23424.Total Lipids in VLDL,DIPK2B,Divergent protein kinase domain 2B,37124,0.0133081230823904,0.00270744078309296,0.00800153914752817,0.0186147070172526,8.96659893073703e-07
NMR metabolomics,X23424.Total Lipids in VLDL,MSLN,Mesothelin,39766,0.0245416983208092,0.00500022154110692,0.0147412641002397,0.0343421325413788,9.28633892557722e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CLSTN1,Calsyntenin-1,39489,0.0235303821052445,0.00479621115433058,0.0141298082427565,0.0329309559677324,9.38711288346233e-07
NMR metabolomics,X23424.Total Lipids in VLDL,KLK8,Kallikrein-8,39315,0.0162428083369839,0.00331285002588725,0.00974962228624485,0.0227359943877229,9.53563652201218e-07
NMR metabolomics,X23424.Total Lipids in VLDL,GZMB,Granzyme B,39866,0.0298974786534923,0.00610176373837009,0.0179380217262869,0.0418569355806977,9.68678206577278e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CD55,Complement decay-accelerating factor,39315,0.0118480798656334,0.00241920954588256,0.00710642915570359,0.0165897305755632,9.80447742112617e-07
NMR metabolomics,X23424.Total Lipids in VLDL,DUSP3,Dual specificity protein phosphatase 3,39489,0.0395392253923857,0.00808137372536964,0.0236997328906612,0.0553787178941102,1.00484865138843e-06
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFB,Vascular endothelial growth factor B,37056,0.0131990099984956,0.00270780344699586,0.00789171524238368,0.0185063047546075,1.10390317188936e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SSH3,Protein phosphatase Slingshot homolog 3,36962,0.0137809074583139,0.00283251419974151,0.00822917962682058,0.0193326352898073,1.15638440736922e-06
NMR metabolomics,X23424.Total Lipids in VLDL,GGT5,Glutathione hydrolase 5 proenzyme,39749,0.0105753607948633,0.0021884501330356,0.00628599853411353,0.0148647230556131,1.36189480765718e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SNX18,Sorting nexin-18,37382,0.0208392812413685,0.00431575083448676,0.0123804096057745,0.0292981528769626,1.38961491925554e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,37169,0.0327613749663743,0.00679031818109463,0.0194523513314288,0.0460703986013197,1.41755491353022e-06
NMR metabolomics,X23424.Total Lipids in VLDL,NTF3,Neurotrophin-3,39866,0.0154498638347164,0.00320552310452221,0.00916703854985288,0.02173268911958,1.45047220369914e-06
NMR metabolomics,X23424.Total Lipids in VLDL,MTPN,Myotrophin,39585,0.0148966471410821,0.0030923323660733,0.00883567570357839,0.0209576185785857,1.46881149098441e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CLPS,Colipase,39836,0.0317686414894062,0.00659543362730557,0.0188415915798873,0.0446956913989252,1.47243851566075e-06
NMR metabolomics,X23424.Total Lipids in VLDL,IL1R1,Interleukin-1 receptor type 1,39826,-0.0103097198033209,0.00214112104483939,-0.0145063170512061,-0.00611312255543564,1.48471838940833e-06
NMR metabolomics,X23424.Total Lipids in VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,0.0137415436338965,0.00285831207491833,0.00813925196705661,0.0193438353007365,1.54196639330165e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SATB1,DNA-binding protein SATB1,37411,0.0137481430548428,0.00286199719213422,0.00813862855825968,0.0193576575514258,1.57436811776451e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PTK7,Inactive tyrosine-protein kinase 7,39489,0.0175373143068849,0.00366408974822606,0.0103556984003618,0.024718930213408,1.71465849528667e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CDHR1,Cadherin-related family member 1,39489,0.0194628438063814,0.00406770371355066,0.0114901445278221,0.0274355430849407,1.72786034960385e-06
NMR metabolomics,X23424.Total Lipids in VLDL,MYOM2,Myomesin-2,37021,-0.0234792445066573,0.00491939360027796,-0.0331212559632021,-0.0138372330501125,1.83642846831396e-06
NMR metabolomics,X23424.Total Lipids in VLDL,FGF16,Fibroblast growth factor 16,37056,0.0220103845153221,0.00461186881939278,0.0129711216293122,0.0310496474013319,1.83856537821519e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PRL,Prolactin,40009,-0.0344203130155638,0.00722296688897793,-0.0485773281179605,-0.020263297913167,1.90121797607525e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CRLF1,Cytokine receptor-like factor 1,39931,0.0118289585050471,0.00248546286383757,0.00695745129192543,0.0167004657181687,1.95997352483365e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.0187483685347158,0.00394886398093636,0.0110085951320805,0.026488141937351,2.0776479899028e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LYAR,Cell growth-regulating nucleolar protein,39477,0.0233093751049145,0.00491134066152466,0.0136831474083262,0.0329356028015029,2.09285345216173e-06
NMR metabolomics,X23424.Total Lipids in VLDL,APOBR,Apolipoprotein B receptor,37043,-0.0192461389811526,0.00405940702769649,-0.0272025767554378,-0.0112897012068675,2.14763034271619e-06
NMR metabolomics,X23424.Total Lipids in VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,0.029225731217267,0.00616443438919877,0.0171434398144374,0.0413080226200966,2.14844358745563e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CD7,T-cell antigen CD7,37037,0.0193504915352348,0.00408583562736623,0.011342253705597,0.0273587293648726,2.20256787973844e-06
NMR metabolomics,X23424.Total Lipids in VLDL,GNLY,Granulysin,39858,0.0229208819151901,0.00485418265869395,0.01340668390415,0.0324350799262303,2.35653241177509e-06
NMR metabolomics,X23424.Total Lipids in VLDL,TBC1D17,TBC1 domain family member 17,39489,0.019760132414025,0.00418955823587628,0.0115485982717075,0.0279716665563425,2.41987615771217e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CR2,Complement receptor type 2,39931,0.0203129721526317,0.00431754798889252,0.0118505780944024,0.028775366210861,2.56296880510285e-06
NMR metabolomics,X23424.Total Lipids in VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,0.0187073259322885,0.00397829035654878,0.0109098768334529,0.0265047750311241,2.59716244877448e-06
NMR metabolomics,X23424.Total Lipids in VLDL,FSTL3,Follistatin-related protein 3,39803,0.0134195504278939,0.00285463388106645,0.00782446802100364,0.0190146328347841,2.6109402078555e-06
NMR metabolomics,X23424.Total Lipids in VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,0.0161136034528063,0.00342867278137293,0.00939340480131531,0.0228338021042972,2.63225544525182e-06
NMR metabolomics,X23424.Total Lipids in VLDL,TPSAB1,Tryptase alpha/beta-1,40038,0.0233479742757708,0.0049797740322381,0.0135876171725841,0.0331083313789575,2.7737841518456e-06
NMR metabolomics,X23424.Total Lipids in VLDL,NINJ1,Ninjurin-1,39477,0.0251757213484374,0.00537641126080221,0.0146379552772651,0.0357134874196098,2.85606633178448e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN10,Ataxin-10,39489,0.0324974703827472,0.00696959701464277,0.0188370602340474,0.046157880531447,3.14596442563249e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,-0.0105554037947035,0.0022678743613857,-0.0150004375430194,-0.00611037004638749,3.27657328861246e-06
NMR metabolomics,X23424.Total Lipids in VLDL,DPP7,Dipeptidyl peptidase 2,39754,0.0266555488507504,0.00572723473243202,0.0154301687751836,0.0378809289263171,3.27908375000372e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,0.0444982334114738,0.00956913916293591,0.0257427206521194,0.0632537461708282,3.34864511996305e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN2,Ataxin-2,36991,0.0492862563241795,0.0106177170997733,0.0284755308086238,0.0700969818397352,3.48582265121845e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,39858,0.0177255374756592,0.00382293971927747,0.0102325756258753,0.025218499325443,3.56944523908117e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,39477,0.0254161802326751,0.00550823971278111,0.0146200303956241,0.036212330069726,3.97728841185791e-06
NMR metabolomics,X23424.Total Lipids in VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.0308096698366242,0.0066790804775125,0.0177186721006997,0.0439006675725486,4.002640846122e-06
NMR metabolomics,X23424.Total Lipids in VLDL,COL1A1,Collagen alpha-1(I) chain,40052,-0.0108768888587348,0.00235809685431293,-0.0154987586931882,-0.00625501902428146,4.00764365779326e-06
NMR metabolomics,X23424.Total Lipids in VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.0123622650566365,0.00268226736218267,0.00710502102675844,0.0176195090865145,4.07957883875746e-06
NMR metabolomics,X23424.Total Lipids in VLDL,UROS,Uroporphyrinogen-III synthase,37039,0.0301220349108377,0.00653834210865675,0.0173068843778704,0.0429371854438049,4.1238057519662e-06
NMR metabolomics,X23424.Total Lipids in VLDL,TNC,Tenascin,39931,-0.0206349964709564,0.00448209124994434,-0.0294198953208473,-0.0118500976210655,4.17873956482432e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,0.0161752047201479,0.00351470238523024,0.00928638804509659,0.0230640213951991,4.21948591539162e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ARTN,Artemin,39587,0.0196211445370249,0.00426853181169317,0.0112548221861063,0.0279874668879435,4.32582282515591e-06
NMR metabolomics,X23424.Total Lipids in VLDL,OLFM4,Olfactomedin-4,36654,0.0539844327079676,0.0117502322289411,0.030953977539243,0.0770148878766922,4.38290898796497e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD2,Sushi domain-containing protein 2,39858,-0.0123302289687203,0.00268455815643166,-0.0175919629553264,-0.00706849498211426,4.40208615673251e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SHISA5,Protein shisa-5,37437,0.0100353515114604,0.00218754714191097,0.00574775911331494,0.0143229439096059,4.52620082490205e-06
NMR metabolomics,X23424.Total Lipids in VLDL,AHNAK2,Protein AHNAK2,37043,0.0127768977765191,0.0028003215817215,0.00728826747634494,0.0182655280766932,5.09669777623053e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PSME2,Proteasome activator complex subunit 2,39666,0.0157312205142121,0.00345022465452782,0.00896878019133757,0.0224936608370866,5.16659208111387e-06
NMR metabolomics,X23424.Total Lipids in VLDL,OBP2B,Odorant-binding protein 2b,39701,-0.0273077001942978,0.00600145640003024,-0.0390705547383571,-0.0155448456502386,5.39984915555184e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SLC13A1,Solute carrier family 13 member 1,37368,0.0259282202700048,0.00570623097484074,0.0147440075593169,0.0371124329806926,5.57165474762286e-06
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFD,Vascular endothelial growth factor D,40024,-0.0153436962828476,0.00338224034518701,-0.0219728873594142,-0.00871450520628108,5.75939231472565e-06
NMR metabolomics,X23424.Total Lipids in VLDL,KLK11,Kallikrein-11,39779,0.0125770498240441,0.00277311814988472,0.00714173825027001,0.0180123613978181,5.79289789322251e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA1,Annexin A1,37072,0.0189107424680626,0.00417485879013228,0.0107280192394033,0.0270934656967219,5.95926187443407e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,0.0170626416148694,0.00376705259124489,0.00967921853602937,0.0244460646937093,5.9643602573168e-06
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,0.0157107688788721,0.00347380329053425,0.00890211442942496,0.0225194233283192,6.15924844138516e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CRTAP,Cartilage-associated protein,37039,0.0212590052293329,0.00471340685979126,0.012020727784142,0.0304972826745238,6.52868926545443e-06
NMR metabolomics,X23424.Total Lipids in VLDL,HSBP1,Heat shock factor-binding protein 1,37043,0.0414539645986847,0.00922030448402026,0.0233821678100049,0.0595257613873644,6.98529980198447e-06
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,0.0180541475789899,0.00401879799236579,0.010177303513953,0.0259309916440269,7.09184729434898e-06
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA1549L,UPF0606 protein KIAA1549L,37169,-0.011818459347413,0.00263792055784353,-0.0169887836407863,-0.00664813505403965,7.51883527400681e-06
NMR metabolomics,X23424.Total Lipids in VLDL,FOSB,Protein fosB,39489,0.0166249567120444,0.00372156475048464,0.00933068980109452,0.0239192236229943,7.98077802008823e-06
NMR metabolomics,X23424.Total Lipids in VLDL,BRD3,Bromodomain-containing protein 3,37021,0.019743473378657,0.00443031668113901,0.0110600526836245,0.0284268940736894,8.40172401983943e-06
NMR metabolomics,X23424.Total Lipids in VLDL,DPP10,Inactive dipeptidyl peptidase 10,39866,0.0146781201713537,0.00329937398460998,0.00821134716151815,0.0211448931811893,8.69501335736661e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC10A,C-type lectin domain family 10 member A,39749,-0.0152654452149134,0.00343259340453096,-0.0219933282877941,-0.00853756214203272,8.75850653748242e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB2A2,Mammaglobin-A,37021,-0.0133148612616774,0.00299979966263969,-0.0191944686004512,-0.0074352539229036,9.12893030043155e-06
NMR metabolomics,X23424.Total Lipids in VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,39489,0.0597602174340482,0.0134754912525209,0.0333482545791073,0.0861721802889891,9.28150341745177e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,0.0214735783586204,0.00486677397420098,0.0119347013691865,0.0310124553480543,1.03079035702623e-05
NMR metabolomics,X23424.Total Lipids in VLDL,EIF5,Eukaryotic translation initiation factor 5,37021,0.0185759391555946,0.00421043200765754,0.0103234924205859,0.0268283858906034,1.03289190568614e-05
NMR metabolomics,X23424.Total Lipids in VLDL,IL6,Interleukin-6,39788,0.0296121213596461,0.00674531104020826,0.0163913117208379,0.0428329309984542,1.14064546664048e-05
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE1,Ribonuclease pancreatic,37445,0.00935361130169646,0.00213696947539925,0.00516515112991392,0.013542071473479,1.21197584948366e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CLSTN2,Calsyntenin-2,40058,-0.0163627759670246,0.00375186295447778,-0.023716427357801,-0.00900912457624815,1.30125728643555e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,37056,0.0157390063788614,0.00361189233757975,0.00865969739720513,0.0228183153605177,1.32519755042443e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA5,Protein disulfide-isomerase A5,36962,0.025527156379203,0.00586995590647864,0.0140220428025049,0.0370322699559012,1.37930089178562e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PADI4,Protein-arginine deiminase type-4,39456,0.0290665620343023,0.00669763497865003,0.0159391974761482,0.0421939265924563,1.43493829553586e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CREBZF,CREB/ATF bZIP transcription factor,36962,-0.0108884327929694,0.00250932560015696,-0.015806710969277,-0.00597015461666175,1.4408210298183e-05
NMR metabolomics,X23424.Total Lipids in VLDL,IFNGR1,Interferon gamma receptor 1,39931,0.00828447089327637,0.0019233527939361,0.00451469941716161,0.0120542423693911,1.66234825760238e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PMS1,PMS1 protein homolog 1,37039,0.0204228024406097,0.00474577993515455,0.0111210737677068,0.0297245311135126,1.69440355575937e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PSPN,Persephin,39866,0.0385599285377786,0.00897428717722504,0.0209703256704175,0.0561495314051396,1.74373260481062e-05
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.0130238768092297,0.00304070331374719,-0.0189836553041742,-0.00706409831428522,1.85538907049592e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CST7,Cystatin-F,39882,0.0375947201074195,0.00879406964312892,0.0203583436068868,0.0548310966079522,1.92235644612074e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.0146765459886843,0.00344546561491864,0.0079234333834438,0.0214296585939249,2.06149165050834e-05
NMR metabolomics,X23424.Total Lipids in VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,0.0152870640987058,0.00359267099568298,0.00824542894716712,0.0223286992502444,2.10173047855465e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN2,Contactin-2,40030,0.0178605300971622,0.00422124732387532,0.00958688534236662,0.0261341748519579,2.33829809213678e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,0.0751712433612614,0.0177920332512564,0.0402988581887989,0.110043628533724,2.40274572735797e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPT2,Angiopoietin-2,40030,-0.0152671197893801,0.00362913682616388,-0.0223802279686613,-0.00815401161009894,2.6038687198699e-05
NMR metabolomics,X23424.Total Lipids in VLDL,FOLH1,Glutamate carboxypeptidase 2,37056,0.043975054714329,0.0104666774375195,0.0234603669367908,0.0644897424918672,2.6697341521008e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.00743607813227426,0.00177804832877302,0.00395110340787915,0.0109210528566694,2.90566780409662e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,0.0135223123803458,0.00323645697379365,0.00717885671171022,0.0198657680489813,2.95492710594031e-05
NMR metabolomics,X23424.Total Lipids in VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,37169,0.0234455782909847,0.0056232272257,0.0124240529286127,0.0344671036533566,3.0731357467889e-05
NMR metabolomics,X23424.Total Lipids in VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,39585,0.0209656619141919,0.00503278334276691,0.0111014065623688,0.0308299172660151,3.11893939991104e-05
NMR metabolomics,X23424.Total Lipids in VLDL,AZU1,Azurocidin,39344,0.0303650786721396,0.00730402799701842,0.0160491837979835,0.0446809735462957,3.23755336624635e-05
NMR metabolomics,X23424.Total Lipids in VLDL,LIF,Leukemia inhibitory factor,39489,0.0203001696524847,0.00489269478128992,0.0107104878811565,0.029889851423813,3.3558390326898e-05
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RAP,Interleukin-1 receptor accessory protein,39858,-0.0168820868282586,0.00408382137158433,-0.0248863767165639,-0.00887779693995329,3.58485000591214e-05
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,0.0199603223539291,0.00482919665427621,0.0104950969115477,0.0294255477963105,3.59870060636018e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GLP1R,Glucagon-like peptide 1 receptor,36991,-0.0149399475479794,0.00361559439873534,-0.0220265125695007,-0.00785338252645817,3.61715000604597e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CFD,Complement factor D,37453,0.00718896550743437,0.00174281948556229,0.00377303931573229,0.0106048916991365,3.73094249868909e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ACTN2,Alpha-actinin-2,37021,-0.0232673578277228,0.00564137389571433,-0.0343244506633229,-0.0122102649921228,3.73964405936766e-05
NMR metabolomics,X23424.Total Lipids in VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,0.0265371470205355,0.00644701311819558,0.0139010013088722,0.0391732927321989,3.87470761314499e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PROCR,Endothelial protein C receptor,37021,-0.0143291116802996,0.00349054224819705,-0.0211705744867659,-0.00748764887383343,4.06535391321147e-05
NMR metabolomics,X23424.Total Lipids in VLDL,LY9,T-lymphocyte surface antigen Ly-9,39699,0.0110705870835204,0.00269963207623863,0.0057793082140927,0.0163618659529481,4.13822419982098e-05
NMR metabolomics,X23424.Total Lipids in VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,36991,-0.0132072117300177,0.0032213752979309,-0.0195211073139623,-0.00689331614607317,4.15875249580051e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,0.0239815179727351,0.00588658220909687,0.0124438168429052,0.035519219102565,4.64982093463778e-05
NMR metabolomics,X23424.Total Lipids in VLDL,APOA4,Apolipoprotein A-IV,37453,0.0137556395758802,0.00337873162265265,0.00713332559548097,0.0203779535562793,4.7027568646454e-05
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,0.0273066157479063,0.00670940852108338,0.0141561750465828,0.0404570564492297,4.73002846133624e-05
NMR metabolomics,X23424.Total Lipids in VLDL,FSTL1,Follistatin-related protein 1,37043,-0.00890156442804022,0.00218826383558796,-0.0131905615457926,-0.00461256731028781,4.77217396715486e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAV,Integrin alpha-V,40030,0.00640485915654531,0.00157552589160091,0.00331682840900754,0.00949288990408309,4.82142383779377e-05
NMR metabolomics,X23424.Total Lipids in VLDL,IL17RA,Interleukin-17 receptor A,39858,0.0170674552496886,0.00419852915846146,0.00883833809910409,0.025296572400273,4.82407387166511e-05
NMR metabolomics,X23424.Total Lipids in VLDL,DNPEP,Aspartyl aminopeptidase,37388,0.0228789469172724,0.00564095528144622,0.0118226745656378,0.033935219268907,5.02294420170246e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,-0.0142156617750207,0.00350955345428897,-0.0210943865454271,-0.00733693700461435,5.13795210362137e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CLASP1,CLIP-associating protein 1,36962,0.0283096642671519,0.00700044251251177,0.0145887969426289,0.042030531591675,5.28518532385143e-05
NMR metabolomics,X23424.Total Lipids in VLDL,BMP4,Bone morphogenetic protein 4,39720,-0.0177020177319858,0.00437984830851928,-0.0262865204166836,-0.00911751504728801,5.33162798641634e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TK1,"Thymidine kinase, cytosolic",37169,0.0177657980878923,0.00439689724470025,0.00914787948827981,0.0263837166875048,5.36300467588887e-05
NMR metabolomics,X23424.Total Lipids in VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,0.0158768523909503,0.00393433433873683,0.00816555708702609,0.0235881476948744,5.48028745231311e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SEZ6L,Seizure 6-like protein,39913,0.0103203128047926,0.00256575786883919,0.0052914273818678,0.0153491982277174,5.78901849690443e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PCDHB15,Protocadherin beta-15,37368,-0.0152359943808894,0.00379276590962,-0.0226698155637446,-0.00780217319803421,5.92328437053037e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ERC2,ERC protein 2,37039,0.0287086494435287,0.00715316141528524,0.0146884530695696,0.0427288458174878,6.01760068966808e-05
NMR metabolomics,X23424.Total Lipids in VLDL,IL15RA,Interleukin-15 receptor subunit alpha,39587,0.0130652570929429,0.00326778778895015,0.00666039302660062,0.0194701211592852,6.41185179103873e-05
NMR metabolomics,X23424.Total Lipids in VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,39477,0.0194445674768825,0.00486560687577094,0.00990797800037141,0.0289811569533935,6.46275924380305e-05
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.0115428930489246,0.00289215306502179,0.00587427304148192,0.0172115130563673,6.61124718646624e-05
NMR metabolomics,X23424.Total Lipids in VLDL,MBL2,Mannose-binding protein C,37257,-0.0407928268308741,0.0102583253142589,-0.0608991444468215,-0.0206865092149266,7.02872645134064e-05
NMR metabolomics,X23424.Total Lipids in VLDL,AMPD3,AMP deaminase 3,37388,0.0267083863945193,0.00676084084267582,0.0134571383428747,0.0399596344461639,7.83991371564197e-05
NMR metabolomics,X23424.Total Lipids in VLDL,LMOD1,Leiomodin-1,37411,-0.0132760329285354,0.00336119052761328,-0.0198639663626574,-0.00668809949441338,7.86122664089058e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CHGB,Secretogranin-1,39952,0.0148348607370697,0.00375859251359058,0.00746801941043211,0.0222017020637072,7.94997550092349e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,0.023072987651107,0.00585320950741844,0.0116006970165669,0.0345452782856472,8.11835446526132e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SELENOP,Selenoprotein P,37453,0.00834193247864885,0.00212121825137521,0.00418434470595343,0.0124995202513443,8.44442793145271e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CLSPN,Claspin,39453,0.0128867145981942,0.00328188291601366,0.00645422408280745,0.019319205113581,8.65176970964917e-05
NMR metabolomics,X23424.Total Lipids in VLDL,VWF,von Willebrand factor,40052,-0.0272713035756849,0.00696197858234622,-0.0409167815970835,-0.0136258255542863,8.99596723725037e-05
NMR metabolomics,X23424.Total Lipids in VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,0.0203978174953207,0.00521045769140405,0.0101853204201687,0.0306103145704726,9.08693383444573e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GFRA2,GDNF family receptor alpha-2,39788,0.00775599470200941,0.00198317018963616,0.00386898113032255,0.0116430082736963,9.23314689338069e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB1A1,Uteroglobin,39903,0.0203481169746689,0.00521148595804576,0.0101336044968992,0.0305626294524385,9.4816583802124e-05
NMR metabolomics,X23424.Total Lipids in VLDL,EXTL1,Exostosin-like 1,37021,0.0178037738800309,0.00456029347276319,0.00886559867341506,0.0267419490866468,9.50543035264705e-05
NMR metabolomics,X23424.Total Lipids in VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,0.0323383575983047,0.00832230880689304,0.0160266323367944,0.0486500828598151,0.000102517081035474
NMR metabolomics,X23424.Total Lipids in VLDL,CASP1,Caspase-1,39489,0.0246880675966163,0.0063711751909936,0.0122005642222688,0.0371755709709637,0.000107076277545626
NMR metabolomics,X23424.Total Lipids in VLDL,KLRK1,NKG2-D type II integral membrane protein,37388,0.0163979063235377,0.00423965154668881,0.00808818929202759,0.0247076233550477,0.000110359362016279
NMR metabolomics,X23424.Total Lipids in VLDL,SIL1,Nucleotide exchange factor SIL1,37043,0.0123069320558746,0.00318563656942695,0.00606308437979775,0.0185507797319514,0.000112420769237511
NMR metabolomics,X23424.Total Lipids in VLDL,SDK2,Protein sidekick-2,37124,0.0136864698466143,0.00354787224735341,0.0067326402418016,0.020640299451427,0.000115021287063123
NMR metabolomics,X23424.Total Lipids in VLDL,CAPS,Calcyphosin,37388,0.0319284922503263,0.00830583010008123,0.0156490652541671,0.0482079192464855,0.000121546428029313
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,-0.00892503022173023,0.00232722258824194,-0.0134863864946844,-0.00436367394877603,0.000126011074864466
NMR metabolomics,X23424.Total Lipids in VLDL,GZMH,Granzyme H,39585,0.0275358133008319,0.00718046946035573,0.0134620931585347,0.0416095334431291,0.000126146063613493
NMR metabolomics,X23424.Total Lipids in VLDL,CRTAC1,Cartilage acidic protein 1,40052,0.01099614505764,0.00286798165102429,0.00537490102163244,0.0166173890936476,0.000126498960645484
NMR metabolomics,X23424.Total Lipids in VLDL,RPA2,Replication protein A 32 kDa subunit,37056,0.0116745242408062,0.00305042477565257,0.00569569168052715,0.0176533568010852,0.000130217974045695
NMR metabolomics,X23424.Total Lipids in VLDL,LTA4H,Leukotriene A-4 hydrolase,40030,0.0213481304637794,0.00558534737101799,0.0104008496165841,0.0322954113109746,0.000132779627280679
NMR metabolomics,X23424.Total Lipids in VLDL,INHBB,Inhibin beta B chain,37124,0.018045453564348,0.00472500283412923,0.00878444800945467,0.0273064591192412,0.000134526992679059
NMR metabolomics,X23424.Total Lipids in VLDL,GIMAP7,GTPase IMAP family member 7,37124,-0.0118539559005236,0.00311478970033445,-0.0179589437131791,-0.00574896808786806,0.000142039113571838
NMR metabolomics,X23424.Total Lipids in VLDL,LHB,Lutropin subunit beta,39477,0.0320427384533672,0.00843156264259948,0.0155168756738722,0.0485686012328622,0.000145050847383227
NMR metabolomics,X23424.Total Lipids in VLDL,MYL3,Myosin light chain 3,37043,-0.026389147164158,0.0069517664343363,-0.0400146093754571,-0.0127636849528589,0.00014768743666268
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,39788,0.0111191921670899,0.00293079032252587,0.00537484313493919,0.0168635411992406,0.00014883423248881
NMR metabolomics,X23424.Total Lipids in VLDL,SCP2,Non-specific lipid-transfer protein,39477,0.0281065348351617,0.00742969528555998,0.0135443320754642,0.0426687375948593,0.000155527798063562
NMR metabolomics,X23424.Total Lipids in VLDL,CHGA,Chromogranin-A,37437,-0.0282978938219162,0.00748161305278688,-0.0429618554053784,-0.0136339322384539,0.000156036713618777
NMR metabolomics,X23424.Total Lipids in VLDL,NECTIN1,Nectin-1,37056,0.0115808637117079,0.00306470436954815,0.0055740431473935,0.0175876842760223,0.000158287601089239
NMR metabolomics,X23424.Total Lipids in VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,0.0137638576164748,0.00364818104173217,0.00661342277467971,0.0209142924582698,0.000162010245540638
NMR metabolomics,X23424.Total Lipids in VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,39489,0.0173506338204002,0.00460047963933874,0.00833369372729626,0.0263675739135041,0.000162877936702424
NMR metabolomics,X23424.Total Lipids in VLDL,FOLR1,Folate receptor alpha,39809,0.00983624570877396,0.00260947512116478,0.00472167447129098,0.0149508169462569,0.000164207561868434
NMR metabolomics,X23424.Total Lipids in VLDL,MATN3,Matrilin-3,39720,-0.0112481897927916,0.00298590586859689,-0.0171005652952416,-0.00539581429034174,0.000165755710667813
NMR metabolomics,X23424.Total Lipids in VLDL,CCL28,C-C motif chemokine 28,39815,0.0213406508986746,0.00567401904743028,0.0102195735657112,0.0324617282316379,0.000169760558725667
NMR metabolomics,X23424.Total Lipids in VLDL,GPR158,Probable G-protein coupled receptor 158,37411,0.0127817798029207,0.00340440306755899,0.00610914979050507,0.0194544098153363,0.00017442443928372
NMR metabolomics,X23424.Total Lipids in VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,0.0148522470341689,0.00395823690584845,0.00709410269870595,0.0226103913696319,0.000175881988260184
NMR metabolomics,X23424.Total Lipids in VLDL,PEAR1,Platelet endothelial aggregation receptor 1,40052,0.00808948699271688,0.00215682411347257,0.00386211173031064,0.0123168622551231,0.000176993039814986
NMR metabolomics,X23424.Total Lipids in VLDL,NUP50,Nuclear pore complex protein Nup50,37021,-0.0118079499021348,0.00315820221599392,-0.0179980262454829,-0.00561787355878674,0.000185669349610321
NMR metabolomics,X23424.Total Lipids in VLDL,CST6,Cystatin-M,39524,0.016686288364675,0.00446752579077379,0.00792993781475836,0.0254426389145916,0.000188367423699643
NMR metabolomics,X23424.Total Lipids in VLDL,MYO6,Unconventional myosin-VI,37411,0.0135731815967268,0.0036416078353265,0.00643563023948689,0.0207107329539668,0.00019436801230342
NMR metabolomics,X23424.Total Lipids in VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,36962,0.0212061953139288,0.00569705996486727,0.010039957782789,0.0323724328450687,0.000198238623406689
NMR metabolomics,X23424.Total Lipids in VLDL,CSF1,Macrophage colony-stimulating factor 1,39931,0.00927008433606746,0.00249637939753594,0.00437718071689702,0.0141629879552379,0.000205175253643308
NMR metabolomics,X23424.Total Lipids in VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,0.0318795218724087,0.00858534339117865,0.0150522488256986,0.0487067949191189,0.000205457625226091
NMR metabolomics,X23424.Total Lipids in VLDL,SNU13,NHP2-like protein 1,37021,0.0219261853346888,0.005913258467891,0.0103361987376225,0.0335161719317552,0.000209785421146073
NMR metabolomics,X23424.Total Lipids in VLDL,NTRK3,NT-3 growth factor receptor,40009,-0.00753262473649618,0.00203171978278008,-0.0115147955107451,-0.00355045396224722,0.000210005866831513
NMR metabolomics,X23424.Total Lipids in VLDL,AREG,Amphiregulin,39788,-0.0164800393309944,0.00445521812749396,-0.0252122668608826,-0.00774781180110629,0.000217142335745775
NMR metabolomics,X23424.Total Lipids in VLDL,HMBS,Porphobilinogen deaminase,40030,0.0151305645070816,0.00409467454821699,0.00710500239257633,0.0231561266215869,0.000220454848458568
NMR metabolomics,X23424.Total Lipids in VLDL,CCND2,G1/S-specific cyclin-D2,37169,0.0129576989808681,0.00351100095913598,0.0060761371009616,0.0198392608607747,0.000224618718102934
NMR metabolomics,X23424.Total Lipids in VLDL,CSF3,Granulocyte colony-stimulating factor,39587,0.0168432484086582,0.00456970219185267,0.00788663211262696,0.0257998647046894,0.000228704128412654
NMR metabolomics,X23424.Total Lipids in VLDL,DDX25,ATP-dependent RNA helicase DDX25,37039,-0.0131500102601879,0.00357627197468145,-0.0201595033305635,-0.00614051718981223,0.000236915806365757
NMR metabolomics,X23424.Total Lipids in VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,0.0169194678958338,0.00460583235713768,0.00789203647584396,0.0259468993158237,0.00024018372904536
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,0.0120194363752712,0.0032819000633019,0.00558691225119945,0.0184519604993429,0.000250721727723298
NMR metabolomics,X23424.Total Lipids in VLDL,GBP2,Guanylate-binding protein 2,39587,0.0205504425678044,0.00564926229150761,0.00947788847644944,0.0316229966591593,0.000275940315177817
NMR metabolomics,X23424.Total Lipids in VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.0208108230800436,0.00572083948221407,0.00959797769490404,0.0320236684651832,0.000276108749748376
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN1,Tetraspanin-1,39585,0.0139967454937674,0.00384891479523491,0.00645287249510696,0.0215406184924278,0.000277203870691893
NMR metabolomics,X23424.Total Lipids in VLDL,FAM171B,Protein FAM171B,37368,0.00958697462429144,0.00264550573080887,0.00440178339190607,0.0147721658566768,0.000291290507829578
NMR metabolomics,X23424.Total Lipids in VLDL,ROBO4,Roundabout homolog 4,37043,-0.00616867419171497,0.00170270312664089,-0.00950597231993111,-0.00283137606349882,0.000292445704364597
NMR metabolomics,X23424.Total Lipids in VLDL,LMNB1,Lamin-B1,37348,0.0200506676250789,0.00553541377207713,0.00920125663180776,0.0309000786183501,0.0002931205079725
NMR metabolomics,X23424.Total Lipids in VLDL,DLL4,Delta-like protein 4,37043,0.029697660561607,0.00821830913511927,0.0135897746567732,0.0458055464664408,0.000303101750728433
NMR metabolomics,X23424.Total Lipids in VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,0.0242006877893983,0.00670482514861607,0.0110592304981109,0.0373421450806858,0.000307980928411681
NMR metabolomics,X23424.Total Lipids in VLDL,CPE,Carboxypeptidase E,39906,-0.0132327131537049,0.00367647145268124,-0.0204385972009601,-0.00602682910644965,0.000320039514998138
NMR metabolomics,X23424.Total Lipids in VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,0.0124652178023514,0.003478701615104,0.00564696263674755,0.0192834729679552,0.000340509596339486
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH12,Protocadherin-12,37411,0.00864441937577654,0.00241517587934906,0.00391067465225239,0.0133781640993007,0.000345839593552852
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,0.0111449133607897,0.00312490002334047,0.0050201093150424,0.0172697174065371,0.000362855262779199
NMR metabolomics,X23424.Total Lipids in VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,0.0147826528499241,0.00414680614683861,0.00665491280212045,0.0229103928977278,0.000365380729579066
NMR metabolomics,X23424.Total Lipids in VLDL,HEPACAM2,HEPACAM family member 2,37388,-0.0142342640170608,0.0039994564275602,-0.0220731986150787,-0.00639532941904277,0.000373474312408192
NMR metabolomics,X23424.Total Lipids in VLDL,IL10RA,Interleukin-10 receptor subunit alpha,39587,0.0197779521752083,0.00556688689509261,0.00886685386082683,0.0306890504895899,0.000382291642449462
NMR metabolomics,X23424.Total Lipids in VLDL,NME3,Nucleoside diphosphate kinase 3,39885,0.00806152881258503,0.00227013090933087,0.00361207223029652,0.0125109853948735,0.000384681628938921
NMR metabolomics,X23424.Total Lipids in VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,39477,0.0135495670190129,0.0038184390302956,0.00606542651963351,0.0210337075183922,0.000388632196332108
NMR metabolomics,X23424.Total Lipids in VLDL,FAM3D,Protein FAM3D,37382,0.0282705594981528,0.00796863430232006,0.0126520362656055,0.0438890827307002,0.000389883005638132
NMR metabolomics,X23424.Total Lipids in VLDL,SAG,S-arrestin,36991,-0.0179694757292033,0.00507063408732682,-0.0279079185403639,-0.00803103291804276,0.000395726150357227
NMR metabolomics,X23424.Total Lipids in VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,37437,0.0200730450006006,0.00566537286169577,0.0089689141916769,0.0311771758095243,0.000396763585972487
NMR metabolomics,X23424.Total Lipids in VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,-0.014393096401524,0.00407896200727919,-0.0223878619357912,-0.00639833086725677,0.00041891348419953
NMR metabolomics,X23424.Total Lipids in VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0219990033222815,0.00624946222466134,-0.0342479492826177,-0.00975005736194523,0.000432516215587578
NMR metabolomics,X23424.Total Lipids in VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,0.0145960607605084,0.00415084509344439,0.00646040437735744,0.0227317171436595,0.00043866969747812
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTSL5,ADAMTS-like protein 5,37437,-0.0131552812528948,0.00374290826542313,-0.0204913814531242,-0.00581918105266551,0.000441648827551722
NMR metabolomics,X23424.Total Lipids in VLDL,GPR101,Probable G-protein coupled receptor 101,36991,-0.0209822357772381,0.00597895430435414,-0.0327009862137722,-0.00926348534070399,0.000450709823680739
NMR metabolomics,X23424.Total Lipids in VLDL,CDH17,Cadherin-17,39868,-0.0221905394319175,0.00632885915308961,-0.0345951033719731,-0.00978597549186185,0.000455718438657289
NMR metabolomics,X23424.Total Lipids in VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,39537,0.0167398119138981,0.00477847343902268,0.00737400397341369,0.0261056198543826,0.000461034311887433
NMR metabolomics,X23424.Total Lipids in VLDL,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.0163600822032715,0.00467763341874952,-0.0255282437040206,-0.00719192070252245,0.000470888531319026
NMR metabolomics,X23424.Total Lipids in VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,0.0167996413325569,0.00480529931929163,0.00738125466674531,0.0262180279983685,0.000473686618802003
NMR metabolomics,X23424.Total Lipids in VLDL,KIT,Mast/stem cell growth factor receptor Kit,39908,-0.00957151118995961,0.00273858954872303,-0.0149391467054567,-0.00420387567446247,0.000475249372173435
NMR metabolomics,X23424.Total Lipids in VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,-0.00937019660573008,0.00268229536474844,-0.014627495520637,-0.00411289769082314,0.000478298395401241
NMR metabolomics,X23424.Total Lipids in VLDL,LY6D,Lymphocyte antigen 6D,39761,0.012010543022723,0.00344710885628597,0.00525420966440255,0.0187668763810435,0.000494871439973976
NMR metabolomics,X23424.Total Lipids in VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,0.016261848698545,0.00466864531040256,0.00711130389015594,0.025412393506934,0.000496804230891407
NMR metabolomics,X23424.Total Lipids in VLDL,SAFB2,Scaffold attachment factor B2,37411,0.00910959078440543,0.00261541484767503,0.00398337768296238,0.0142358038858485,0.000497321102765387
NMR metabolomics,X23424.Total Lipids in VLDL,RBPMS,RNA-binding protein with multiple splicing,37056,0.021591984011356,0.00620135145904048,0.00943733515163666,0.0337466328710753,0.000499631506868012
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA4C,Semaphorin-4C,39788,0.00939180299650344,0.00269924794203678,0.00410127703011135,0.0146823289628955,0.000503853731702007
NMR metabolomics,X23424.Total Lipids in VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,0.00840939767258934,0.00241852146531735,0.00366909560056734,0.0131496997446113,0.00050824846666988
NMR metabolomics,X23424.Total Lipids in VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.0125063449322211,0.00359718637736726,0.00545585963258128,0.0195568302318609,0.000509025545889045
NMR metabolomics,X23424.Total Lipids in VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,0.0146534555608194,0.00422145037208041,0.00637941283154181,0.022927498290097,0.000519530670361483
NMR metabolomics,X23424.Total Lipids in VLDL,FLT1,Vascular endothelial growth factor receptor 1,39755,0.00764271881247858,0.00220355580676335,0.00332374943122242,0.0119616881937347,0.00052503691028003
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.0125837549578805,0.0036293853019113,-0.0196973501496266,-0.00547015976613433,0.000527321242739471
NMR metabolomics,X23424.Total Lipids in VLDL,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.0160587365755391,0.00463181377001755,-0.0251370915647735,-0.00698038158630473,0.000527584372478839
NMR metabolomics,X23424.Total Lipids in VLDL,STX3,Syntaxin-3,37388,0.0125553237885353,0.00362931693034978,0.00544186260504975,0.0196687849720209,0.000543012401459361
NMR metabolomics,X23424.Total Lipids in VLDL,KIRREL2,Kin of IRRE-like protein 2,39489,0.013041436953006,0.00377341727790169,0.0056455390883187,0.0204373348176933,0.000549438328440114
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,39788,-0.0178296463933127,0.00518082151140111,-0.0279840565556588,-0.00767523623096648,0.000580045539483353
NMR metabolomics,X23424.Total Lipids in VLDL,EP300,Histone acetyltransferase p300,37056,0.00970496853133529,0.00282689267633085,0.00416425888572681,0.0152456781769438,0.000598582699074071
NMR metabolomics,X23424.Total Lipids in VLDL,SSB,Lupus La protein,39489,0.0198448897893181,0.00578447437043345,0.00850732002326859,0.0311824595553677,0.000603546373438466
NMR metabolomics,X23424.Total Lipids in VLDL,IL15,Interleukin-15,39866,0.0105906165112219,0.00309197804529091,0.00453033954245167,0.016650893479992,0.000615908065320715
NMR metabolomics,X23424.Total Lipids in VLDL,RLN1,Prorelaxin H1,37411,-0.0263659012744907,0.00769784894009582,-0.0414536851970785,-0.0112781173519029,0.00061639502094464
NMR metabolomics,X23424.Total Lipids in VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.0190308118001236,0.00557114569228147,0.00811136624325191,0.0299502573569953,0.000637474488678209
NMR metabolomics,X23424.Total Lipids in VLDL,PI3,Elafin,39594,0.0172479698830384,0.00505053061541552,0.00734892987682394,0.0271470098892528,0.000639240851005221
NMR metabolomics,X23424.Total Lipids in VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,-0.00697108568617822,0.00204723454604089,-0.0109836653964184,-0.00295850597593807,0.000662994861180828
NMR metabolomics,X23424.Total Lipids in VLDL,IFNG,Interferon gamma,39587,0.037095789562404,0.0108975724977128,0.0157365474668869,0.0584550316579212,0.000665623483621852
NMR metabolomics,X23424.Total Lipids in VLDL,PON1,Serum paraoxonase/arylesterase 1,37445,-0.00829984483795113,0.0024416591044098,-0.0130854966825943,-0.00351419299330791,0.000677615772858106
NMR metabolomics,X23424.Total Lipids in VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,-0.0104644119511635,0.00307997039435188,-0.0165011539240932,-0.00442766997823381,0.000681570947876438
NMR metabolomics,X23424.Total Lipids in VLDL,NRP2,Neuropilin-2,39858,-0.00922881850708397,0.00271812231255584,-0.0145563382396934,-0.00390129877447451,0.000687220629509802
NMR metabolomics,X23424.Total Lipids in VLDL,DRAXIN,Draxin,39749,0.0135665943415323,0.00400779434605369,0.00571131742326706,0.0214218712597975,0.000713368009924515
NMR metabolomics,X23424.Total Lipids in VLDL,CTRL,Chymotrypsin-like protease CTRL-1,37388,-0.0212522617883396,0.00628631367474077,-0.0335734365908315,-0.00893108698584771,0.000725008424282461
NMR metabolomics,X23424.Total Lipids in VLDL,FUCA1,Tissue alpha-L-fucosidase,39928,0.02588209724783,0.00767119506018888,0.0108465549298598,0.0409176395658002,0.000742775516641953
NMR metabolomics,X23424.Total Lipids in VLDL,CHRM1,Muscarinic acetylcholine receptor M1,37039,-0.0118161206705998,0.0035038581158132,-0.0186836825775937,-0.00494855876360591,0.000747529878602687
NMR metabolomics,X23424.Total Lipids in VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,-0.0225543928784785,0.00672217426712754,-0.0357298544420485,-0.00937893131490856,0.000795192322260206
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.0087418479679173,0.00260976834800801,0.0036267020058216,0.013856993930013,0.000810942641452954
NMR metabolomics,X23424.Total Lipids in VLDL,IL17C,Interleukin-17C,39587,-0.0211973785841899,0.00633012044462609,-0.0336044146556571,-0.00879034251272281,0.000813960164755344
NMR metabolomics,X23424.Total Lipids in VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,37169,0.0139782813405217,0.00417786916835982,0.00578965777053643,0.0221669049105069,0.000822748662097378
NMR metabolomics,X23424.Total Lipids in VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,-0.00609633848517759,0.00182919293073675,-0.00968155662942162,-0.00251112034093357,0.000862055096916333
NMR metabolomics,X23424.Total Lipids in VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,0.0222259769576111,0.00667485203715526,0.00914326696478683,0.0353086869504355,0.000871069085110823
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA3,Alpha-1-antichymotrypsin,37407,0.00459604451280466,0.00138148488642821,0.00188833413540537,0.00730375489020394,0.000880555770586305
NMR metabolomics,X23424.Total Lipids in VLDL,EPO,Erythropoietin,39866,0.0244448305392399,0.0073527497482297,0.0100334410327097,0.0388562200457701,0.000887496044190833
NMR metabolomics,X23424.Total Lipids in VLDL,NCR1,Natural cytotoxicity triggering receptor 1,39835,0.0112266196363296,0.00338137678036139,0.00459912114682132,0.017854118125838,0.000901761490529029
NMR metabolomics,X23424.Total Lipids in VLDL,GBA,Lysosomal acid glucosylceramidase,37039,0.0166783989014877,0.00502684358396278,0.0068257854769206,0.0265310123260547,0.000909532646271791
NMR metabolomics,X23424.Total Lipids in VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,0.009415531122033,0.00283989524011929,0.00384933645139918,0.0149817257926668,0.000917424319671929
NMR metabolomics,X23424.Total Lipids in VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.0129275311262888,0.00389962677360321,-0.020570799602551,-0.00528426265002647,0.000918682307796505
NMR metabolomics,X23424.Total Lipids in VLDL,TERF1,Telomeric repeat-binding factor 1,37056,-0.00925228872119808,0.00279122393944018,-0.0147230876425008,-0.00378148979989534,0.000919629969132898
NMR metabolomics,X23424.Total Lipids in VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,39908,-0.0155262942311039,0.00468456018300553,-0.0247080321897947,-0.00634455627241303,0.00092058331499873
NMR metabolomics,X23424.Total Lipids in VLDL,RPS10,40S ribosomal protein S10,37021,-0.0135915590049196,0.00410076549267778,-0.0216290593705681,-0.00555405863927118,0.0009208955271713
NMR metabolomics,X23424.Total Lipids in VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.0224037427847246,0.00675995496466621,0.00915423105397885,0.0356532545154704,0.000921128535772702
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.0219463397134434,0.00664825853889994,0.00891575297719951,0.0349769264496873,0.000965265497683309
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA2,Ephrin type-A receptor 2,39248,0.00923747096321854,0.00279854530040807,0.00375232217441872,0.0147226197520184,0.000966249024891653
NMR metabolomics,X23424.Total Lipids in VLDL,MANSC4,MANSC domain-containing protein 4,37021,0.0196410862175776,0.00595152667994454,0.00797609392488633,0.0313060785102689,0.000968810401161408
NMR metabolomics,X23424.Total Lipids in VLDL,PRKCQ,Protein kinase C theta type,39587,0.0135894393155965,0.00413283273664449,0.00548908715177335,0.0216897914794197,0.00101063733544399
NMR metabolomics,X23424.Total Lipids in VLDL,CTRC,Chymotrypsin-C,39856,0.0193349376173796,0.0058831821473304,0.00780390060861205,0.0308659746261472,0.00101667851868345
NMR metabolomics,X23424.Total Lipids in VLDL,PRRT3,Proline-rich transmembrane protein 3,37043,0.0113695443001008,0.00346142553749483,0.0045851502466109,0.0181539383535906,0.00102378276145806
NMR metabolomics,X23424.Total Lipids in VLDL,NPTX2,Neuronal pentraxin-2,37437,-0.0105346946756721,0.00321814169284553,-0.0168422523936494,-0.0042271369576949,0.00106477403271643
NMR metabolomics,X23424.Total Lipids in VLDL,CALCB,Calcitonin gene-related peptide 2,37388,0.0122825025784974,0.00375791003797661,0.00491699890406321,0.0196480062529315,0.00108412051888521
NMR metabolomics,X23424.Total Lipids in VLDL,BLVRB,Flavin reductase,39858,0.020024683245848,0.00614483572755012,0.00798080521984973,0.0320685612718462,0.00112124914008122
NMR metabolomics,X23424.Total Lipids in VLDL,SCARF2,Scavenger receptor class F member 2,40009,-0.00872950787663837,0.00268167887494659,-0.0139855984715337,-0.00347341728174305,0.00113529936666586
NMR metabolomics,X23424.Total Lipids in VLDL,RCC1,Regulator of chromosome condensation,37368,0.0156864078221329,0.00483484089555718,0.0062101196668408,0.025162695977425,0.00117963150347791
NMR metabolomics,X23424.Total Lipids in VLDL,KLK15,Kallikrein-15,37351,0.0155521835722554,0.00480973825922057,0.0061250965841831,0.0249792705603277,0.00122586768951307
NMR metabolomics,X23424.Total Lipids in VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,0.0185346268082895,0.00574151289494412,0.00728126153419898,0.0297879920823799,0.00124834142320652
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB5,Integrin beta-5,39913,0.0116623245324075,0.0036163427461357,0.00457429274998152,0.0187503563148335,0.00126271173507904
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC14A,C-type lectin domain family 14 member A,39858,-0.00927739134204758,0.00287979209921952,-0.0149217838565178,-0.00363299882757733,0.00127754682065692
NMR metabolomics,X23424.Total Lipids in VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,-0.00795372080664858,0.00246919815778162,-0.0127933491959006,-0.0031140924173966,0.00127966699091263
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,0.0132637457032719,0.00412731497176689,0.00517420835860876,0.021353283047935,0.00131371627766488
NMR metabolomics,X23424.Total Lipids in VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,0.0160791015850771,0.00500382939140142,0.00627159597793036,0.0258866071922239,0.00131458368787213
NMR metabolomics,X23424.Total Lipids in VLDL,ALPP,"Alkaline phosphatase, placental type",39788,0.0323055523738252,0.0100602627723816,0.0125874373399573,0.052023667407693,0.00132442645577359
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN1,Contactin-1,40052,-0.00811162378577896,0.00253880947666905,-0.0130876903600503,-0.00313555721150763,0.00140074502899056
NMR metabolomics,X23424.Total Lipids in VLDL,SLITRK1,SLIT and NTRK-like protein 1,37056,0.00974918736964794,0.00305124294852548,0.00376875119053799,0.0157296235487579,0.00140085641526246
NMR metabolomics,X23424.Total Lipids in VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,0.0367864496686932,0.0115466983458253,0.0141549209108756,0.0594179784265109,0.00144593909358186
NMR metabolomics,X23424.Total Lipids in VLDL,TYMP,Thymidine phosphorylase,39764,0.0205614175868594,0.00645464687974551,0.00791030970255821,0.0332125254711606,0.00144772184783279
NMR metabolomics,X23424.Total Lipids in VLDL,MELTF,Melanotransferrin,37437,0.00881458422433353,0.00277324893641187,0.00337901630896626,0.0142501521397008,0.00148405853028358
NMR metabolomics,X23424.Total Lipids in VLDL,VIM,Vimentin,39585,0.0355271844688458,0.0111785273575442,0.0136172708480592,0.0574370980896325,0.00148498180576246
NMR metabolomics,X23424.Total Lipids in VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,0.00814863670072646,0.00256686200593078,0.00311758716910214,0.0131796862323508,0.00150403105454021
NMR metabolomics,X23424.Total Lipids in VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,-0.025640326336201,0.00811001346415955,-0.0415359527259537,-0.00974469994644828,0.00157226804733463
NMR metabolomics,X23424.Total Lipids in VLDL,TMOD4,Tropomodulin-4,36962,-0.0123202175080306,0.00389995290912519,-0.019964125209916,-0.00467630980614524,0.00158634078543106
NMR metabolomics,X23424.Total Lipids in VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,-0.0100034433916516,0.00316877200017982,-0.016214236512004,-0.00379265027129911,0.00159760645773546
NMR metabolomics,X23424.Total Lipids in VLDL,NAPRT,Nicotinate phosphoribosyltransferase,37388,0.00985215292446553,0.00312105669570847,0.00373488180087693,0.0159694240480541,0.00159930861461101
NMR metabolomics,X23424.Total Lipids in VLDL,CLIC5,Chloride intracellular channel protein 5,37039,-0.00963919939532209,0.00305946234618063,-0.0156357455938361,-0.00364265319680806,0.00163289481704342
NMR metabolomics,X23424.Total Lipids in VLDL,CDH6,Cadherin-6,39868,-0.0113679764979684,0.00362426614118838,-0.0184715381346976,-0.00426441486123915,0.00171212124919594
NMR metabolomics,X23424.Total Lipids in VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.0106038110030753,0.00338520053824272,-0.0172388040580311,-0.0039688179481196,0.00173691347026734
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,-0.00919666670860941,0.00293799386816288,-0.0149551346902086,-0.00343819872701017,0.00175037305142806
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.0173925346446284,0.00557247290706942,0.00647048774677238,0.0283145815424845,0.00180535783406333
NMR metabolomics,X23424.Total Lipids in VLDL,CEP152,Centrosomal protein of 152 kDa,36962,0.0124247272625233,0.00399031315762815,0.00460371347357216,0.0202457410514745,0.00185141333866825
NMR metabolomics,X23424.Total Lipids in VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,0.0302887695702312,0.00974872834470677,0.0111812620146059,0.0493962771258565,0.00189364285262708
NMR metabolomics,X23424.Total Lipids in VLDL,HBQ1,Hemoglobin subunit theta-1,40030,-0.0176100432640478,0.0057145664177854,-0.0288105934429072,-0.00640949308518841,0.00206233034040602
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1D,V-type proton ATPase subunit D,39788,0.00763766676934907,0.00248131895460653,0.00277428161832026,0.0125010519203779,0.00208701821388209
NMR metabolomics,X23424.Total Lipids in VLDL,METAP1,Methionine aminopeptidase 1,39489,0.00893316898031563,0.00290475464534455,0.00323984987544031,0.014626488085191,0.00210610812949961
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP5,Rho GTPase-activating protein 5,36962,0.0216907740640284,0.00707617159084876,0.00782147774596482,0.0355600703820919,0.00217875076210306
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,-0.0115961014822393,0.00379059599147929,-0.0190256696255387,-0.00416653333893988,0.00222379022861181
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.010349740746808,0.003399838464247,0.00368605735688393,0.0170134241367322,0.00233757404161642
NMR metabolomics,X23424.Total Lipids in VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,-0.0167479891470221,0.0055052643051533,-0.0275383071851226,-0.00595767110892163,0.00235336312091512
NMR metabolomics,X23424.Total Lipids in VLDL,HTR1B,5-hydroxytryptamine receptor 1B,36991,-0.0124093203779114,0.00408647444996078,-0.0204188102998345,-0.00439983045598829,0.00239667398491439
NMR metabolomics,X23424.Total Lipids in VLDL,GIPC2,PDZ domain-containing protein GIPC2,37388,0.00828364146190144,0.00274094711889592,0.00291138510886543,0.0136558978149374,0.00251428962800195
NMR metabolomics,X23424.Total Lipids in VLDL,NCAM1,Neural cell adhesion molecule 1,39931,0.00860510021784629,0.00285420749865902,0.00301085352047462,0.014199346915218,0.00257480066400728
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM3,Intercellular adhesion molecule 3,40052,-0.0072744009990345,0.00241324255098018,-0.0120043563989557,-0.00254444559911334,0.00257913945302373
NMR metabolomics,X23424.Total Lipids in VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,0.00771087681977073,0.0025648934732671,0.00268368561216721,0.0127380680273742,0.0026485264850702
NMR metabolomics,X23424.Total Lipids in VLDL,BCAM,Basal cell adhesion molecule,39858,-0.00665976626814785,0.0022438520216903,-0.0110577162306608,-0.00226181630563487,0.00300182302703367
NMR metabolomics,X23424.Total Lipids in VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,0.0156536879561956,0.00528044289627425,0.00530401987949807,0.0260033560328931,0.00303738439799332
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,0.0111935005154026,0.00379249488280867,0.00376021054509756,0.0186267904857075,0.00316805340762616
NMR metabolomics,X23424.Total Lipids in VLDL,AMBN,Ameloblastin,39587,-0.008021561063967,0.00271937074382984,-0.0133515277218735,-0.00269159440606052,0.00318462710874674
NMR metabolomics,X23424.Total Lipids in VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,39721,0.0164546276965233,0.00559348573540958,0.00549139565512054,0.0274178597379261,0.00326836879790199
NMR metabolomics,X23424.Total Lipids in VLDL,NMRK2,Nicotinamide riboside kinase 2,36962,-0.0114621361428722,0.00390352569962943,-0.0191130465141458,-0.0038112257715985,0.00332671806160081
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.0119055240897429,0.00406504060141286,0.00393804451097372,0.0198730036685121,0.0034079610523322
NMR metabolomics,X23424.Total Lipids in VLDL,ELAVL4,ELAV-like protein 4,36991,0.023565847149914,0.00806352224784236,0.00776134354414299,0.0393703507556851,0.00347797664122186
NMR metabolomics,X23424.Total Lipids in VLDL,RAB44,Ras-related protein Rab-44,37368,0.0117576824801207,0.00403248837856563,0.00385400525813208,0.0196613597021094,0.00355430884667582
NMR metabolomics,X23424.Total Lipids in VLDL,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.0110623458554741,0.00379415654829949,-0.0184988926901411,-0.00362579902080707,0.00355573296031132
NMR metabolomics,X23424.Total Lipids in VLDL,NPR1,Atrial natriuretic peptide receptor 1,37021,-0.0115430870765457,0.00396666190564646,-0.0193177444116127,-0.0037684297414786,0.00362004792959872
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,0.0202816113589755,0.00700417630661827,0.00655342579800372,0.0340097969199473,0.00378983136644977
NMR metabolomics,X23424.Total Lipids in VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,-0.00952018265649608,0.00329641651830498,-0.0159811590323738,-0.00305920628061832,0.00388283854603517
NMR metabolomics,X23424.Total Lipids in VLDL,CADPS,Calcium-dependent secretion activator 1,37039,-0.0119362613436647,0.0041354286157134,-0.0200417014304629,-0.00383082125686639,0.00390381369304179
NMR metabolomics,X23424.Total Lipids in VLDL,BABAM1,BRISC and BRCA1-A complex member 1,37056,0.00818660586746302,0.00283759736713021,0.00262491502788782,0.0137482967070382,0.0039198719006137
NMR metabolomics,X23424.Total Lipids in VLDL,SULT1A1,Sulfotransferase 1A1,40009,-0.0354756742894872,0.0122968641877985,-0.0595775280975723,-0.0113738204814022,0.00392010358697193
NMR metabolomics,X23424.Total Lipids in VLDL,MYOM1,Myomesin-1,36991,0.0130169144884265,0.00452275743135663,0.00415230992296748,0.0218815190538855,0.00400733167346033
NMR metabolomics,X23424.Total Lipids in VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,0.00744746068222739,0.00258874184700526,0.00237352666209708,0.0125213947023577,0.00402275681620576
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM26,Tripartite motif-containing protein 26,36962,0.015334868567695,0.0053406797651881,0.00486713622792629,0.0258026009074636,0.00409400295340374
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G2A,"Phospholipase A2, membrane associated",39826,-0.0148850611111003,0.00519159534106948,-0.0250605879795965,-0.0047095342426041,0.00414734023227754
NMR metabolomics,X23424.Total Lipids in VLDL,TNN,Tenascin-N,37437,0.0117643861513487,0.00410354083744247,0.00372144610996141,0.0198073261927359,0.00415169216918818
NMR metabolomics,X23424.Total Lipids in VLDL,DCN,Decorin,39585,-0.00593867657820944,0.00207213596269892,-0.0100000630650993,-0.00187729009131956,0.00416286992247052
NMR metabolomics,X23424.Total Lipids in VLDL,TSC1,Hamartin,37056,0.0208015700915896,0.00730072980375047,0.00649213967623866,0.0351110005069405,0.00438909042707845
NMR metabolomics,X23424.Total Lipids in VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,39477,0.014173268980646,0.0049818931700278,0.00440875836739148,0.0239377795939005,0.0044475268646129
NMR metabolomics,X23424.Total Lipids in VLDL,CEP290,Centrosomal protein of 290 kDa,37169,0.0140409840790269,0.00495302284810482,0.00433305929674149,0.0237489088613124,0.00459189745280185
NMR metabolomics,X23424.Total Lipids in VLDL,CDH3,Cadherin-3,40009,0.009330491399622,0.00330162949702965,0.00285929758544389,0.0158016852138001,0.00471872742554772
NMR metabolomics,X23424.Total Lipids in VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,0.00766798654111059,0.0027144719713649,0.00234762147723539,0.0129883516049858,0.00473715185324194
NMR metabolomics,X23424.Total Lipids in VLDL,GSTP1,Glutathione S-transferase P,39393,-0.0186602800882632,0.00661590514914029,-0.0316274541805782,-0.00569310599594826,0.00480069419376964
NMR metabolomics,X23424.Total Lipids in VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.0127853876432339,0.00454354558785332,0.00388003829104135,0.0216907369954264,0.00490047441528756
NMR metabolomics,X23424.Total Lipids in VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00806928670227693,0.00287201305638717,0.00244014111175807,0.0136984322927958,0.00496601052878115
NMR metabolomics,X23424.Total Lipids in VLDL,QSOX1,Sulfhydryl oxidase 1,37186,0.0112672614899329,0.00401328591332717,0.00340122109981163,0.0191333018800541,0.00500017198784722
NMR metabolomics,X23424.Total Lipids in VLDL,NEDD9,Enhancer of filamentation 1,37056,0.0089471794525291,0.00319100726548225,0.00269280521218389,0.0152015536928743,0.00505665157164231
NMR metabolomics,X23424.Total Lipids in VLDL,PLXDC2,Plexin domain-containing protein 2,37388,0.00713778668091394,0.00255995865510268,0.00212026771691268,0.0121553056449152,0.00530687729554067
NMR metabolomics,X23424.Total Lipids in VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,0.0120264968197068,0.00432629176892929,0.00354696495260541,0.0205060286868082,0.00544571145435401
NMR metabolomics,X23424.Total Lipids in VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,0.0149814741107975,0.00541039358484995,0.00437710268449159,0.0255858455371034,0.00562903290408328
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2L15,Bcl-2-like protein 15,37056,0.0149555935232527,0.0054032303753678,0.00436526198753185,0.0255459250589736,0.00564976632417059
NMR metabolomics,X23424.Total Lipids in VLDL,CDKL5,Cyclin-dependent kinase-like 5,36991,-0.0139017867170198,0.00502805239093877,-0.0237567694032598,-0.00404680403077977,0.00570292723634657
NMR metabolomics,X23424.Total Lipids in VLDL,SPP1,Osteopontin,40012,-0.0118349763701825,0.0042897704159831,-0.0202429263855094,-0.00342702635485564,0.00580645051628471
NMR metabolomics,X23424.Total Lipids in VLDL,PLIN3,Perilipin-3,39868,0.0112844214329179,0.00409215813476438,0.00326379148877971,0.0193050513770561,0.0058298373422897
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,39868,0.00704944857791653,0.00255664378275233,0.00203842676372195,0.0120604703921111,0.00583458796432419
NMR metabolomics,X23424.Total Lipids in VLDL,CENPJ,Centromere protein J,37169,0.0190921254238299,0.00693223746047176,0.00550494000130524,0.0326793108463545,0.00589323733320361
NMR metabolomics,X23424.Total Lipids in VLDL,COL9A2,Collagen alpha-2(IX) chain,37169,0.012109143797387,0.00440374148562466,0.00347781048556269,0.0207404771092113,0.00597230865183295
NMR metabolomics,X23424.Total Lipids in VLDL,ACHE,Acetylcholinesterase,37124,0.00853932868468866,0.00312276616881203,0.00241870699381708,0.0146599503755602,0.00625504589860048
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA1549,UPF0606 protein KIAA1549,37169,0.0178781546645033,0.00656130142131767,0.00501800387872068,0.030738305450286,0.00644268577036135
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,-0.00823874988566099,0.00303048902581808,-0.0141785083762644,-0.00229899139505756,0.00656405306147125
NMR metabolomics,X23424.Total Lipids in VLDL,MYH7B,Myosin-7B,36962,-0.0114269607654997,0.00420657970598446,-0.0196718569892292,-0.00318206454177016,0.00660728886478001
NMR metabolomics,X23424.Total Lipids in VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,39862,0.0759426295440629,0.028016842250919,0.0210296187322616,0.130855640355864,0.00672319222644403
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD6,Programmed cell death protein 6,39868,-0.0179910250775347,0.00663980313565338,-0.0310050392234154,-0.00497701093165412,0.0067441775028108
NMR metabolomics,X23424.Total Lipids in VLDL,STX5,Syntaxin-5,37056,0.0105295928794154,0.0038903482203324,0.00290451036756386,0.0181546753912669,0.00680647789256987
NMR metabolomics,X23424.Total Lipids in VLDL,BCAN,Brevican core protein,39749,0.00857637152154906,0.00317375080423348,0.00235581994525144,0.0147969230978467,0.00689383433767764
NMR metabolomics,X23424.Total Lipids in VLDL,TMEM25,Transmembrane protein 25,37411,-0.0115103203149289,0.00427178837638901,-0.0198830255326514,-0.0031376150972065,0.00705818785569795
NMR metabolomics,X23424.Total Lipids in VLDL,PDRG1,p53 and DNA damage-regulated protein 1,37039,0.0135977700628442,0.00506554746339382,0.00366929703459227,0.0235262430910961,0.00727589355771544
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,0.00547073765200273,0.00204125477969178,0.00146987828380685,0.00947159702019861,0.00736925043964165
NMR metabolomics,X23424.Total Lipids in VLDL,IL20RA,Interleukin-20 receptor subunit alpha,39587,0.0115294216648882,0.00434376452336521,0.0030156431990924,0.020043200130684,0.00795657262062717
NMR metabolomics,X23424.Total Lipids in VLDL,MAPK13,Mitogen-activated protein kinase 13,36962,0.010713539232994,0.00407832504344047,0.00272002214785066,0.0187070563181373,0.00862553256836642
NMR metabolomics,X23424.Total Lipids in VLDL,L1CAM,Neural cell adhesion molecule L1,39913,0.00715220329341878,0.00272457784553904,0.00181203071616226,0.0124923758706753,0.00867136504827545
NMR metabolomics,X23424.Total Lipids in VLDL,FMR1,Synaptic functional regulator FMR1,39477,0.00890290130051311,0.00339345352567896,0.00225173239018236,0.0155540702108439,0.00871027881667431
NMR metabolomics,X23424.Total Lipids in VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,37056,0.0170897676921494,0.00653446520762767,0.00428221588519922,0.0298973194990997,0.0089243306934425
NMR metabolomics,X23424.Total Lipids in VLDL,PGLYRP1,Peptidoglycan recognition protein 1,39962,0.0104638022201841,0.00400227574618487,0.00261934175766175,0.0183082626827064,0.00894510375410563
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RL1,Interleukin-1 receptor-like 1,40002,-0.0116253587313307,0.00446575197576298,-0.0203782326038261,-0.00287248485883522,0.00924357108802796
NMR metabolomics,X23424.Total Lipids in VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,0.0135658132064067,0.00521378176721879,0.00334680094265784,0.0237848254701555,0.00927924535907316
NMR metabolomics,X23424.Total Lipids in VLDL,RBM19,Probable RNA-binding protein 19,37021,-0.0118026350671719,0.00454244963349142,-0.0207058363488151,-0.00289943378552876,0.00937917257813118
NMR metabolomics,X23424.Total Lipids in VLDL,GKN1,Gastrokine-1,39123,0.00694914373458613,0.00267795848941245,0.00170034509533773,0.0121979423738345,0.00946977106986418
NMR metabolomics,X23424.Total Lipids in VLDL,REG3A,Regenerating islet-derived protein 3-alpha,40052,-0.0145072327894024,0.00559260098626221,-0.0254687307224763,-0.00354573485632847,0.00949506391371842
NMR metabolomics,X23424.Total Lipids in VLDL,NDRG1,Protein NDRG1,39489,0.0171241489524586,0.00660165747589714,0.00418490029970016,0.0300633976052169,0.00949780165238623
NMR metabolomics,X23424.Total Lipids in VLDL,CRNN,Cornulin,39397,0.0159466018245341,0.00616504277718245,0.00386311798125649,0.0280300856678117,0.00970134207513639
NMR metabolomics,X23424.Total Lipids in VLDL,CPVL,Probable serine carboxypeptidase CPVL,39990,0.00990594783920875,0.00383232158199569,0.0023945975384972,0.0174172981399203,0.00975104453065449
NMR metabolomics,X23424.Total Lipids in VLDL,MYH4,Myosin-4,37021,-0.0117699607835186,0.00456548492396614,-0.0207183112344922,-0.00282161033254492,0.00994728374059068
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL12,Stromal cell-derived factor 1,39587,0.00978115527250727,0.00379935369409404,0.00233442203208295,0.0172278885129316,0.0100497152750992
NMR metabolomics,X23424.Total Lipids in VLDL,FCAR,Immunoglobulin alpha Fc receptor,39866,0.0114430327930685,0.00445764158611746,0.00270605528427831,0.0201800103018587,0.0102654934011956
NMR metabolomics,X23424.Total Lipids in VLDL,CDK1,Cyclin-dependent kinase 1,36962,0.00887220385651404,0.0034612838029596,0.00208808760271322,0.0156563201103149,0.0103802084620416
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.0119358513477539,0.00465668971723506,-0.0210629631935346,-0.00280873950197322,0.0103814032554931
NMR metabolomics,X23424.Total Lipids in VLDL,PSMC3,26S proteasome regulatory subunit 6A,36962,-0.00733731983064776,0.00286604819807025,-0.0129547742988655,-0.00171986536243007,0.0104758460476806
NMR metabolomics,X23424.Total Lipids in VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,0.0142491317321316,0.00558276843598874,0.00330690559759366,0.0251913578666695,0.0107093911414283
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,0.00881161387401804,0.00346322347848818,0.0020236958561812,0.0155995318918549,0.0109597786084498
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA4,Ephrin type-A receptor 4,37124,0.00683972103313976,0.00268896389376401,0.0015693518013623,0.0121100902649172,0.0109820673533734
NMR metabolomics,X23424.Total Lipids in VLDL,SCN2B,Sodium channel subunit beta-2,37039,-0.00697993618910531,0.00275103392244472,-0.012371962677097,-0.00158790970111367,0.0111855883230214
NMR metabolomics,X23424.Total Lipids in VLDL,PXDNL,Peroxidasin-like protein,37368,0.0143890262120304,0.00568203007882858,0.00325224725752633,0.0255258051665344,0.0113405314297109
NMR metabolomics,X23424.Total Lipids in VLDL,STX1B,Syntaxin-1B,37039,0.0102693698181098,0.00405593111917178,0.00231974482453312,0.0182189948116865,0.0113548919228698
NMR metabolomics,X23424.Total Lipids in VLDL,RYR1,Ryanodine receptor 1,37021,-0.00817936483776996,0.00323411162024053,-0.0145182236134414,-0.00184050606209852,0.0114473948494789
NMR metabolomics,X23424.Total Lipids in VLDL,RALB,Ras-related protein Ral-B,37056,0.00705994027523781,0.00279457354721313,0.00158257612270007,0.0125373044277755,0.0115385891544918
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,-0.00639847530595527,0.00253672181281207,-0.0113704500590669,-0.00142650055284363,0.0116693658751864
NMR metabolomics,X23424.Total Lipids in VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.00816746260122735,0.00323827699296181,0.00182043969502221,0.0145144855074325,0.0116731098563229
NMR metabolomics,X23424.Total Lipids in VLDL,GFRAL,GDNF family receptor alpha-like,36942,-0.0149786992290707,0.00594002010501431,-0.0266211386348988,-0.0033362598232427,0.0116920965813224
NMR metabolomics,X23424.Total Lipids in VLDL,CD109,CD109 antigen,39858,-0.00810019439675473,0.00321550539861636,-0.0144025849780428,-0.00179780381546666,0.0117750349685949
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA1,Alpha-1-antitrypsin,37247,-0.00194210942218557,0.000772445233655039,-0.00345610208014945,-0.000428116764221693,0.0119406968985671
NMR metabolomics,X23424.Total Lipids in VLDL,NME1,Nucleoside diphosphate kinase A,37056,-0.00523966585392181,0.00208587693103584,-0.00932798463875206,-0.00115134706909156,0.0120176757438799
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA7A,Semaphorin-7A,40002,0.0064418159391453,0.00256764116339384,0.00140923925889337,0.0114743926193972,0.0121223519385293
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA6C,Semaphorin-6C,37056,0.00625879289617854,0.00250104922338324,0.0013567364183474,0.0111608493740097,0.0123451138752135
NMR metabolomics,X23424.Total Lipids in VLDL,ITGBL1,Integrin beta-like protein 1,37437,0.0085317067149503,0.0034110722388781,0.00184600512674923,0.0152174083031514,0.0123896966275238
NMR metabolomics,X23424.Total Lipids in VLDL,SH3GL3,Endophilin-A3,37083,0.0196261309925406,0.00788021550147455,0.0041809086096505,0.0350713533754307,0.0127664559569232
NMR metabolomics,X23424.Total Lipids in VLDL,PLAUR,Urokinase plasminogen activator surface receptor,39757,0.00635880379678713,0.00255403619819258,0.00135289284832968,0.0113647147452446,0.0127949557060962
NMR metabolomics,X23424.Total Lipids in VLDL,WNT9A,Protein Wnt-9a,39587,0.00664079081036043,0.00268053876136731,0.0013869348380805,0.0118946467826404,0.0132444411093079
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN3,Neuronal-specific septin-3,37411,-0.0180382383677415,0.00728501673365191,-0.0323168711656993,-0.00375960556978379,0.0132957373238744
NMR metabolomics,X23424.Total Lipids in VLDL,CTSV,Cathepsin L2,39967,0.00965953494153274,0.00390361958566521,0.00200844055362892,0.0173106293294366,0.0133522316645344
NMR metabolomics,X23424.Total Lipids in VLDL,SOX9,Transcription factor SOX-9,37039,0.00637901940490388,0.00257873863359872,0.00132469168305039,0.0114333471267574,0.0133847906327575
NMR metabolomics,X23424.Total Lipids in VLDL,RAD51,DNA repair protein RAD51 homolog 1,37169,0.0124181585906844,0.00503256595344677,0.00255432932192874,0.0222819878594401,0.0136162284441695
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,37039,0.0069267906349332,0.00281082308871088,0.00141757738105987,0.0124360038888065,0.0137397012023447
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC7A,C-type lectin domain family 7 member A,40058,0.0133598962980793,0.00545403622582787,0.00266998529545672,0.024049807300702,0.0143142759003477
NMR metabolomics,X23424.Total Lipids in VLDL,CEP164,Centrosomal protein of 164 kDa,39587,0.0141345066629906,0.00577113123044685,0.00282308945131479,0.0254459238746664,0.014329244946038
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.00744892160029742,0.00304269995266248,0.00148522969307895,0.0134126135075159,0.0143708783801336
NMR metabolomics,X23424.Total Lipids in VLDL,RAB39B,Ras-related protein Rab-39B,37021,0.0207295772196895,0.00847735444540703,0.00411396250669175,0.0373451919326873,0.0144866452453385
NMR metabolomics,X23424.Total Lipids in VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.00908354975730848,0.00371927132345598,0.00179377796333475,0.0163733215512822,0.0146073671458671
NMR metabolomics,X23424.Total Lipids in VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,0.0108147008401665,0.00443089074369887,0.00213015498251674,0.0194992466978163,0.0146674279054837
NMR metabolomics,X23424.Total Lipids in VLDL,BEX3,Protein BEX3,36962,-0.0109223603623135,0.00447519233773892,-0.0196937373442818,-0.00215098338034524,0.0146741708037269
NMR metabolomics,X23424.Total Lipids in VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,0.0150628255330749,0.00618888244478463,0.002932615941297,0.0271930351248528,0.0149519234661308
NMR metabolomics,X23424.Total Lipids in VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,0.0118040818032695,0.00485308661571217,0.00229203203647364,0.0213161315700654,0.0150172638507625
NMR metabolomics,X23424.Total Lipids in VLDL,MSMB,Beta-microseminoprotein,39780,0.0155422664177068,0.00639536506646367,0.00300735088743796,0.0280771819479755,0.015099838529422
NMR metabolomics,X23424.Total Lipids in VLDL,NPTN,Neuroplastin,39477,0.019440446687925,0.00800226098780949,0.00375601515181839,0.0351248782240316,0.0151363200729385
NMR metabolomics,X23424.Total Lipids in VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,-0.00842208814083877,0.00349193982643192,-0.0152662902006453,-0.0015778860810322,0.0158847452901406
NMR metabolomics,X23424.Total Lipids in VLDL,ADRA2A,Alpha-2A adrenergic receptor,37021,-0.0164400844214691,0.00684630167048805,-0.0298588356956256,-0.00302133314731247,0.0163503263331892
NMR metabolomics,X23424.Total Lipids in VLDL,THBS2,Thrombospondin-2,39858,-0.00824044009554033,0.00343436079670499,-0.0149717872570821,-0.00150909293399855,0.0164328754792414
NMR metabolomics,X23424.Total Lipids in VLDL,DCLRE1C,Protein artemis,36962,-0.00711478697805728,0.00296741512275302,-0.0129309206186532,-0.00129865333746135,0.0165150773342671
NMR metabolomics,X23424.Total Lipids in VLDL,SLC4A1,Band 3 anion transport protein,37437,-0.010666523674307,0.00445442205643688,-0.0193971909049233,-0.00193585644369074,0.0166523403964221
NMR metabolomics,X23424.Total Lipids in VLDL,PRR4,Proline-rich protein 4,37031,-0.0159285187011289,0.0066734570761701,-0.0290084945704223,-0.00284854283183549,0.0170076037933585
NMR metabolomics,X23424.Total Lipids in VLDL,TFF3,Trefoil factor 3,39839,0.0109858887988106,0.00462054091979556,0.00192962859601131,0.0200421490016099,0.0174364845807949
NMR metabolomics,X23424.Total Lipids in VLDL,REN,Renin,39868,-0.0149078920039141,0.0062817167781316,-0.027220056889052,-0.00259572711877615,0.0176455242721066
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC1,Sialoadhesin,39931,0.00941754088677813,0.0039815768774061,0.00161365020706216,0.0172214315664941,0.0180282900962959
NMR metabolomics,X23424.Total Lipids in VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.00885943512523938,0.00376644956971761,0.00147719396859287,0.0162416762818859,0.0186770644482247
NMR metabolomics,X23424.Total Lipids in VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,37056,0.00840920520016127,0.00358102156562013,0.00139040293154581,0.0154280074687767,0.018875526607008
NMR metabolomics,X23424.Total Lipids in VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.0144287694536062,0.00615405048041025,-0.0264907083952103,-0.00236683051200216,0.0190622966790228
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,-0.00994902011344033,0.00424406585261272,-0.0182673891845613,-0.00163065104231939,0.0190790208841793
NMR metabolomics,X23424.Total Lipids in VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,0.0153734230763981,0.0065740311665689,0.00248832198992305,0.0282585241628731,0.0193734607734702
NMR metabolomics,X23424.Total Lipids in VLDL,MORF4L2,Mortality factor 4-like protein 2,36962,-0.0082922734159506,0.0035515263292506,-0.0152532650212818,-0.00133128181061942,0.0195663956357422
NMR metabolomics,X23424.Total Lipids in VLDL,DPEP1,Dipeptidase 1,39713,-0.0105046940801005,0.00451621457188974,-0.0193564746410044,-0.00165291351919662,0.0200313439972222
NMR metabolomics,X23424.Total Lipids in VLDL,SCGN,Secretagogin,39587,-0.00950878289508747,0.00410760791927483,-0.0175596944168661,-0.00145787137330881,0.0206301311107106
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA3G,Semaphorin-3G,37124,0.00967727888761336,0.00418502435112611,0.00147463115940618,0.0178799266158205,0.0207731388635697
NMR metabolomics,X23424.Total Lipids in VLDL,DCUN1D2,DCN1-like protein 2,36962,-0.0177315158361223,0.00768877357409418,-0.0328015120413469,-0.00266151963089769,0.0211174159244437
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,40052,0.00643111811820477,0.00279443662482056,0.00095402233355648,0.0119082139028531,0.0213816338373174
NMR metabolomics,X23424.Total Lipids in VLDL,NRTN,Neurturin,39587,0.0108824871834493,0.00473140832989775,0.00160892685684965,0.0201560475100488,0.0214582795710557
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC6A,C-type lectin domain family 6 member A,39477,0.010144741062067,0.00442947949042845,0.00146296126082721,0.0188265208633067,0.0220184512363381
NMR metabolomics,X23424.Total Lipids in VLDL,TFF2,Trefoil factor 2,39908,0.0124475350098682,0.00543682194543835,0.00179136399680901,0.0231037060229273,0.0220639741044905
NMR metabolomics,X23424.Total Lipids in VLDL,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.0185499532062207,0.00813010905063161,-0.0344849669454586,-0.00261493946698274,0.0225266804194149
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA10,Ephrin type-A receptor 10,39489,0.013886762895202,0.00611377531629224,0.00190376327526916,0.0258697625151347,0.0231369670105467
NMR metabolomics,X23424.Total Lipids in VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,0.0127606705770224,0.00563191029244929,0.00172212640382178,0.023799214750223,0.0234783067524079
NMR metabolomics,X23424.Total Lipids in VLDL,MMP8,Neutrophil collagenase,39985,0.015390713801669,0.00682915543746021,0.00200556914424696,0.028775858459091,0.0242298385328821
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.00807202216122176,0.00358445205114378,0.00104649614097995,0.0150975481814636,0.0243414490535471
NMR metabolomics,X23424.Total Lipids in VLDL,AIF1L,Allograft inflammatory factor 1-like,37043,0.0125495231257893,0.00559804575578506,0.00157735344445063,0.0235216928071281,0.0249928982362064
NMR metabolomics,X23424.Total Lipids in VLDL,ENO1,Alpha-enolase,39830,0.0167628401579293,0.00753454724164985,0.00199512756429563,0.0315305527515631,0.026108768486351
NMR metabolomics,X23424.Total Lipids in VLDL,COPE,Coatomer subunit epsilon,39489,0.0100251259501762,0.00450939079663403,0.00118671998877349,0.0188635319115789,0.0262188293323129
NMR metabolomics,X23424.Total Lipids in VLDL,CDH23,Cadherin-23,37388,-0.00569787063904911,0.00256465875265112,-0.0107246017942453,-0.000671139483852915,0.0263209057517579
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN4,Contactin-4,39858,-0.00504818887027658,0.00227452603785625,-0.00950625990447483,-0.000590117836078321,0.026470332511037
NMR metabolomics,X23424.Total Lipids in VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.0106356843123499,0.00479221584178429,0.00124294126245268,0.0200284273622471,0.0264787693238196
NMR metabolomics,X23424.Total Lipids in VLDL,DCUN1D1,DCN1-like protein 1,36991,-0.0158349276262347,0.00715555154917302,-0.0298598086626138,-0.00181004658985554,0.0269177456365942
NMR metabolomics,X23424.Total Lipids in VLDL,TMEM132A,Transmembrane protein 132A,37043,0.0132175609538067,0.00598752407053829,0.00148201377555166,0.0249531081320618,0.0272951220775809
NMR metabolomics,X23424.Total Lipids in VLDL,UNC5D,Netrin receptor UNC5D,37056,0.00560399090939862,0.00254253531964257,0.000620621682899189,0.0105873601358981,0.0275348222830796
NMR metabolomics,X23424.Total Lipids in VLDL,DUSP29,Dual specificity phosphatase 29,37039,-0.0139359772503138,0.00634240335455339,-0.0263670878252385,-0.00150486667538919,0.0280184567474982
NMR metabolomics,X23424.Total Lipids in VLDL,MAMDC2,MAM domain-containing protein 2,37437,-0.00692943062339848,0.00315590257063729,-0.0131149996618476,-0.000743861584949391,0.0281299324957688
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.00560132515260627,0.00255459411707541,0.000594320683138464,0.0106083296220741,0.0283469801812123
NMR metabolomics,X23424.Total Lipids in VLDL,SPINT1,Kunitz-type protease inhibitor 1,39794,0.00541508865217158,0.0024781700822813,0.000557875290900223,0.0102723020134429,0.0288948689742064
NMR metabolomics,X23424.Total Lipids in VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,-0.0173883605229596,0.00799419115642996,-0.0330569751895623,-0.00171974585635689,0.0296380785560488
NMR metabolomics,X23424.Total Lipids in VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,-0.00525465709636167,0.00242084122707469,-0.00999950590142808,-0.000509808291295273,0.029979409263708
NMR metabolomics,X23424.Total Lipids in VLDL,FDX2,"Ferredoxin-2, mitochondrial",37021,0.0116726072104473,0.00538493820660569,0.00111812832550015,0.0222270860953944,0.0302039595050185
NMR metabolomics,X23424.Total Lipids in VLDL,TEF,Thyrotroph embryonic factor,37021,0.00877516761999377,0.00405280594389377,0.00083166796996199,0.0167186672700256,0.0303896736143989
NMR metabolomics,X23424.Total Lipids in VLDL,PLB1,"Phospholipase B1, membrane-associated",37388,0.0123592008414593,0.00571681363351998,0.00115424611976016,0.0235641555631585,0.0306430733091729
NMR metabolomics,X23424.Total Lipids in VLDL,CRHR1,Corticotropin-releasing factor receptor 1,39585,0.0127647016752221,0.00591664779958901,0.00116807198802764,0.0243613313624166,0.0309879557909309
NMR metabolomics,X23424.Total Lipids in VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,0.00679189300740585,0.00315496911678649,0.000608153538504326,0.0129756324763074,0.0313523832333801
NMR metabolomics,X23424.Total Lipids in VLDL,PODXL2,Podocalyxin-like protein 2,39913,0.00561386765926708,0.00261888891297093,0.000480845389844056,0.0107468899286901,0.0320793978160615
NMR metabolomics,X23424.Total Lipids in VLDL,GAL,Galanin peptides,39931,-0.0131275445766994,0.00613468643775519,-0.0251515299946995,-0.0011035591586992,0.0323787969582162
NMR metabolomics,X23424.Total Lipids in VLDL,COL9A1,Collagen alpha-1(IX) chain,39866,0.00891150683365797,0.00416516988049576,0.000747773867886279,0.0170752397994297,0.0324078301708412
NMR metabolomics,X23424.Total Lipids in VLDL,IL36G,Interleukin-36 gamma,37021,0.0137689794671832,0.00644473460419663,0.00113729964295785,0.0264006592914086,0.0326595471261366
NMR metabolomics,X23424.Total Lipids in VLDL,CD33,Myeloid cell surface antigen CD33,39913,0.0159233501580589,0.0074809942860084,0.00126060135748246,0.0305860989586354,0.033310238387486
NMR metabolomics,X23424.Total Lipids in VLDL,VASN,Vasorin,39642,0.00553814994003861,0.00260641619865101,0.000429574190682621,0.0106467256893946,0.033617621855537
NMR metabolomics,X23424.Total Lipids in VLDL,CD27,CD27 antigen,39913,-0.00787921922192802,0.00370848446667354,-0.0151478487766082,-0.000610589667247873,0.0336313417177859
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.0059808946310393,0.00281651138534145,-0.0115012569463085,-0.000460532315770054,0.0337291099964787
NMR metabolomics,X23424.Total Lipids in VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,-0.0126870962443004,0.00598820483268472,-0.0244239777163625,-0.000950214772238379,0.0341360855951727
NMR metabolomics,X23424.Total Lipids in VLDL,LPA,Apolipoprotein(a),37186,-0.0355580093725571,0.0168011106519537,-0.0684881862503863,-0.00262783249472784,0.0343285876412059
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC12A,C-type lectin domain family 12 member A,37056,0.00406412047769318,0.00192479761269267,0.000291517156815559,0.00783672379857081,0.0347521087764132
NMR metabolomics,X23424.Total Lipids in VLDL,DDA1,DET1- and DDB1-associated protein 1,37021,0.00800199646614275,0.00379647188225368,0.000560911576925533,0.01544308135536,0.0350718707645623
NMR metabolomics,X23424.Total Lipids in VLDL,LIFR,Leukemia inhibitory factor receptor,39866,-0.00489117911768927,0.00232423053637777,-0.00944667096898971,-0.000335687266388832,0.0353565571286862
NMR metabolomics,X23424.Total Lipids in VLDL,GSAP,Gamma-secretase-activating protein,39477,0.017640295637433,0.00838669775442273,0.00120236803876444,0.0340782232361015,0.0354497341390585
NMR metabolomics,X23424.Total Lipids in VLDL,ESPL1,Separin,36962,-0.010812195259865,0.00514483388961953,-0.0208960696835193,-0.000728320836210702,0.0356105728831835
NMR metabolomics,X23424.Total Lipids in VLDL,MN1,Transcriptional activator MN1,37039,-0.0118294622118293,0.00564816395462458,-0.0228998635628935,-0.000759060860765128,0.0362442371734612
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G1B,Phospholipase A2,40031,-0.00812653301087675,0.00389402636583329,-0.01575882468791,-0.000494241333843508,0.0369107208394452
NMR metabolomics,X23424.Total Lipids in VLDL,SUMF1,Formylglycine-generating enzyme,37056,0.0136202075439285,0.00653234478742727,0.000816811760571093,0.026423603327286,0.0370847405320443
NMR metabolomics,X23424.Total Lipids in VLDL,SLC39A14,Zinc transporter ZIP14,39489,0.00648103586055794,0.00311239383214698,0.000380743949549865,0.012581327771566,0.0373284207712079
NMR metabolomics,X23424.Total Lipids in VLDL,CD209,CD209 antigen,39885,-0.0077008065666447,0.00370468297132385,-0.0149619851904394,-0.000439627942849945,0.0376637316546139
NMR metabolomics,X23424.Total Lipids in VLDL,IL31,Interleukin-31,37056,-0.0113996046354828,0.00548950145797314,-0.0221590274931102,-0.00064018177785548,0.0378560166673387
NMR metabolomics,X23424.Total Lipids in VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,36991,-0.014149078651863,0.00681448411397403,-0.0275054675152521,-0.00079268978847391,0.0378833775420135
NMR metabolomics,X23424.Total Lipids in VLDL,ID4,DNA-binding protein inhibitor ID-4,37169,-0.00877418967831725,0.00422602037509042,-0.0170571896134945,-0.000491189743140018,0.037891845114226
NMR metabolomics,X23424.Total Lipids in VLDL,TEX33,Testis-expressed protein 33,37169,-0.00785672849048377,0.00379094179090667,-0.0152869744006609,-0.000426482580306695,0.0382380021132292
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.00895270378107466,0.00432682753065153,0.000472121820997652,0.0174332857411517,0.0385512619618465
NMR metabolomics,X23424.Total Lipids in VLDL,ART5,Ecto-ADP-ribosyltransferase 5,36991,-0.0120870574316265,0.00587900737818248,-0.0236099118928642,-0.00056420297038883,0.0398052197191342
NMR metabolomics,X23424.Total Lipids in VLDL,TCN1,Transcobalamin-1,37235,0.00671009030813832,0.00326741061050281,0.000305965511552818,0.0131142151047238,0.0400297931962259
NMR metabolomics,X23424.Total Lipids in VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,0.00542885018107662,0.00265432847310181,0.000226366373797081,0.0106313339883562,0.040846856514843
NMR metabolomics,X23424.Total Lipids in VLDL,IL2RG,Cytokine receptor common subunit gamma,37368,0.00733481632974302,0.00359833934957544,0.00028207120457515,0.0143875614549109,0.0415304526978314
NMR metabolomics,X23424.Total Lipids in VLDL,PGM2,Phosphoglucomutase-2,37039,0.0117185357715487,0.00577871106162446,0.000392262090764761,0.0230448094523326,0.0425925176238132
NMR metabolomics,X23424.Total Lipids in VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,37388,0.00743914249118893,0.00367757039678298,0.000231104513494292,0.0146471804688836,0.0431091100981701
NMR metabolomics,X23424.Total Lipids in VLDL,TXNL1,Thioredoxin-like protein 1,36971,0.0188600745343157,0.00933758414982055,0.000558409600667428,0.037161739467964,0.0434241933039192
NMR metabolomics,X23424.Total Lipids in VLDL,FDX1,"Adrenodoxin, mitochondrial",37021,0.0122357060613863,0.0060673221463663,0.000343754654508329,0.0241276574682642,0.0437516185931749
NMR metabolomics,X23424.Total Lipids in VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,0.0100254050887171,0.00497145907160958,0.000281345308362295,0.0197694648690719,0.0437581442116209
NMR metabolomics,X23424.Total Lipids in VLDL,IL11,Interleukin-11,39587,0.0119234561358756,0.00593078192038942,0.000299123571912328,0.0235477886998388,0.0444021267712274
NMR metabolomics,X23424.Total Lipids in VLDL,PADI2,Protein-arginine deiminase type-2,39587,0.0109205649995333,0.00543209192933413,0.000273664818038376,0.0215674651810281,0.0444081029302373
NMR metabolomics,X23424.Total Lipids in VLDL,DDI2,Protein DDI1 homolog 2,37124,0.0144179356920913,0.00717847326417172,0.000348128094314731,0.0284877432898679,0.0446108294718259
NMR metabolomics,X23424.Total Lipids in VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,0.00946563543750297,0.00471666199064379,0.00022097793584114,0.0187102929391648,0.0447827746753622
NMR metabolomics,X23424.Total Lipids in VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,0.0285023570633508,0.0142230496204377,0.000625179807292982,0.0563795343194086,0.0450916579602772
NMR metabolomics,X23424.Total Lipids in VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.0229686950391303,0.0114709895488608,0.000485555523363181,0.0454518345548974,0.0452666172118805
NMR metabolomics,X23424.Total Lipids in VLDL,ENDOU,Poly(U)-specific endoribonuclease,36430,0.00990008152536693,0.00494458332864709,0.000208698201218637,0.0195914648495152,0.0452838696172862
NMR metabolomics,X23424.Total Lipids in VLDL,FRMD7,FERM domain-containing protein 7,37039,0.00640880789275112,0.00320839423147753,0.000120355199055167,0.0126972605864471,0.0457900474845952
NMR metabolomics,X23424.Total Lipids in VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,0.00926301540905092,0.00466430356906775,0.000120980413678131,0.0184050504044237,0.0470604434154607
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF8,SLAM family member 8,39477,0.00983529836241434,0.00495943096257954,0.000114813675758441,0.0195557830490702,0.0473681006693055
NMR metabolomics,X23424.Total Lipids in VLDL,SHPK,Sedoheptulokinase,37169,-0.00792691171362731,0.00399819331782511,-0.0157633706165645,-9.04528106900893e-05,0.0474300371406261
NMR metabolomics,X23424.Total Lipids in VLDL,FZD8,Frizzled-8,36991,0.00801143998583322,0.00406275585681917,4.84385064676452e-05,0.0159744414651988,0.0486394008812091
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS4,Galectin-4,39862,0.00986325628423624,0.00502614295783322,1.20160868831275e-05,0.0197144964815894,0.0497343148948065
NMR metabolomics,X23424.Total Lipids in VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,0.00913339417292997,0.00466297901423275,-6.04469496622885e-06,0.0182728330408262,0.0501691551839364
NMR metabolomics,X23424.Total Lipids in VLDL,ARG1,Arginase-1,39754,0.00964819587610158,0.00492956894762797,-1.37592612492327e-05,0.0193101510134524,0.0503403986434595
NMR metabolomics,X23424.Total Lipids in VLDL,RBP7,Retinoid-binding protein 7,37382,0.0111976795115093,0.00575718426445229,-8.64016468172038e-05,0.0224817606698358,0.0517965971751335
NMR metabolomics,X23424.Total Lipids in VLDL,GHRHR,Growth hormone-releasing hormone receptor,39489,0.00999821183186009,0.0051446876300363,-8.53759230110673e-05,0.0200817995867312,0.0519851677808731
NMR metabolomics,X23424.Total Lipids in VLDL,IL1A,Interleukin-1 alpha,39587,0.0098676878273561,0.00508905238239072,-0.000106854842129704,0.0198422304968419,0.0525188375064197
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA5,Annexin A5,39415,0.00558706210818627,0.00288363008027058,-6.48528491440674e-05,0.0112389770655166,0.0527011108952913
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,-0.00761115593136842,0.00393372912140561,-0.0153212650093234,9.8953146586582e-05,0.0530307263849505
NMR metabolomics,X23424.Total Lipids in VLDL,VCAN,Versican core protein,40009,-0.00545253923675257,0.00281823845118977,-0.0109762866010845,7.12081275793894e-05,0.0530404980055797
NMR metabolomics,X23424.Total Lipids in VLDL,MAPT,Microtubule-associated protein tau,39489,0.00969526560764816,0.00501855532349495,-0.000141102826401935,0.0195316340416982,0.0533919064980141
NMR metabolomics,X23424.Total Lipids in VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,0.014413481181358,0.00747852514734089,-0.000244428107430143,0.0290713904701461,0.053958252997018
NMR metabolomics,X23424.Total Lipids in VLDL,F3,Tissue factor,39931,-0.00497927247294533,0.00258858154354592,-0.0100528922982953,9.43473524046747e-05,0.0544283450828169
NMR metabolomics,X23424.Total Lipids in VLDL,BMP10,Bone morphogenetic protein 10,37124,0.00519049334432342,0.00270087116366612,-0.000103214136462167,0.010484200825109,0.054654232614249
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,-0.0092830272838045,0.00485132608637421,-0.0187916264130979,0.000225571845488952,0.0557053535077196
NMR metabolomics,X23424.Total Lipids in VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,-0.00959980412931505,0.00503853502187628,-0.0194753327721926,0.000275724513562461,0.0567660144635506
NMR metabolomics,X23424.Total Lipids in VLDL,FGF9,Fibroblast growth factor 9,36931,0.00735530042631858,0.00387413346350196,-0.000238001162145262,0.0149486020147824,0.0576434850058806
NMR metabolomics,X23424.Total Lipids in VLDL,S100G,Protein S100-G,37411,-0.00810509363560741,0.00428929325427331,-0.0165121084139831,0.00030192114276829,0.0588313959753912
NMR metabolomics,X23424.Total Lipids in VLDL,HSP90B1,Endoplasmin,39405,0.0121433789058062,0.00642729663959231,-0.000454122507794696,0.0247408803194072,0.058864247463469
NMR metabolomics,X23424.Total Lipids in VLDL,EPN1,Epsin-1,37169,0.00776766632848452,0.00411184160142513,-0.000291543210308728,0.0158268758672778,0.0589005947866631
NMR metabolomics,X23424.Total Lipids in VLDL,SCARB1,Scavenger receptor class B member 1,39489,0.0102393579002555,0.00543153159070417,-0.00040644401752467,0.0208851598180357,0.0594254862784781
NMR metabolomics,X23424.Total Lipids in VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,0.0155626105657986,0.00826767252488865,-0.000642027582983162,0.0317672487145804,0.0598113542777951
NMR metabolomics,X23424.Total Lipids in VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,-0.00847136735197969,0.00450529929211575,-0.0173017539645266,0.000359019260567185,0.0600876338658126
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB116,Beta-defensin 116,36991,-0.0138620857059557,0.00738671811176465,-0.0283400532050144,0.000615881793102997,0.0605919300089506
NMR metabolomics,X23424.Total Lipids in VLDL,IL20,Interleukin-20,39587,0.00871650736185803,0.00465370956495808,-0.000404763385459802,0.0178377781091759,0.0610836752497661
NMR metabolomics,X23424.Total Lipids in VLDL,PLAU,Urokinase-type plasminogen activator,39858,0.00509046230587127,0.00272666968813465,-0.000253810282872651,0.0104347348946152,0.0619316453498531
NMR metabolomics,X23424.Total Lipids in VLDL,CNTNAP2,Contactin-associated protein-like 2,39866,0.00727867462347563,0.00390366199711473,-0.000372502890869245,0.0149298521378205,0.0622591431446812
NMR metabolomics,X23424.Total Lipids in VLDL,GSN,Gelsolin,37383,0.00331215276881101,0.00178051238756883,-0.000177651510823888,0.00680195704844591,0.0628754635295442
NMR metabolomics,X23424.Total Lipids in VLDL,ABO,Histo-blood group ABO system transferase,37445,0.0254446509404911,0.0136967570217886,-0.00140099282221462,0.0522902947031968,0.063231326021149
NMR metabolomics,X23424.Total Lipids in VLDL,PPM1B,Protein phosphatase 1B,37056,0.0112759210841301,0.00609156271201341,-0.000663541831416137,0.0232153839996764,0.0641815270735622
NMR metabolomics,X23424.Total Lipids in VLDL,SIRPB1,Signal-regulatory protein beta-1,39835,0.00780645894050114,0.00421950470831983,-0.000463770287805714,0.016076688168808,0.0643191870429516
NMR metabolomics,X23424.Total Lipids in VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,0.0101820033291771,0.00550664595070203,-0.000611022734198921,0.020975029392553,0.064474637486542
NMR metabolomics,X23424.Total Lipids in VLDL,AMIGO1,Amphoterin-induced protein 1,37039,0.0087910001523956,0.00476696789823046,-0.000552256928136105,0.0181342572329273,0.0651838266848442
NMR metabolomics,X23424.Total Lipids in VLDL,IL36A,Interleukin-36 alpha,37056,-0.0103582223834559,0.0056228171695338,-0.0213789440357422,0.000662499268830306,0.0654717401203085
NMR metabolomics,X23424.Total Lipids in VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,-0.00568451231063756,0.00309379901581997,-0.0117483583816447,0.00037933376036957,0.0661750708186478
NMR metabolomics,X23424.Total Lipids in VLDL,SAT1,Diamine acetyltransferase 1,37021,-0.0086952478979432,0.00474664220216495,-0.0179986666141865,0.00060817081830011,0.0669928618696914
NMR metabolomics,X23424.Total Lipids in VLDL,SOD3,Extracellular superoxide dismutase,37445,-0.0106383164879168,0.00581523301852215,-0.0220361732042202,0.000759540228386648,0.0673634363540672
NMR metabolomics,X23424.Total Lipids in VLDL,JUN,Transcription factor AP-1,39587,0.00902352051384322,0.00494745145554031,-0.000673484339015786,0.0187205253667022,0.0681903225852688
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.00440753225886707,0.00242014366067079,-0.000335949316047686,0.00915101383378182,0.0686013858831293
NMR metabolomics,X23424.Total Lipids in VLDL,COMMD9,COMM domain-containing protein 9,37368,0.00679341894151688,0.00374812126879921,-0.000552898745329582,0.0141397366283633,0.0699332596864685
NMR metabolomics,X23424.Total Lipids in VLDL,MMP9,Matrix metalloproteinase-9,39843,0.010450810328322,0.00577443416667645,-0.000867080638363799,0.0217687012950079,0.0703391524846357
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA10,Annexin A10,39489,0.013500026365168,0.00746894911418147,-0.00113911389862766,0.0281391666289637,0.0707056417554532
NMR metabolomics,X23424.Total Lipids in VLDL,FGF12,Fibroblast growth factor 12,37056,0.00808410893301979,0.00447750606692591,-0.000691802958154998,0.0168600208241946,0.0710202434532093
NMR metabolomics,X23424.Total Lipids in VLDL,SLC12A2,Solute carrier family 12 member 2,37021,-0.00477848509077317,0.00266173573340215,-0.00999548712824138,0.000438516946695045,0.0726365713385965
NMR metabolomics,X23424.Total Lipids in VLDL,HLA_DRA,,39799,-0.00606412888137775,0.0033798214515365,-0.0126885789263893,0.000560321163633789,0.0727976837240203
NMR metabolomics,X23424.Total Lipids in VLDL,HEBP1,Heme-binding protein 1,39585,-0.00916480057632186,0.0051235737939426,-0.0192070052124494,0.000877404059805638,0.0736740790204109
NMR metabolomics,X23424.Total Lipids in VLDL,LEG1,Protein LEG1 homolog,36703,-0.0119468955166653,0.00668247370561932,-0.0250445439796792,0.00115075294634855,0.0738325980581023
NMR metabolomics,X23424.Total Lipids in VLDL,GH2,Growth hormone variant,39477,0.0279848333464717,0.0156660833194505,-0.00272068995965124,0.0586903566525946,0.0740648353706432
NMR metabolomics,X23424.Total Lipids in VLDL,RELB,Transcription factor RelB,37056,0.00837499136188872,0.0046997941079752,-0.000836605089742669,0.0175865878135201,0.0747736681259332
NMR metabolomics,X23424.Total Lipids in VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.00520279520646343,0.00292899767644696,-0.000538040239372609,0.0109436306522995,0.0757015367951096
NMR metabolomics,X23424.Total Lipids in VLDL,TAP1,Antigen peptide transporter 1,37169,-0.00996237141976777,0.00561631753317732,-0.0209703537847953,0.00104561094525979,0.0761147563256811
NMR metabolomics,X23424.Total Lipids in VLDL,CYB5A,Cytochrome b5,36962,0.0121528258145778,0.00685314442767899,-0.001279337263673,0.0255849888928287,0.0761987353491487
NMR metabolomics,X23424.Total Lipids in VLDL,ACE,Angiotensin-converting enzyme,37445,-0.00434175068246696,0.00244851017307629,-0.00914083062169648,0.000457329256762562,0.0762144248114647
NMR metabolomics,X23424.Total Lipids in VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,0.00784299956127871,0.00442568569128167,-0.000831344393633356,0.0165173435161908,0.0763920170107412
NMR metabolomics,X23424.Total Lipids in VLDL,TLR4,Toll-like receptor 4,37056,0.00466822854236527,0.00263443734805127,-0.000495268659815226,0.00983172574454576,0.0764172775841588
NMR metabolomics,X23424.Total Lipids in VLDL,JCHAIN,Immunoglobulin J chain,39587,-0.0102177938971665,0.00577063813662848,-0.0215282446449583,0.00109265685062534,0.0766379002345018
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,0.00538719547808411,0.00304281853146687,-0.000576728843590957,0.0113511197997592,0.0766726388398067
NMR metabolomics,X23424.Total Lipids in VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,0.00444110928525549,0.00250953662602554,-0.000477582501754564,0.00935980107226554,0.0768015593751195
NMR metabolomics,X23424.Total Lipids in VLDL,TAGLN3,Transgelin-3,36962,-0.0101046160938341,0.00571871227590148,-0.021313292154601,0.00110405996693275,0.0772617118556415
NMR metabolomics,X23424.Total Lipids in VLDL,TTN,Titin,37021,-0.0115425826747151,0.00653610555717212,-0.0243533495667724,0.00126818421734231,0.0774236430990713
NMR metabolomics,X23424.Total Lipids in VLDL,NGF,Beta-nerve growth factor,39749,0.00206755974229104,0.00117197600912227,-0.000229513235588613,0.00436463272017069,0.0777233174658956
NMR metabolomics,X23424.Total Lipids in VLDL,HLA_A,,37411,0.00543461943740038,0.00308245068120366,-0.000606983897758787,0.0114762227725595,0.077908861047196
NMR metabolomics,X23424.Total Lipids in VLDL,UNG,Uracil-DNA glycosylase,37368,0.00583912244936394,0.00331188047896014,-0.000652163289397935,0.0123304081881258,0.0779089832289202
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN15,Tetraspanin-15,37021,-0.00830163970528352,0.0047182622658783,-0.017549433746405,0.000946154335837937,0.0785209861560675
NMR metabolomics,X23424.Total Lipids in VLDL,REG1A,Lithostathine-1-alpha,39804,-0.00773070743400819,0.00442731973655233,-0.0164082541176508,0.000946839249634363,0.0808063828104978
NMR metabolomics,X23424.Total Lipids in VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,-0.00782528529147934,0.00452080484946338,-0.0166860627964276,0.00103549221346889,0.083484193468285
NMR metabolomics,X23424.Total Lipids in VLDL,MYL4,Myosin light chain 4,37043,-0.00857148569460965,0.0049567489229631,-0.0182867135836173,0.00114374219439803,0.0837867737999929
NMR metabolomics,X23424.Total Lipids in VLDL,IGLC2,Immunoglobulin lambda constant 2,37422,-0.00402059475940899,0.00233028106270477,-0.00858794564231034,0.000546756123492367,0.0844837704139828
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN5,Contactin-5,39897,0.00590367285612062,0.00343158738512542,-0.0008222384187252,0.0126295841309664,0.0853806401603749
NMR metabolomics,X23424.Total Lipids in VLDL,CSH1,Chorionic somatomammotropin hormone 1,37445,0.00571261045371137,0.0033233817563967,-0.000801217788826167,0.0122264386962489,0.085652648475342
NMR metabolomics,X23424.Total Lipids in VLDL,DNLZ,DNL-type zinc finger protein,36991,-0.0146633355837841,0.00857256127137817,-0.0314655556756853,0.00213888450811709,0.0871977313935563
NMR metabolomics,X23424.Total Lipids in VLDL,TUBB3,Tubulin beta-3 chain,36991,-0.00457937940684483,0.00268664572840145,-0.00984520503451167,0.000686446220822017,0.0883119449985703
NMR metabolomics,X23424.Total Lipids in VLDL,CD48,CD48 antigen,39908,0.00469566525080714,0.00275854934431394,-0.000711091464048183,0.0101024219656625,0.0887330005488869
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD5,Sushi domain-containing protein 5,37064,-0.0054947147558216,0.00323587029689703,-0.0118370205377398,0.000847591026096586,0.0895192514442211
NMR metabolomics,X23424.Total Lipids in VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,-0.0109503895591347,0.0064546722503516,-0.0236015471698238,0.00170076805155442,0.0898137613912992
NMR metabolomics,X23424.Total Lipids in VLDL,SPESP1,Sperm equatorial segment protein 1,37437,0.00471921836242667,0.00278567578368449,-0.000740706173594923,0.0101791428984483,0.0902688759911831
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP3L,Microfibrillar-associated protein 3-like,37039,-0.0104202564818064,0.0061516712551651,-0.0224775321419299,0.00163701917831723,0.0903097535479708
NMR metabolomics,X23424.Total Lipids in VLDL,GUK1,Guanylate kinase,37021,-0.00670530703648056,0.0039592563618445,-0.0144654495056958,0.00105483543273466,0.090369282037526
NMR metabolomics,X23424.Total Lipids in VLDL,PTTG1,Securin,37169,0.00673608019028827,0.00398440104087691,-0.00107334584983046,0.014545506230407,0.090934156568283
NMR metabolomics,X23424.Total Lipids in VLDL,CHL1,Neural cell adhesion molecule L1-like protein,39900,-0.0050123358032049,0.00296919366505197,-0.0108319553867068,0.00080728378029696,0.0914088903378209
NMR metabolomics,X23424.Total Lipids in VLDL,MKI67,Proliferation marker protein Ki-67,37056,0.00632408658449108,0.00375468584131339,-0.00103509766448317,0.0136832708334653,0.0921437932899474
NMR metabolomics,X23424.Total Lipids in VLDL,KEL,Kell blood group glycoprotein,39489,0.00567286769265554,0.00338225679830803,-0.0009563556320282,0.0123020910173393,0.0935149037779305
NMR metabolomics,X23424.Total Lipids in VLDL,NLGN2,Neuroligin-2,36991,-0.00753580892749253,0.00449895900376816,-0.0163537685748781,0.00128215071989306,0.0939557493913623
NMR metabolomics,X23424.Total Lipids in VLDL,RGMA,Repulsive guidance molecule A,40009,-0.00494144343277281,0.00295156204475955,-0.0107265050405015,0.0008436181749559,0.0941147740459041
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBR3,Transforming growth factor beta receptor type 3,40052,-0.00503737054911543,0.0030123801527625,-0.0109416356485299,0.00086689455029907,0.0944997314370376
NMR metabolomics,X23424.Total Lipids in VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,37056,-0.00960290863781649,0.00574792616717017,-0.02086884392547,0.00166302664983704,0.0948098756400505
NMR metabolomics,X23424.Total Lipids in VLDL,ADA2,Adenosine deaminase 2,39782,-0.00656198119723227,0.00393199553310444,-0.014268692442117,0.00114473004765244,0.095163219786848
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.0074147487697645,0.00447645636689883,-0.0161886032488862,0.0013591057093572,0.0976670607476512
NMR metabolomics,X23424.Total Lipids in VLDL,CD160,CD160 antigen,40058,0.00705414899830647,0.00427309541477358,-0.00132111801464974,0.0154294160112627,0.0987929228180008
NMR metabolomics,X23424.Total Lipids in VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,-0.0110888146597995,0.00673630032361267,-0.0242919632940803,0.00211433397448131,0.0997568346912331
NMR metabolomics,X23424.Total Lipids in VLDL,SEZ6L2,Seizure 6-like protein 2,39788,-0.00376399197149991,0.00228867612749678,-0.0082497971813936,0.000721813238393774,0.100068885763661
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,39858,-0.0052080259901545,0.00317062773069312,-0.011422456342313,0.00100640436200401,0.100488450958688
NMR metabolomics,X23424.Total Lipids in VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,0.00890228084659293,0.00542887696828362,-0.00173831801124297,0.0195428797044288,0.101070443472834
NMR metabolomics,X23424.Total Lipids in VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.00731218589005795,0.00446428259086195,-0.00143780798803146,0.0160621797681474,0.101459292476349
NMR metabolomics,X23424.Total Lipids in VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,-0.00326971430900604,0.0020000192048803,-0.00718975195057142,0.000650323332559335,0.102106163298749
NMR metabolomics,X23424.Total Lipids in VLDL,DHODH,Dihydroorotate dehydrogenase,37021,0.00721612878148926,0.00443565532440218,-0.00147775565433902,0.0159100132173175,0.103793717179584
NMR metabolomics,X23424.Total Lipids in VLDL,LTO1,Protein LTO1 homolog,39587,0.00621058398335791,0.00384593195317869,-0.00132744264487232,0.0137486106115881,0.106364325600613
NMR metabolomics,X23424.Total Lipids in VLDL,SHD,SH2 domain-containing adapter protein D,37002,0.0128058309098754,0.00794785080504342,-0.0027719566680097,0.0283836184877605,0.107153197471001
NMR metabolomics,X23424.Total Lipids in VLDL,LY96,Lymphocyte antigen 96,39749,-0.00542379091853212,0.00336783861582275,-0.0120247546055447,0.00117717276848047,0.107315939856705
NMR metabolomics,X23424.Total Lipids in VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,-0.00936709456681046,0.00584489853605958,-0.0208230956974872,0.00208890656386631,0.109044772037214
NMR metabolomics,X23424.Total Lipids in VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,37169,0.00662628056476159,0.00415204342928106,-0.00151172455662929,0.0147642856861525,0.110533011323914
NMR metabolomics,X23424.Total Lipids in VLDL,RASA1,Ras GTPase-activating protein 1,39489,0.00496487510742692,0.00311206346773355,-0.00113476928933084,0.0110645195041847,0.110651002717479
NMR metabolomics,X23424.Total Lipids in VLDL,H2AP,Huntingtin-interacting protein M,36962,-0.00763364102678759,0.00479069893990651,-0.0170234109490043,0.00175612889542917,0.111087993710497
NMR metabolomics,X23424.Total Lipids in VLDL,NXPE4,NXPE family member 4,37021,-0.00529728588547035,0.00333948682412327,-0.011842680060752,0.00124810828981126,0.112704942227162
NMR metabolomics,X23424.Total Lipids in VLDL,ENPEP,Glutamyl aminopeptidase,37021,0.00631293455953844,0.0040030286573638,-0.00153300160889461,0.0141588707279715,0.114810456582132
NMR metabolomics,X23424.Total Lipids in VLDL,SLC44A4,Choline transporter-like protein 4,37039,-0.0101677172357927,0.00647178322365132,-0.0228524123541493,0.00251697788256388,0.116187067195758
NMR metabolomics,X23424.Total Lipids in VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,-0.00986880857867441,0.00629931068588415,-0.0222154575230073,0.00247784036565852,0.117220862091228
NMR metabolomics,X23424.Total Lipids in VLDL,PCNA,Proliferating cell nuclear antigen,36962,0.00957226190621528,0.00611351175565175,-0.00241022113486215,0.0215547449472927,0.117430123443727
NMR metabolomics,X23424.Total Lipids in VLDL,CDSN,Corneodesmosin,39992,0.00629718276988881,0.00403168663218062,-0.0016049230291852,0.0141992885689628,0.11832582162519
NMR metabolomics,X23424.Total Lipids in VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,-0.00446301279193317,0.00286582993739552,-0.0100800394692284,0.00115401388536206,0.119418752004053
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,0.00728099501157576,0.00467986273964226,-0.00189153595812306,0.0164535259812746,0.119776421592646
NMR metabolomics,X23424.Total Lipids in VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,0.00473234761996865,0.00304576456395067,-0.00123735092537468,0.010702046165312,0.120268871976872
NMR metabolomics,X23424.Total Lipids in VLDL,CTNNA1,Catenin alpha-1,36991,-0.00520479358716224,0.00335255189941481,-0.0117757953100153,0.00136620813569079,0.120569816065952
NMR metabolomics,X23424.Total Lipids in VLDL,SMC3,Structural maintenance of chromosomes protein 3,36962,0.00784553007410486,0.0050587875396407,-0.00206969350359091,0.0177607536518006,0.120956603638377
NMR metabolomics,X23424.Total Lipids in VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,0.00691239907904176,0.00446240945104909,-0.00183392344501446,0.015658721603098,0.121398931907525
NMR metabolomics,X23424.Total Lipids in VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.00712883363768466,0.00460855443482321,-0.0161616003299381,0.00190393305456882,0.12191865789728
NMR metabolomics,X23424.Total Lipids in VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,-0.00376647361660195,0.00243735849426508,-0.0085436962653615,0.00101074903215759,0.122294687789424
NMR metabolomics,X23424.Total Lipids in VLDL,MORF4L1,Mortality factor 4-like protein 1,37169,-0.0059384857226401,0.00385086654275353,-0.013486184146437,0.00160921270115681,0.12306900494838
NMR metabolomics,X23424.Total Lipids in VLDL,DDX1,ATP-dependent RNA helicase DDX1,37382,0.00728306328790546,0.00478114818267007,-0.00208798715012788,0.0166541137259388,0.127710176690934
NMR metabolomics,X23424.Total Lipids in VLDL,RAP1A,Ras-related protein Rap-1A,37056,-0.00989389833568169,0.00649714592213387,-0.0226283043430641,0.0028405076717007,0.12783099701008
NMR metabolomics,X23424.Total Lipids in VLDL,SPARCL1,SPARC-like protein 1,39871,-0.00394984453265393,0.00259532643357204,-0.00903668434245514,0.00113699527714727,0.128052223404958
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF1,Signaling lymphocytic activation molecule,39587,-0.00849156143493327,0.00558260003598784,-0.0194334575054694,0.0024503346356029,0.128260757911022
NMR metabolomics,X23424.Total Lipids in VLDL,NOP56,Nucleolar protein 56,37021,0.0160313092102075,0.0105455266380181,-0.00463792300030784,0.0367005414207229,0.128484749023433
NMR metabolomics,X23424.Total Lipids in VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,-0.00439933390493196,0.00290423754950777,-0.0100916395019672,0.00129297169210328,0.129843746382194
NMR metabolomics,X23424.Total Lipids in VLDL,HDAC8,Histone deacetylase 8,37056,0.00914076142155663,0.0060380126063119,-0.0026937432868147,0.020975266129928,0.13008296213731
NMR metabolomics,X23424.Total Lipids in VLDL,ZP3,Zona pellucida sperm-binding protein 3,37043,-0.0372855484675929,0.0246580548443628,-0.0856153359625441,0.0110442390273582,0.130531324951724
NMR metabolomics,X23424.Total Lipids in VLDL,REST,RE1-silencing transcription factor,36962,-0.00513866189221705,0.00341310305958925,-0.011828343889012,0.00155102010457788,0.132201978193584
NMR metabolomics,X23424.Total Lipids in VLDL,PSAPL1,Proactivator polypeptide-like 1,37382,0.00714962341125403,0.00475010984102497,-0.00216059187715492,0.016459838699663,0.132309112581906
NMR metabolomics,X23424.Total Lipids in VLDL,S100A3,Protein S100-A3,37368,0.00647929744798709,0.00430975496687189,-0.00196782228708181,0.014926417183056,0.132758596981213
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,-0.00478812518054475,0.00319708539777329,-0.0110544125601804,0.00147816219909091,0.134247358622793
NMR metabolomics,X23424.Total Lipids in VLDL,CDAN1,Codanin-1,37388,0.00321820659987072,0.00215260595405101,-0.00100090107006926,0.0074373142698107,0.134930408678745
NMR metabolomics,X23424.Total Lipids in VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,-0.00700197917301503,0.00469034098075536,-0.0161950474952955,0.00219108914926548,0.135495944158963
NMR metabolomics,X23424.Total Lipids in VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,-0.00407443899920036,0.00274865636587152,-0.00946180547630855,0.00131292747790783,0.13827426156464
NMR metabolomics,X23424.Total Lipids in VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.00772444730944371,0.00521338321665978,-0.00249378379520947,0.0179426784140969,0.138451538482418
NMR metabolomics,X23424.Total Lipids in VLDL,TCP11,T-complex protein 11 homolog,37169,-0.00840012408848502,0.00568553781220221,-0.0195437782004014,0.00274353002343132,0.139577477323791
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD4,Sushi domain-containing protein 4,37368,0.00583455451127159,0.00398648252705972,-0.00197895124176546,0.0136480602643087,0.143330746191078
NMR metabolomics,X23424.Total Lipids in VLDL,HCG22,Protein PBMUCL2,37021,-0.00755186001970916,0.00517805613465561,-0.0177008500436342,0.00259713000421583,0.144744450684093
NMR metabolomics,X23424.Total Lipids in VLDL,IL9,Interleukin-9,37169,-0.00797157413424221,0.00546767532022344,-0.0186882177618801,0.00274506949339572,0.144879085618335
NMR metabolomics,X23424.Total Lipids in VLDL,CHRDL2,Chordin-like protein 2,39868,0.00777792319283773,0.00536772126559936,-0.00274281048773703,0.0182986568734125,0.147352223972811
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBR1,TGF-beta receptor type-1,37056,0.00299686998415969,0.00208077868135372,-0.0010814562312936,0.00707519619961297,0.149816533607709
NMR metabolomics,X23424.Total Lipids in VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,-0.00664213820463595,0.00461280892415271,-0.0156832436959753,0.00239896728670337,0.149909960635142
NMR metabolomics,X23424.Total Lipids in VLDL,GAMT,Guanidinoacetate N-methyltransferase,37021,-0.0050597022888492,0.00352029765784202,-0.0119594856982196,0.00184008112052116,0.150658279608528
NMR metabolomics,X23424.Total Lipids in VLDL,ACTN4,Alpha-actinin-4,39587,0.00429354002165857,0.00299273788777351,-0.00157222623837751,0.0101593062816947,0.151405922683462
NMR metabolomics,X23424.Total Lipids in VLDL,AIDA,"Axin interactor, dorsalization-associated protein",37039,0.0115800767351788,0.0080811638163148,-0.00425900434479824,0.0274191578151558,0.151889727290274
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4C,C-type lectin domain family 4 member C,39866,0.00625508631210904,0.00438299386580179,-0.00233558166486248,0.0148457542890806,0.153562967613172
NMR metabolomics,X23424.Total Lipids in VLDL,MMP13,Collagenase 3,39489,-0.00436407637480146,0.00305861304549773,-0.010358957943977,0.0016308051943741,0.153653070491586
NMR metabolomics,X23424.Total Lipids in VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,0.00486064855409905,0.00342182270827397,-0.00184612395411793,0.011567421062316,0.155489896767137
NMR metabolomics,X23424.Total Lipids in VLDL,IL22,Interleukin-22,37368,-0.00887822931684026,0.0062509454953083,-0.0211300824876445,0.00337362385396402,0.15554290890763
NMR metabolomics,X23424.Total Lipids in VLDL,CCNE1,G1/S-specific cyclin-E1,37056,0.0129509548591171,0.00914110212918615,-0.00496560531408778,0.0308675150323219,0.156570091633103
NMR metabolomics,X23424.Total Lipids in VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00696909716456859,0.00492747949673802,-0.0166269569781751,0.00268876264903794,0.157287757324428
NMR metabolomics,X23424.Total Lipids in VLDL,HIP1,Huntingtin-interacting protein 1,37021,0.00453206224047799,0.00320543408081414,-0.00175058855791772,0.0108147130388737,0.157424172730633
NMR metabolomics,X23424.Total Lipids in VLDL,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.0131566822656043,0.00930727060577111,-0.0313989326529156,0.0050855681217071,0.157505414901318
NMR metabolomics,X23424.Total Lipids in VLDL,EDNRB,Endothelin receptor type B,37056,0.00627956975332017,0.00445679679398993,-0.00245575196290009,0.0150148914695404,0.158862508021223
NMR metabolomics,X23424.Total Lipids in VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.011232518628308,0.00798321792663977,-0.026879625764522,0.00441458850790592,0.159446243086169
NMR metabolomics,X23424.Total Lipids in VLDL,CPLX2,Complexin-2,36962,-0.00402428272136825,0.00286866799201744,-0.00964687198572243,0.00159830654298593,0.160688197847771
NMR metabolomics,X23424.Total Lipids in VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",36962,0.0123662373597834,0.00886526494899836,-0.00500968194025338,0.0297421566598202,0.163066946113252
NMR metabolomics,X23424.Total Lipids in VLDL,TJP3,Tight junction protein ZO-3,36991,-0.00573684892072879,0.00414768429292776,-0.0138663101348672,0.00239261229340961,0.166643916978399
NMR metabolomics,X23424.Total Lipids in VLDL,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.00824641844616207,0.0059663699823522,-0.00344766671924824,0.0199405036115724,0.166949095937094
NMR metabolomics,X23424.Total Lipids in VLDL,MET,Hepatocyte growth factor receptor,39879,-0.0025385201875787,0.0018604596506648,-0.00618502110288171,0.00110798072772431,0.172442439686609
NMR metabolomics,X23424.Total Lipids in VLDL,ZNF75D,Zinc finger protein 75D,37169,0.0077095082788859,0.00565192503353854,-0.00336826478684964,0.0187872813446214,0.172574900021808
NMR metabolomics,X23424.Total Lipids in VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,-0.00765050486118857,0.00561143793719363,-0.0186489232180881,0.00334791349571094,0.172787131741407
NMR metabolomics,X23424.Total Lipids in VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,36991,-0.00636197573705013,0.00466723762697426,-0.0155097614859197,0.00278581001181942,0.172870039550353
NMR metabolomics,X23424.Total Lipids in VLDL,PROK1,Prokineticin-1,39866,0.00839582847031853,0.00617032833585761,-0.00369801506796239,0.0204896720085994,0.173634708431469
NMR metabolomics,X23424.Total Lipids in VLDL,CBX2,Chromobox protein homolog 2,37021,-0.00525487858060169,0.00386573274348351,-0.0128317147578294,0.00232195759662599,0.174059425472671
NMR metabolomics,X23424.Total Lipids in VLDL,IGLON5,IgLON family member 5,36962,0.0119048813661397,0.00881928244312242,-0.00538091222238021,0.0291906749546597,0.17708113095032
NMR metabolomics,X23424.Total Lipids in VLDL,KRT14,"Keratin, type I cytoskeletal 14",39064,0.00371790667230017,0.00276431513635869,-0.00170015099496286,0.00913596433956319,0.17865664985497
NMR metabolomics,X23424.Total Lipids in VLDL,CLNS1A,Methylosome subunit pICln,37039,-0.00430379591167478,0.00321472905750538,-0.0106046648643853,0.00199707304103576,0.180667326023074
NMR metabolomics,X23424.Total Lipids in VLDL,KLK14,Kallikrein-14,40030,-0.0057486976172129,0.00430193791569748,-0.01418049593198,0.00268310069755415,0.181468674609884
NMR metabolomics,X23424.Total Lipids in VLDL,NRXN3,Neurexin-3,37039,0.00447378973371215,0.00334882634766394,-0.00208990990770916,0.0110374893751335,0.181595988235978
NMR metabolomics,X23424.Total Lipids in VLDL,PCARE,Photoreceptor cilium actin regulator,36991,-0.0108654408209669,0.00813990800339283,-0.0268196605076168,0.0050887788656831,0.181953227970394
NMR metabolomics,X23424.Total Lipids in VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,-0.0108336756521764,0.00812534954155159,-0.0267593607536175,0.00509200944926468,0.182450511613597
NMR metabolomics,X23424.Total Lipids in VLDL,MUCL3,Mucin-like protein 3,36962,-0.00573277357977632,0.00430110062771621,-0.0141629308101001,0.00269738365054744,0.182600272054124
NMR metabolomics,X23424.Total Lipids in VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,-0.008384548347675,0.0063012780315045,-0.0207350532894238,0.00396595659407382,0.183340277318021
NMR metabolomics,X23424.Total Lipids in VLDL,PAPPA,Pappalysin-1,39587,0.00597487038957134,0.00452322839497276,-0.00289065726457527,0.014840398043718,0.186543754875117
NMR metabolomics,X23424.Total Lipids in VLDL,GLI2,Zinc finger protein GLI2,37056,-0.00434142433190437,0.00328723634813731,-0.0107844075742535,0.00210155891044475,0.186627230929001
NMR metabolomics,X23424.Total Lipids in VLDL,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.0215385885861222,0.0163653390679416,-0.0105374759870433,0.0536146531592878,0.188156198967737
NMR metabolomics,X23424.Total Lipids in VLDL,SPRR1B,Cornifin-B,37169,0.0110138245395061,0.00836947920768275,-0.00539035470755211,0.0274180037865643,0.188213154640227
NMR metabolomics,X23424.Total Lipids in VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,-0.00509377969952097,0.00388615657398361,-0.0127106465845288,0.00252308718548691,0.189965166129119
NMR metabolomics,X23424.Total Lipids in VLDL,IL33,Interleukin-33,39587,0.00487662322822107,0.00373092033110942,-0.00243598062075339,0.0121892270771955,0.191203571677496
NMR metabolomics,X23424.Total Lipids in VLDL,GBP6,Guanylate-binding protein 6,37021,-0.00574987372240519,0.00441322642100075,-0.0143997975075667,0.00290005006275627,0.192640904580597
NMR metabolomics,X23424.Total Lipids in VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,-0.00629988556017355,0.00485492638363643,-0.0158155412721009,0.00321577015175385,0.194438140799655
NMR metabolomics,X23424.Total Lipids in VLDL,KIF20B,Kinesin-like protein KIF20B,36991,0.00928310149177144,0.00716941732560977,-0.00476895646642372,0.0233351594499666,0.19540526364654
NMR metabolomics,X23424.Total Lipids in VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,-0.00696259803705328,0.00538432817679154,-0.0175158812635647,0.00359068518945815,0.195991307377478
NMR metabolomics,X23424.Total Lipids in VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,0.00442172598703835,0.00344913519393597,-0.00233857899307614,0.0111820309671528,0.19987126029495
NMR metabolomics,X23424.Total Lipids in VLDL,GDF15,Growth/differentiation factor 15,40052,0.00516690743705424,0.0040421108854298,-0.00275562989838818,0.0130894447724966,0.201172708135315
NMR metabolomics,X23424.Total Lipids in VLDL,TCN2,Transcobalamin-2,40012,0.00353318377875651,0.00278848950399702,-0.00193225564907764,0.00899862320659066,0.205152071131521
NMR metabolomics,X23424.Total Lipids in VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,-0.00443405539250502,0.00350496680993577,-0.0113037903399791,0.00243567955496909,0.205865870002585
NMR metabolomics,X23424.Total Lipids in VLDL,ART3,Ecto-ADP-ribosyltransferase 3,39931,-0.00396438138715975,0.00314564391914045,-0.010129843468675,0.00220108069435554,0.207587900941973
NMR metabolomics,X23424.Total Lipids in VLDL,PPT1,Palmitoyl-protein thioesterase 1,37039,0.00938829226034744,0.00745779442412119,-0.00522898481093009,0.024005569331625,0.208104501238937
NMR metabolomics,X23424.Total Lipids in VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,-0.020299479920862,0.0162629767010646,-0.0521749142549487,0.0115759544132247,0.211978706765429
NMR metabolomics,X23424.Total Lipids in VLDL,ESR1,Estrogen receptor,37056,0.00708675942893281,0.00568039510612712,-0.00404681497907635,0.018220333836942,0.212206264729776
NMR metabolomics,X23424.Total Lipids in VLDL,KLK12,Kallikrein-12,39477,-0.0163348933169636,0.0131298162526187,-0.0420693331720963,0.00939954653816898,0.213478941230723
NMR metabolomics,X23424.Total Lipids in VLDL,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.00636125412441366,0.00518440548554747,-0.0165226888760867,0.00380018062725938,0.219845154913682
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB7,Integrin beta-7,40030,0.00531515714644282,0.0043364015168127,-0.00318418982651008,0.0138145041193957,0.220326853735579
NMR metabolomics,X23424.Total Lipids in VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,36962,-0.00300373317375242,0.00245093248217487,-0.00780756083881518,0.00180009449131033,0.220391187821076
NMR metabolomics,X23424.Total Lipids in VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,-0.00727048191171188,0.00596538955386282,-0.018962645437283,0.00442168161385925,0.222950297334945
NMR metabolomics,X23424.Total Lipids in VLDL,THY1,Thy-1 membrane glycoprotein,40009,0.00313099906018797,0.00257451118971847,-0.00191504287166024,0.00817704099203618,0.22394448587857
NMR metabolomics,X23424.Total Lipids in VLDL,LAMA1,Laminin subunit alpha-1,37021,-0.00629535113644005,0.00518166589532791,-0.0164514162912828,0.00386071401840265,0.224415337917116
NMR metabolomics,X23424.Total Lipids in VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00396614908079766,0.00327183313795951,-0.00244664386960298,0.0103789420311983,0.225453496060889
NMR metabolomics,X23424.Total Lipids in VLDL,CEP112,Centrosomal protein of 112 kDa,37021,0.005397327594416,0.00445888414744441,-0.00334208533457504,0.014136740523407,0.226121873248127
NMR metabolomics,X23424.Total Lipids in VLDL,IL3RA,Interleukin-3 receptor subunit alpha,39587,0.00352572515585701,0.00292290824076895,-0.00220317499605014,0.00925462530776415,0.227743595456026
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,-0.00399903340836557,0.00331888134851573,-0.0105040408514564,0.00250597403472526,0.228246555566638
NMR metabolomics,X23424.Total Lipids in VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,0.0100992725094501,0.00839989363668482,-0.00636451901845211,0.0265630640373524,0.229265390356327
NMR metabolomics,X23424.Total Lipids in VLDL,LPO,Lactoperoxidase,39344,-0.00683794316523186,0.00570115049470568,-0.018012198134855,0.00433631180439128,0.230391941641346
NMR metabolomics,X23424.Total Lipids in VLDL,TLR2,Toll-like receptor 2,37169,-0.00259145000832258,0.00216709321212002,-0.00683895270407782,0.00165605268743265,0.231788725984405
NMR metabolomics,X23424.Total Lipids in VLDL,GPA33,Cell surface A33 antigen,39788,0.014962028405448,0.0125139617559119,-0.00956533663613933,0.0394893934470354,0.23186001680121
NMR metabolomics,X23424.Total Lipids in VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,0.00300687837571386,0.00252530459790963,-0.00194271863618901,0.00795647538761674,0.233789403758596
NMR metabolomics,X23424.Total Lipids in VLDL,LYPLA2,Acyl-protein thioesterase 2,36991,0.011939198535425,0.0100376571843284,-0.00773460954585863,0.0316130066167087,0.234287778512205
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.0031520211988052,0.00267405896108099,-0.00839317676252394,0.00208913436491354,0.238519034144167
NMR metabolomics,X23424.Total Lipids in VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,-0.0102485705011229,0.00873973980550499,-0.0273784605199127,0.00688131951766686,0.240961428863963
NMR metabolomics,X23424.Total Lipids in VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,0.00367125074755515,0.00313487971990417,-0.00247311350345702,0.00981561499856733,0.241580634401642
NMR metabolomics,X23424.Total Lipids in VLDL,SELL,L-selectin,37453,0.00253099241157108,0.00216126915585148,-0.00170509513389782,0.00676707995703999,0.241592110154857
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4M,C-type lectin domain family 4 member M,37410,-0.00541582468368963,0.0046249555831332,-0.0144807376266307,0.00364908825925144,0.241619222009127
NMR metabolomics,X23424.Total Lipids in VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.00545449439615074,0.00468999087041722,-0.00373788770986701,0.0146468765021685,0.244847607877115
NMR metabolomics,X23424.Total Lipids in VLDL,IL2RA,Interleukin-2 receptor subunit alpha,39732,-0.00435337123582699,0.00374569770618988,-0.0116949387399592,0.00298819626830518,0.245158552457681
NMR metabolomics,X23424.Total Lipids in VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,0.00452989251405518,0.00391493901799075,-0.00314338796120669,0.0122031729893171,0.247257280921389
NMR metabolomics,X23424.Total Lipids in VLDL,RTKN2,Rhotekin-2,37021,-0.00574558884210341,0.00496634314072472,-0.0154796213979239,0.00398844371371703,0.24733203905297
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJA1,DnaJ homolog subfamily A member 1,36962,-0.00510298307806592,0.00441693994846482,-0.013760185377057,0.00355421922092512,0.247980105261497
NMR metabolomics,X23424.Total Lipids in VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,-0.00607897494253969,0.00526858673705611,-0.0164054049471697,0.00424745506209028,0.248596877973807
NMR metabolomics,X23424.Total Lipids in VLDL,MSLNL,Mesothelin-like protein,37039,-0.00395872027752896,0.0034632879859006,-0.0107467647298941,0.00282932417483622,0.25303752340659
NMR metabolomics,X23424.Total Lipids in VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,0.00625259493760113,0.00548843551566465,-0.00450473867310158,0.0170099285483038,0.25462706251932
NMR metabolomics,X23424.Total Lipids in VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,-0.00691864681715954,0.00608392013594653,-0.0188431302836147,0.00500583664929565,0.255474508632433
NMR metabolomics,X23424.Total Lipids in VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,0.00278603160293006,0.00245061585947018,-0.0020171754816315,0.00758923868749162,0.255612746281372
NMR metabolomics,X23424.Total Lipids in VLDL,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.0073990692241906,0.00652035215854353,-0.0201789594549359,0.00538082100655471,0.256493711744583
NMR metabolomics,X23424.Total Lipids in VLDL,FBN2,Fibrillin-2,37039,0.00650671702806388,0.00573691909169973,-0.00473764439166758,0.0177510784477953,0.25673835544755
NMR metabolomics,X23424.Total Lipids in VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,-0.0047098712454509,0.00416141568934108,-0.0128662459965594,0.00344650350565762,0.257741164839268
NMR metabolomics,X23424.Total Lipids in VLDL,NMI,N-myc-interactor,37311,0.00779075755922887,0.0068886872288914,-0.00571106940939828,0.021292584527856,0.258096499889324
NMR metabolomics,X23424.Total Lipids in VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,37056,-0.00516884565308532,0.00457754723187048,-0.0141408382275515,0.00380314692138082,0.258845119007982
NMR metabolomics,X23424.Total Lipids in VLDL,MMP15,Matrix metalloproteinase-15,37437,0.00533985057203615,0.00472974352063694,-0.00393044672841226,0.0146101478724846,0.258920444621211
NMR metabolomics,X23424.Total Lipids in VLDL,SPINT3,Kunitz-type protease inhibitor 3,37382,0.0155843067044766,0.0139170490557357,-0.0116931094447654,0.0428617228537185,0.262819036638759
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL14,C-X-C motif chemokine 14,39587,0.00658318981788789,0.00588954818354816,-0.0049603246218665,0.0181267042576423,0.263680168684006
NMR metabolomics,X23424.Total Lipids in VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,0.00583220318722877,0.00522112354843758,-0.00440119896770888,0.0160656053421664,0.263997715166132
NMR metabolomics,X23424.Total Lipids in VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,-0.00551411023639209,0.00494536844167826,-0.0152070323820815,0.00417881190929729,0.264868664935766
NMR metabolomics,X23424.Total Lipids in VLDL,FGF7,Fibroblast growth factor 7,36962,-0.00844973268037554,0.00761102440709537,-0.0233673405182825,0.00646787515753139,0.266934734058851
NMR metabolomics,X23424.Total Lipids in VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,-0.0048582321135033,0.00438549460410507,-0.0134538015375492,0.00373733731054263,0.267970244090133
NMR metabolomics,X23424.Total Lipids in VLDL,BSND,Barttin,36962,-0.00355591672243538,0.00322468376040355,-0.00987629689282634,0.00276446344795558,0.270169915847097
NMR metabolomics,X23424.Total Lipids in VLDL,IL19,Interleukin-19,39419,0.00720033691562291,0.00653516164477358,-0.0056085799081333,0.0200092537393791,0.27057260592029
NMR metabolomics,X23424.Total Lipids in VLDL,SKIV2L,Helicase SKI2W,37021,0.00423809820283059,0.00384742864904014,-0.00330286194928809,0.0117790583549493,0.270681663558661
NMR metabolomics,X23424.Total Lipids in VLDL,CHP1,Calcineurin B homologous protein 1,36991,0.00759350904043261,0.00692768193304834,-0.00598474754834214,0.0211717656292074,0.273050261379833
NMR metabolomics,X23424.Total Lipids in VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.00681726581650285,0.00625517054951091,-0.0190774000935442,0.00544286846053854,0.275794153927234
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX2,Peroxiredoxin-2,37249,0.00626885307881881,0.00581081532685517,-0.00512034496181732,0.0176580511194549,0.2806851645252
NMR metabolomics,X23424.Total Lipids in VLDL,FAM171A2,Protein FAM171A2,37411,0.0161584546781689,0.0150011109837124,-0.0132437228499074,0.0455606322062451,0.281432195922138
NMR metabolomics,X23424.Total Lipids in VLDL,CHIT1,Chitotriosidase-1,39906,0.0154704650632503,0.0143802746746542,-0.0127148732990719,0.0436558034255726,0.282027737096384
NMR metabolomics,X23424.Total Lipids in VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,-0.00652371057559118,0.00609181314994915,-0.0184636643494915,0.00541624319830916,0.284235017492308
NMR metabolomics,X23424.Total Lipids in VLDL,RETN,Resistin,39790,0.0041596878676412,0.00388781442150086,-0.00346042839850047,0.0117798041337829,0.284667193276288
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,36991,-0.00699284018283683,0.00661781042317379,-0.0199637486122575,0.0059780682465838,0.290681768097603
NMR metabolomics,X23424.Total Lipids in VLDL,CRYBB2,Beta-crystallin B2,37388,0.00572609269846334,0.0054232761257885,-0.00490352850808212,0.0163557139050088,0.291061789984563
NMR metabolomics,X23424.Total Lipids in VLDL,IL20RB,Interleukin-20 receptor subunit beta,37056,-0.00434625317294792,0.00412844722001813,-0.0124380097241835,0.00374550337828761,0.292471491114698
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP2,Metalloproteinase inhibitor 2,37437,-0.00255781283027791,0.00243465412854769,-0.00732973492223138,0.00221410926167556,0.293467607109674
NMR metabolomics,X23424.Total Lipids in VLDL,GAD1,Glutamate decarboxylase 1,36962,-0.00258279971044075,0.00248019174550992,-0.00744397553164019,0.00227837611075869,0.297722620524335
NMR metabolomics,X23424.Total Lipids in VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,0.0057347273538544,0.00550796700646838,-0.00506088797882364,0.0165303426865324,0.297816091660491
NMR metabolomics,X23424.Total Lipids in VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,-0.00718468022969689,0.00690825652266893,-0.020724863014128,0.0063555025547342,0.298352509047884
NMR metabolomics,X23424.Total Lipids in VLDL,GUCY2C,Heat-stable enterotoxin receptor,37169,-0.00849389361712526,0.00817672244145482,-0.0245202696023767,0.00753248236812619,0.298921505788064
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B4,Protein ATP1B4,36962,-0.00414651565391772,0.00400521055128346,-0.0119967283344333,0.00370369702659785,0.300557126083344
NMR metabolomics,X23424.Total Lipids in VLDL,CD177,CD177 antigen,39844,-0.0123137198709869,0.0118974849341381,-0.0356327903418975,0.0110053505999237,0.300691518394048
NMR metabolomics,X23424.Total Lipids in VLDL,RAB6B,Ras-related protein Rab-6B,39489,0.00463887703926263,0.0044829963276442,-0.00414779576292,0.0134255498414453,0.300791624789071
NMR metabolomics,X23424.Total Lipids in VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00457512183397487,0.00442511229004621,-0.0132483419224655,0.00409809825451571,0.301202141952909
NMR metabolomics,X23424.Total Lipids in VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,36962,-0.00494912490282912,0.00479375362324225,-0.0143448820043839,0.0044466321987257,0.30189858642731
NMR metabolomics,X23424.Total Lipids in VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,-0.0019824843051153,0.00192746975465697,-0.00576032502424296,0.00179535641401236,0.303713674037429
NMR metabolomics,X23424.Total Lipids in VLDL,DCC,Netrin receptor DCC,37039,0.00221798199924223,0.0021586718729746,-0.00201301487178799,0.00644897887027245,0.304215574307056
NMR metabolomics,X23424.Total Lipids in VLDL,REXO2,"Oligoribonuclease, mitochondrial",37021,-0.0046839939832355,0.00456523926180595,-0.0136318629363752,0.00426387496990417,0.304904400798844
NMR metabolomics,X23424.Total Lipids in VLDL,TFF1,Trefoil factor 1,39789,0.00734412606534832,0.00717212919704226,-0.00671324716085451,0.0214014992915512,0.305859665141303
NMR metabolomics,X23424.Total Lipids in VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,0.00241609765881103,0.0023678504405704,-0.00222488920470696,0.00705708452232902,0.307568362604372
NMR metabolomics,X23424.Total Lipids in VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.00307676275473404,0.00302656519197991,-0.00285530502154658,0.00900883053101466,0.309369269125355
NMR metabolomics,X23424.Total Lipids in VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00582797737065431,0.00574455194422708,-0.00543134444003077,0.0170872991813394,0.310352085192818
NMR metabolomics,X23424.Total Lipids in VLDL,TSLP,Thymic stromal lymphopoietin,39585,0.00578465750144487,0.005727284174103,-0.00544081947979702,0.0170101344826868,0.312502424996292
NMR metabolomics,X23424.Total Lipids in VLDL,IL17F,Interleukin-17F,39587,-0.00743123243098633,0.0073870733608941,-0.0219098962183388,0.00704743135636612,0.314441685793056
NMR metabolomics,X23424.Total Lipids in VLDL,DOCK9,Dedicator of cytokinesis protein 9,36991,0.0111240394531077,0.0111206313510456,-0.0106723979949417,0.032920476901157,0.317180651435788
NMR metabolomics,X23424.Total Lipids in VLDL,CYTH3,Cytohesin-3,36962,0.00691049588259455,0.00691606390852639,-0.00664498937811717,0.0204659811433063,0.317718732165873
NMR metabolomics,X23424.Total Lipids in VLDL,ERVV_1,,37021,-0.00459103652282036,0.00459753844851051,-0.013602211881901,0.00442013883626024,0.318013750011737
NMR metabolomics,X23424.Total Lipids in VLDL,MTR,Methionine synthase,37021,0.00606865376708264,0.00615486058121276,-0.00599487297209436,0.0181321805062596,0.324154329425285
NMR metabolomics,X23424.Total Lipids in VLDL,CHEK2,Serine/threonine-protein kinase Chk2,39585,0.00314870151438454,0.00319490971250229,-0.00311332152211994,0.00941072455088902,0.324375563231978
NMR metabolomics,X23424.Total Lipids in VLDL,KLHL41,Kelch-like protein 41,37411,0.00478863625834402,0.00487980416715968,-0.00477577990928896,0.014353052425977,0.326453812576836
NMR metabolomics,X23424.Total Lipids in VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,-0.00525059378538466,0.00537208113269953,-0.0157798728054757,0.00527868523470641,0.328396422987668
NMR metabolomics,X23424.Total Lipids in VLDL,SHH,Sonic hedgehog protein,37056,-0.00407032187107269,0.00417050137472072,-0.0122445045655253,0.00410386082337991,0.329092748767964
NMR metabolomics,X23424.Total Lipids in VLDL,TP73,Tumor protein p73,37039,-0.0032071258726433,0.00330427647767542,-0.00968350776888712,0.00326925602360052,0.33176605373865
NMR metabolomics,X23424.Total Lipids in VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,-0.00402727842751794,0.00414990163774067,-0.0121610856374896,0.00410652878245377,0.331839303964785
NMR metabolomics,X23424.Total Lipids in VLDL,NELL1,Protein kinase C-binding protein NELL1,39913,0.00377353192535924,0.00389375912602123,-0.00385823596164238,0.0114052998123609,0.332498372845339
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,0.00691039633379947,0.00713350191262549,-0.0070712674149465,0.0208920600825454,0.332700629020223
NMR metabolomics,X23424.Total Lipids in VLDL,CASP4,Caspase-4,37169,-0.0152459367969474,0.0157404397103973,-0.0460971986293261,0.0156053250354313,0.332770430379634
NMR metabolomics,X23424.Total Lipids in VLDL,BOC,Brother of CDO,39585,-0.00215701637777436,0.00223437864805479,-0.00653639852796174,0.00222236577241302,0.334371171937964
NMR metabolomics,X23424.Total Lipids in VLDL,PALM3,Paralemmin-3,37021,0.00697569567062434,0.00723062669915733,-0.00719633265972402,0.0211477240009727,0.334691334984424
NMR metabolomics,X23424.Total Lipids in VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,-0.0029657748968448,0.00307504151453789,-0.00899285626533907,0.00306130647164947,0.334829796954902
NMR metabolomics,X23424.Total Lipids in VLDL,TPSG1,Tryptase gamma,37056,0.00247522842658254,0.00257061087221331,-0.00256316888295555,0.00751362573612064,0.335617849180651
NMR metabolomics,X23424.Total Lipids in VLDL,EDDM3B,Epididymal secretory protein E3-beta,37368,0.00472211505600658,0.00491660529943349,-0.00491443133088305,0.0143586614428962,0.33684991466175
NMR metabolomics,X23424.Total Lipids in VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.00702182595187293,0.00733934827350848,-0.00736329666420368,0.0214069485679495,0.33871757398267
NMR metabolomics,X23424.Total Lipids in VLDL,AGBL2,Cytosolic carboxypeptidase 2,36991,0.00834912310082767,0.00875055595518313,-0.00880196657133127,0.0255002127729866,0.340037999968882
NMR metabolomics,X23424.Total Lipids in VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00289511310211912,0.0030350396398157,-0.00305356459191967,0.0088437907961579,0.340150795978713
NMR metabolomics,X23424.Total Lipids in VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,36991,-0.00665572552696716,0.00699714081667281,-0.0203701215276459,0.00705867047371154,0.341517088640648
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,0.0107545476976004,0.0113082253977914,-0.0114095740820708,0.0329186694772715,0.341599649505433
NMR metabolomics,X23424.Total Lipids in VLDL,S100A16,Protein S100-A16,39456,-0.00561472203993222,0.00592203892248629,-0.0172219183280053,0.00599247424814091,0.343090063405301
NMR metabolomics,X23424.Total Lipids in VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,37437,0.00196969633745282,0.00207796709489523,-0.00210311916854183,0.00604251184344748,0.343199360373998
NMR metabolomics,X23424.Total Lipids in VLDL,FBLN2,Fibulin-2,37437,-0.00272289301669411,0.00289091984498522,-0.00838909591286514,0.00294330987947693,0.346272002073439
NMR metabolomics,X23424.Total Lipids in VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,-0.00296202857104842,0.00315372843949557,-0.00914333631245974,0.00321927917036291,0.347634690270822
NMR metabolomics,X23424.Total Lipids in VLDL,IL13,Interleukin-13,39587,0.00434763807995263,0.00464638429713903,-0.00475927514243987,0.0134545513023451,0.349440231832672
NMR metabolomics,X23424.Total Lipids in VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,0.00574972877273762,0.00615904716872564,-0.00632200367796464,0.0178214612234399,0.350554654404926
NMR metabolomics,X23424.Total Lipids in VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.00264461237151847,0.0028416500910239,-0.00821424654992532,0.00292502180688838,0.35204562757087
NMR metabolomics,X23424.Total Lipids in VLDL,KRT8,"Keratin, type II cytoskeletal 8",36991,0.0057844149496348,0.00621969440640121,-0.00640618608691158,0.0179750159861812,0.352379927244904
NMR metabolomics,X23424.Total Lipids in VLDL,TOP1,DNA topoisomerase 1,37382,0.0101042485801246,0.0108714443467564,-0.011203782339518,0.0314122794997671,0.352682779478127
NMR metabolomics,X23424.Total Lipids in VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,-0.00485340996295517,0.00523380938243433,-0.0151116763525265,0.00540485642661612,0.353778105093978
NMR metabolomics,X23424.Total Lipids in VLDL,TBR1,T-box brain protein 1,37039,-0.0042568600028281,0.00460124592591813,-0.0132753020176276,0.00476158201197144,0.354902867878212
NMR metabolomics,X23424.Total Lipids in VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,-0.00473436564753111,0.00514628761311592,-0.0148210893692383,0.00535235807417609,0.357611892773835
NMR metabolomics,X23424.Total Lipids in VLDL,NPHS2,Podocin,37056,-0.00896233867453698,0.00975118477510899,-0.0280746608337506,0.0101499834846766,0.358058741427839
NMR metabolomics,X23424.Total Lipids in VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",37021,0.00353679013944577,0.00385105068078578,-0.00401126919489435,0.0110848494737859,0.358428333074349
NMR metabolomics,X23424.Total Lipids in VLDL,WIF1,Wnt inhibitory factor 1,40030,0.00293157361053145,0.00319464588551469,-0.00332993232507733,0.00919307954614024,0.358814701795584
NMR metabolomics,X23424.Total Lipids in VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,0.011067826491062,0.0121010257372251,-0.0126501839538992,0.0347858369360231,0.360405869606311
NMR metabolomics,X23424.Total Lipids in VLDL,PRG3,Proteoglycan 3,37437,-0.00435436511859354,0.00477152499499106,-0.013706554108776,0.00499782387158894,0.361483337154595
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC1A,C-type lectin domain family 1 member A,39585,0.00278411462946706,0.0030555702653766,-0.00320480309067108,0.0087730323496052,0.36222483190671
NMR metabolomics,X23424.Total Lipids in VLDL,ACTA2,"Actin, aortic smooth muscle",39585,0.00374786305280013,0.00411970885553553,-0.00432676630404951,0.0118224924096498,0.362973700115787
NMR metabolomics,X23424.Total Lipids in VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.00195237851325768,0.0021528869102555,-0.00226727983084309,0.00617203685735846,0.364494572508309
NMR metabolomics,X23424.Total Lipids in VLDL,PLXDC1,Plexin domain-containing protein 1,39477,0.00296782570697924,0.0032802723886529,-0.00346150817478043,0.00939715958873892,0.365611921547098
NMR metabolomics,X23424.Total Lipids in VLDL,AXL,Tyrosine-protein kinase receptor UFO,39931,0.00234663554251634,0.00259724149373754,-0.00274395778520924,0.00743722887024192,0.366268441629227
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00439923554223622,0.00487356863610538,-0.0139514300690028,0.00515295898453033,0.366716325008103
NMR metabolomics,X23424.Total Lipids in VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,0.00324104272958025,0.0035957413859451,-0.00380661038687214,0.0102886958460326,0.367412921434871
NMR metabolomics,X23424.Total Lipids in VLDL,PRND,Prion-like protein doppel,37388,-0.00436995150166172,0.00485131167274806,-0.0138785223802479,0.00513861937692447,0.367722766728915
NMR metabolomics,X23424.Total Lipids in VLDL,RSPO1,R-spondin-1,39749,0.0030229001061458,0.00336399055683885,-0.00357052138525835,0.00961632159754995,0.368876494123972
NMR metabolomics,X23424.Total Lipids in VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,-0.00348106432061362,0.00389584688418841,-0.0111169242136229,0.00415479557239567,0.371588590961519
NMR metabolomics,X23424.Total Lipids in VLDL,TNR,Tenascin-R,39749,-0.00356767204919749,0.00400048415917719,-0.0114086210011848,0.00427327690278981,0.372508249313291
NMR metabolomics,X23424.Total Lipids in VLDL,CORO6,Coronin-6,36991,-0.00322658107399581,0.00361808849091722,-0.0103180345161936,0.00386487236820195,0.372520963705683
NMR metabolomics,X23424.Total Lipids in VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,0.00830261603813152,0.00931941082101293,-0.00996342917105382,0.0265686612473169,0.373001397206846
NMR metabolomics,X23424.Total Lipids in VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,-0.00544542786637555,0.00617452580896567,-0.0175474984519483,0.00665664271919717,0.377837047283254
NMR metabolomics,X23424.Total Lipids in VLDL,CD5L,CD5 antigen-like,37380,0.00391282790797992,0.00446302915233779,-0.00483470923060215,0.012660365046562,0.380654197568162
NMR metabolomics,X23424.Total Lipids in VLDL,IFNL1,Interferon lambda-1,39489,0.003747063753017,0.00427936402529008,-0.00464048973655155,0.0121346172425855,0.381254295864098
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL6,Fc receptor-like protein 6,39866,-0.00549331646568168,0.00628475191337797,-0.0178114302159025,0.00682479728453913,0.382092956689497
NMR metabolomics,X23424.Total Lipids in VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,-0.00719622257446718,0.00826161894312663,-0.0233889957029954,0.00899655055406102,0.383746569523076
NMR metabolomics,X23424.Total Lipids in VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,0.00399259104193504,0.00458467764511276,-0.00499337714248597,0.012978559226356,0.383848616555072
NMR metabolomics,X23424.Total Lipids in VLDL,ENOPH1,Enolase-phosphatase E1,37368,0.00462292851099774,0.00532871355708139,-0.00582135006088178,0.0150672070828773,0.385655824740022
NMR metabolomics,X23424.Total Lipids in VLDL,CA8,Carbonic anhydrase-related protein,37056,0.00216095953468336,0.00249256680325345,-0.0027244713996934,0.00704639046906013,0.385978850846975
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.00309047174556632,0.00356610916458266,-0.00389910221701568,0.0100800457081483,0.386164479343849
NMR metabolomics,X23424.Total Lipids in VLDL,PKLR,Pyruvate kinase PKLR,39881,-0.00526265833917255,0.00609336496048975,-0.0172056536617325,0.00668033698338736,0.387781963356973
NMR metabolomics,X23424.Total Lipids in VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.00645837777398206,0.0074795172437116,-0.0211182315716568,0.00820147602369267,0.387891800060699
NMR metabolomics,X23424.Total Lipids in VLDL,KCNIP4,Kv channel-interacting protein 4,39489,0.00431803432754285,0.00500118098645997,-0.00548428040591868,0.0141203490610044,0.387929217168492
NMR metabolomics,X23424.Total Lipids in VLDL,NRN1,Neuritin,37411,-0.00288543130785929,0.00336130985398759,-0.00947359862167497,0.00370273600595638,0.390673192270023
NMR metabolomics,X23424.Total Lipids in VLDL,DLGAP5,Disks large-associated protein 5,37411,-0.00429654852763446,0.00500899562869551,-0.0141141799598777,0.00552108290460875,0.391036594990141
NMR metabolomics,X23424.Total Lipids in VLDL,SCG3,Secretogranin-3,39885,-0.00264935022203964,0.00308906370101894,-0.00870391507603676,0.00340521463195748,0.391095947904276
NMR metabolomics,X23424.Total Lipids in VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,36991,0.00395843211354121,0.00463330450166284,-0.00512284470971796,0.0130397089368004,0.392930453204102
NMR metabolomics,X23424.Total Lipids in VLDL,CD58,Lymphocyte function-associated antigen 3,39835,-0.00141602401122801,0.00165942734867262,-0.00466850161462634,0.00183645359217032,0.39349417634172
NMR metabolomics,X23424.Total Lipids in VLDL,KRT19,"Keratin, type I cytoskeletal 19",39842,0.00527192938351917,0.00622931198617776,-0.00693752210938924,0.0174813808764276,0.397392470090969
NMR metabolomics,X23424.Total Lipids in VLDL,CEP350,Centrosome-associated protein 350,36962,-0.00291740971213104,0.00346185738597956,-0.00970265018865097,0.0038678307643889,0.399395068545978
NMR metabolomics,X23424.Total Lipids in VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,-0.00278136694663674,0.0033011252733669,-0.00925157248243587,0.00368883858916238,0.399494877207084
NMR metabolomics,X23424.Total Lipids in VLDL,APOH,Beta-2-glycoprotein 1,39858,0.00284538417503248,0.00338456896835432,-0.00378837100294199,0.00947913935300694,0.400532385929559
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS11B,Transmembrane protease serine 11B,36991,-0.00615254403453543,0.00732673571798357,-0.0205129460417832,0.00820785797271236,0.401070159789986
NMR metabolomics,X23424.Total Lipids in VLDL,HTR1A,5-hydroxytryptamine receptor 1A,36991,-0.00605739014091206,0.00725101497473325,-0.0202693794913892,0.00815459920956511,0.403516094702048
NMR metabolomics,X23424.Total Lipids in VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,-0.00610564322148234,0.00732330061963632,-0.0204593124359695,0.00824802599300485,0.404448830319136
NMR metabolomics,X23424.Total Lipids in VLDL,TNNI3,"Troponin I, cardiac muscle",39585,0.00668696878898058,0.00802502518756141,-0.00904208057863978,0.022416018156601,0.404708215541476
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA11,Serpin A11,40052,-0.00323421514810469,0.00389923358464663,-0.0108767129740121,0.00440828267780271,0.406862647901299
NMR metabolomics,X23424.Total Lipids in VLDL,AMY2A,Pancreatic alpha-amylase,39246,0.00367396841855237,0.00448619348929851,-0.00511897082047271,0.0124669076575774,0.412827592232637
NMR metabolomics,X23424.Total Lipids in VLDL,CD70,CD70 antigen,39866,0.00329461246363262,0.00402557154881117,-0.00459550777203727,0.0111847326993025,0.413128994302363
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM2,Intercellular adhesion molecule 2,40052,-0.00243703177624911,0.0029848577378649,-0.00828735294246431,0.00341328938996609,0.414246263490488
NMR metabolomics,X23424.Total Lipids in VLDL,ISM2,Isthmin-2,37437,-0.00346109390835145,0.00424941377517893,-0.0117899449077022,0.00486775709099925,0.415380082291935
NMR metabolomics,X23424.Total Lipids in VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,39372,0.00280001284437087,0.0034710308069559,-0.0040032075372627,0.00960323322600443,0.419862952715409
NMR metabolomics,X23424.Total Lipids in VLDL,TEX101,Testis-expressed protein 101,37039,0.00368915383577044,0.00464163959359432,-0.00540845976767442,0.0127867674392153,0.426746834904998
NMR metabolomics,X23424.Total Lipids in VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.00370618421728409,0.00466582467488912,-0.0128512005800668,0.00543883214549859,0.427020262244692
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.00216484607701106,0.00272689382549339,-0.00317986582095598,0.0075095579749781,0.427272741732656
NMR metabolomics,X23424.Total Lipids in VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,-0.00368537203816093,0.00464302648132969,-0.0127857039415671,0.00541495986524526,0.427359151975889
NMR metabolomics,X23424.Total Lipids in VLDL,INSL4,Early placenta insulin-like peptide,37368,-0.00404839627812094,0.00510485477717386,-0.0140539116413817,0.00595711908513981,0.42776362568222
NMR metabolomics,X23424.Total Lipids in VLDL,FGF6,Fibroblast growth factor 6,37056,0.00309672164682445,0.00391639689835117,-0.00457941627394384,0.0107728595675927,0.429129318841501
NMR metabolomics,X23424.Total Lipids in VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.00289446541625047,0.0036625375919305,-0.0100730390964343,0.00428410826393332,0.429372871200003
NMR metabolomics,X23424.Total Lipids in VLDL,CBLN1,Cerebellin-1,36991,-0.00724827509122621,0.00917821473824129,-0.0252375759781791,0.0107410257957267,0.42970204602556
NMR metabolomics,X23424.Total Lipids in VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.00513062876045279,0.00650267034879297,-0.00761460512318143,0.017875862644087,0.430124235393388
NMR metabolomics,X23424.Total Lipids in VLDL,CASQ2,Calsequestrin-2,37021,0.00366075400833774,0.00466023489648903,-0.00547330638878075,0.0127948144054562,0.432157068059222
NMR metabolomics,X23424.Total Lipids in VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,0.00472153128200644,0.00603735751602728,-0.00711168944940703,0.0165547520134199,0.434197560874411
NMR metabolomics,X23424.Total Lipids in VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,-0.00538990477069149,0.00693543661578967,-0.0189833605376392,0.00820355099625626,0.437079216019955
NMR metabolomics,X23424.Total Lipids in VLDL,DENND2B,DENN domain-containing protein 2B,37021,-0.00381145189499451,0.00492777088568376,-0.0134698828309347,0.00584697904094567,0.439261896449792
NMR metabolomics,X23424.Total Lipids in VLDL,FOS,Proto-oncogene c-Fos,36931,-0.00260730164063281,0.00337946690377124,-0.00923105677202444,0.00401645349075882,0.440417043662295
NMR metabolomics,X23424.Total Lipids in VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,37021,-0.00414813551469539,0.00537922557101769,-0.0146914176338901,0.00639514660449928,0.440637851572158
NMR metabolomics,X23424.Total Lipids in VLDL,COL4A4,Collagen alpha-4(IV) chain,37147,-0.00385647205033396,0.00500322935232458,-0.0136628015808901,0.00594985748022222,0.440841223031998
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA2,Protein disulfide-isomerase A2,36962,0.00292247004326249,0.00379761515563382,-0.00452085566177981,0.0103657957483048,0.441578356739409
NMR metabolomics,X23424.Total Lipids in VLDL,CLINT1,Clathrin interactor 1,36962,-0.00355629184242682,0.00467855800813279,-0.0127262655383671,0.00561368185351345,0.447193172627204
NMR metabolomics,X23424.Total Lipids in VLDL,HBZ,Hemoglobin subunit zeta,37437,-0.00765338056264092,0.0100727584290824,-0.0273959870836423,0.0120892259583605,0.447381477044451
NMR metabolomics,X23424.Total Lipids in VLDL,TNXB,Tenascin-X,39858,-0.00185020073340594,0.00245152321575473,-0.00665518623628521,0.00295478476947334,0.450431263231353
NMR metabolomics,X23424.Total Lipids in VLDL,PSCA,Prostate stem cell antigen,37382,0.0182854061013992,0.0242374233317665,-0.0292199436288631,0.0657907558316615,0.450605022987239
NMR metabolomics,X23424.Total Lipids in VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.0103787182576797,0.0137698422227691,-0.0373676090143071,0.0166101724989477,0.451025995518348
NMR metabolomics,X23424.Total Lipids in VLDL,IL21R,Interleukin-21 receptor,37056,-0.00389491587868139,0.00519479220374794,-0.0140767085980274,0.00628687684066458,0.453404689775719
NMR metabolomics,X23424.Total Lipids in VLDL,DBH,Dopamine beta-hydroxylase,37430,-0.00776771170821765,0.0104032342350636,-0.0281580508089423,0.012622627392507,0.455279850679391
NMR metabolomics,X23424.Total Lipids in VLDL,DOC2B,Double C2-like domain-containing protein beta,37039,0.00258736079612303,0.00346863266814218,-0.00421115923343563,0.0093858808256817,0.455722373770616
NMR metabolomics,X23424.Total Lipids in VLDL,NEB,Nebulin,37021,-0.00267629089924082,0.00358793776036538,-0.00970864890955697,0.00435606711107534,0.455733044471706
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH17,Protocadherin-17,39868,-0.00248267385833876,0.00333284526345109,-0.00901505057470289,0.00404970285802538,0.456336322692779
NMR metabolomics,X23424.Total Lipids in VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,-0.00440185481204013,0.00591231629906625,-0.01598999475821,0.00718628513412971,0.456573492378699
NMR metabolomics,X23424.Total Lipids in VLDL,SAP18,Histone deacetylase complex subunit SAP18,37169,0.00519219697794576,0.00697390156961657,-0.00847665009850272,0.0188610440543942,0.456576151158677
NMR metabolomics,X23424.Total Lipids in VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,0.00184288590927826,0.00247701326416928,-0.00301206008849353,0.00669783190705004,0.456892678422313
NMR metabolomics,X23424.Total Lipids in VLDL,GUCA2A,Guanylin,39796,-0.00228290642149345,0.0030747040657391,-0.00830932639034208,0.00374351354735518,0.457807479707308
NMR metabolomics,X23424.Total Lipids in VLDL,MB,Myoglobin,40052,-0.00366148954735498,0.00494217001578516,-0.0133481427782939,0.00602516368358393,0.4587849676959
NMR metabolomics,X23424.Total Lipids in VLDL,MYL6B,Myosin light chain 6B,37039,-0.00652867214938019,0.00882561308205602,-0.02382687379021,0.0107695294914496,0.459470045546145
NMR metabolomics,X23424.Total Lipids in VLDL,VNN2,Vascular non-inflammatory molecule 2,39788,-0.00325604736361887,0.00440676238619991,-0.0118933016405707,0.00538120691333295,0.459993680774952
NMR metabolomics,X23424.Total Lipids in VLDL,RRP15,RRP15-like protein,36991,0.00637435207323691,0.00863032552150367,-0.0105410859489103,0.0232897900953841,0.460163572481814
NMR metabolomics,X23424.Total Lipids in VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,0.00397737517581328,0.00539285801681817,-0.00659262653715032,0.0145473768887769,0.460815500646009
NMR metabolomics,X23424.Total Lipids in VLDL,CD200,OX-2 membrane glycoprotein,39866,-0.00180550557930078,0.002451315575719,-0.00661008410771001,0.00299907294910846,0.461409552467612
NMR metabolomics,X23424.Total Lipids in VLDL,AMY2B,Alpha-amylase 2B,38832,0.00337440014058952,0.00458817304044135,-0.00561841901867552,0.0123672192998546,0.462073248555299
NMR metabolomics,X23424.Total Lipids in VLDL,OMG,Oligodendrocyte-myelin glycoprotein,39788,0.0045239043944652,0.00618737866197313,-0.00760335778300213,0.0166511665719325,0.464698046743898
NMR metabolomics,X23424.Total Lipids in VLDL,MORN4,MORN repeat-containing protein 4,36962,0.00555951799456815,0.00762740848017211,-0.00939020262656918,0.0205092386157055,0.46608388713995
NMR metabolomics,X23424.Total Lipids in VLDL,ACRV1,Acrosomal protein SP-10,37056,0.00505925259494037,0.00697266875586825,-0.00860717816656139,0.0187256833564421,0.468107077290684
NMR metabolomics,X23424.Total Lipids in VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,37169,-0.00373630842429798,0.00515794141173252,-0.0138458735912937,0.00637325674269775,0.468845348188239
NMR metabolomics,X23424.Total Lipids in VLDL,ERCC1,DNA excision repair protein ERCC-1,36962,0.00227494581273664,0.0031455268017886,-0.00389028671876901,0.00844017834424229,0.469550238977674
NMR metabolomics,X23424.Total Lipids in VLDL,KDM3A,Lysine-specific demethylase 3A,37056,-0.00639136163416932,0.00889765230749589,-0.0238307601568613,0.0110480368885226,0.472572716600143
NMR metabolomics,X23424.Total Lipids in VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,37039,0.00416228170073267,0.00580961763700368,-0.00722456886779454,0.0155491322692599,0.473728229218225
NMR metabolomics,X23424.Total Lipids in VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,-0.00383340205964185,0.00535854460950543,-0.0143361494942725,0.00666934537498879,0.474386247093345
NMR metabolomics,X23424.Total Lipids in VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,37021,0.00222642349974362,0.00312864659348307,-0.0039057238234832,0.00835857082297044,0.476709561866818
NMR metabolomics,X23424.Total Lipids in VLDL,OFD1,Oral-facial-digital syndrome 1 protein,37169,-0.00455156604280114,0.00649104771203274,-0.0172740195583853,0.00817088747278303,0.483186298882015
NMR metabolomics,X23424.Total Lipids in VLDL,OTOA,Otoancorin,36991,-0.0035416388185265,0.00505735269834344,-0.0134540501072796,0.00637077247022665,0.483755499479183
NMR metabolomics,X23424.Total Lipids in VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,0.00407545178695704,0.00584601229451586,-0.00738273231029405,0.0155336358842081,0.485731165356746
NMR metabolomics,X23424.Total Lipids in VLDL,NOS2,"Nitric oxide synthase, inducible",37021,0.00263176123736799,0.00378154359400899,-0.00478006420688964,0.0100435866816256,0.486473099079427
NMR metabolomics,X23424.Total Lipids in VLDL,KRT17,"Keratin, type I cytoskeletal 17",37021,0.00259328193032892,0.00372716505606231,-0.00471196157955321,0.00989852544021106,0.486579737438294
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,39962,-0.00197111070237612,0.0028382652300757,-0.0075341105533245,0.00359188914857226,0.487392967274049
NMR metabolomics,X23424.Total Lipids in VLDL,LMOD2,Leiomodin-2,36991,-0.00424304271825243,0.00612227387548827,-0.0162426995142094,0.00775661407770459,0.488290348471891
NMR metabolomics,X23424.Total Lipids in VLDL,MORC3,MORC family CW-type zinc finger protein 3,37388,0.00185199317659819,0.00267266345897051,-0.00338642720298401,0.0070904135561804,0.488359627441529
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB118,Beta-defensin 118,36991,0.00383880489853844,0.0055455595886108,-0.00703049189513873,0.0147081016922156,0.488804894727232
NMR metabolomics,X23424.Total Lipids in VLDL,COL3A1,Collagen alpha-1(III) chain,37437,-0.00153101074608515,0.00222096772602661,-0.00588410748909731,0.00282208599692702,0.490618604169982
NMR metabolomics,X23424.Total Lipids in VLDL,ZPR1,Zinc finger protein ZPR1,36991,0.00629785337735246,0.00916713038417241,-0.0116697221756255,0.0242654289303304,0.492092468406186
NMR metabolomics,X23424.Total Lipids in VLDL,TET2,Methylcytosine dioxygenase TET2,37161,-0.00648302926660148,0.00944188285133802,-0.024989119655224,0.012023061122021,0.492331276571862
NMR metabolomics,X23424.Total Lipids in VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.00260688707210234,0.00380053633052218,-0.0100559382799258,0.00484216413572114,0.492771819331544
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,-0.00876456396565853,0.0128452372658336,-0.0339412290066924,0.0164121010753753,0.495048187232266
NMR metabolomics,X23424.Total Lipids in VLDL,OGN,Mimecan,39858,0.0025654733249816,0.00376393227618755,-0.00481183393634601,0.0099427805863092,0.495505632091759
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00287047103143185,0.00424019656700816,-0.00544031423990413,0.0111812563027678,0.498438801733961
NMR metabolomics,X23424.Total Lipids in VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,0.00299999787482372,0.00446775241302797,-0.00575679685471111,0.0117567926043585,0.501925934334015
NMR metabolomics,X23424.Total Lipids in VLDL,HRAS,GTPase Hras,37161,0.00616590290916085,0.00933195794805249,-0.012124734669022,0.0244565404873437,0.50879703856913
NMR metabolomics,X23424.Total Lipids in VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,39858,-0.00211332098521978,0.00320642793621251,-0.0083979197401963,0.00417127776975675,0.509848184623384
NMR metabolomics,X23424.Total Lipids in VLDL,TPT1,Translationally-controlled tumor protein,39587,0.00409326749631007,0.00621918853322964,-0.00809634202882003,0.0162828770214402,0.510440168029286
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB5,Serpin B5,39585,0.0030435013817628,0.00463974861229444,-0.00605040589833429,0.0121374086618599,0.511857810866311
NMR metabolomics,X23424.Total Lipids in VLDL,EXOSC10,Exosome component 10,37021,-0.00380568339488672,0.00582602495011088,-0.015224692297104,0.00761332550733059,0.513625053095084
NMR metabolomics,X23424.Total Lipids in VLDL,CDH22,Cadherin-22,37169,-0.00179295680304931,0.00276749353124707,-0.00721724412429357,0.00363133051819495,0.517084706215106
NMR metabolomics,X23424.Total Lipids in VLDL,CD82,CD82 antigen,37169,-0.00257669642203143,0.00402377633621709,-0.0104632980410169,0.00530990519695407,0.521944597164649
NMR metabolomics,X23424.Total Lipids in VLDL,FZD10,Frizzled-10,37039,0.003650255743327,0.00571688279118189,-0.0075548345273895,0.0148553460140435,0.523156380425787
NMR metabolomics,X23424.Total Lipids in VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,37348,0.00249960375700425,0.00391619920512935,-0.00517614668504927,0.0101753541990578,0.523306897139195
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN7,Tetraspanin-7,36991,0.00570669457146139,0.008994303413262,-0.0119221401185321,0.0233355292614549,0.5257794706764
NMR metabolomics,X23424.Total Lipids in VLDL,IL4,Interleukin-4,39587,0.00544710310562303,0.00860469924963292,-0.0114181074236575,0.0223123136349036,0.526717918674701
NMR metabolomics,X23424.Total Lipids in VLDL,CSF2RB,Cytokine receptor common subunit beta,37056,-0.0026134291858976,0.00414421518034468,-0.0107360909393732,0.00550923256757797,0.528299275135991
NMR metabolomics,X23424.Total Lipids in VLDL,NLGN1,Neuroligin-1,37039,-0.00403255195721979,0.0064219697135688,-0.0166196125958146,0.00855450868137506,0.530060216917464
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,0.00495935902835672,0.00795814223358236,-0.0106385997494647,0.0205573178061782,0.533174796016475
NMR metabolomics,X23424.Total Lipids in VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,0.00421416692947605,0.00677921869675341,-0.00907310171616063,0.0175014355751127,0.534195824778137
NMR metabolomics,X23424.Total Lipids in VLDL,IL25,Interleukin-25,36903,-0.00201523278264215,0.00328301030451943,-0.00844993297950022,0.00441946741421592,0.539333833155164
NMR metabolomics,X23424.Total Lipids in VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,0.00421755164701078,0.00689068224947837,-0.00928818556196683,0.0177232888559884,0.540504753944781
NMR metabolomics,X23424.Total Lipids in VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,0.00490274089256828,0.00801257161770282,-0.0108018994781292,0.0206073812632658,0.540627002463026
NMR metabolomics,X23424.Total Lipids in VLDL,CRISP2,Cysteine-rich secretory protein 2,40030,-0.00323873996473887,0.00534331709675104,-0.0137116414743709,0.00723416154489316,0.544437539306919
NMR metabolomics,X23424.Total Lipids in VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,-0.00196903287481233,0.00330281168315156,-0.00844254377378938,0.00450447802416472,0.551072800821528
NMR metabolomics,X23424.Total Lipids in VLDL,LRP2BP,LRP2-binding protein,37039,-0.0045169684664036,0.00761148447382473,-0.0194354780351001,0.0104015411022929,0.552896108604218
NMR metabolomics,X23424.Total Lipids in VLDL,ZNF830,Zinc finger protein 830,37368,-0.00451738428989408,0.00769578778985658,-0.019601128358013,0.0105663597782248,0.557217281985513
NMR metabolomics,X23424.Total Lipids in VLDL,NENF,Neudesin,37368,0.00614600099501445,0.0104849854310294,-0.0144045704498031,0.026696572439832,0.557769978907913
NMR metabolomics,X23424.Total Lipids in VLDL,UGDH,UDP-glucose 6-dehydrogenase,37021,0.00556533353638878,0.00957108377363655,-0.0131939906599389,0.0243246577327164,0.560931194037099
NMR metabolomics,X23424.Total Lipids in VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,0.00194832453471461,0.0033844674461178,-0.00468523165967627,0.00858188072910549,0.564850438015887
NMR metabolomics,X23424.Total Lipids in VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,-0.00163605420646895,0.0028460296882517,-0.00721427239544227,0.00394216398250437,0.565399211339229
NMR metabolomics,X23424.Total Lipids in VLDL,TNPO1,Transportin-1,37169,-0.00193614273533857,0.00338123296461359,-0.00856335934598121,0.00469107387530408,0.566915470265248
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC50,Coiled-coil domain-containing protein 50,37411,-0.00422017456038569,0.00737809754982281,-0.0186812457580384,0.010240896637267,0.567340391259482
NMR metabolomics,X23424.Total Lipids in VLDL,SOX2,Transcription factor SOX-2,37391,0.00129610165483841,0.00226852440893711,-0.00315020618667832,0.00574240949635514,0.567777809595605
NMR metabolomics,X23424.Total Lipids in VLDL,CD164L2,CD164 sialomucin-like 2 protein,37039,0.00200763717702671,0.00351496774500423,-0.00488169960318158,0.00889697395723499,0.567895491557018
NMR metabolomics,X23424.Total Lipids in VLDL,IGFL4,Insulin growth factor-like family member 4,37056,-0.00418456247158546,0.00734263283320203,-0.0185761228246614,0.0102069978814905,0.56875559429695
NMR metabolomics,X23424.Total Lipids in VLDL,EFNB2,Ephrin-B2,37039,-0.00326770646139174,0.00574994377411139,-0.0145375962586501,0.00800218333586658,0.569839377683136
NMR metabolomics,X23424.Total Lipids in VLDL,TG,Thyroglobulin,37368,0.00588005325226197,0.0103768264268101,-0.0144585265442859,0.0262186330488099,0.570959804020118
NMR metabolomics,X23424.Total Lipids in VLDL,FH,"Fumarate hydratase, mitochondrial",36991,0.00446318064412666,0.00789548180388967,-0.0110119636914971,0.0199383249797504,0.571891033426156
NMR metabolomics,X23424.Total Lipids in VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,-0.00159378241388332,0.0028279395512732,-0.0071365439343788,0.00394897910661216,0.573046362349105
NMR metabolomics,X23424.Total Lipids in VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,-0.00278989065731355,0.0049534847856197,-0.0124987208371282,0.00691893952250106,0.573296198400059
NMR metabolomics,X23424.Total Lipids in VLDL,RANGAP1,Ran GTPase-activating protein 1,39477,-0.0026567609379952,0.00471994225175482,-0.0119078477514346,0.00659432587544424,0.573524702787563
NMR metabolomics,X23424.Total Lipids in VLDL,PALLD,Palladin,37056,0.00217254624267805,0.00389250885126871,-0.00545677110580863,0.00980186359116473,0.576761528235052
NMR metabolomics,X23424.Total Lipids in VLDL,FOLR3,Folate receptor gamma,39858,-0.0100424512209632,0.0180279071413549,-0.0453771492180189,0.0252922467760925,0.577500850469864
NMR metabolomics,X23424.Total Lipids in VLDL,DAND5,DAN domain family member 5,37056,-0.00283210653752284,0.00513123579655145,-0.0128893286987637,0.007225115623718,0.581002513678857
NMR metabolomics,X23424.Total Lipids in VLDL,IL17A,Interleukin-17A,39558,-0.002219345722037,0.00403579920605519,-0.0101295121659052,0.00569082072183117,0.582385634680089
NMR metabolomics,X23424.Total Lipids in VLDL,CALY,Neuron-specific vesicular protein calcyon,37021,-0.00195834211754883,0.00361990269474984,-0.00905335139925853,0.00513666716416086,0.588521544867214
NMR metabolomics,X23424.Total Lipids in VLDL,LCN15,Lipocalin-15,37411,-0.00318236034931745,0.0059192369993501,-0.0147840648680436,0.00841934416940874,0.590841230965803
NMR metabolomics,X23424.Total Lipids in VLDL,EPGN,Epigen,37368,-0.00253803745533327,0.00476575676265588,-0.0118789207101388,0.00680284579947225,0.594348986540852
NMR metabolomics,X23424.Total Lipids in VLDL,PI16,Peptidase inhibitor 16,37445,0.00121400071935694,0.00227968291000077,-0.00325417778424457,0.00568217922295845,0.594367321081624
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC11A,C-type lectin domain family 11 member A,39822,-0.002378128737767,0.00451163511014026,-0.0112209335536419,0.0064646760781079,0.598124412049623
NMR metabolomics,X23424.Total Lipids in VLDL,CNTF,Ciliary neurotrophic factor,36991,0.00168562662119954,0.00323924134178438,-0.00466328640869785,0.00803453965109693,0.602809626068634
NMR metabolomics,X23424.Total Lipids in VLDL,PDCL2,Phosducin-like protein 2,36962,-0.00262721693903301,0.00507951211726503,-0.0125830606888725,0.00732862681080645,0.605012466392952
NMR metabolomics,X23424.Total Lipids in VLDL,RUVBL1,RuvB-like 1,39477,0.00497501668696475,0.00968166486146635,-0.0140010464415093,0.0239510798154388,0.607357406841047
NMR metabolomics,X23424.Total Lipids in VLDL,NOS1,"Nitric oxide synthase, brain",39489,-0.00262123682250112,0.00514534660339035,-0.0127061161651462,0.00746364252014396,0.6104522019887
NMR metabolomics,X23424.Total Lipids in VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,0.00310071522939822,0.00613491194566246,-0.0089237121841002,0.0151251426428966,0.613269897908811
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,0.00325177507431703,0.00648739558876563,-0.00946352027966361,0.0159670704282977,0.616206946770794
NMR metabolomics,X23424.Total Lipids in VLDL,COL5A1,Collagen alpha-1(V) chain,37124,0.00187559671174128,0.00377952850981573,-0.00553227916749756,0.00928347259098012,0.619725199539451
NMR metabolomics,X23424.Total Lipids in VLDL,PRTN3,Myeloblastin,39421,-0.00215476321957385,0.00440739776880505,-0.0107932628464318,0.00648373640728406,0.624921562512265
NMR metabolomics,X23424.Total Lipids in VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,-0.00256928823702836,0.00528816101270733,-0.0129340838219347,0.007795507347878,0.627076877516732
NMR metabolomics,X23424.Total Lipids in VLDL,STC2,Stanniocalcin-2,39831,-0.00121643202453352,0.00252258292899663,-0.00616069456536691,0.00372783051629987,0.629658507814649
NMR metabolomics,X23424.Total Lipids in VLDL,PRC1,Protein regulator of cytokinesis 1,37368,-0.00209322548787476,0.00440682443645795,-0.0107306013833323,0.00654415040758282,0.634797260045845
NMR metabolomics,X23424.Total Lipids in VLDL,MAGEA3,Melanoma-associated antigen 3,37169,0.0037917898470284,0.00799862883474863,-0.0118855226690789,0.0194691023631357,0.63546847678234
NMR metabolomics,X23424.Total Lipids in VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,-0.00228841894167314,0.00485962409315855,-0.0118132821642639,0.00723644428091761,0.637716639247641
NMR metabolomics,X23424.Total Lipids in VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,-0.00275250768953671,0.00597401162098805,-0.0144615704666733,0.00895655508759987,0.644987790138085
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,-0.00213916808166905,0.00468810674361009,-0.0113278572991448,0.00704952113580673,0.648184056831921
NMR metabolomics,X23424.Total Lipids in VLDL,WFDC12,WAP four-disulfide core domain protein 12,39990,0.00269441362294656,0.00592801617929285,-0.00892449808846742,0.0143133253343605,0.649459295308641
NMR metabolomics,X23424.Total Lipids in VLDL,IFNL2,Interferon lambda-2,36991,-0.00268404874721445,0.00591468729683108,-0.0142768358490034,0.00890873835457447,0.649984706826804
NMR metabolomics,X23424.Total Lipids in VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,0.00253424895091405,0.00560610741240129,-0.00845372157739248,0.0135222194792206,0.651239389389999
NMR metabolomics,X23424.Total Lipids in VLDL,MYOC,Myocilin,39858,0.00196944137624105,0.00437977733468279,-0.00661492219973722,0.0105538049522193,0.652956654844324
NMR metabolomics,X23424.Total Lipids in VLDL,SHC1,SHC-transforming protein 1,36962,-0.00496781740273574,0.0110540575057487,-0.0266337701140032,0.0166981353085317,0.653142477211785
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,39866,0.00258440938443921,0.00591551062265371,-0.00900999143596205,0.0141788102048405,0.662199231257825
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS5,Transmembrane protease serine 5,39667,-0.00157527473803824,0.00362772442482701,-0.00868561461069918,0.0055350651346227,0.664125763420794
NMR metabolomics,X23424.Total Lipids in VLDL,FGF3,Fibroblast growth factor 3,37056,0.00126877908280473,0.00294147290982644,-0.00449650782045509,0.00703406598606455,0.666227188398188
NMR metabolomics,X23424.Total Lipids in VLDL,SPRING1,SREBP regulating gene protein,36962,0.00246379799948738,0.00572675601512298,-0.00876064379015365,0.0136882397891284,0.667038496153083
NMR metabolomics,X23424.Total Lipids in VLDL,PNMA2,Paraneoplastic antigen Ma2,36991,0.0017615705004603,0.00414502271223133,-0.00636267401551311,0.0098858150164337,0.670854920882543
NMR metabolomics,X23424.Total Lipids in VLDL,AKAP12,A-kinase anchor protein 12,37124,0.000855810729058685,0.0020144333588544,-0.00309247865429593,0.0048041001124133,0.670960619555324
NMR metabolomics,X23424.Total Lipids in VLDL,HDAC9,Histone deacetylase 9,36991,-0.00260034885812386,0.00613118549901211,-0.0146174724361876,0.00941677471993986,0.67148638223027
NMR metabolomics,X23424.Total Lipids in VLDL,FGF5,Fibroblast growth factor 5,39587,0.00131836512189121,0.00315663670151063,-0.00486864281306962,0.00750537305685204,0.676209707826379
NMR metabolomics,X23424.Total Lipids in VLDL,TXK,Tyrosine-protein kinase TXK,37169,-0.00292346791926377,0.00708478683361757,-0.0168096501131542,0.0109627142746267,0.679876884054257
NMR metabolomics,X23424.Total Lipids in VLDL,IL4R,Interleukin-4 receptor subunit alpha,39866,-0.00140441794714178,0.00340681545681439,-0.008081776242498,0.00527294034821443,0.680170689354632
NMR metabolomics,X23424.Total Lipids in VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,-0.00116491140216034,0.0028495193421135,-0.0067499693127028,0.00442014650838213,0.682685703162514
NMR metabolomics,X23424.Total Lipids in VLDL,NECTIN4,Nectin-4,39913,0.0011302844212858,0.0028034673015641,-0.00436451148977984,0.00662508033235143,0.686825779521298
NMR metabolomics,X23424.Total Lipids in VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,37169,-0.00250164818996398,0.00626503287708481,-0.0147811126290502,0.00977781624912225,0.689676156158643
NMR metabolomics,X23424.Total Lipids in VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.00441614510290974,0.0110711575469167,-0.0261156138948665,0.017283323689047,0.689982655013271
NMR metabolomics,X23424.Total Lipids in VLDL,PGR,Progesterone receptor,37056,0.0039861271592239,0.0100373749952593,-0.0156871278314842,0.023659382149932,0.691279165033097
NMR metabolomics,X23424.Total Lipids in VLDL,IL2,Interleukin-2,39587,0.0011763599308502,0.0029702405827769,-0.00464531161139252,0.00699803147309293,0.692074472339758
NMR metabolomics,X23424.Total Lipids in VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,0.00157277790921637,0.00398844956878057,-0.00624458324559354,0.00939013906402628,0.693340278139543
NMR metabolomics,X23424.Total Lipids in VLDL,ZNF174,Zinc finger protein 174,37056,0.00142737760924054,0.00364906580287481,-0.00572479136439409,0.00857954658287517,0.695683459252156
NMR metabolomics,X23424.Total Lipids in VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,0.00187090315585395,0.00481176875806938,-0.00756016360996205,0.0113019699216699,0.69741692691481
NMR metabolomics,X23424.Total Lipids in VLDL,GAGE2A,G antigen 2A,36962,-0.00225947450620289,0.00583374368681522,-0.0136936121323607,0.00917466311995494,0.698532095793538
NMR metabolomics,X23424.Total Lipids in VLDL,MAG,Myelin-associated glycoprotein,37039,-0.00170374436372537,0.00440450228921926,-0.0103365688505951,0.00692908012314438,0.698896591342728
NMR metabolomics,X23424.Total Lipids in VLDL,TPSD1,Tryptase delta,37411,0.0013412389545992,0.00349245765734761,-0.00550397805380212,0.00818645596300052,0.700955777966067
NMR metabolomics,X23424.Total Lipids in VLDL,SLK,STE20-like serine/threonine-protein kinase,37169,0.00272991713768322,0.00732540687697448,-0.0116278803411868,0.0170877146165532,0.709404293829933
NMR metabolomics,X23424.Total Lipids in VLDL,TLR1,Toll-like receptor 1,37056,0.000920973055344739,0.00249369995580715,-0.00396667885803728,0.00580862496872676,0.711895209088371
NMR metabolomics,X23424.Total Lipids in VLDL,TXNDC15,Thioredoxin domain-containing protein 15,39913,-0.000938341525659213,0.00258733922698203,-0.00600952641054399,0.00413284335922556,0.716858725795035
NMR metabolomics,X23424.Total Lipids in VLDL,GPHA2,Glycoprotein hormone alpha-2,37382,-0.00160850721329468,0.00444411383908259,-0.0103189703378966,0.0071019559113072,0.71740174157014
NMR metabolomics,X23424.Total Lipids in VLDL,TPBGL,Trophoblast glycoprotein-like,37039,0.00136222997725716,0.00386970479706367,-0.00622239142498763,0.00894685137950195,0.724825695293122
NMR metabolomics,X23424.Total Lipids in VLDL,CDC123,Cell division cycle protein 123 homolog,36962,0.00212030247977354,0.006084991143652,-0.00980628016178438,0.0140468851213315,0.727509421651864
NMR metabolomics,X23424.Total Lipids in VLDL,ALPI,Intestinal-type alkaline phosphatase,37056,-0.00398299272025327,0.0115589177075381,-0.026638471427028,0.0186724859865215,0.730414278168859
NMR metabolomics,X23424.Total Lipids in VLDL,SCIN,Adseverin,36991,0.00239795512401923,0.00705681632884444,-0.0114334048805159,0.0162293151285543,0.734007360297896
NMR metabolomics,X23424.Total Lipids in VLDL,OSTN,Osteocrin,37039,-0.00135579805150453,0.0039921565064534,-0.00918042480415319,0.00646882870114412,0.734151549028599
NMR metabolomics,X23424.Total Lipids in VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,-0.00134952083729149,0.00398077608205239,-0.00915184195811417,0.00645280028353119,0.734607981450679
NMR metabolomics,X23424.Total Lipids in VLDL,BTLA,B- and T-lymphocyte attenuator,36962,0.0027720115209411,0.00829581950648759,-0.0134877947117746,0.0190318177536568,0.73827504582804
NMR metabolomics,X23424.Total Lipids in VLDL,TFRC,Transferrin receptor protein 1,39918,-0.00124369919998764,0.00372274801790913,-0.00854028531508953,0.00605288691511425,0.738322836292715
NMR metabolomics,X23424.Total Lipids in VLDL,IL2RB,Interleukin-2 receptor subunit beta,39587,-0.00115380660196525,0.00346030703675677,-0.00793600839400852,0.00562839519007802,0.738806220814233
NMR metabolomics,X23424.Total Lipids in VLDL,PITHD1,PITH domain-containing protein 1,36931,-0.00252158127864209,0.00756348223775715,-0.0173460064646461,0.0123028439073619,0.738846062971031
NMR metabolomics,X23424.Total Lipids in VLDL,BRD2,Bromodomain-containing protein 2,36991,-0.00107696958516035,0.00323156385159158,-0.00741083473427984,0.00525689556395914,0.738939003484069
NMR metabolomics,X23424.Total Lipids in VLDL,UBQLN3,Ubiquilin-3,37021,-0.00148916970761945,0.00449101224808887,-0.0102915537138736,0.00731321429863472,0.740204999523796
NMR metabolomics,X23424.Total Lipids in VLDL,HMCN2,Hemicentin-2,37100,0.0017935439508533,0.00542574749030975,-0.00884092113015382,0.0124280090318604,0.740980861360385
NMR metabolomics,X23424.Total Lipids in VLDL,GIPR,Gastric inhibitory polypeptide receptor,37056,0.00143734491337081,0.00436603532548508,-0.00712008432457994,0.00999477415132156,0.7420017700476
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJA4,DnaJ homolog subfamily A member 4,37388,-0.00218795060741994,0.00665600006891298,-0.0152337107424894,0.0108578095276495,0.742373529706398
NMR metabolomics,X23424.Total Lipids in VLDL,AOC3,Membrane primary amine oxidase,39931,0.000937270239374319,0.00286308998324605,-0.00467438612778793,0.00654892660653657,0.743397476113493
NMR metabolomics,X23424.Total Lipids in VLDL,LAYN,Layilin,39713,0.000982655473467186,0.00307576577539265,-0.00504584544630241,0.00701115639323679,0.749364343308639
NMR metabolomics,X23424.Total Lipids in VLDL,IL24,Interleukin-24,39587,-0.00142789136811436,0.00450075612346355,-0.0102493733701029,0.00739359063387419,0.751053659547465
NMR metabolomics,X23424.Total Lipids in VLDL,STEAP4,Metalloreductase STEAP4,36991,-0.00224484395843427,0.00717359383233765,-0.0163050878698161,0.0118153999529475,0.754337623981217
NMR metabolomics,X23424.Total Lipids in VLDL,ALMS1,Alstrom syndrome protein 1,37169,0.00130551444899244,0.00427663671955416,-0.00707669352133372,0.00968772241931861,0.760167868305252
NMR metabolomics,X23424.Total Lipids in VLDL,CNTNAP4,Contactin-associated protein-like 4,37039,0.00300006994494566,0.00987216001814738,-0.0163493636906232,0.0223495035805145,0.761215009533875
NMR metabolomics,X23424.Total Lipids in VLDL,ENG,Endoglin,40052,-0.000473763505268699,0.00161492878881766,-0.00363902393135132,0.00269149692081392,0.769246972067082
NMR metabolomics,X23424.Total Lipids in VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,0.00159853369654757,0.00545324550697217,-0.00908982749711788,0.012286894890213,0.769423242700918
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,39720,0.000919623598956569,0.00314891029931187,-0.0052522405876947,0.00709148778560784,0.770256015787094
NMR metabolomics,X23424.Total Lipids in VLDL,SLC1A4,Neutral amino acid transporter A,37039,-0.00142923391156011,0.00490005385622782,-0.0110333394697666,0.00817487164664641,0.770538046078294
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP3,Microfibril-associated glycoprotein 3,39585,0.00135683868939476,0.00467804250468645,-0.00781212461979068,0.0105258019985802,0.771786314384429
NMR metabolomics,X23424.Total Lipids in VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,0.00246781730214382,0.00869390934923924,-0.0145722450223651,0.0195078796266527,0.776525281141864
NMR metabolomics,X23424.Total Lipids in VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,-0.00130082490952552,0.00459982332423406,-0.0103164786250243,0.00771482880597325,0.777335466345215
NMR metabolomics,X23424.Total Lipids in VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,0.000943964094762451,0.0033592096623855,-0.00564008684351312,0.00752801503303803,0.778708833682902
NMR metabolomics,X23424.Total Lipids in VLDL,RBM25,RNA-binding protein 25,36962,-0.00122646442532307,0.00436793370508866,-0.00978761448729685,0.0073346856366507,0.778877256238655
NMR metabolomics,X23424.Total Lipids in VLDL,OPTC,Opticin,39788,-0.00116224938384137,0.00420436330959551,-0.00940280147064858,0.00707830270296583,0.782214602889132
NMR metabolomics,X23424.Total Lipids in VLDL,CDC25A,M-phase inducer phosphatase 1,36962,0.00110052166111636,0.00398554355030137,-0.00671114369747433,0.00891218701970705,0.782453823205686
NMR metabolomics,X23424.Total Lipids in VLDL,EVI2B,Protein EVI2B,36962,0.00107057003775931,0.00394367827503382,-0.00665903938130698,0.00880017945682559,0.786037806298883
NMR metabolomics,X23424.Total Lipids in VLDL,DKKL1,Dickkopf-like protein 1,39788,0.00216595754440735,0.00802137087385977,-0.0135559293683578,0.0178878444571725,0.787145777644792
NMR metabolomics,X23424.Total Lipids in VLDL,PRR5,Proline-rich protein 5,37056,0.00120282002560717,0.00454949269283916,-0.00771418565235759,0.0101198257035719,0.791486991166063
NMR metabolomics,X23424.Total Lipids in VLDL,CRX,Cone-rod homeobox protein,39585,0.00271103151831953,0.0103182877743599,-0.0175128125194258,0.0229348755560649,0.792754083285763
NMR metabolomics,X23424.Total Lipids in VLDL,PFDN6,Prefoldin subunit 6,37039,0.00165155479560238,0.00629960337866177,-0.0106956678265747,0.0139987774177795,0.793195974397439
NMR metabolomics,X23424.Total Lipids in VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,0.00122111471860229,0.00469291827564424,-0.00797700510166042,0.010419234538865,0.794710717671052
NMR metabolomics,X23424.Total Lipids in VLDL,CA11,Carbonic anhydrase-related protein 11,39477,0.000776603053518496,0.00299052410443095,-0.00508482419116616,0.00663803029820315,0.795107916834723
NMR metabolomics,X23424.Total Lipids in VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-0.00157828637248292,0.0061565016593409,-0.0136450296247911,0.0104884568798252,0.797676175110841
NMR metabolomics,X23424.Total Lipids in VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,0.000850925995005186,0.00332542071166798,-0.00566689859986405,0.00736875058987442,0.798042841238932
NMR metabolomics,X23424.Total Lipids in VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,-0.00101905729184487,0.0041368521330193,-0.00912728747256271,0.00708917288887296,0.805425560287956
NMR metabolomics,X23424.Total Lipids in VLDL,GFRA3,GDNF family receptor alpha-3,39709,0.000638462167265781,0.00263602584344373,-0.00452814848588393,0.0058050728204155,0.80862341783954
NMR metabolomics,X23424.Total Lipids in VLDL,GID8,Glucose-induced degradation protein 8 homolog,37411,0.000769765033501607,0.00319687163160602,-0.0054961033644462,0.00703563343144941,0.809723871728512
NMR metabolomics,X23424.Total Lipids in VLDL,MLLT1,Protein ENL,36962,-0.00161143314875015,0.00682617182966598,-0.0149907299348955,0.0117678636373952,0.813384456469883
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,37382,0.00119739515876748,0.00512743162573702,-0.00885237082767708,0.011247161145212,0.815355524035129
NMR metabolomics,X23424.Total Lipids in VLDL,RLN2,Prorelaxin H2,37095,0.00315307254982943,0.0135610155973345,-0.0234265180209462,0.029732663120605,0.816145469743854
NMR metabolomics,X23424.Total Lipids in VLDL,SCN3B,Sodium channel subunit beta-3,36991,0.000981147900844944,0.00424596864274675,-0.00734095063893869,0.00930324644062857,0.81725817980104
NMR metabolomics,X23424.Total Lipids in VLDL,CGN,Cingulin,37039,0.000833515236178374,0.0037100858876171,-0.00643825310355115,0.0081052835759079,0.822245728135166
NMR metabolomics,X23424.Total Lipids in VLDL,IL5,Interleukin-5,39587,0.00306222050088701,0.0137533055668652,-0.0238942584101687,0.0300186994119427,0.823808149255555
NMR metabolomics,X23424.Total Lipids in VLDL,DIPK1C,Divergent protein kinase domain 1C,37039,-0.000903643409013576,0.00408404949864064,-0.00890838042634922,0.00710109360832207,0.824892159903917
NMR metabolomics,X23424.Total Lipids in VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,0.00118101728985451,0.00535314101721128,-0.0093111391038796,0.0116731736835886,0.825390692408367
NMR metabolomics,X23424.Total Lipids in VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,-0.00068217584802078,0.00321273505814815,-0.00697913656199116,0.00561478486594959,0.83184905579827
NMR metabolomics,X23424.Total Lipids in VLDL,POF1B,Protein POF1B,37056,0.000913714917648453,0.00432348294561488,-0.00756031165575671,0.00938774149105362,0.832627034738687
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN7,Septin-7,37169,0.00103478501916516,0.00489995688321212,-0.00856913047193059,0.0106387005102609,0.832748119102981
NMR metabolomics,X23424.Total Lipids in VLDL,TP53BP1,TP53-binding protein 1,37056,0.00175568273629594,0.00840599526278189,-0.0147200679787566,0.0182314334513484,0.834560144823636
NMR metabolomics,X23424.Total Lipids in VLDL,SLC51B,Organic solute transporter subunit beta,37021,0.00150804968597374,0.00724434161429341,-0.0126908598780413,0.0157069592499888,0.835099982148556
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,-0.000773234356968176,0.00371649729312435,-0.0080575690514919,0.00651110033755554,0.835189529876195
NMR metabolomics,X23424.Total Lipids in VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,-0.000472842193211609,0.00228043044067165,-0.00494248585692804,0.00399680147050483,0.835741376126632
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,0.00156916333417676,0.00757842997935467,-0.0132845594253584,0.0164228860937119,0.835968416133167
NMR metabolomics,X23424.Total Lipids in VLDL,SEZ6,Seizure protein 6 homolog,37039,-0.000612828445792756,0.00296785968009469,-0.00642983341877836,0.00520417652719284,0.836412654498238
NMR metabolomics,X23424.Total Lipids in VLDL,HMMR,Hyaluronan mediated motility receptor,36942,-0.000927682115494339,0.00454237854001225,-0.00983074405391834,0.00797537982292966,0.838178296761542
NMR metabolomics,X23424.Total Lipids in VLDL,CAPN3,Calpain-3,37368,0.000726424788613609,0.00359509613709564,-0.00631996364009385,0.00777281321732107,0.839872934284851
NMR metabolomics,X23424.Total Lipids in VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,37021,-0.000961060974173545,0.00485519450159778,-0.0104772421973052,0.00855512024895811,0.843091233726425
NMR metabolomics,X23424.Total Lipids in VLDL,HK2,Hexokinase-2,39585,-0.000511112823991358,0.00260748739042266,-0.00562178810921978,0.00459956246123706,0.844599102269215
NMR metabolomics,X23424.Total Lipids in VLDL,GSTM4,Glutathione S-transferase Mu 4,37021,0.00129880496363,0.00684468968409521,-0.0121167868171966,0.0147143967444566,0.849505091229791
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB2,Integrin beta-2,39731,-0.000510789397298046,0.00274011298232519,-0.00588141084265541,0.00485983204805932,0.852124220902235
NMR metabolomics,X23424.Total Lipids in VLDL,PFDN4,Prefoldin subunit 4,36962,0.000953657482388836,0.00520373245802476,-0.00924565813533968,0.0111529731001174,0.854593616488633
NMR metabolomics,X23424.Total Lipids in VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,-0.000709293078407097,0.00390045188596542,-0.00835417877489932,0.00693559261808513,0.855704065433388
NMR metabolomics,X23424.Total Lipids in VLDL,KIRREL1,Kin of IRRE-like protein 1,36991,0.00104265177357295,0.0057496926339245,-0.0102267457889191,0.012312049336065,0.856103167058323
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP30,Rho GTPase-activating protein 30,37169,-0.000650660011064572,0.00375597426171206,-0.0080123695640202,0.00671104954189106,0.862470643331982
NMR metabolomics,X23424.Total Lipids in VLDL,OMP,Olfactory marker protein,36991,0.000802341217509066,0.00464058303328515,-0.00829320152772983,0.00989788396274797,0.862735337000258
NMR metabolomics,X23424.Total Lipids in VLDL,PYDC1,Pyrin domain-containing protein 1,37043,-0.000666621212282199,0.00394395317024592,-0.0083967694259642,0.00706352700139981,0.86578066175334
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,0.000424179428429412,0.00256916294510686,-0.00461137994398004,0.00545973880083887,0.868864078671993
NMR metabolomics,X23424.Total Lipids in VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,0.00180075462723826,0.0110429160864084,-0.0198433609021222,0.0234448701565987,0.870466728481459
NMR metabolomics,X23424.Total Lipids in VLDL,DUOX2,Dual oxidase 2,39585,0.00107559858738765,0.00679961511722985,-0.0122516470423829,0.0144028442171582,0.874312884041312
NMR metabolomics,X23424.Total Lipids in VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,-0.0007578173069404,0.00483849427692803,-0.0102412660897193,0.00872563147583853,0.875544712080567
NMR metabolomics,X23424.Total Lipids in VLDL,ANK2,Ankyrin-2,37021,-0.0010580987584724,0.006788533313072,-0.0143636240520935,0.0122474265351487,0.87614135847458
NMR metabolomics,X23424.Total Lipids in VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,-0.000484843742053779,0.00329539907059868,-0.00694382592042718,0.00597413843631962,0.883033252126193
NMR metabolomics,X23424.Total Lipids in VLDL,EPB41L5,Band 4.1-like protein 5,37039,0.000895099765814108,0.00613044763380124,-0.0111205775964363,0.0129107771280645,0.883916614901167
NMR metabolomics,X23424.Total Lipids in VLDL,UPK3A,Uroplakin-3a,36991,0.000640640574702866,0.00455634056370078,-0.00828978693015065,0.00957106807955639,0.888184794596744
NMR metabolomics,X23424.Total Lipids in VLDL,DPEP2,Dipeptidase 2,39788,0.000389059041652753,0.00277167994506739,-0.00504343365067932,0.00582155173398483,0.888369911284033
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA2013,Uncharacterized protein KIAA2013,37368,0.000675543095529498,0.00547341520521383,-0.0100523507066896,0.0114034368977486,0.901774303737509
NMR metabolomics,X23424.Total Lipids in VLDL,RBP1,Retinol-binding protein 1,37039,0.000789379690328917,0.0067046182238905,-0.0123516720284965,0.0139304314091543,0.906278073034836
NMR metabolomics,X23424.Total Lipids in VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,37039,0.000398496661845281,0.0034177984780785,-0.00630038835518859,0.00709738167887915,0.907183136490264
NMR metabolomics,X23424.Total Lipids in VLDL,REG1B,Lithostathine-1-beta,40052,0.000580546399127118,0.00517889652736205,-0.0095700907945025,0.0107311835927567,0.910746716695558
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,-0.000384098987793826,0.00344195894569055,-0.00713033852134731,0.00636214054575966,0.911147668615845
NMR metabolomics,X23424.Total Lipids in VLDL,IKZF2,Zinc finger protein Helios,39477,0.000942911261499332,0.00896435525666055,-0.0166272250415554,0.018513047564554,0.916230757360909
NMR metabolomics,X23424.Total Lipids in VLDL,TFAP2A,Transcription factor AP-2-alpha,36991,-0.000589818338778922,0.00566015611516593,-0.0116837243245041,0.0105040876469463,0.917008009359154
NMR metabolomics,X23424.Total Lipids in VLDL,DLL1,Delta-like protein 1,39913,0.000274838161991838,0.00270886919055287,-0.00503454545149179,0.00558422177547547,0.919187662166118
NMR metabolomics,X23424.Total Lipids in VLDL,PSMA1,Proteasome subunit alpha type-1,39477,-0.000412338746721198,0.00443029114107392,-0.00909570938322608,0.00827103188978369,0.925847073212771
NMR metabolomics,X23424.Total Lipids in VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,39949,-0.000178092302496214,0.00192556981092472,-0.00395220913190867,0.00359602452691624,0.926311393226852
NMR metabolomics,X23424.Total Lipids in VLDL,KHDC3L,KH domain-containing protein 3,36962,0.000583366301214462,0.00635829413963723,-0.0118788902124745,0.0130456228149034,0.926898971270395
NMR metabolomics,X23424.Total Lipids in VLDL,CA3,Carbonic anhydrase 3,40017,0.000524168706074844,0.00574326211107633,-0.0107326250316348,0.0117809624437844,0.927281791067864
NMR metabolomics,X23424.Total Lipids in VLDL,NCLN,Nicalin,39587,0.000457149822919226,0.00502454118380638,-0.00939095089734127,0.0103052505431797,0.927506942691785
NMR metabolomics,X23424.Total Lipids in VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,0.000645980218682674,0.00743862197753566,-0.0139337188572872,0.0152256792946526,0.930798912441583
NMR metabolomics,X23424.Total Lipids in VLDL,IL3,Interleukin-3,36962,-0.000495189435398581,0.00570240571480858,-0.0116719046364234,0.0106815257656262,0.93080106155122
NMR metabolomics,X23424.Total Lipids in VLDL,EVPL,Envoplakin,37169,-0.000256853431207974,0.00314298751740302,-0.00641710896531789,0.00590340210290195,0.934868454317048
NMR metabolomics,X23424.Total Lipids in VLDL,DCDC2C,Doublecortin domain-containing protein 2C,36962,-0.000495243439232185,0.00607018578780508,-0.0123928075833301,0.0114023207048658,0.934977015496892
NMR metabolomics,X23424.Total Lipids in VLDL,ARG2,"Arginase-2, mitochondrial",37368,0.000327325021600133,0.00418847580579046,-0.00788208755774918,0.00853673760094944,0.937710720568648
NMR metabolomics,X23424.Total Lipids in VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,-0.000577037501900554,0.00778704975619342,-0.0158396550240396,0.0146855800202385,0.940930197661003
NMR metabolomics,X23424.Total Lipids in VLDL,ZP4,Zona pellucida sperm-binding protein 4,36962,0.000226292660300923,0.00307868135762272,-0.0058079228006396,0.00626050812124145,0.941406889892524
NMR metabolomics,X23424.Total Lipids in VLDL,C9orf40,Uncharacterized protein C9orf40,37382,0.000532012346981968,0.00757581425715268,-0.0143165835970373,0.0153806082910012,0.944015531708945
NMR metabolomics,X23424.Total Lipids in VLDL,YY1,Transcriptional repressor protein YY1,37056,0.000174472308002887,0.00265327570210761,-0.00502594806812803,0.0053748926841338,0.947572029896588
NMR metabolomics,X23424.Total Lipids in VLDL,FGF20,Fibroblast growth factor 20,37056,-0.000259362096960029,0.00410661156585319,-0.00830832076603228,0.00778959657211222,0.94964228098956
NMR metabolomics,X23424.Total Lipids in VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,0.000251700679864105,0.00399464466804091,-0.00757780286949607,0.00808120422922428,0.949759871756071
NMR metabolomics,X23424.Total Lipids in VLDL,CDH4,Cadherin-4,36991,-0.000281209175540072,0.00446779497362154,-0.00903808732383829,0.00847566897275814,0.949814142695628
NMR metabolomics,X23424.Total Lipids in VLDL,IL10,Interleukin-10,39587,0.000385859822136053,0.00754551854203633,-0.0144033565202552,0.0151750761645273,0.95921651219653
NMR metabolomics,X23424.Total Lipids in VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,-0.000190860094755792,0.00396273015414671,-0.00795781119688335,0.00757609100737177,0.961586432418036
NMR metabolomics,X23424.Total Lipids in VLDL,CD99,CD99 antigen,39858,8.58317773587646e-05,0.00182493907037068,-0.00349104880056777,0.0036627123552853,0.962487767644633
NMR metabolomics,X23424.Total Lipids in VLDL,IFNW1,Interferon omega-1,37021,0.000148340234004017,0.00338435993446824,-0.00648500523755373,0.00678168570556176,0.965039698029866
NMR metabolomics,X23424.Total Lipids in VLDL,GAD2,Glutamate decarboxylase 2,37056,-0.000194222501693394,0.00445171650366306,-0.00891958684887299,0.0085311418454862,0.965201052581885
NMR metabolomics,X23424.Total Lipids in VLDL,PMCH,Pro-MCH,37021,0.000267871975502694,0.00792061943489835,-0.0152565421168981,0.0157922860679034,0.973021539903421
NMR metabolomics,X23424.Total Lipids in VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,8.49757140531861e-05,0.00255221473600513,-0.00491736516851686,0.00508731659662323,0.97343984432084
NMR metabolomics,X23424.Total Lipids in VLDL,BTNL10,Butyrophilin-like protein 10,36962,-0.000120794348956783,0.0037755897834368,-0.00752095032449292,0.00727936162657935,0.974477718185773
NMR metabolomics,X23424.Total Lipids in VLDL,PSMG4,Proteasome assembly chaperone 4,37056,0.000136321761294791,0.00529801478483914,-0.0102477872169899,0.0105204307395795,0.979472506057701
NMR metabolomics,X23424.Total Lipids in VLDL,KLK1,Kallikrein-1,39720,-0.000289540754112121,0.0119764958586959,-0.023763472637156,0.0231843911289318,0.980712726359249
NMR metabolomics,X23424.Total Lipids in VLDL,HDDC2,5'-deoxynucleotidase HDDC2,37382,-9.78092267119575e-05,0.00413040853748768,-0.00819340996018781,0.0079977915067639,0.981107986059091
NMR metabolomics,X23424.Total Lipids in VLDL,GJA8,Gap junction alpha-8 protein,36962,0.000128150105116276,0.00571301402786993,-0.0110693573895088,0.0113256575997413,0.982104286044066
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAX,Integrin alpha-X,37169,0.000110582814332913,0.00504824418576684,-0.0097839757897701,0.0100051414184359,0.982523902659449
NMR metabolomics,X23424.Total Lipids in VLDL,KLK3,Prostate-specific antigen,37437,-0.000162613247862279,0.00751676179139475,-0.014895466358996,0.0145702398632714,0.98274069417133
NMR metabolomics,X23424.Total Lipids in VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,37056,7.89895733459011e-05,0.003959719225219,-0.00768206010808334,0.00784003925477515,0.984084935437559
NMR metabolomics,X23424.Total Lipids in VLDL,RGS8,Regulator of G-protein signaling 8,39587,-0.000122590783472966,0.00627027578654401,-0.0124123313250992,0.0121671497581533,0.984401721627376
NMR metabolomics,X23424.Total Lipids in VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,-0.000115476541564728,0.00711482189014712,-0.0140605274462531,0.0138295743631236,0.987050775004091
NMR metabolomics,X23424.Total Lipids in VLDL,ANKRA2,Ankyrin repeat family A protein 2,36962,-8.04281159991689e-05,0.00519875288763903,-0.0102699837757717,0.0101091275437733,0.987656930608154
NMR metabolomics,X23424.Total Lipids in VLDL,CD2,T-cell surface antigen CD2,37021,-4.41110838256486e-05,0.00366811804280854,-0.00723362244773038,0.00714540028007908,0.990405424400008
NMR metabolomics,X23424.Total Lipids in VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,4.941744349595e-05,0.00562591641191828,-0.0109773787238639,0.0110762136108558,0.9929916912599
NMR metabolomics,X23424.Total Lipids in VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,-1.67764365383891e-05,0.00471556234612573,-0.00925927863494482,0.00922572576186804,0.997161436989284
